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The protozoan parasite Neospora caninum is among the most frequently diagnosed 
infectious causes of bovine abortion thus causing significant economic losses, 
production inefficiency and welfare concern to the cattle sector worldwide. The 
control of bovine neosporosis relies on management techniques within which the 
identification of infected animals by serological testing plays a key role. However, the 
reliable diagnosis of the disease is hindered by the complex host-parasite interactions 
and the intrinsic limitations of the serological diagnostic tools currently available; as 
a result, some infected animals may not be detected. At the herd, regional and national 
levels, this can potentially undermine efforts for the control of the disease. 
The work presented in this thesis was undertaken to further investigate avenues to 
improve the diagnosis of N. caninum infection in cattle. 
It has been shown previously that recombinant antigens expressed by the rapidly 
proliferating tachyzoite stage and the slowly multiplying bradyzoite stage of N. 
caninum can be successfully employed for the detection of specific antibody responses 
during acute and persistent infections respectively. Following the establishment of 
persistent infections, sustained by the bradyzoite stage, the antibody levels against the 
tachyzoite stage may decline below the detection limits of currently available 
diagnostic tests which are exclusively based on antigens expressed by the tachyzoite. 
Consequently, the use of bradyzoite antigens for the development of serological 
diagnostic tests, may enhance the identification of infected animals. 
Novel antigens putatively expressed by the quiescent bradyzoite stage of N. caninum 
have been identified, expressed as recombinant proteins and assayed for the detection 
of specific antibodies. The recognition of recombinant tNcSRS12A-B and tNcSRS44-
A by specific antibodies in sera from persistently N. caninum-infected cattle suggested 
that these proteins could be used for the detection of persistently infected animals. 
Indirect ELISAs based on previously characterised N. caninum antigens, such as the 
tachyzoite surface protein rNcSRS2, the immunodominant dense granule protein 
rNcGRA7 and the bradyzoite specific surface antigens rNcSAG4, rNcBSR4 and 
rNcSRS9, as well as a commercial test using whole tachyzoite lysate as antigenic 




seroprevalence of bovine neosporosis in British dairy cattle. Moderate, but not high, 
agreement was found amongst the tests based on whole tachyzoite lysate, rNcSRS2 
and rNcGRA7, and amongst the bradyzoite-specific antigen-based iELISAs. In 
contrast, only slight agreement was observed when each test detecting antibody 
responses indicative of acute infection (whole tachyzoite lysate, rNcSRS2 and 
rNcGRA7) was compared with each test detecting antibody responses indicative of 
persistent infection (bradyzoite-specific antigen-based iELISAs). Most N. caninum 
antibody-positive cattle samples showed detectable antibodies only against either 
antigens predominantly expressed by the tachyzoite or bradyzoite antigens thus 
suggesting that the exclusive use of one type of test may result in the misclassification 
of a proportion of animals, which test negative despite harbouring the parasite. This 
may result in the underestimation of the seroprevalence. Consequently, the 
combination of multiple tests in parallel, both tachyzoite and bradyzoite antigen-based, 
would improve the diagnosis of bovine neosporosis. 
Molecular tools for the genetic discrimination of different N. caninum isolates were 
also investigated. A novel multilocus fragment typing (MLFT) tool based on twelve 
highly polymorphic microsatellite markers was developed and applied to the analysis 
of DNA samples obtained from laboratory-maintained N. caninum isolates and tissues 
collected from bovine foetuses aborted due to N. caninum. The locus-specific nested 
PCRs associated with automated fragment analysis by capillary electrophoresis 
enabled to evaluate the markers in terms of typeability and discriminatory power. 
Overall, the typing tool was characterised by good typeability and discriminatory 
power and enabled to provide information on the genetic diversity amongst the 
laboratory-maintained and clinical N. caninum isolates studied. The MLFT tool may 
help to investigate the likely source of infection within abortion outbreaks and aid the 
study of the association between the genetic heterogeneity of N. caninum and the 
diverse biological features in vitro and in vivo. Furthermore, the loci characterised by 
the highest discriminatory power and typeability may be used alongside already 
established microsatellite markers for the development of an improved typing tool 
which could be proposed at the inter-laboratory level. 
Finally, current perceptions and common veterinary practice related to the diagnosis 




cattle practitioners in the United Kingdom. The survey highlighted the awareness of 
the limitations of current serological techniques and the demand for additional tools in 
terms of diagnostics and vaccines to tackle the economic losses and animal welfare 


































































Neospora caninum is a microscopic protozoan parasite which causes abortion in cattle 
determining significant economic losses, production inefficiency and animal welfare 
concern. Since there are no vaccines or treatments, the impact of bovine neosporosis 
(the disease caused by N. caninum) can only be reduced by removing infected animals 
from the herd or excluding them from breeding replacement stock. Indeed, the parasite 
can be transmitted during pregnancy from dam to foetus through the placenta. 
In live animals, the infection with N. caninum is diagnosed by detecting specific 
antibodies in serum, plasma or milk. However, some animals may test negative with 
the antibody assays available despite being infected with the parasite. 
A questionnaire-based survey for UK large animal veterinary practitioners highlighted 
the awareness of the limitations of current serological techniques and the demand for 
improved diagnostic tests and a vaccine to tackle bovine neosporosis. 
The work presented in this thesis was undertaken to investigate avenues to improve 
the identification of N. caninum-infected cows. There are two life cycle stages of N. 
caninum: the slowly proliferating bradyzoite stage which establishes persistent 
infections and the rapidly multiplying tachyzoite stage found during acute infections. 
Novel antigens displayed by the bradyzoite were identified, produced using bacterial 
systems and used for the identification of cows which tested antibody negative with 
tests based on tachyzoite antigens. Most commercially available diagnostic tests use 
exclusively tachyzoite antigens. 
Within a study to assess the prevalence of N. caninum antibodies in British dairy cattle, 
six tests using previously described tachyzoite and bradyzoite antigens were assessed 
and compared. Since most test-positive cows showed detectable antibodies only 
against either tachyzoite or bradyzoite antigens, a combination of assays using 
antigens of both life cycle stages of N. caninum should be considered to improve the 
diagnosis of neosporosis. 
Due to the genetic variation of N. caninum, different strains of the parasite can be 
identified in a herd. A molecular technique which enables the discrimination of 
different strains of the parasite was developed. Characterised by high discriminatory 
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Chapter 1: General introduction 
 
 
1.1 Neospora caninum 
 
Neospora caninum (Apicomplexa: Coccidia) is an obligate intracellular tissue-cyst 
forming eukaryotic parasite belonging to the phylum Apicomplexa (Dubey and 
Schares 2011, Dubey et al., 2007). Over six thousand species of parasitic protozoans 
which have, as a defining feature, a characteristically polarised cell structure with an 
apical complex (Adl et al., 2007) are included within the Apicomplexa. The apical 
complex is a cytoskeletal arrangement composed of a set of structural and secretory 
elements that are instrumental in the host cell attachment and invasion processes 
(Gubbels and Duraisingh 2012, Kemp et al., 2013). 
The phylum encompasses major veterinary pathogens such as Eimeria spp., an 
economically significant pathogen in the modern poultry industry (Quiroz-Castaneda 
and Dantan-Gonzalez 2015), Toxoplasma gondii, Cryptosporidium spp., Theileria 
spp., Babesia spp., Beisnoitia spp. and Sarcocystis spp., all of which cause clinical 
disease and economic losses in a variety of livestock hosts. Several apicomplexans are 
also important zoonotic pathogens. T. gondii, a primary abortifacient in sheep, is a 
leading opportunistic parasite associated with congenital and neurological birth 
defects in humans (Weiss and Dubey 2009). Certain species of the genus 
Cryptosporidium can cause neonatal enteritis in many animal species and can cause 
waterborne illness in people (Efstratiou et al., 2017). 
Initially reported in Norway in 1984, as an unidentified protozoan parasite causing 
severe encephalomyelitis and myositis in domestic dog puppies (Bjerkas et al., 1984), 
N. caninum was formally recognised and named in 1988 after the retrospective 
examination of dog tissues (Dubey et al., 1988a) and the in vitro isolation of the 
parasite (Dubey et al., 1988b). 
The recognition of N. caninum was initially controversial due to the close resemblance 
to Hammondia heydorni: a coccidian parasite sporadically found in dog faeces that has 
limited clinical significance. It was argued that the two species referred to the same 




molecular differences between the two organisms confirmed the validity of the genus 
Neospora (Dubey et al., 2002b, McAllister 2000) which also includes Neospora 
hughesi (Marsh et al., 1998). Despite being ultrastructurally very similar to N. 
caninum, N. hughesi shows distinct differences in the sequence of the internal 
transcribed spacer 1 (ITS1) region of the genome (Marsh et al., 1998) and within the 
amino acid sequences of two immunodominant surface antigens (Marsh et al., 1999). 
N. hughesi is associated with myeloencephalitis in horses (Howe et al., 2014). 
Early reports of N. caninum showed striking morphological and developmental 
analogies with T. gondii. This may have resulted in N. caninum infections being 
frequently misdiagnosed as T. gondii prior its formal recognition (Bjerkas and Dubey 
1991). In subsequent years, key differences between the two parasites regarding their 
natural host range, pathogenesis, virulence factors and antigenicity were observed 
(Dubey et al., 2002a, Dubey and Lindsay 1996). More recently, divergences between 
the two closely related apicomplexans, which are estimated to have diverged from a 
common ancestor around 28 million years ago, were described by extensive 
comparative genomic and transcriptomic analyses (Reid et al., 2012). 
Only a few years after clinical disease was described in dogs, cases of congenital 
protozoan infections causing encephalomyelitis were reported in calves (O'Toole and 
Jeffrey 1987, Parish et al., 1987). Later, N. caninum was associated for the first time 
with an abortion outbreak in a dairy farm in the USA (Thilsted and Dubey 1989). The 
isolation of the parasite from aborted bovine foetuses (Conrad et al., 1993a) and the 
experimental reproduction of foetal infection that resulted in foetal death (Barr et al., 
1994) confirmed the pathogenic nature of N. caninum in cattle. 
N. caninum quickly emerged as one of the most frequently diagnosed infectious causes 
of bovine abortion (Obendorf et al., 1995). Currently bovine neosporosis (i.e. the 
disease caused by N. caninum in cattle) is thought to have a global distribution and is 
considered a primary bovine reproductive problem (Goodswen et al., 2013), 
responsible for significant economic losses and production inefficiency to the cattle 
sector worldwide (Larson et al., 2004, Reichel et al., 2013). A comprehensive review 
of the published data estimated the global economic impact of bovine neosporosis to 






1.2 Life cycle, host spectrum and infectious stages 
 
1.2.1 Heteroxenous life cycle: definitive and intermediate hosts 
 
N. caninum is characterised by a facultative heteroxenous life cycle involving a 
definitive host, in which the sexually mature stage of the parasite occurs, and an 
intermediate host in which the parasite undergoes some developmental changes and 
multiplies (Figure 1.1). 
The definitive host range of N. caninum is restricted (Dubey et al., 2017). Dogs (Canis 
lupus familiaris) (McAllister et al., 1998) and related canids such as coyote (Canis 
latrans) (Gondim et al., 2004c), dingo (Canis lupus dingo) (King et al., 2010), and 
wolf (Canis lupus) (Dubey et al., 2011) act as definitive hosts. Despite the detection 
of specific antibody responses, parasite DNA or both in other wild canids, such as red 
foxes (Vulpes vulpes) (Bartley et al., 2013b, Stuart et al., 2013), South American grey 
foxes (Dusicyon griseus) (Martino et al., 2004) and two genera of canids native to 
South America (Lycalopex gymnocercus and Cerdocyon thous) (Canon-Franco et al., 
2004, Gondim et al., 2004b), none of these species has been confirmed as a definitive 
host for N. caninum to date. 
In red foxes, experimental infection through feeding N. caninum-infected tissues did 
not result in shedding of parasite oocysts (Schares et al., 2002b) and no experimental 
data were produced for the other canid species suspected to act as definitive hosts 
(Donahoe et al., 2015, Rosypal and Lindsay 2005). 
Cattle (Bos taurus) and a wide range of animal species, both domestic (reviewed in 
Dubey and Schares 2011) and wild (reviewed in Donahoe et al., 2015) can act as 
intermediate hosts. In contrast to the current view that N. caninum has a more restricted 
intermediate host spectrum compared to T. gondii, which infects almost any warm-
blooded vertebrates, there is increasing evidence that the host range may potentially 
include most warm-blooded animals. 
In addition to cattle, proven intermediate hosts, from which viable N. caninum was 
successfully isolated, include: sheep (Ovis aries) (Dubey et al., 1990), water-buffalo 
(Bubalus bubalis) (Reichel et al., 2015), European wood buffalo (Bison bonasus) 




and axis deer (Axis axis) (Basso et al., 2014). In goats (Capra hircus) (Dubey et al., 
1992a), alpacas (Vicugna pacos), llamas (Lama glama) (Serrano-Martinez et al., 
2007a) and several other species viable parasites were not isolated, although clinical 
neosporosis was confirmed. The detection of N. caninum DNA has been reported in 
tissues of a multitude of animals including rodent and avian species (Dubey et al., 
2017). 
Dogs and cattle maintain the domestic life cycle of N. caninum which is of primary 
clinical and economic interest and has been extensively investigated. However, a 
sylvatic life cycle maintained by wild canids and wild ruminants is also possible 
(Almeria 2013, Rosypal and Lindsay 2005). In areas in which domestic and wild hosts 
coexist, it is likely that the two cycles overlap; nevertheless, the significance of wildlife 
as a reservoir of N. caninum has not been clarified to date (Almeria 2013). 
In contrast to T. gondii, one the most common parasitic zoonoses worldwide (Tenter 
et al., 2000), there is no definitive evidence that N. caninum can infect or cause disease 
in humans (Barratt et al., 2010). A serological survey showed no evidence of human 
exposure to N. caninum in the general population and a cohort of farm workers in 
England (McCann et al., 2008) suggesting that neosporosis in healthy humans is 
unlikely. Nevertheless, the detection of anti-N. caninum antibodies in human sera was 
reported by other studies (Ibrahim et al., 2009, Lobato et al., 2006, Tranas et al., 1999). 
One of these described a significantly higher N. caninum seroprevalence amongst 
people infected with human immunodeficiency virus (HIV) or diagnosed with 
neurological disease compared to healthy individuals (Lobato et al., 2006). 
Consequently, the potential role of N. caninum as an opportunistic organism in 
immunocompromised patients and a possible link to neurological illnesses has been 






Figure 1.1 – Heteroxenous life cycle of N. caninum (adapted from Guido et al., 2016). (A) 
Horizontal infection through the ingestion of food or water contaminated with oocysts. (B) 
Vertical transmission from dam to foetus. (C) Differentiation of the rapidly multiplying 
tachyzoite stage into the quiescent bradyzoite stage. (D) Reactivation of the parasite during 
pregnancy and reconversion of bradyzoites into tachyzoites. (E) Abortion resulting from the 
recrudescence of persistent infection with vertical transmission of the parasite. (F) Ingestion 
of bradyzoite-containing tissue cysts through the consumption of contaminated intermediate 
host’s tissues by a definitive carnivore host. 
 
1.2.2 Infectious stages 
 
N. caninum exhibits three, morphologically distinct, known infectious stages: (1) the 
sporozoites-containing oocyst, (2) the rapidly multiplying tachyzoite and (3) the 
slowly multiplying bradyzoite which develops within tissue cysts (Dubey et al., 2002a) 
(Figure 1.2). 
 
1.2.2.1 Oocysts containing sporozoites 
Sexual reproduction of N. caninum takes place in the canid host resulting in the 
production of oocysts that are excreted in the faeces (McAllister et al., 1998), usually 
in low numbers (Dubey et al., 2017). Oocysts are shed in a non-sporulated form. 
Sporulation occurs in the environment within 24 hours to produce sporulated oocysts 





Oocysts measure approximately 1012 m in diameter and are characterised by a 
robust 0.6-0.8 m-thick wall which would confer resistance to drying and freezing 
allowing prolonged persistence in the environment and survival of the sporozoites for 
extended periods of time (Dubey et al., 2007, Uzeda et al., 2007). Once the oocysts 
are ingested by the host, often via contaminated feed or water, excystation takes place 
and sporozoites are released in the small intestine. By analogy with T. gondii infection 
in the cat, it is assumed that sporozoites invade the intestinal epithelium where they 
develop into tachyzoites (Dubey et al., 2004). 
 
1.2.2.2 Tachyzoites 
Tachyzoites are lunate-shaped with a central nucleus and measure approximately 26-
7.5 m (Dubey et al., 2002a) (Figure 1.2). Growth and multiplication of tachyzoites is 
rapid and occurs asexually within host cells by endodyogeny: a process in which two 
daughter cells surrounded by their own membrane are assembled within the mother 
cell (Conrad et al., 1993a). The tachyzoites can invade a wide range of nucleated cell 
types (Hemphill et al., 2006) and disseminate throughout the body via the blood and 
lymphatic systems (Dubey and Schares 2006). Differences in the rate of invasion and 
growth, depending on the host cell type and strain of N. caninum have been reported 
(Regidor-Cerrillo et al., 2011). After a phase of rapid proliferation, which was 
estimated to consist of approximately 20 divisions (occurring within a timeframe of 
approximately 3 weeks) (Goodswen et al., 2013) the tachyzoites differentiate into the 
bradyzoite stage which also multiplies by endodyogeny but at a much slower pace 
(Dubey and Lindsay 1996). 
 
1.2.2.3 Bradyzoites and tissue cysts 
Bradyzoites are slender, variable in size (6.51.5 m on average) with a terminally 
located nucleus (Dubey et al., 2004). Unlike tachyzoites, they contain a higher number 
of amylopectin granules (Speer et al., 1999) which stain red with the periodic acid 
Schiff (PAS) reaction. Amylopectin is a storage form of glucose which represents an 
endogenous energy source for long-term survival. Encapsulated within intracellular 
thick-walled (0.5-4.0 m) cysts (Figure 1.2), that are microscopically distinguishable 




within an infected host for several months or years and are thought to be able to survive 
for the entire life of the host (Dubey and Lindsay 2006) without causing significant 
clinical manifestations. However, it is unclear whether the same tissue cysts can 
survive for the whole life of the host or whether the long-term persistence of the 
parasite is due to the succession of cycles of reactivation into the tachyzoite stage 
followed by differentiation into the bradyzoite stage and quiescence (Dubey et al., 
2017). 
Depending on the host and cell type parasitised, tissue cysts may contain a variable 
number of bradyzoites and be different sizes depending on their maturity (Dubey 
2003). 
Unlike tachyzoites which can develop in many different tissues, N. caninum 
bradyzoite-containing tissue cysts are generally observed in the cells of the central 
nervous system (CNS) (i.e. brain and spinal cord) and skeletal muscles (Peters et al., 
2001). 
Since N. caninum tissue cysts are rarely found in naturally infected animals, the 
information available on this stage of the parasite is limited to experimental animal 
models. Mice (McGuire et al., 1997a, McGuire et al., 1997b) and gerbils (Gondim et 
al., 2001) develop relatively few tissues cysts whereas, experimentally infected fat-
tailed dunnarts (Sminthopsis crassicaudata) were shown to produce higher numbers 
(King et al., 2011) thus representing a promising model for the study of tissue cyst 
development. 
The biological mechanisms which trigger the differentiation from tachyzoite to 
bradyzoite and the genesis of N. caninum tissue cysts have not been fully elucidated 
to date. However, complex interactions between the parasite and the host immune 
responses are assumed to play a major role in the stage conversion processes (Dubey 
and Lindsay 1996, Vonlaufen et al., 2002). Furthermore, in vitro models of stage 
conversion based on the alteration of culture conditions such as pH and temperature 
(Weiss et al., 1999) or the exposure to chemicals such as nitric oxide (NO) and the NO 
donor sodium nitroprusside (Vonlaufen et al., 2004, Vonlaufen et al., 2002), 
highlighted the effect of physicochemical stress in the initiation of the tachyzoite-to-




Bradyzoites are orally infective; the N. caninum life cycle is completed when tissue 
cysts are ingested by definitive carnivore hosts and bradyzoites are released in the 
small intestine (Dubey et al., 2004). Currently unknown gametogonic stages of N. 
caninum are presumed to precede oocysts formation in the gut of the definitive canine 
host. Although schizont- and gamont-like stages of N. caninum were observed in small 
intestine histological sections from a dog pup (Kul et al., 2015), Dubey and colleagues 
(2017) have disputed the weak evidence to support that these were N. caninum and 
confirmed that the oocyst is the only sexual stage of the parasite unambiguously 





Figure 1.2 – Infectious stages of N. caninum (reproduced from Speer et al., 1999 and 
McAllister et al., 1998). Ultrastructure of (A) tachyzoite, (B) bradyzoite, (C) tissue cyst, (D) 
unsporulated oocyst and (E) sporulated oocyst with two sporocysts (arrow) and two 









1.3 Transmission of infection 
 
N. caninum can be transmitted via either the horizontal or the vertical route (Figure 
1.1). Horizontal transmission occurs by the ingestion of tissue cysts containing N. 
caninum bradyzoites, which is relevant for the carnivore definitive host (Dijkstra et 
al., 2001b), or by the ingestion of food or water contaminated with sporulated oocysts 
(Dubey et al., 2007). The uptake of sporulated oocysts is the only demonstrated mode 
of infection after birth in cattle and herbivores in general (McCann et al., 2007). There 
are no reports of cow to cow transmission of N. caninum to date (Dubey et al., 2017). 
Vertical transmission occurs when tachyzoites from an infected dam cross the placenta 
and spread to the foetus. Two distinct pathways of vertical transmission, designated 
exogenous and endogenous transplacental transmission, are possible (Trees and 
Williams, 2005). Exogenous transplacental transmission occurs when a dam acquires 
a primary infection following ingestion of N. caninum oocysts during pregnancy. 
Endogenous transplacental transmission is due to the recrudescence of the parasite in 
a persistently infected dam following the reactivation of bradyzoites into tachyzoites 
which leads to foetal infection (Williams et al., 2009). 
N. caninum is considered as one of the most efficiently transplacentally transmitted 
organisms. A mother to foetus transmission probability of up to 94.8% was observed 
in naturally infected cows with high antibody titres (More et al., 2009). 
Vertical transmission may lead to abortion; however, in most cases, results in the birth 
of healthy but congenitally infected calves. These congenitally infected calves are 
persistently infected and may transmit the parasite to their offspring in consecutive 
pregnancies, contributing significantly to the maintenance and spread of the infection 
within the herd (Piergili Fioretti et al., 2003). 
Although congenital transmission is considered the major route of infection in cattle, 
mathematical modelling studies have indicated that it would not be sufficient to sustain 
the infection within a herd. Therefore, postnatal transmission appears to be required 
for the disease to become and persist as endemic in a population (French et al., 1999) 
Although possible, venereal transmission through contaminated semen is considered 




Serrano-Martinez et al., 2007b); however, very high doses of tachyzoites were 
required for the intra-vaginal infection of cows (Serrano-Martinez et al., 2007c). 
Despite the detection of N. caninum DNA in milk and colostrum of infected cows 
(Moskwa et al., 2007) and the infection of neonatal calves by feeding milk 
experimentally contaminated with N. caninum tachyzoites (Uggla et al., 1998), there 
is no evidence that lactogenic transmission can occur in field conditions (Davison et 
al., 2001, Dijkstra et al., 2001b). 
 
 
1.4 Molecular and cell biology 
 
1.4.1 N. caninum genome and transcriptome 
 
The whole nuclear genome sequence of the N. caninum Liverpool isolate (Nc-Liv) was 
firstly published in 2012 (Reid et al., 2012). Genomic data already available for T. 
gondii (strain ME49) (Gajria et al., 2008), were used as a framework to construct the 
N. caninum genome based on predicted protein sequence similarity. According to early 
estimations, the nuclear genome of N. caninum consists of approximately 61 Mb with 
7,121 genes organised in 14 chromosomes (Reid et al., 2012). However, the complete 
sequence, available in GeneDB http://www.genedb.org/Homepage/Ncaninum and 
ToxoDB http://www.toxodb.org/toxo/, is subjected to frequent updates and 
amendments occurring whenever improved gene annotation data become available. 
For example, the combination of proteomic data and transcriptomic information 
generated using the RNASeq technology has recently enabled the identification of loci 
which were not previously annotated (Krishna et al., 2015). 
The information currently accessible is restricted to the nuclear genome. DNA 
sequences contained within the mitochondrion and the apicoplast (i.e. the vestigial 
non-photosynthetic plastid found in most apicomplexan) of N. caninum have not been 
sequenced to date (Goodswen et al., 2013). 
Differences and similarities between the genomes of T. gondii and N. caninum have 
been extensively investigated to identify the genetic basis of host restriction, 
transmission strategies, virulence and zoonotic potential of the two apicomplexans 




both T. gondii and N. caninum are characterised by uniquely long (810-860 
nucleotides) untranslated regions (UTRs) which enrich most gene families 
(Ramaprasad et al., 2015). UTRs play a key role in the post-transcriptional regulation 
of gene expression and in the modulation of mRNA transport from the nucleus, as well 
as their subcellular localisation, translation efficiency and stability (Mignone et al., 
2002). In Apicomplexan parasites with complex life cycles, such as T. gondii and N. 
caninum, which require high precision regulation of gene expression, UTRs may play 
an important post-transcriptional regulatory role within several gene families 
(Ramaprasad et al., 2015). 
Although the genomes of N. caninum and T. gondii are very similar, with widely 
conserved regions and a high degree of synteny (i.e. the co-localisation of genes within 
a chromosome), remarkable differences have been observed (Reid et al., 2012). Such 
differences are more significant within gene families involved in the host-parasite 
interactions (Reid et al., 2012, Ramaprasad et al., 2015). 
Gene families encoding surface antigens are considerably expanded in N. caninum. In 
particular, the parasite displays a wider set of genes encoding surface-associated 
glycoprotein denominated SAG-related surface sequences (SRS) (Adomako-
Ankomah et al., 2014). However, compared to N. caninum, T. gondii expresses a 
greater number of these genes (Reid et al., 2012). 
Given the pivotal role of the SRS proteins in host cell recognition and invasion, it was 
hypothesised that the potentially more restricted host spectrum of N. caninum may be 
linked to differences in the repertoire of surface antigens genes and expression patterns 
(Nolan et al., 2015, Reid et al., 2012). Nevertheless, further studies are required to 
support this hypothesis. 
Interestingly, genes encoding SAG-unrelated surface antigens (SUSA) which are 
thought to interact with the host immune system (Pollard et al., 2008) are also more 
numerous in N. caninum although a greater number is expressed in T. gondii (Reid et 
al., 2012). 
The repertoires and expression profiles of gene products known or predicted to be 
localised at the level of the apical complex differ between N. caninum and T. gondii. 
For example, the genome of N. caninum differs substantially from the genome of T. 




ROP18, ROP16 and ROP5) are located (Reid et al., 2012). In addition, two genes 
encoding proteins of the microneme apical organelles, denominated MIC26 and 
MIC19, have been identified uniquely in N. caninum. Interspecific differences also 
exist regarding the dense granule genes GRA11 and GRA12, which have been 
identified in T. gondii, are absent from the N. caninum genome sequence (Reid et al., 
2012). 
Recently, the transcriptome analyses of different N. caninum isolates, carried out using 
high throughput RNA sequencing (RNA-Seq), highlighted marked differences 
between the expression profiles of the high virulence isolate Nc-Spain7 and the low 
virulence isolate Nc-Spain1H, thus providing useful insights into the mechanisms 
involved in virulence (Horcajo et al., 2018). When examined throughout the tachyzoite 
lytic cycle, the expression profile of the low virulence isolate was characterised by the 
over-expression of genes related to early bradyzoite conversion such as NcBAG1 and 
NcSAG4. This pre-bradyzoite transcriptome of Nc-Spain1H may be linked to its 
slower growth rate and may explain the lower virulence of the isolate (Horcajo et al., 
2018). 
 
1.4.2 Host cell-parasite interactions 
 
The first step of N. caninum tachyzoite invasion into the host cell is the establishment 
of a reversible, low affinity, contact with the cell membrane. This primary contact is 
mediated by surface antigens constitutively expressed by the parasite (Hemphill et al., 
2004). Once adhered, the tachyzoites orientate themselves perpendicularly to the cell 
membrane. At this stage, secretory components are sequentially discharged by 
tachyzoite organelles the micronemes, rhoptries and dense granules (English et al., 
2015). 
Microneme (MIC) and rhoptry (ROP) proteins contribute to the establishment of a 
moving junction: a structure which tightly connects the apical pole of the parasite to 
the plasma membrane and slides over the parasite as it enters the host cell (Besteiro et 
al., 2011). 
Similar to T. gondii, it is assumed that N. caninum penetrates the host cells by pulling 
MIC complexes and the moving junction towards its posterior end. In such manner, 




the parasitophorous vacuole (PV) (Nolan et al., 2015). Subsequently, dense granule 
proteins (GRA) are released into the PV (Ellis et al., 2000, Lally et al., 1997). 
Although the precise function of GRA proteins is still unknown, they are thought to 
maintain the environment of the PV enabling survival and multiplication of the 
protozoa (Liu et al., 2013). 
The PV is surrounded by the parasitophorous vacuole membrane (PVM) within which 
the parasite proliferates by endodyogeny and interacts with many host cell structures 
and organelles by diverting them to its PV (Hemphill et al., 2006, Nolan et al., 2015). 
This enables N. caninum to sequester and scavenge nutrients from the host cell. These 
include cholesterol from endocytic organelles and sphingolipids from the Golgi 
apparatus (Nolan et al., 2015). 
When a critical mass is reached, the tachyzoites egress from the host cell (Hemphill 
1999). Egression enables the parasite to spread and invade neighbouring cells and 
results in cell lysis and tissue damage with deleterious consequences for the host 
(Hemphill et al., 2004). 
During the stage conversion from tachyzoite to bradyzoite, the PVM undergoes 
structural modifications and thickens forming the tissue cyst wall; however, the 
mechanisms underlying this phenomenon are not completely known (Guionaud et al., 
2010). 
 
1.4.3 Antigenic repertoire of N. caninum 
 
Most of the N. caninum antigens that have been identified and characterised to date, 
are either localised on the protozoa surface or within the secretory organelles 
(Vonlaufen et al., 2004). Updated information regarding the proteome of N. caninum 
was recently obtained using high throughput liquid chromatography-tandem mass 
spectrometry (LC-MS/MS), which enabled the study of the relative abundance of 
several antigenic proteins in different isolates (Horcajo et al., 2018). 
 
1.4.3.1 Surface antigens: SAG-related sequences (SRS) 
The surface of N. caninum is covered with glycosylphosphatidylinositol (GPI)-





Several SRS proteins of N. caninum have been identified and characterised to date. 
These include NcSAG1 and NcSRS2 which are tachyzoite-specific and NcSAG4 
(Fernandez-Garcia et al., 2006), NcBSR4 (Risco-Castillo et al., 2007) and NcSRS9 
(Risco-Castillo et al., 2011) which are expressed by the bradyzoite stage. In addition, 
NcSRS67, a SRS with no orthologue in T. gondii, has been recently identified in N. 
caninum (Nc-1 strain) tachyzoite extract (Bezerra et al., 2017, Pollo-Oliveira et al., 
2013). 
In vitro immunolabelling and confocal laser microscopy of N. caninum tachyzoites 
demonstrated the primary role of the two major immunodominant surface antigens, 
NcSAG1 and NcSRS2 (Howe et al., 1998), within the invasion process (Nishikawa et 
al., 2000). Monoclonal and polyclonal antibodies directed against these two proteins 
prevented the tachyzoites from adhering and invading target cells (Haldorson et al., 
2006, Nishikawa et al., 2000). 
Characterised by high immunogenicity, NcSAG1 and NcSRS2 have been extensively 
investigated within the development of vaccines and frequently employed for the 
development of diagnostic tests (Baszler et al., 2008, Otsuki et al., 2013). 
 
1.4.3.2 Microneme proteins (MIC) 
Micronemes are cigar-shaped organelles that cluster at the apical end of the parasite 
(Carruthers and Tomley 2008) and secrete MICs which are not only essential for the 
adhesion to the host cells but are also crucial for the gliding motility (Dowse and 
Soldati 2004). MICs are characterised by adhesive domains which interact with 
receptors localised on the surfaces of target host cells. MICs operate as protein 
complexes by interacting with several elements such as rhoptry neck proteins (RONs) 
amongst other. Many MICs have been discovered in T. gondii and several N. caninum 
homologues and orthologues have been identified and characterised to date. These 
include: NcMIC1 (Keller et al., 2002), NcMIC2, NcMIC2-like, NcMIC3 
(Naguleswaran et al., 2001), NcMIC4 (Keller et al., 2004) NcMIC6 (Li et al., 2015), 
NcMIC8 (Wang et al., 2017), NcMIC10 (Yin et al., 2012), SPATR, NcPDI and 
NcSUB1 which is characterised by proteolytic activity and high immunogenicity 





1.4.3.3 Rhoptry proteins (RONs and ROPs) 
Rhoptries are club-shaped organelles located at the anterior pole of the apicomplexans 
(Kemp et al., 2013). Rhoptry proteins comprise the rhoptry neck proteins (RONs), 
which are localised in long neck-like part of the organelle and are involved in the 
formation of the moving junction (Marugan-Hernandez et al., 2011), and the ROP 
kinase family: a group of proteins implicated as determinants of virulence in both N. 
caninum and T. gondii (Reid et al., 2012). 
A NcROP5-deficient strain of N. caninum which was experimentally constructed, 
exhibited significantly weaker cell invasion capabilities, reduced proliferation and 
virulence compared to the Nc-1 wild type strain suggesting a key role of this protein 
within cell invasion mechanisms (Ma et al., 2017). 
 
1.4.3.4 Dense granule proteins (GRA) 
GRA proteins are secreted by vesicles called dense granules which are found 
throughout the parasite but generally concentrated at the apical end. Despite fifteen 
GRA proteins have been identified in N. caninum, either at the protein or 
transcriptional levels (Reid et al., 2012), only few have been characterised to date. 
These include NcGRA1 (Atkinson et al., 2001), NcGRA2 (Ellis et al., 2000), 
NcGRA6 (Lally et al., 1996b), NcGRA7 (Alvarez-Garcia et al., 2007, Hemphill et al., 
1998) and NcMAG1 (Guionaud et al., 2010) among others. 
NcGRA2 and NcGRA7 are abundantly expressed by N. caninum tachyzoites and 
secreted during and after invasion into the parasitophorous vacuole (Vonlaufen et al., 
2004). Importantly, NcGRA7 has been successfully used for the development of tests 
for the detection of specific antibodies in sera from infected cattle (Aguado-Martinez 
et al., 2008). 
Furthermore, like T. gondii, N. caninum expresses a type-I nucleoside triphosphate 
hydrolase (NTPase) which is also localised within the dense granules (Mercier and 
Cesbron-Delauw 2015). The upregulation of NcNTPase observed during tachyzoite 
egression from the host cell suggested a potential role of this protein in the progression 







1.4.4 Stage-specific expression of N. caninum antigens 
 
N. caninum is characterised by differential protein expression between tachyzoites and 
bradyzoites (Kang et al., 2008b) depending on variations in gene transcription between 
the two parasite stages (Kang et al., 2008a). Similar to T. gondii, N. caninum 
tachyzoites and bradyzoites can be differentiated by transmission electron microscopy 
(TEM), based on differences in the ultrastructural morphology, or through the 
detection of antigens that are expressed in a stage-specific fashion (Vonlaufen et al., 
2004). 
Differential expression of surface antigens, which appears to be a strategy to evade the 
host immune system, has been observed in most apicomplexan parasites. In T. gondii, 
the major surface antigens TgSAG1 and TgSAG2 are specifically expressed at the 
tachyzoite stage (Kasper 1989). Likewise, the N. caninum immunodominant surface 
antigens NcSAG1 and NcSRS2 are highly expressed by the tachyzoite stage and 
down-regulated during the tachyzoites-to-bradyzoite stage conversion (Vonlaufen et 
al., 2002). 
Although highly expressed by the tachyzoite stage, NcGRA7 is also expressed by the 
bradyzoite stage. The antigen has been shown to be differentially located in the 
tachyzoite and the bradyzoite stages of T. gondii (Torpier et al., 1993) and has been 
detected at the periphery of the tissue cysts after stage conversion in N. caninum (Fuchs 
et al., 1998, Vonlaufen et al., 2004). 
In addition to NcGRA7, other dense granule proteins, such as NcGRA1 and NcGRA2, 
have been detected within the tissue cyst wall of N. caninum using 
immunofluorescence (Kang et al., 2008a, Kang et al., 2008b). Differences in the 
expression profiles of these antigens were instrumental in the discrimination between 
tachyzoites and bradyzoites in vitro. In addition, proteomic analysis of N. caninum 
during stage differentiation showed that NcGRA9 is highly expressed by the 
bradyzoite stage (Marugan-Hernandez et al., 2010). Similarly, TgGRA9, the 
orthologue of NcGRA9 in T. gondii, was abundantly expressed by the bradyzoite stage 
and efficiently secreted in the cyst wall matrix (Caffaro et al., 2013). However, this 
antigenic protein is expressed by tachyzoites and bradyzoites in both N. caninum 




Furthermore, NcMIC1 was not detected in N. caninum tissue cysts successfully stained 
with MAb CC2, a monoclonal antibody specific for a cyst wall-associated antigen. 
This suggested that the expression of this MIC protein may be significantly reduced 
during the quiescent stage of the parasite (Keller et al., 2002). 
Immunolabelling using either monoclonal or polyclonal antibodies as well as the 
analysis of cDNA expression libraries has enabled the identification of several 
bradyzoite-specific antigens (Vonlaufen et al., 2004). These include NcSAG4 
(Fernandez-Garcia et al., 2006), NcBSR4 (Risco-Castillo et al., 2007), NcSRS9 
(Risco-Castillo et al., 2011), NcSRS13 (Reid et al., 2012), NcMAG1(Guionaud et al., 
2010) and NcBAG1 (Kobayashi et al., 2013). 
Several bradyzoite-specific antigens are shared between N. caninum and T. gondii. 
NcSAG4 and NcSRS6 have been shown to be overexpressed in bradyzoites of both T. 
gondii (Wasmuth et al., 2012) and N. caninum (Fernandez-Garcia et al., 2006). 
Polyclonal antibodies raised against TgBAG1 have been shown to cross-react with N. 
caninum tissue cysts (Tunev et al., 2002), in which NcBAG1 is highly expressed 
(Kobayashi et al., 2013). However, other antigens which are considered to be 
tachyzoite-specific in T. gondii showed overexpression in N. caninum bradyzoites; for 
example, TgROP9 has been reported as a tachyzoite-specific antigenic protein 
involved in the early stages of cell invasion in T. gondii, whereas its orthologue in N. 
caninum (NcROP9) is highly expressed at the bradyzoite stage (Marugan-Hernandez 
et al., 2011). 
Nevertheless, the wealth of information regarding the antigenic repertoire of the 
bradyzoite stage is limited. This is likely due to low bradyzoite production levels both 
in vivo (McGuire et al., 1997b) and in vitro (Weiss et al., 1999). 
In contrast to T. gondii, in which sporozoite-specific antigens have been identified 
(Hill et al., 2011), there is scarce information regarding antigens which might be 












The pathogenesis of bovine neosporosis is complex and is not yet fully elucidated. 
Regardless of whether the N. caninum challenge originates from a primary infection 
during pregnancy or the reactivation of a persistent quiescent infection, the disease is 
initiated by a maternal parasitaemia (Macaldowie et al., 2004). This was indicated by 
the detection of N. caninum DNA in the blood of naturally infected cattle (Okeoma et 
al., 2004). The parasite then establishes itself in the cells of the placenta, invading the 
caruncular septa in the placentome, from where it is able to cross to and infect 
trophoblast cells in the chorionic villi (Barr et al., 1994, Bartley et al., 2004, Maley et 
al., 2003). 
Rapid multiplication of the tachyzoites takes place within the placental tissue eliciting 
a non-suppurative inflammatory response with infiltration of maternal inflammatory 
cells, mostly CD4+ve, CD8+ve and γδ T-cells (Innes et al., 2005). CD4+ve T cells and γδ 
T-cells produce IFN- (Innes et al., 2005). Simultaneously with the onset of placental 
infection, the parasite enters the foetal bloodstream and invades further tissues, with a 
predilection for the CNS (Macaldowie et al., 2004). 
At present, it is not clear whether the foetal damage is due to a primary tissue damage (i.e. 
necrosis), deriving from the multiplication of N. caninum (Gibney et al., 2008), or to 
insufficient oxygenation and nutrition secondary to placental damage. Experimental 
evidence suggested that the release of maternal pro-inflammatory cytokines at the 
maternofoetal interface level might play a key role in leading to foetal death (Innes 2007, 
Rosbottom et al., 2008). 
 
1.5.2 Consequences of the disease 
 
In cattle, neosporosis affects primarily pregnant dams and their foetuses; less 
frequently congenitally infected new-born calves. 
Generally, N. caninum naturally infected adult cattle do not show any clinical signs 
(Dubey and Lindsay 1996); however, transitory fever associated with inappetence has 
been observed in experimentally infected animals (Dubey et al., 2006a). Nevertheless, 




seropositive to the parasite (Barling et al., 2001, Barling et al., 2000). In a later study 
such a relationship in beef cattle was not observed (Waldner et al., 2004). Reduced 
milk production, which is correlated with N. caninum abortions due to the interference 
with timing and length of lactation and dry periods, body condition and udder health 
(McAllister 2016), does not appear to be associated with the presence of N. caninum-
specific antibodies in non-aborting dairy cows (Bartels et al., 2006b). 
Abortion is the main clinical manifestation; however, reabsorption of the conceptus, 
still-birth, the birth of impaired calves or the birth of asymptomatic calves that are 
persistently infected with the parasite may also occur (Dubey and Lindsay 2006, 
McAllister 2016). N. caninum abortions can occur from 4 months of gestation to term, 
although they are typically observed within the fifth and seventh month (McAllister 
2016). 
Several factors contribute to determine the different outcomes that the infection may 
have: (1) infectious dose, (2) virulence of the N. caninum isolate and (3) stage of 
pregnancy during which infection occurs. 
As observed in sheep experimentally infected with N. caninum, the induction of 
disease may be dose-dependent (Buxton et al., 1997). Moreover, it has been shown 
that some N. caninum isolates induce abortion more readily than others (Regidor-
Cerrillo et al., 2014). 
The timing during pregnancy in which infection occurs is considered particularly 
important (Williams et al., 2000). Evidence suggested that the gestational age of the 
foetus when it encounters the parasite, the relative maturity of the foetal immune 
system, and the effectiveness of the maternal immune responses are all critical factors 
in determining the clinical outcome (Innes et al., 2001, 2002). This is supported by the 
increased abortion risk during the second trimester (Lopez-Gatius et al., 2004b, Pare 
et al., 1997) when the foetus is not yet fully immunocompetent (Osburn 1981). In 
addition, at this stage the downregulation of the maternal Th1 cellular immune 
responses, with a bias towards Th2-like responses, appears to be important to enable 
the dam to successfully carry the pregnancy (Innes et al., 2001). 
In general, the earlier the infection occurs in pregnancy, the more severe the 
consequences to the developing foetus (Macaldowie et al., 2004, Williams et al., 




the foetus being reabsorbed giving the outward appearance of infertility (Innes 2007). 
Experimental infection of cattle with N. caninum at day 70 of gestation resulted in 
rapid foetal death (Macaldowie et al., 2004). 
On the other hand, the presence of a quiescent infection acquired prior to pregnancy, 
in persistently infected dams, appears not to affect the early foetal period, despite 
having a significant abortive effect after the first trimester of gestation (Lopez-Gatius 
et al., 2004b). 
Abortion induced by N. caninum can arise from the third month of gestation to term; 
in most diagnosed cases, infected dams abort at 5 to 6 months of pregnancy (Lopez-
Gatius et al., 2004b, Williams et al., 2009). During the second trimester, depending on 
the extent of placental and foetal lesions, N. caninum infection can cause either 
abortion or the birth of congenitally infected calves (Dubey et al., 1992b, Maley et al., 
2003, Rosbottom et al., 2008, Williams et al., 2000). Later in pregnancy, during the 
third trimester, the parasite generally causes the birth of congenitally infected live 
calves which show few or no clinical signs, as demonstrated by several experimental 
studies (Benavides et al., 2012, Gibney et al., 2008, Williams et al., 2000). Similar to 
the infection in cows post-natally, in these animals, N. caninum establishes persistent 
infections in the CNS. Such persistent infections are characterised by the presence of 
tissue cysts containing bradyzoites that multiply slowly (Dubey et al., 2017). 
Sporadically, clinical signs are observed in congenitally infected calves younger than 
2 months of age. Clinically affected animals may be underweight, weak and unable to 
rise. Flexion or hyperextension of the forelimbs and/or hind limbs, ataxia, decreased 
spinal reflexes, loss of conscious proprioception, scoliosis, hydrocephalus, spinal cord 
narrowing and exophthalmia have also been reported (Dubey and Lindsay 2006). 
Repeated abortions due to neosporosis are possible but infrequent. A study, examining 
aborted foetuses collected from dairy herds with and without history of N. caninum 
abortion reported that only 1.5% of the aborting cows aborted twice because of the 
parasite (Anderson et al., 1995). 
 
1.5.2.1 Abortion patterns 
Distinct abortion patterns may occur: (1) epidemic and (2) endemic (sporadic) 




by abortion storms defined as the abortion in more than 10% of the cattle at risk (i.e. 
pregnant) within a period of 12 weeks. Conversely, during endemic neosporosis a 
limited number of cases are observed over several months or years within a herd 
(Goodswen et al., 2013). The various patterns of abortions may be related to the 
different routes of transmission. Epidemic patterns are mainly associated to a primary 
horizontal (point source) infection in a group of naïve animals (Basso et al., 2010), 
whereas endemic patterns occur as a result of recurrent vertical transmission within 
infected family lines (reviewed by Dubey et al., 2007). 
 
 
1.6 Immune responses to N. caninum in cattle 
 
Following exposure to N. caninum, cattle develop cell-mediated and humoral immune 
responses which provide only partial protection against the parasite. 
Clearance of the parasite from infected cattle is considered unlikely, if not impossible, 
and infected cows have a greater risk of abortion compared to non-infected (Lopez-
Gatius et al., 2004a, Weston et al., 2005). Despite this, a degree of protection against 
disease is indicated by the fact that previously infected dams are less likely to abort 
than naïve animals as observed in a case of a point source exposure to N. caninum 
(McAllister et al., 2000). In addition, there is evidence that the risk of abortion and 
vertical transmission decreases during subsequent pregnancies (Dijkstra et al., 2003). 
A vaccination study reported that cows subcutaneously inoculated prior to mating and 
subsequently challenged at mid-gestation developed immune responses sufficient to 
prevent vertical transmission to their offspring (Innes et al., 2001). In another 
vaccination experiment, the intravenous injection with live N. caninum tachyzoites, 
but not whole-tachyzoite lysate, proved effective in protecting cattle against 
foetopathy (Williams et al., 2007). 
Given the obligate intracellular nature of N. caninum, cell-mediated immune responses 
are expected to play a major role in controlling the infection and reducing the 
multiplication of the parasite in the host (Innes et al., 2005). This is supported by the 




cell-mediated and gamma interferon (IFN-γ) responses detected in cows immunised 
and subsequently challenged with live tachyzoites (Williams et al., 2007). 
The contribution of N. caninum-specific antibodies to protective immunity is unclear 
(Andrianarivo et al., 2001); however, a complementary role of the humoral immune 
responses in reducing parasite invasion of host cells has been suggested (Haldorson et 
al., 2006, Innes et al., 2002). 
 
1.6.1 Cell-mediated immune responses 
 
As for other intracellular pathogens, the host immune responses to N. caninum are 
generally characterised by a T-helper type 1 (Th1) cell-mediated immune response, in 
which the activation of antigen presenting cells (APCs) triggers the production of 
specific cytokines such as interleukin-12 (IL-12) that activates T-cells (Dion et al., 
2011). 
Polymorphonuclear neutrophils (PMNs) may contribute significantly to the early 
innate host defences occurring during N. caninum infection (Villagra-Blanco et al., 
2017). Effector mechanisms used by PMNs include phagocytosis, production of 
reactive oxygen species (ROS), release of antimicrobial peptides and synthesis of 
neutrophil extracellular traps (NETs) (Brinkman et al., 2004). NETs are web-like 
structures consisting of granule and cytosolic proteins assembled on a scaffold of 
decondensed chromatin (Brinkman et al., 2004, Papayannopoulos, 2017) which trap, 
neutralise and kill bacteria (Brinkman et al., 2004), fungi (Urban et al., 2006), viruses 
(Saitoh et al., 2012) and protozoan parasites (Abi Abdallah et al., 2012). In vitro, N. 
caninum tachyzoites have been shown to trigger the formation of NETs, preventing 
the penetration of the parasite into bovine umbilical vein endothelial cells (BUVEC) 
(Villagra-Blanco et al., 2017). These findings suggested that NETs may represent an 
effective mechanism during the early innate immune response, which might contribute 
to a reduction in infection rates during the acute phase of bovine neosporosis (Villagra-
Blanco et al., 2017). 
The early innate immune response to N. caninum infection is mediated by activated 
natural killer (NK) cells (Boysen et al., 2006). NK cells are responsible for the 
production of cytokines and the lysis of target cells (Carayannopoulos and Yokoyama, 




12 from activated APCs, plays a key role in the early stages of protozoan infections, 
before the onset T and B cell-mediated immune responses (Korbel et al., 2004). Intact 
N. caninum tachyzoites directly trigger bovine NK cells to produce IFN-γ in vitro, 
even in the absence of IL-12 (Boysen et al., 2006). 
During N. caninum infections, NKs are considered important for providing the 
cytokine environment necessary for the activation of CD4+ve and CD8+ve T cells which 
are responsible for the recognition and destruction of parasitised cells (Klevar et al., 
2007).  
Activated, CD4+ve and CD8+ve T cells produce pro-inflammatory cytokines such as 
IFN-γ, TNFα, IL-12 and IL-17 which initiate an inflammatory response. The activation 
of cytotoxic CD4+ve T cells and the production of IFN-γ play a particularly important 
role in the control of N. caninum (Boysen et al., 2006, Rojo-Montejo et al., 2013, 
Rosbottom et al., 2007, Staska et al., 2005). 
In vitro, IFN-γ and TNF-α demonstrated an inhibitory effect on the intracellular 
multiplication of the parasite (Yamane et al., 2000). Furthermore, N. caninum-specific 
CD4+ve T cell clones and NK cells can efficiently lyse cells infected with the parasite 
(Boysen et al., 2006, Staska et al., 2003, Yamane et al., 2000). 
High systemic levels of IFN-γ have been correlated with protection against N. caninum 
abortion in both experimentally (Williams et al., 2007) and naturally infected cattle 
(Lopez-Gatius et al., 2007). Significantly higher antigen-specific lymphocyte 
proliferation and IFN-γ production in PBMCs and lymph node tissue were observed 
in non-aborting compared to aborting dams following subcutaneous challenge with N. 
caninum (NC-1 strain) at mid-gestation (day 140) (Bartley et al., 2013a). 
An in vivo study suggested that the presence of a parasite-induced maternal immune 
response in the placenta, consisting of CD4+ve and CD8+ve T cells infiltration with 
significant up-regulation of the expression of IFN-γ, IL-4, IL-10, IL-12 and TNF-α, is 
not detrimental to foetal survival, but might contribute to the control of N. caninum at 
the placental level (Rosbottom et al., 2011). 
In a recent study, PBMCs and mononuclear cells from the spleen and uterine lymph 
nodes of non-aborting heifers, experimentally infected (Nc-Spain 7 strain) at 110 days 
of pregnancy, showed lower in vitro IFN-γ/IL-4 production ratios and higher IL-4 




highlighted that the protective role might not be exclusively dependant on the synthesis 
of IFN-γ (Darwich et al., 2016). 
Although the pro-inflammatory response is beneficial for the elimination of the 
parasite, in the gravid uterus it may have a detrimental effect (Innes 2007). At the 
placental level, inflammatory responses with the production of cytokines, chemokines, 
NO and prostaglandins (Buxton et al., 2002, Dubey et al., 2006b, Quinn et al., 2002a) 
may result in tissue damage leading to loss of placental functionality with insufficient 
oxygenation and vascular supply of nutrients which may ultimately lead to abortion 
(Canton et al., 2014, Macaldowie et al., 2004). Given the protective effect of the Th1 
pro-inflammatory responses with production of IFN-γ observed in many studies, it has 
been postulated that excess of IFN-γ response over a critical threshold would 
determine the onset of foetopathy (Almeria et al., 2016). 
In pregnant cattle, the outcome of N. caninum infection (i.e. abortion or foetal infection 
without clinical signs) is dependent on the balance between Th1 type responses which 
mediate the control of the parasite and Th2 type responses which occur physiologically 
to enable successful foetal implantation (Innes et al., 2005). During pregnancy, the rise 
in progesterone levels inhibits the Th1 responses, which results in the dose-dependent 
inhibition of the expression of IFN-γ and IL-17, and promotes the Th2 responses 
(Maeda et al., 2013). The Th2 immune response mediates the activation and 
maintenance of humoral responses and is characterised by the production of anti-
inflammatory cytokines, such as IL-10, IL-4 and transforming growth factor beta 
(TGFβ) which counter-regulate the pro-inflammatory Th1 response (Almeria et al., 
2017). These mediators are highly expressed at the maternofoetal interface and are 
involved in the regulation of pregnancy avoiding foetal rejection (Entrican 2002). At 
the same time, the natural bias toward Th2 type responses may alter the host-parasite 
interaction thus enabling the protozoan to become more active in the pregnant host 
facilitating vertical transmission (Innes et al., 2002). 
Recently, the reproductive immunology Th1/Th2 paradigm of women has been 
extended into the Th1/Th2/Th17 paradigm. Th17 cells produce pro-inflammatory 
cytokines IL-17, IL-21 and IL-22 which are involved in the host defence against 




downregulation of Th17 responses may be important to enable successful embryo 
implantation and pregnancy (Saito et al., 2010). 
In cattle, Th17 cell responses with the production of IL-17 have been identified and a 
potential protective role against foetal death and host tissue damage during neosporosis 
has been suggested (Peckham et al., 2014). It has been hypothesised that this role 
might be related to the production of protective antibodies or the involvement of Th17 
cells in the orchestration of neutrophil/effector cell influx at the site of infection; 
however, further investigations are required to elucidate the role of this type of cell-
mediated immune response during neosporosis (Peckham et al., 2014). 
In addition to CD4+ve T cells, γδ-T cells have been identified as a major source of 
IL-17 during the infection with protozoan parasites, such as Plasmodium berghei 
(Ribot et al., 2010) and Leishmania major (Akilov et al., 2009). A role of γδ-T cells 
in the production of IL-17 during N. caninum infection has been observed. However, 
these cells may act as a shorter term innate immune response compared to Th17 cells, 
which would provide more consistent IL-17 production (Peckham et al., 2014). 
 
1.6.2 Humoral immune responses 
 
Antibody responses to N. caninum are characterised by the early onset of IgM 
antibodies which peak two weeks post-infection and decline rapidly within four weeks 
(De Marez et al., 1999). Whereas, the concentrations of IgG antibodies can increase 
for 3-6 months and are believed to persist for life after a primary infection. 
Subcutaneous or intravenous inoculation with N. caninum tachyzoites elicit the 
production of specific antibodies within 14 days (Bartley et al., 2004, Maley et al., 
2001). An initial increase in the levels of the IgG1 subclass is followed by a slightly 
delayed rise in IgG2 (Williams et al., 2000). 
Serum antibody responses to N. caninum fluctuate throughout gestation depending on 
the physiological status of the dam (Andrianarivo et al., 2005, Guy et al., 2001) and 
the activity of the parasite (Innes 2007). A marked increase in antibody titres is 
observed during the second half of gestation and has been associated with vertical 
transmission in numerous experimental and field studies (Guy et al., 2001, Nogareda 
et al., 2007, Pare et al., 1996, Stenlund et al., 1999). The rise of maternal antibody 




tachyzoites in persistently infected animals (Guy et al., 2001). Another longitudinal 
study in non-aborting cows showed variations in N. caninum-specific antibody levels 
during different gestational periods, with a significant increase in antibody titres, after 
the fifth month of gestation (Cardoso et al., 2009). A correlation between the timing 
of an increase in antibodies titres and the risk of congenital infection was observed 
(Williams et al., 2003, Pare et al., 1997). 
 
1.6.3 Foetal immune responses 
 
Given the importance of the gestational age in determining the outcome of N. caninum 
infection, foetal immune responses represent a critical factor in the pathogenesis of 
bovine neosporosis (Innes et al., 2002). 
During gestation, bovine foetuses progressively develop immunocompetence. 
Mitogenic cellular immune responses in foetal splenic and thymic cells were observed 
around day 100 of pregnancy in N. caninum-infected bovines (Innes et al., 2005). From 
day 120 the foetus can mount specific cell-mediated and humoral immune responses 
to the parasite (Almeria et al., 2003, Bartley et al., 2004). As a consequence, infections 
occurring before this gestational age (during the first trimester) are likely to find the 
foetus unable to respond effectively to the pathogen which can rapidly proliferate 
throughout the foetal tissues (Innes 2007) causing foetal death and reabsorption 
(Collantes-Fernandez et al., 2006, Regidor-Cerrillo et al., 2014). 
The stage of foetal development plays a key role in the outcome of other reproductive 
infections of cattle. Maternal infection with Akabane virus can cause abortions, 
stillbirths, premature births and congenital defects, whose type is dependent on the 
stage of pregnancy. In a prospective study, infections between 76 and 104 days of 
gestation resulted in foetal hydranencephaly and porencephaly, whereas cases of 
arthrogryposis were observed as a consequence of infections between 103 and 174 
days of pregnancy (Kirkland et al., 1988). Foetuses of less than 2 months of age were 
not affected by the virus (Kirkland et al., 1988). 
In analogy with the in utero infection with bovine viral diarrhoea virus (BVDV), the 
occurrence of immunotolerance in calves congenitally infected with N. caninum has 
been hypothesised. Before day 120 of pregnancy, transplacental infections with the 




calves which do not produce any immune responses to the pathogen (i.e. they are 
immunologically tolerant) (Anderson et al., 2000a, McInnes et al., 2006b). 
At present, there is not sufficient evidence that this may also occur during N. caninum 
infections and this scenario is considered likely to be infrequent although possible. 
With the development of specific foetal immune responses around mid-gestation 
(Bartley et al., 2012), the outcome of infection at this stage is variable with the 
possibility of the birth of congenitally infected asymptomatic calves or the occurrence 
of abortion. At this stage, foetal death is likely due to the incomplete development of 
the innate immune responses mediated by phagocytic cells which do not fully develop 
until late gestation (Horcajo et al., 2016). 
Infections occurring in late gestation are more likely to result in the birth of live 
congenitally infected calves that do not show any obvious clinical signs (Collantes-
Fernandez et al., 2006, Rosbottom et al., 2007). 
 
 
1.7 Diagnosis of bovine neosporosis 
 
Although epidemiological data and clinical history, such as the abortion pattern within 
the herd and the gestational age at the time of abortion, may be suggestive of 
neosporosis, laboratory methods are required for a definitive diagnosis (McAllister 
2016). 
From the clinician’s point of view, it is important to differentiate between the 
recognition of N. caninum as the cause of abortion and the identification of animals 
infected with the protozoan. Being able to discriminate between infected and 
uninfected animals is the basis of disease management and a number of diagnostic 
tools have been developed for this purpose (Dubey and Schares 2006). 
Since the direct detection of N. caninum in aborted foetuses does not necessarily rule 
out other causes of abortion, accurate analysis of the severity of the lesions and 
exclusion of other causes is required. Therefore, the diagnosis of bovine neosporosis 
should be approached within a wider diagnostic plan of abortion in which the major 
causes of foetal mortality in cattle should be included (Dubey et al., 2007). 
In some cases, diagnosis of bovine neosporosis can only be made at the herd level by 




serology and by comparing the presence of N. caninum-specific antibodies in aborting 
and non-aborting animals. A statistically significant increase of the abortion risk in 
seropositive cows would be suggestive of an ongoing bovine neosporosis problem 
(McAllister 2016). 
Examination of aborted foetuses and serological testing should complement each other 
where possible. 
 
1.7.1 Examination of aborted foetuses 
 
The direct examination of aborted foetuses offers the greatest chances of reaching an 
aetiological diagnosis regardless the cause of bovine abortion (McAllister 2016). 
Gross lesions are rare in N. caninum-associated abortions, although hydrocephalus, 
hypoplasia of the cerebellum and medulla as well as scattered pale to dark foci of 
necrosis in the brain, spinal cord, heart and skeletal muscle have been reported (Dubey 
et al., 1998, Dubey and Schares 2006). 
Entire chilled foetuses and placental cotyledons, or tissue samples, can be submitted 




Microscopic lesions are generally localised in the CNS, heart, liver, and placenta. 
Distinctive histological findings are multifocal non-suppurative encephalomyelitis 
with mononuclear perivascular cuffs, microgliosis and necrosis (Helman et al., 1998, 
Nishimura et al., 2013a), which is considered almost pathognomonic (Dubey 2003, 
Dubey and Schares 2006, Morales et al., 2001). Non-suppurative myocarditis, 
myositis and periportal hepatitis with necrosis have also been described (Dubey and 
Schares 2006). 
At the placental level, the lesions are typically restricted to the cotyledons in which 
focal areas of necrosis and inflammation with mononuclear infiltrate may be observed 







Immunohistochemistry (IHC), employing monoclonal (MAbs) or polyclonal 
antibodies recognising N. caninum tachyzoites or bradyzoite antigens, is frequently 
used alongside the analysis of histopathological lesions to improve the diagnosis 
(Uzeda et al., 2013). This technique has the advantage of enabling the assessment of 
the number, distribution and micro-anatomical localisation of pathogens in tissue 
sections (Ramos-Vara et al., 2008). IHC is particularly useful when characteristic 
lesions of neosporosis are not evident (Boger and Hattel 2003). 
Cross-reactivity between N. caninum and T. gondii has been observed in tissues of 
both experimentally and naturally infected animals examined with IHC (reviewed in 
Gondim et al., 2017). However, in one study, the combination of two MAbs targeting 
NcSRS2 and NcGRA7 enabled the specific detection of N. caninum by avoiding cross-
reactions with related apicomplexan in tissue sections from bovine foetuses (Uzeda et 
al., 2013). Importantly, other genetically related protozoan, such as Sarcocystis spp. 
and Besnoitia besnoiti, should be considered when validating the specificity of novel 
IHC protocols due to the possibility of cross-reactions (Uzeda et al., 2013). 
 
1.7.1.3 Molecular detection of N. caninum 
More recently, polymerase chain reaction (PCR) has become increasingly applied to 
the direct detection of N. caninum DNA (or RNA) in fresh, frozen, formalin-fixed and 
paraffin wax-embedded foetal tissues (Dubey and Schares 2006). Foetal brain is 
generally considered the best specimen for PCR analysis followed by heart, liver and 
placenta (Dubey 2003). Nevertheless, protocols for the amplification of parasite DNA 
from different samples such as cerebrospinal fluid (CSF) (Buxton et al., 2001) and 
amniotic fluid (Ho et al., 1997) have been described. 
Due to its analytical sensitivity, PCR is particularly helpful for the diagnosis of bovine 
abortions when foetal and placental tissues have undergone autolysis and 
histopathology would not be feasible (McAllister 2016). 
The likelihood of detecting N. caninum in specific foetal tissues may vary depending 
on the gestational stage at which foetal death occurs. In one study, the frequency of 
PCR positive results in brain, heart, kidney and lung samples was significantly higher 




second and third (Collantes-Fernandez et al., 2006). Interestingly, in foetuses aborted 
during late gestation (third trimester) N. caninum DNA was almost exclusively 
detected in the foetal brain and only sporadically in diaphragm, heart and kidney. 
These findings were attributed to variations of the parasite load in certain foetal tissues 
during pregnancy (Collantes-Fernandez et al., 2006) and are also likely to reflect the 
development of the foetal immune response during gestation. 
A variety of PCR protocols have been established. These include conventional 
(Holmdahl and Mattsson 1996), nested (Buxton et al., 1998) and multiplex PCRs 
(reviewed in Dubey et al., 2017). Quantitative PCRs have also been developed and 
have the advantage to enable the estimation of the parasitic burden in tissue of aborted 
foetuses (Nishimura et al., 2013a, Regidor-Cerrillo et al., 2014, Reitt et al., 2007). 
The target DNA sequences reported encompass: the internal transcribe spacer 1 (ITS1) 
region (Buxton et al., 1998, Holmdahl and Mattsson 1996), the Nc-5 gene (Liddell et 
al., 1999), the 18S and 28S ribosomal DNA (rDNA) (Fazaeli et al., 2000), the HSP70 
gene and the 14-3-3 gene (Lally et al., 1996a). Amongst these ITS1 and Nc-5 are the 
most frequently cited in literature (reviewed in Sinnott et al., 2017). 
Furthermore, PCR methods are key tools for the study of N. caninum genetic 
heterogeneity through the analysis of variable genetic loci, such as micro- and mini-
satellites, which can provide additional epidemiological and phylogenetic information 
(Campero et al., 2015, Medina-Esparza et al., 2016). 
Importantly, with the current availability of the sequenced genome of N. caninum 
Liverpool (Nc-Liv) the development of further PCR protocols using novel DNA 
targets would be enormously facilitated (Goodswen et al., 2013). 
 
1.7.1.4 Antibody detection in foetal fluids 
Beyond the stage of foetal immunocompetence (from 110-120 days of gestation) 
(Swift and Kennedy 1972), many but not all foetuses develop specific antibodies in 
response to the transplacental invasion of N. caninum tachyzoites (Alvarez-Garcia et 
al., 2003, Bartley et al., 2004). Such antibody responses can be detected in foetal 
blood, pleural and peritoneal serosanguinous fluids as well as in the abomasal content 
(Dubey and Schares 2006). The immunoglobulins detected are predominantly IgG1, 




The sensitivity of foetal serology, assessed with either IFAT or ELISA, has been 
reported to be low (Alvarez-Garcia et al., 2003, Pereira-Bueno et al., 2003, Sondgen 
et al., 2001). In one study, only 25% of the foetuses with histopathological lesions 
suggestive of neosporosis were also antibody positive (Pereira-Bueno et al., 2003). 
Consequently, negative foetal serology results do not necessarily rule out N. caninum 
as the causative agent. Reduced sensitivity may result from the lack of foetal 
immunocompetence or the degradation of the immunoglobulins during the autolytic 
processes which follow the death and expulsion of the aborted foetus (Wouda et al., 
1997). Nevertheless, the demonstration of antibodies against N. caninum in foetal 
fluids represents the first specific indicator of the involvement of N. caninum in foetal 
infection (De Meerschman et al., 2002). 
Alongside the aborted foetus and placenta, the submission of a serum sample from the 
aborting dam for serological analysis is highly recommended within a comprehensive 
diagnostic strategy for bovine neosporosis and bovine abortions in general (McAllister 
2016). 
 
1.7.2 In vivo diagnosis of bovine neosporosis 
 
The determination of specific antibodies in cattle serum, plasma or milk is indicative 
of N. caninum infection (Dubey 2003), and is currently considered the primary method 
for the diagnosis of bovine neosporosis in live animals (Alvarez-Garcia et al., 2013). 
Although the PCR detection of N. caninum DNA in blood (Ferre et al., 2005, Okeoma 
et al., 2004), serum (McInnes et al., 2006b), semen (Ferre et al., 2005, Ortega-Mora 
et al., 2003, Serrano-Martinez et al., 2007b), colostrum and milk (Moskwa et al., 2007) 
as well as the analysis of pro-inflammatory cytokines as indicators of exposure to the 
parasite (reviewed in Almeria and Lopez-Gatius 2015) could also be applied in vivo, 
these markers of infection are confined to the research field because of their transitory 
nature. 
 
1.7.2.1 Serological techniques 
Numerous techniques have been developed for the detection of N. caninum-specific 
antibodies. These encompass a wide variety of enzyme-linked immunosorbent assays 




agglutination test (NAT), Western blot (WB) analysis and immunochromatographic 
test (Sinnott et al., 2017). 
 
1.7.2.1.1 ELISA 
Routinely, the ELISA is the elective technique for the analysis of bovine sera within 
the investigation of bovine abortion outbreaks and for the serological screening of 
cattle herds as it enables high throughput analyses. 
Numerous commercial and in-house ELISAs, designed on different formats (e.g. 
indirect, competitive, sandwich or dot ELISA), are available. These assays utilise a 
variety of antigen preparations such as whole or fixed N. caninum tachyzoites, aqueous 
or detergent soluble tachyzoite extracts, single native or recombinant tachyzoite 
antigens (reviewed in Dubey et al., 2017). Antigens incorporated in immune 
stimulating complexes (ISCOMs) (Bjorkman et al., 1994, Frossling et al., 2006) were 
also used for the development of diagnostic ELISAs. In addition, several recombinant 
antigens predominantly expressed by the tachyzoite stage of potential diagnostic value 
have been characterised and applied to the ELISA format. Amongst these, recombinant 
NcSRS2 (Andreotti et al., 2009, Borsuk et al., 2011, Liu et al., 2007), 
NcSAG1(Chahan et al., 2003, Howe et al., 2002) and NcGRA7 (Aguado-Martinez et 
al., 2008, Huang et al., 2007, Jenkins et al., 1997) are the most frequently employed. 
Almost all currently marketed ELISAs are based on total sonicated tachyzoite lysate 
antigens; however, tests utilising native NcSRS2 purified protein, native N. caninum 
tachyzoite surface antigen (GP65) captured using monoclonal antibodies or ISCOM-
incorporated tachyzoite proteins are also available (Alvarez-Garcia et al., 2013). 
Besides enabling the discrimination of infected from uninfected animals, certain 
ELISA protocols were designed to provide information on the stage of infection and 
distinguish between acutely and persistently infected animals. 
Avidity ELISAs are based on the principle that the first antibodies produced show 
lower affinity to the antigens than those produced later (Bjorkman et al., 2005). 
Therefore, they can provide additional information regarding the time elapsed from a 
primary infection (Bjorkman et al., 2003). Within the investigation of several 
outbreaks of bovine neosporosis, low avidity IgG responses were correlated to recent 
primary point-source infections which resulted in epidemic abortions (Basso et al., 




high avidity values are associated with persistent infection (Aguado-Martinez et al., 
2005, Bjorkman et al., 2006). 
Recombinant antigens expressed by the bradyzoite stage of N. caninum, which is 
found during persistent infections, can also be applied for the determination of the 
stage of infection. 
The combined use of two ELISAs using respectively the bradyzoite stage-specific 
NcSAG4 and the tachyzoite-expressed NcGRA7 antigen proved useful to discern 
acute (recent primary infection, recrudescence and reinfection) from persistent 
infections in cattle (Aguado-Martinez et al., 2008). 
None of the ELISA tests, and in general commercial serological tests, use bradyzoite-
specific antigens of N. caninum (Dubey et al., 2017). 
 
1.7.2.1.2 Indirect Fluorescent Antibody Test (IFAT) 
The IFAT has been traditionally considered the reference method for the serodiagnosis 
of N. caninum and has been used for the validation of serological tests based on 
different principles (Alvarez-Garcia et al., 2003). IFAT protocols are expensive, as 
they require the in vitro production of N. caninum tachyzoites, and are laborious 
(Sinnott et al., 2015). Importantly, the interpretation of the results is subjective and 
can be affected by the experience and level of training of the operator (Campero et al., 
2015). 
The IFAT cut-off thresholds differ considerably between laboratories thus hindering 
the easy comparison of results (Sinnott et al., 2017). Although a 1:200 serum dilution 
is commonly recommended as cut-off for adult cows, a range of different dilutions has 
been reported (von Blumroder et al., 2004). 
 
1.7.2.1.3 Neospora Agglutination Test (NAT) 
The NAT is based on the agglutination of N. caninum whole intact tachyzoites when 
in the presence of sera containing specific antibodies and is characterised by simple 
execution (Packham et al., 1998, Romand et al., 1998). However, in a study aimed at 
comparing commercial and in-house ELISAs, IFATs and a NAT (United States 




significantly lower specificity (66.0%) as compared to other tests (Wapenaar et al., 
2007c). 
 
1.7.2.1.4 Western blot analysis 
WB analysis has been used for the identification of immunodominant tachyzoite 
antigens by host sera (Alvarez-Garcia et al., 2002) and is generally regarded as a 
reliable method to detect N. caninum-specific antibodies in cattle (Sinnott et al., 2017). 
Due to the long execution times the technique is not suitable for the screening of large 
numbers of samples but is useful as a confirmatory method when uncertain results are 
obtained with different serological tests (Aguado-Martinez et al., 2005). For example, 
WB analysis is often recommended to retest samples in which borderline levels of 
fluorescence render the interpretation of IFAT difficult (Ghalmi et al., 2014). 
 
1.7.2.1.5 Immunochromatographic test 
A rapid immunochromatographic test using the recombinant NcSAG1 antigen 
produced in E. coli was also developed (Liao et al., 2005) but has not been made 
commercially available. The future development of lateral flow devices using N. 
caninum antigens for the detection of specific antibodies in whole blood, plasma, 
serum or milk may represent a possible option to increase the rapidity and applicability 
to field conditions of the diagnostic tools for bovine neosporosis. 
 
1.7.2.1.6 Recombinant antigens for the serological diagnosis of toxoplasmosis 
in livestock species and neosporosis in cattle 
Serological tests for the diagnosis of toxoplasmosis generally employ a preparation of 
whole T. gondii lysate antigen (TLA) (Holec-Gasior 2014). However, as for the 
diagnosis of bovine neosporosis, the use of recombinant antigens has been widely 
investigated. 
T. gondii antigens used for the diagnosis of toxoplasmosis in livestock species include 
recombinant surface antigens (TgSAG1, TgSAG2), dense granule proteins (TgGRA1, 
TgGRA2, TgGRA6, TgGRA7, TgGRA15), the microneme protein 1 (TgMIC1), the 
rhoptry proteins 1 (TgROP1) as well as the matrix antigen 1 (TgMAG1) (Ferra et al., 
2015). Applied singly or in combination, these recombinant antigens have been used 




as tools for the detection of T. gondii infection in livestock, such as sheep, pigs and 
horses (Ferra et al., 2015). 
Recombinant antigens for the serodiagnosis of N. caninum in cattle include NcSAG1 
(Chahan et al., 2003, Howe et al., 2002), NcSRS2 (Andreotti et al., 2009, Borsuk et 
al., 2011, Liu et al., 2007), NcGRA6 (Ghalmi et al., 2014) and NcGRA7 (Aguado-
Martinez et al., 2008, Huang et al., 2007, Jenkins et al., 1997). Bradyzoite-specific 
antigens have also been described, including NcSAG4 (Fernandez-Garcia et al., 2006), 
NcBRS4 and NcSRS9 (Risco-Castillo et al., 2011). 
 
1.7.2.2 Pre-colostral serology 
The detection of N. caninum-specific antibodies in the pre-colostral serum of new-
born calves can be used to investigate the route of transmission and indirectly assess 
the infection status of the dam (Dubey et al., 2007, Hietala and Thurmond 1999). 
In cattle and other ruminants, transplacental transfer of immunoglobulins does not take 
place because of the syndesmochorial placenta. Passive immunity is transferred from 
dam to calf postnatally through the ingestion of colostrum. Therefore, the presence of 
specific antibody responses in pre-colostral calves is indicative of the activity of the 
foetal immune system following exposure to the pathogen in utero (Innes 2007). 
Nevertheless, the absence of specific antibodies in stillborn or new-born pre-colostral 
calves, although suggestive that N. caninum infection is unlikely, is not conclusive of 
absence of infection (Dubey and Schares 2006) since the development of specific 
antibodies is dependent on the timing of in utero infection (Anderson et al., 1997). 
Effectively, calves infected late during gestation might not have had sufficient time to 
seroconvert before birth (Dubey et al., 2007). 
Given the difficulty of obtaining pre-colostral sera in most field conditions, pre-
colostral serology is an impractical diagnostic option. However, it can be very 
informative for research purposes (Guido et al., 2016). 
 
1.7.2.3 Bulk milk testing 
In dairy herds, the detection of N. caninum-specific antibodies in bulk milk is useful 
to provide an estimate of the seroprevalence within the group of animals that contribute 
to the milk sample (Schares et al., 2003). Good correlation between bulk milk 




serum or plasma samples was reported (Bartels et al., 2005, Milne et al., 2006, 
Wapenaar et al., 2007a). 
The interpretation of bulk milk test results requires specific considerations. Following 
exposure to a pathogen, milk antibodies appear later and at a lower concentration, 
approximately 30-fold less, in milk than in serum (Butler 1983). Bulk milk antibody 
levels are dependent on the proportion of seropositive animals; however, the stage of 
lactation and the milk yield also influence the concentration of specific antibodies 
(Frossling et al., 2006). 
ELISAs commonly used for testing cattle sera have been adapted for use on bulk milk 
samples; however, the sensitivity reported is generally limited (Schares et al., 2004). 
A minimum of 10-15% serologically positive animals appears to be necessary to 
produce positive bulk milk testing results (Bartels et al., 2005, Frossling et al., 2006, 
Wapenaar et al., 2007a). Consequently, the method may underestimate the proportion 
of infected herds by misclassifying those in which the seroprevalence of N. caninum 
is low as uninfected. Nonetheless, the serological examination of bulk milk is 
considered a cost-effective and non-invasive diagnostic option which can provide a 
useful preliminary indication of the N. caninum serostatus in dairy herds. 
 
1.7.3 Limitations of current serological diagnostics 
 
Cows infected with N. caninum may elude the currently available serological 
diagnostics due to variations in antibody titres observed throughout the infection, as a 
result of the dynamics of the host-parasite interaction in vivo, in particular in pregnant 
animals and the intrinsic characteristics of the diagnostic tests used. 
This is supported by reports of N. caninum serologically negative dams giving birth to 
seropositive calves or aborting foetuses in which parasite DNA was detected (Mazuz 
et al., 2014, Sager et al., 2001) as well as post-mortem evidence of N. caninum 
infection found in tissues of seronegative non-aborting cows (Benavides et al., 2012). 
In cattle, fluctuations in N. caninum-specific antibody titres are well documented (Guy 
et al., 2001, Jenkins et al., 2002, Waldner et al., 1998). These can occur depending on 
the physiological status of the dam and the activity of the parasite which is dependent 




drop below the detection limits of the serological tests so that previously serologically 
positive animals may become seronegative (Figure 1.3). 
A prospective serological study in dairy cattle found that more than one-third of cows, 
with low antibody titres (1:200) during pregnancy, became serologically negative at 
the end of gestation (Mazuz et al., 2014). In addition, two studies conducted in 
Argentina reported that 5% (More et al., 2009, Pare et al., 1996) and 3% (More et al., 
2009) of dams that were seronegative at calving gave birth to pre-colostrally 
seropositive calves. 
Most if not all the work reporting fluctuations in specific N. caninum antibody 
concentrations in cattle refers to humoral responses that recognise the tachyzoite stage 
of the parasite because these are targeted by the vast majority of commercial and in-
house diagnostic tests. Concerns about the sensitivity of tests based only on tachyzoite 
antigens were raised following an interesting observation of a cow whose antibody 
response was able to recognise bradyzoite-specific but not tachyzoite-specific antigens 
(Benavides et al., 2012). This animal was kept under experimental conditions as a 
negative control for a N. caninum infection experiment and tested repeatedly negative 
with commercial and experimental tachyzoite-based ELISAs; however, parasite DNA 
was detected in several tissues post-mortem, and further serological analysis carried 
out with a bradyzoite-specific (SAG4) antigen-based ELISA highlighted seropositivity 
to antigens related to the quiescent bradyzoite stage of N. caninum. 
In experimentally infected animals, humoral responses to N. caninum bradyzoite-
specific antigens show individual variability (Aguado-Martinez et al., 2008). Indeed, 
antibody responses against bradyzoite antigens will depend on the intensity and 
duration of specific antigen exposure during the host–parasite interaction in cattle. In 
addition, rupture of tissue cysts may also be necessary to enhance detectable host 
immune responses against bradyzoite antigens. As suggested for some bradyzoite-
specific antigens of the closely related apicomplexan Toxoplasma gondii, antigens 
specific to the quiescent stage may hardly be exposed (Gross et al., 2004). There is no 
conclusive information on the extent to which these antigens are exposed to the host 
immune system because this may be difficult to assess and will be subject to individual 
variability in immunocompetence. The limited immunogenicity observed for the N. 




late upregulation of expression during persistent infection, with only transient 





















Figure 1.3 – Hypothetical antibody responses following N. caninum infection in cattle 
(adapted from Guido et al., 2016). (A) Ingestion of sporulated oocysts with release of 
sporozoites may expose the host immune system to sporozoite-specific antigens; there is little 
information about sporozoite-specific antibody responses. (B) Tachyzoites multiply rapidly 
by endodyogeny inside several cell types that then rupture triggering the development of 
tachyzoite-specific antibody responses. These antibody responses are found in most infected 




Tachyzoites convert into the quiescent bradyzoite/tissue cyst stage, bradyzoite-specific 
antibodies are produced; however, the quantity and duration of these responses are unknown. 
(D) During conversion into the bradyzoite/tissue cyst stage, tachyzoite-specific antibody 
responses may decline below the cut-offs of current diagnostic tests. This may result in false 
negative results. (E) Immunomodulation during pregnancy may enable reactivation of 
bradyzoites into tachyzoites that spread throughout the body, thus boosting the tachyzoite-
specific immune responses. (F) Antibodies against bradyzoites/tissue cysts may decline at this 
stage, although there is little information about the dynamics of these stage-specific humoral 
responses because diagnostic tests targeting bradyzoite-specific humoral responses are not 
currently used. 
 
In view of the limitations of current diagnostic tests, it has been difficult to assess the 
frequency and hence the epidemiological impact of animals which are persistently 
infected with N. caninum but test serologically negative. The development of 
improved diagnostic tests may aid the correct identification of these animals, thus 























1.8 Control of bovine neosporosis 
 
Control programmes for bovine neosporosis have as key objectives the minimisation 
of the reproductive losses and the reduction of the infection prevalence at the herd 
level. Current control strategies rely on management techniques aimed at interrupting 
the life cycle of N. caninum at any one or several stages (McAllister 2016). Integrating 
measures to prevent horizontal transmission from the canid host and methods to reduce 
the risk of vertical transmission from dam to foetus in infected herds are essential for 
the implementation of effective control plans (Frossling et al., 2005). 
Given the different control options available, an accurate assessment of the impact of 
the disease at the herd level and a thorough cost-benefit analysis are required before 
embarking on any disease control efforts (Reichel et al., 2014). The costs of bovine 
neosporosis encompass the loss of calf revenue from aborted cows, the decreased milk 
production due to prolonged calving intervals, the costs for rebreeding or eventually 
replacing aborting cows and the expense associated with investigation of abortion 
cases. Furthermore, infected herds may be subjected to an overall reduction of the 
value of the breeding stock (Reichel et al., 2013). 
 
1.8.1 Prevention of horizontal infection 
 
1.8.1.1 General hygiene measures 
Measures to minimise the contamination of feedstuff, water and cattle areas with N. 
caninum oocysts are instrumental to prevent postnatal transmission from infected 
canids. Most epidemiological studies agree that the presence of dogs in breeding cattle 
premises represents a risk factor for bovine neosporosis; therefore, the number of dogs 
on farm should be limited and the access of stray canids should be controlled. In 
infected herds, adult farm dogs are likely to have already experienced N. caninum 
infection and may be less likely to shed oocysts (Antony and Williamson 2003). 
However, dog puppies, which are likely to be naïve to the parasite, are considered to 
have a higher risk of producing oocysts following infection. No dogs, but especially 
litters of puppies, should have access to cattle and feedstuff storage areas; dog proof 
fencing and the protection of feed storage areas and feed mixing equipment from dog 




drinking water using elevated troughs with potable water may help in preventing cattle 
exposure to N. caninum oocysts (McAllister 2016). 
Since dogs can acquire the infection by ingesting infected bovine tissues, the prompt 
removal and appropriate disposal of aborted foetuses, afterbirths as well as dead 
livestock is important to stop the parasite life cycle (Basso et al., 2001, Dijkstra et al., 
2001a). Furthermore, dogs should not be fed raw ruminant tissues as dog food as it 
may contain N. caninum tissue cysts (Cavalcante et al., 2011). 
The detection of N. caninum DNA in tissues from feral mice and rats suggested that 
these species can act as intermediate hosts for the parasite. Although there is no 
definitive evidence, rodents may represent a source of infection to domestic and wild 
canids and play a role in maintaining and spreading neosporosis (Ferroglio et al., 2007, 
Jenkins et al., 2007). Therefore, on farm rodent control would be also recommended. 
This would also reduce the risk of leptospirosis thus producing additional benefits 
within the control of reproductive losses in cattle in general (Reichel et al., 2013). 
Similarly, a potential role of free-range poultry in the epidemiology of N. caninum has 
been suggested. The presence of chickens, which can be infected with the parasite 
(Costa et al., 2008), was correlated to an increased risk of bovine abortion (Bartels et 
al., 1999) and increased seroprevalence in cattle (Otranto et al., 2003). 
 
1.8.2 Management of vertical transmission 
 
Serological testing associated with the adequate management of positive animals is the 
most common method to limit endogenous transmission within a herd (Guido et al., 
2016). Infected cows can be removed from the herd (test-and-cull regime) or excluded 
from breeding to generate replacement stock (selective breeding) (Reichel et al., 
2014). 
The reliable identification of all N. caninum-infected animals requires serological tests 
in which the cut-off thresholds are adjusted to provide the maximum level of 
diagnostic sensitivity (Reichel and Ellis 2002). However, the possibility of false 
negative results which may affect the effectiveness of the disease control measures 





1.8.2.1 Test and cull 
Culling N. caninum-seropositive dams was shown to reduce the within-herd 
prevalence over time in farms in which adequate measures to prevent horizontal 
infection were in place (Frossling et al., 2005, Hall et al., 2005). 
Some authors questioned whether retaining infected animals would be more beneficial 
than aiming at a herd in which all animals are completely naïve to the pathogen hence 
more susceptible to horizontal infections (Innes et al., 2000, McAllister et al., 2000). 
This concern arose from the observation that cattle can develop partial immunity to 
the parasite and the risk of abortion tends to decrease over time in cows repeatedly 
exposed to the parasite (Innes et al., 2000). Although repeated environmental exposure 
to N. caninum can eventually lead to a lower risk of abortion, there is evidence that 
such risk is still higher than in seronegative animals (Reichel et al., 2013). Most 
importantly, these dams are still able to transmit the parasite to their offspring thus 
maintaining the infection in the herd and deferring the abortion risk to the next 
generation (Reichel et al., 2013). 
Due to the high costs involved, culling seropositive animals may be economically 
sustainable only in herds with low seroprevalence in which only a small proportion of 
animals would need to be removed. 
 
1.8.2.2 Selective breeding 
The exclusion of heifers born from antibody-positive dams from breeding reduces the 
risk of in utero infections at the herd level (Frossling et al., 2005). This control option 
is effective provided that endogenous vertical transmission is the predominant route 
of infection and post-natal exogenous transmission is negligible (Hall et al., 2005, 
Landmann et al., 2011). 
In farms with high N. caninum seroprevalence (≥50%), avoiding breeding replacement 
stock from seropositive dams was shown to be economically sustainable (Hasler et al., 
2008). Within a cost-benefit simulation model investigating different control options 
in endemically infected beef herds, the best economic return was provided by the 





Serological analysis of all potential replacement heifers, regardless of the serological 
status of their dams, could be performed to increase the level of confidence that the 
prospective breeding females do not harbour N. caninum. Serology can be done pre-
colostrum ingestion, but is most commonly carried out after 6 months of age when 
maternal antibody levels, from passive transfer via colostrum, have declined 
(McAllister 2016). 
 
1.8.2.3 Testing replacement breeding stock 
Purchased cows and heifers represent a risk of introducing N. caninum into the herd. 
As a rule, replacement breeding stock should be obtained from herds with outstanding 
breeding performances and no history of bovine neosporosis (Roelandt et al., 2015). 
Serological testing of prospectively purchased animals should be performed. Due to 
the possibility of false negative results, some authors recommend repeat testing 4-6 
weeks after introduction to the herd and re-testing doubtful samples using WB analysis 
(Alvarez-Garcia et al., 2003, Ortega-Mora et al., 2006). Antibody testing the mothers 
of the animals whose daughters are to be introduced into the herd may increase the 
chances of identifying individuals which test falsely negative and infected family lines 
in which the parasite is vertically transmitted. 
 
1.8.2.4 Reproductive management 
Embryo transfer (ET) from seropositive donors to seronegative recipients can prevent 
endogenous transmission of N. caninum (Campero et al., 2003, Landmann et al., 2002) 
as during the preimplantation stages, the zona pellucida protects the embryos from the 
parasite (Bielanski et al., 2002). Furthermore, there are several reports of successful 
recovery and implantation of uninfected embryos taken from infected dams which 
stopped the cycle of the parasite (Baillargeon et al., 2001, Campero et al., 2003, 
Landmann et al., 2002). The limiting factors of the use of ET are the high costs which 
may be justified only by the value of the future calf in high genetic merit cattle herds. 
A significant reduction in the abortion risk was observed in N. caninum seropositive 
high-producing dairy cattle inseminated with beef bull semen (Lopez-Gatius et al., 
2005). This was attributed to the favourable effect of cross-breeding on foetal health 
and placental function (Almeria et al., 2009, Lopez-Gatius et al., 2005). Although 




breeding replacements from infected cattle are removed because female dairy × beef 
crosses are not usually retained for milk production. 
 
1.8.2.5 Reduction of predisposing factors 
Given the role of the host immune responses in the control and reactivation of N. 
caninum, concomitant infections, management factors and other stressors, which may 
cause immunosuppression, may be implicated in the reactivation of bradyzoites to 
tachyzoites with subsequent vertical transmission. Some authors suggested that 
infectious diseases, such as bovine rhinotracheitis (IBR) and bovine viral diarrhoea 
(BVD), characterised by immunosuppression may lead to recrudescence of N. 
caninum and foetal infection in pregnant dams (Reichel et al., 2013). Although the 
absence of BVD was shown to have a protective effect against N. caninum infection 
(Vanleeuwen et al., 2010), in several studies an increased risk of abortion in cows 
seropositive for both pathogens was not observed (Bjorkman et al., 2000, Mainar-
Jaime et al., 2001, Stahl et al., 2006). Nevertheless, the control of concomitant 
reproductive infections may help reducing the impact of neosporosis at the herd level. 
The immunosuppressive effects of mycotoxins may also have a role in the 
recrudescence of a persistent N. caninum infection (Bartels et al., 1999, Dubey et al., 
2007). Consequently, providing pregnant dams with good quality and properly stored 
feed and fodder is recommended (McAllister 2016). 
 
1.8.3 Other approaches 
 
1.8.3.1 The “live with the disease” option 
In herds in which the prevalence of neosporosis is low, the costs related to specific 
control measures may exceed the economic losses incurred by the disease. For this 
reason, a non-interventionist “live with the disease” policy may be the preferable 
course of action in some farms (Reichel et al., 2013). In one study based on 
mathematical modelling, Reichel and Ellis (2006) indicated a within-herd prevalence 
of 18-21% as the threshold above which the benefits of test and cull programmes 







Economic analysis suggested that vaccination might be the most efficient intervention 
strategy to control neosporosis in cattle (Reichel and Ellis 2006); however, registered 
vaccines are currently not available. Several years ago, a vaccine based on inactivated 
N. caninum tachyzoites, Bovilis Neoguard® (Intervet International B.V., Boxmeer, 
The Netherlands), was registered in several countries but subsequently withdrawn 
from the market due to the low efficacy (Weston et al., 2012). 
The development of an effective vaccine is certainly one of the primary goals within 
the bovine neosporosis research and considerable resources are invested in the 
investigation of vaccine candidates using both mouse and ruminant models (reviewed 
in Hemphill et al., 2016, Horcajo et al., 2016). 
Live-attenuated vaccines showed promising results in different studies. Intravenous 
and subcutaneous inoculation of cattle with tachyzoites of the attenuated Nc-Nowra 
strain protected pregnant cows against foetopathy by inducing strong antibody and 
cellular responses with the production of IFN-γ (Weber et al., 2013, Williams et al., 
2007). The naturally attenuated Nc-Spain1 isolate, inoculated prior to artificial 
insemination, produced protection against foetal death in 50% of the animals 
subsequently challenged with the Nc-1 strain in early (day 70) gestation. In addition, 
significantly lower pre-colostral antibodies were observed in asymptomatic calves 
born from dams challenged during mid-gestation (day 135) (Rojo-Montejo et al., 
2013). Another study reported a significantly lower incidence of abortion in cows 
vaccinated at mid-gestation with a live isolate denominated Ncls491 (16%) compared 
to the unvaccinated group (26%). In the same trial, no differences in the seroprevalence 
in pre-colostral calves were observed between the vaccinated and unvaccinated groups 
(Mazuz et al., 2015). 
Subunit vaccines have also been developed; however, limited efficacy was observed. 
Non-pregnant cattle immunised with recombinant NcGRA7 combined with oligo-
mannose microsomes (M3-NcGRA7) showed enhance humoral and cell-mediated 
immune responses as well as a reduced parasite burden in the brain following 
challenge with N. caninum tachyzoite (Nc-1 strain) (Nishimura et al., 2013b). In a 
study carried out in pregnant cattle challenged at day 70 of pregnancy, immunisation 




elicited a marked humoral immune response but failed to prevent vertical transmission 
(Hecker et al., 2014). 
In future years, genomic and transcriptomic resources would play a primary role in the 
in silico identification of a priority list of potential vaccine candidates which could be 
experimentally assessed (Goodswen et al., 2013). It is likely that any killed or sub unit 
vaccine will require an adjuvant or delivery system that will enable a long-lasting cell-
mediated immune response to be induced. 
 
1.8.3.3 Antiprotozoal treatment 
Despite the assessment of the efficacy of several drugs against N. caninum both in 
vitro and in vivo in laboratory animals, there are no antiprotozoal compounds licensed 
for use in cattle to treat neosporosis (Muller and Hemphill 2013). 
Toltrazuril is effective against various coccidians and extensively used for the 
treatment of coccidiosis in poultry and cattle; however, limited effectiveness was 
observed against N. caninum in vivo (Haerdi et al., 2006). 
Artemisinin and derivatives, dicationic pentamidine and spiroindolones are the most 
promising drug candidates (Hemphill et al., 2016). 
Nonetheless, it appears unlikely that the pharmacological treatment of N. caninum 
infection in cattle would be cost-effective. Given the pathogenesis of bovine 
neosporosis, preventing abortions would imply long-term administrations resulting in 
an increased risk of unacceptable residues in milk or meat. Furthermore, the 
establishment of withdrawal periods would represent an additional production cost 















































1.9 Aims of the thesis 
 
Prophylaxis through vaccination is generally considered the desirable approach for the 
control of bovine neosporosis (Monney and Hemphill 2014). However, effective 
vaccines may not be commercially available for several years to come (Reichel et al., 
2014). Furthermore, despite the promising effects against N. caninum displayed by 
several antiprotozoal compounds both in vitro and in vivo (Mazuz et al., 2012, Muller 
et al., 2015, Muller and Hemphill 2011, Schorer et al., 2012, Winzer et al., 2015), the 
chemotherapeutic treatment of neosporosis in cattle is not a popular option because of 
the prospective high costs and the risk of unacceptable residues in meat and milk 
(Dubey et al., 2007). 
Consequently, the control options aimed at reducing the impact of bovine neosporosis 
are restricted to management practices in which the key role is played by the reliable 
discrimination of infected from uninfected animals (Reichel et al., 2013). For this 
purpose, serological diagnosis is widely recognised as the approach of choice. 
Additionally, the investigation of the genetic diversity of N. caninum can provide 
valuable information on the source of infection and the predominant route of 
transmission at the herd level, thus helping to shape effective control strategies (Basso 
et al., 2010). 
The capacity of N. caninum to establish persistent infections sustained by the quiescent 
bradyzoite stage represents one of main challenges to the accurate identification of all 
infected animals. In fact, the level of antibodies against the tachyzoite stage, which 
proliferate actively during acute infections, may decline below the detection limits of 
current serological tests when the infection becomes quiescent or at certain stages in 
pregnant animals. 
Most, if not all, commercially available tests are based exclusively on tachyzoite 
antigens (Alvarez-Garcia et al., 2013). These tests may not always identify cattle in 
which tachyzoite antibody responses have declined but a test where both tachyzoite 
and bradyzoite antigens were used may help to improve the consistent detection of all 




In order to improve the current diagnostic options to reliably detect N. caninum 
infection in cattle and to help the development of strategies to control the disease, the 
research in this thesis has the following objectives: 
1. Identify proteins expressed by the bradyzoite stage of N. caninum which could 
be employed for the development of serological assays to detect cattle 
persistently infected with N. caninum (Chapter 2) 
2. Evaluate different recombinant N. caninum stage-specifically expressed 
antigens for the detection of specific antibodies in cattle (Chapter 3) 
3. Determine the seroprevalence of bovine neosporosis in British dairy cattle 
(Chapter 3) 
4. Develop a molecular typing tool which could be applied for the study of the 
genetic diversity of N. caninum within the investigation of abortion outbreaks 
caused by the parasite (Chapter 4) 
5. Explore perceptions and approaches to the diagnosis and control of bovine 






















Chapter 2: Identification and expression of N. 






A key to the success of N. caninum as a parasite is its ability to establish life-long 
persistent infections in which the bradyzoite stage survives, relatively quiescent, 
enclosed in tissue cysts (Hemphill et al., 2006). During pregnancy, persistent 
infections can recrudesce with re-conversion of bradyzoites into the actively 
multiplying tachyzoites that initiate an acute infection similar to that occurring after a 
primary exposure to the parasite. This may lead to invasion of the gravid uterus and 
vertical transmission to the foetus that can result in abortion or the birth of congenitally 
infected offspring (Williams et al., 2009). Although asymptomatic, persistently 
infected cattle are able to transmit the parasite to their progeny over consecutive 
pregnancies, perpetuating the infection within a herd over generations (Innes 2007). 
In particular, where congenitally infected but clinically healthy heifers are retained for 
breeding, spreading of the parasite vertically in the herd can take place very efficiently 
(Bjorkman et al., 1996). 
Given the current lack of effective vaccines and licensed antiprotozoal treatments 
(Goodswen et al., 2013), the control of bovine neosporosis relies exclusively on 
biosecurity and management practice whose effectiveness depends on the correct 
classification of infected and uninfected animals. Alongside the identification of 
acutely infected cattle, the detection and appropriate management of persistently 
infected animals would help significantly in the control of the disease. In addition, the 
discrimination between acutely and persistently infected cattle provides 
epidemiological information that allows identifying the predominant transmission 
pattern (horizontal or vertical) thus the major source of infection within a herd. Such 
information is useful for the selection of optimal control strategies (Aguado-Martinez 
et al., 2008). 
Serological diagnostic tests, primarily ELISAs and IFAT, which are used routinely for 




2006) are based on a variety of tachyzoite antigen preparations, both native and 
recombinant. Generally considered adequate, currently available serological 
diagnostics may fail to detect those animals in which specific antibody titres against 
the tachyzoite stage may have dropped below the cut off limits (reviewed by Dubey 
and Schares 2006). Antibody levels against N. caninum tachyzoite antigens fluctuate 
depending on the stage of pregnancy and the age of the animal (Conrad et al., 1993b, 
Waldner et al., 1998). During persistent infections, in which N. caninum has 
undergone stage conversion into bradyzoites, the host immune system is no longer 
exposed to the tachyzoites and specific antibody responses may decline to a level they 
are no longer detectable (Guido et al., 2016). 
Diagnostic tools that measure the avidity of N. caninum-specific antibodies have been 
proposed for the discrimination between acute and persistent infection (Bjorkman et 
al., 1999, Sager et al., 2003, Schares et al., 2002a). These tests are based on the 
principle that the affinity of specific immunoglobulins for the antigens varies 
depending on the time elapsed after infection. Low avidity is associated with recent 
infection whereas high avidity is indicative of persistent infection (Aguado-Martinez 
et al., 2005, Bjorkman et al., 1999). Nevertheless, the rapid increase of antibody 
avidity after a primary infection hampers the discrimination between persistent 
infection and recrudescence (Bjorkman et al., 2006, Schares et al., 2002a). In addition, 
all reported avidity tests are based exclusively on tachyzoite antigens and may fail in 
identifying those animals in which antibody responses against the tachyzoite may have 
declined, similarly to currently available non-avidity tests. 
Based on differences in gene transcription, different protein expression patterns were 
reported between N. caninum tachyzoites and bradyzoites (Kang et al., 2008a, Kang 
et al., 2008b). As a result, the two infectious stages of the parasite display a different 
antigenic repertoire. This variation in the antigenic composition is also known in T. 
gondii, which is very closely related to N. caninum, in which the expression of 
numerous genes in a stage-specific manner is well documented (Lyons et al., 2002). 
For example, genes of the surface antigen (SAG) 1-related sequence (SRS) 
superfamily, that encode GPI-anchored surface proteins, are differentially expressed 
in tachyzoites and bradyzoites as mostly non-overlapping sets (Jung et al., 2004). A 




including TgSAG1, TgSAG2A, TgSAG2B, TgSRS1 and TgSRS3 are present only on 
the tachyzoites whereas TgBRS4 (Van et al., 2007) TgSRS9 (Kim and Boothroyd 
2005) TgSAG4 and TgSAG4.2 (Odberg-Ferragut et al., 1996) are expressed 
exclusively by the bradyzoites. An immunogenic heat shock protein named TgBAG1 
was also found to be specifically expressed by the bradyzoite stage (Bohne et al., 
1995). In addition, structural antigens of the tissue cyst wall such as CST1 (Zhang et 
al., 2001) and the tissue cyst matrix (TgMAG1) (Ferguson and Parmley 2002, Parmley 
et al., 1994) were also described. 
Antigens that are expressed by the bradyzoite stage can be used for the detection of 
specific antibody responses in those persistently infected animals that harbour the 
parasite at the quiescent stage. Specific antibody responses to the TgBAG1 and 
TgMAG1 antigens were detected in murine and human infection models (Mun et al., 
1999, Parmley et al., 2002). 
In N. caninum, several bradyzoite-specific proteins have been identified and 
characterised to date. NcSAG4 was the first described bradyzoite-specific antigen 
(Fernandez-Garcia et al., 2006) that was used for the serodiagnosis of N. caninum 
infected cattle (Aguado-Martinez et al., 2008, Hu et al., 2011). Other antigens 
including NcBSR4 (Risco-Castillo et al., 2007), NcMAG1 (Guionaud et al., 2010), 
NcSRS9 (Risco-Castillo et al., 2011) and NcBAG1 (Kobayashi et al., 2013) were 
subsequently reported. 
The parallel use of a NcSAG4-based ELISA and a similar ELISA based on the 
NcGRA7 antigen, considered to be a marker of acute infection, has been shown to be 
useful for discriminating chronic/persistent infection from acute primo-infection or 
recrudescence (Aguado-Martinez et al., 2008). Nevertheless, to date, there are no 
commercially available diagnostic tests based on N. caninum bradyzoite antigens. 
For these reasons, expanding the array of stage-specific antigens that could be used for 
the development of novel diagnostic tools may help to increase the sensitivity of the 
serological diagnosis of bovine neosporosis with the aim of improving the control of 







The aims of this study were to: 
1. Identify target genes putatively expressing N. caninum bradyzoite antigens 
2. Express candidate genes as recombinant proteins using bacterial expression 
systems 
3. Assess the immunoreactivity of recombinant antigens 
4. Develop diagnostic ELISAs to detect specific antibodies produced against the 





























2.2 Materials and methods 
 
2.2.1 Identification of N. caninum candidate genes 
 
A panel of N. caninum genes, putatively encoding antigens that are expressed by the 
bradyzoite stage, was selected using the closely related apicomplexan T. gondii as a 
model. Most of the knowledge on the antigenic repertoire of N. caninum was derived 
from research on the more extensively studied parasite T. gondii (Howe and Sibley 
1999). A great wealth of information, in particular regarding the in vitro stage-related 
gene expression profiles, is currently available for T. gondii (Lyons et al., 2002). In 
addition, the availability of the completely sequenced and annotated T. gondii (GT1, 
ME49 and VEG strains) (Kissinger et al., 2003) and N. caninum (Liverpool strain) 
genomes (Reid et al., 2012) offers an invaluable resource for the study of both 
parasites. 
The identification of candidate genes was carried out using two different approaches: 
(1) gene orthology and (2) protein homology. 
T. gondii and N. caninum genomes show a high degree of synteny (i.e. the physical 
co-localisation of genetic loci on the same chromosome amid related species) with a 
one-to-one correspondence between most protein-coding genes. Although divergences 
have been observed, many T. gondii proteins have orthologous proteins encoded 
within the genome of N. caninum (Reid et al., 2012). 
Using the T. gondii genome, maintained by the Eukaryotic Pathogen Database 
Resource Centre and publicly available in ToxoDB (http://www.toxodb.org) (Gajria 
et al., 2008), T. gondii protein coding genes were selected based on their expression at 
the bradyzoite stage as evidenced by the bradyzoite in vitro and/or in vivo 
transcriptome (ME49 strain). The corresponding orthologues were then identified 
within the N. caninum genome which is also available in ToxoDB (Table 2.1); the 
database was consulted in January 2014. 
The focus was on protein coding genes that putatively belonged to the SRS (SAG1-
related sequences) family since this includes the major surface antigens in both T. 
gondii and N. caninum. 
Where corresponding orthologues could not be located, homology searches of T. 




tissue cyst or the tissue cyst wall were performed. The amino acid sequences of known 
and already characterised bradyzoite expressed T. gondii antigens were searched 
against the N. caninum database for the upstream identification of genes encoding 
homologous proteins (Table 2.2). Protein homologues of TgSRS44 and TgSRS13 
were selected. 
TgSRS44, also known as CST1, is one of the major components of the T. gondii tissue 
cyst wall that is induced during the bradyzoite development and is believed to promote 
bradyzoite persistence by conferring mechanical resistance to the tissue cyst wall 
(Tomita et al., 2013). High similarity between the TGME49_264660 T. gondii gene 
encoding SRS44 also known as CST1 and the NCLIV_040495 N. caninum gene were 
observed. The overall identity between the two amino acid sequences was 74% (query 
cover 82%). 
TgSRS13, is a bradyzoite-specific antigen that has been already characterised in T. 
gondii (Reid et al., 2012); therefore, its homologue was considered a good candidate 
for the prospective development of serological tests. At the amino acid level, the 
homology between TGME49_222370 encoding TgSRS13 and the N. caninum 
homologue NCLIV_005760 was 56% (query cover 62%). 
 








TGME49_321490 SAG-related sequence (SRS12D) NCLIV_004430 
TGME49_267130 SAG-related sequence (SRS38A) NCLIV_038900 
TGME49_308840 SAG-related sequence (SRS51) NCLIV_053310 
TGME49_280570 SAG-related sequence (SRS35A) NCLIV_019580 










Table 2.2 – N. caninum genes selected based on protein homology with T. gondii known 























NCLIV_005760 putative SRS13 
 
2.2.2 Selection of regions of interest within candidate genes 
 
Independently of the approach taken for identification, all predicted amino acid 
sequences encoded by the candidate genes were screened for B cell epitopes in order 
to increase the chances of selecting immunogenic proteins recognised by antibodies. 
The presence and location of linear (i.e. single continuous stretch of amino acids within 
a protein sequence) B cell epitopes was initially predicted using the BepiPred method 
(http://www.cbs.dtu.dk/services/BepiPred) (Larsen et al., 2006). Since most B cell 
epitopes are conformational (i.e. discontinuous set of amino acids brought into 
physical proximity by protein folding) (Barlow et al., 1986) the amino acid sequences 
were also screened for conformational B cell epitopes using the CBTOPE prediction 
tool (http://www.imtech.res.in/raghava/cbtope) (Ansari and Raghava, 2010). Regions 
within candidate genes containing at least one predicted linear or conformational B 
cell epitope were selected (Figure 2.1). 
For each gene identified, the relative hydrophobicity/hydrophilicity of the 
correspondent amino acid sequence was evaluated using the ProtScale tool 
(http://www.web.expasy.org/protscale) based on the Kyte-Doolittle method (Kyte and 
Doolittle 1982) (Figures 2.2-2.3). In most cases, N-terminal signal peptides, C-termini 
and highly hydrophobic regions at the extremities of the protein of interest were 
excluded in order to increase the likelihood of obtaining a water-soluble final product. 
Soluble proteins are desirable as they are more easily purified when produced in 
bacterial expression systems. 
Nucleotide sequences encoding the truncated predicted proteins of interest were then 




present, shorter or alternative fragments were selected. Furthermore, the truncated 
amino acid sequences were checked for gaps, resulting from the presence of stop 
codons within the corresponding nucleotide sequence, using the EMBOSS Sixpack 





2 MARTGRTQHR  RRGFRSTARK  LMAVCLDGVL  LFSNGGAVAG  DPVEGLLRRE  LSPDSSDAQG 
3 .#########  ..........  ..........  .....#####  ####......  ########## 
4 4443344433  3433444443  3333233333  2333333333  3333443443  3333333223 
 
1 .........070.........080.........090.........100.........110.........120 
2 ESGIAGVVAT  CTVASSGDAV  TRPATTLTLS  SSTLVATLEC  MGQSMKALPA  DAATVCVAEA 
3 ####......  ..########  #####.....  ..........  ......####  #........#  
4 3333333333  3333333333  3344333333  3333333332  2443443433  3333333333 
 
1 .........130.........140.........150.........160.........170.........180 
2 TASKELNSSN  CSIGDTSMGN  PVKLQELLGT  NDPVQWKAIS  SSDGKNQGES  RMLELSEASL 
3 ########..  ##########  ##......##  ##########  ##########  .......### 
4 3333333344  3344444443  3344333333  4545555555  4443333333  3333223332 
 
1 .........190.........200.........210.........220.........230.........240 
2 PRTDKKFMVG  CQSGEAGENK  SCQVTVNVNA  KPSSVDDKNA  VTCAYGKDSN  PEAVEVEMSE  
3 ###.......  .#########  ##......##  ##########  ....######  ##########  
4 2444454444  4555554444  4554443333  3333334433  4455565444  4433333334 
 
1 .........250.........260.........270.........280.........290.........300 
2 DKNTLTIDCG  KGGSMQPAEF  TSQYCSPEGD  TFEDCSKANY  SDVLPTFAST  WWTNTENKTQ 
3 ####....##  ##########  ##########  ##########  ..........  ########## 
4 4444444433  2234445444  4443444446  6655565433  3444444443  3333333333 
 
1 .........310.........320.........330.........340.........350.........360 
2 ATLTIPKTDF  PPEDQRLLLG  CVPKTQNADQ  STREENLTES  VSETSSCRVL  VTVKAASSAS  
3 ##########  ####......  ...#######  ##########  ####......  .....#####  
4 3333333333  3323333333  4543355544  3333333333  3333433333  3433333343 
 
1 .........370.........380...... 
2 AVSFTPQAVA  ATSGAVLLAG  LFSGSL 
3 ##########  ##........  ......   
4 3333333333  3333433332  333333 
 
Figure 2.1 – Example of selection of target regions based on predicted linear and 
conformational B cell epitopes within NCLIV_004430 (NCLIV_004430-A corresponded to 
the whole sequence, regions NCLIV_004430-B and NCLIV_004430-C are highlighted in 
yellow and blue respectively, overlapping region in green). 
Line 1 – amino acid position, line 2 – amino acid sequence, line 3 – linear B cell epitopes 
prediction: (#) likely epitope residues (.) unlikely epitope residues 
(http://www.cbs.dtu.dk/services/BepiPred), line 4 – conformational epitopes prediction 
(probability scale 0-9, if > 4 the amino acids can be considered as epitope residues, underlined 








Figure 2.2 – Hydrophobicity plot of the amino acid sequence of NCLIV_004430, in red 






Figure 2.3 – Hydrophobicity plot of the amino acid sequence of NCLIV_040495 (first 500 
amino acids), in red parentheses the region NCLIV_040495-A selected and expressed as a 









2.2.3 PCR amplification 
 
Selected sequences were amplified by PCR from N. caninum (NC-1 strain) DNA. N. 
caninum tachyzoites were cultured on confluent Vero cell monolayers grown for 24 h 
in RPMI 1640 (Sigma-Aldrich, Munich, Germany) supplemented with 2 mM 
glutamine (Thermo Fisher Scientific, Waltham, MA, USA), 2% foetal bovine serum 
(FBS), 100 IU/ml penicillin and 50 IU/ml streptomycin (Sigma-Aldrich, Munich, 
Germany), as previously described (Innes et al., 1995). Cell monolayers where 
inoculated with an adjusted multiplicity of infection (MOI) of N. caninum tachyzoites. 
Tachyzoites were maintained by serial passage onto new Vero cells monolayers every 
3-4 days, harvested by disruption with a sterile cell scraper (Corning, USA) and 
washed 3 times by resuspension and centrifugation at 706g for 5 minutes at 4C. 
Genomic DNA was isolated using the Wizard Genomic DNA Purification Kit 
(Promega, Madison, WI, USA) according to manufacturer’s instructions. 
Intra-sequence specific PCR primers were designed for each selected target region. 
Restriction enzyme cleavage sites analysis was carried out 
(http://tools.neb.com/NEBcutter2) and cross checked with the restriction sites 
available in the pQE-30, pQE-31 or pQE-32 vector systems (Qiagen, Manchester, 
UK). The choice between the pQE-30, pQE-31 or pQE-32 depended on whether the 
open reading frame (ORF) was conserved upon insertion of the target sequences. 
Suitable restriction sites were added at the 5’ end of the primers. Designed primers 
(Table 2.3) were manufactured by Eurofins MWG Operon and purified using the high 
purity salt free (HPSF) method by the manufacturer (Eurofins Genomics, Ebersberg, 
Germany). 
Each PCR reaction was performed with 2.5 l genomic DNA (0.25 g) or 2.5l 
DNase/RNase free water (negative control), 5 l 10 custom PCR buffer – SM0005 
(45 mM Tris-HCl, 11 mM (NH4)2SO4, 4.5 mM MgCl2, 0.113 mg/ml bovine serum 
albumin (BSA), 4.4 μM EDTA and 1.0 mM dATP, dATC, dGTC, dTTP) (ABgene, 
Epsom, Surrey, UK), 0.75 units BioTaq (Bioline, London, UK) and 0.05 μM of 
forward and reverse primers. The reaction was made to a final volume of 50 l with 




Initial denaturation (94C for 5 min) was followed by 35 cycles of denaturation (94C 
for 45 s), annealing (from 56 to 59C, depending on the set of primers, for 45 s) and 
elongation (72C for 45 s) with a final extension at 72C for 5 min. Optimum annealing 
temperatures were determined by gradient PCR reactions for each set of primers 
(Table 2.3). 
The PCR products were electrophoresed on a 1.8% (w/v) agarose/TAE gel (Appendix 
I) incorporating Gel Red™ (Biotum, Hayward, CA, USA) and visualised under UV 
light. A 1kb DNA ladder (Promega, Madison, WI, USA) was used to identify relevant 
amplicons that were excised from the gel and purified using the QIAquick Gel 
Extraction Kit (Qiagen, Venlo, The Netherlands) according to the manufacturer’s 













































































































Table 2.3 – Specific intra-sequence primers designed, restriction sites added at the 5’ end of 
each primer, optimum annealing temperatures (Ta) and predicted amplicon sizes. Gene regions 
that were successfully expressed as recombinant proteins are shaded in yellow. 
 
 
* Originally included within the gene denominated NCLIV_040495 (SRS-domain containing protein), 
the selected region NCLIV_040495-A was subsequently separated from downstream gene, based on 
expression, as a result of resequencing and reannotation (Ramaprasad et al., 2015). This sequence is 
currently part of the sequence defined TPA: DNA polymerase, related [Neospora caninum Liverpool], 





















2.2.4.1 Cloning of the target sequences into the pGEM®-T Easy vector 
The purified target amplicons were directly ligated into the linearised, high copy 
number pGEM-T Easy Vector System (Promega, Madison, WI, USA) following the 
manufacturer’s protocol (Appendix II). 
After ligation, carried out as specified by the pGEM-T easy vector manufacturer, 
JM109 competent E. coli (Promega, Madison, WI, USA) were transformed with the 
vector-insert construct and screened using LB/ampicillin/IPTG/X-Gal made by adding 
100 g/ml ampicillin to melted LB-agarose and by spreading 100 l IPTG 100 mM and 
20 l X-Gal 50 mg/ml on the surface of LB/ampicillin plates. Containing the -
galactosidase enzyme gene, the pGEM-T Easy plasmid allows blue/white colony 
screening. When insertion of DNA is successful the -galactosidase enzyme gene is 
disrupted, therefore the enzyme cannot metabolise X-Gal into its normal product that 
confers blue colouration to the colony. White colonies should, theoretically, contain 
only vectors with the inserted DNA fragments of interest. 
The presence or absence of the relevant insert was confirmed by colony PCR on white 
colonies. Identical PCR protocol and conditions described above were used 
substituting the DNA template with 5 l DNase/RNase free water in which a small 
pick from a single bacterial colony was suspended. Colony PCR was carried out on 
six white colonies for each plate. 
PCR positive colonies were then propagated by inoculation of 10 ml L-Broth 
containing 100 g/ml ampicillin and incubated at 37C in a shaking incubator (200 
rpm) overnight. From overnight cultures, glycerol stocks of the transformed JM109 E. 
coli were prepared by adding 200 l glycerol to 800 l bacterial suspension and kept 
at -80C for long-term storage of the plasmids. Additionally, plasmid DNA was 
isolated from aliquots of the overnight cultures using the QIAprep Spin Miniprep Kit 
(Qiagen, Venlo, The Netherlands) and sequenced using the sequencing primers SP6-
promoter and T7-promoter (Eurofins Genomics, Ebersberg, Germany) in order to 





2.2.4.2 Cloning target sequences into the pQE-30 vector 
QiaExpress pQE vectors (Qiagen, Venlo, The Netherlands) (Appendix II) are used 
to express polyhistidine-tagged (6His) proteins that can be easily purified through 
immobilised-metal affinity chromatography (IMAC). The 6His-tag permits the tight, 
yet reversible, binding of the protein to metal chelating surfaces such as those of the 
HisPur™Ni-NTA (Thermo Fisher Scientific, Waltham, MA, USA) constituted by 
nitrilotriacetic acid (NTA) covalently modified to display divalent nickel ions (Ni2+). 
All the sequences of interest maintained an open reading frame when inserted into the 
pQE-30 vector; therefore, pQE-30 was chosen as cloning vector. 
Double digestions using relevant restriction enzymes (New England BioLabs, 
Ipswich, MA, USA) (Table 2.3) were carried out in order to cut the target sequences 
out of the pGEM-T Easy insert/vector constructs as well as to linearise the pQE-30 
vector. The enzymatic reactions were set up in CutSmart™ Buffer (New England 
BioLabs, Ipswich, MA, USA) and incubated at 37C for 1.5 hours. After 45 min of 
incubation, thermosensitive shrimp alkaline phosphatase (TSAP) (Promega, Madison, 
WI, USA) was added to the digested pQE-30 in order to prevent recircularisation. 
Digests were electrophoresed on 1% (w/v) agarose/TAE gel incorporating Gel Red™ 
(Biotum, Hayward, CA, USA) and visualised under UV light. Bands corresponding to 
the sequences of interest and the linearised pQE-30 were excised from the gel. The 
DNA was isolated using the QIAquick Gel Extraction Kit (Qiagen, Venlo, the 
Netherlands). Following ligation of the DNA inserts into the pQE-30 vector, carried 
out as specified by the manufacturer, JM109 competent E. coli were transformed with 
the insert/vector construct. Transformed bacteria were plated onto LB agar plates 
containing ampicillin (100 g/ml) and incubated at 37C, 5% CO2 overnight. Single 
colonies were then screened by colony PCR as described previously. PCR positive 
colonies were propagated by overnight culture in L-Broth/ampicillin (100 g/ml) and 
glycerol stocks made for long-term storage. Plasmid DNA was isolated and sequenced 
using the pQE vector primer 5’ (Eurofins Genomics, Ebersberg, Germany) as indicated 
by the manufacturer of the expression system. 






2.2.5 Expression of recombinant proteins 
 
2.2.5.1 Transformation of M15 [pREP4] E. coli 
M15 [pREP4] is the recommended E. coli strain for the expression of 6His-tagged 
proteins using pQE vectors. The low copy number plasmid pREP4, which confers 
kanamycin resistance, constitutively expresses the lacI gene that allows high level 
production of the lac repression protein required for regulating recombinant protein 
expression. 
M15 [pREP4] E. coli were transformed with the target DNA fragment/pQE-30 vector 
constructs. Transformed bacteria were plated onto LB/ampicillin (100 g/ml) 
/kanamycin (25 g/ml) agar plates and incubated at 37C, 5% CO2 overnight. Colony 
PCR was performed, as described above, to verify the transformation with the correct 
insert. M15 [pREP4] E. coli colonies presenting the correct DNA insert were cultured 
overnight in LB-Broth with ampicillin (100 g/ml) and kanamycin (25 g/ml). 
Plasmid DNA was isolated for sequencing and glycerol stocks made and stored at -
80C until induction of protein expression. 
 
2.2.5.2 Protein expression 
Transformed M15 [pREP4] E. coli glycerol stocks were revived by overnight culture 
in LB-Broth with ampicillin (100 g/ml) and kanamycin (25 g/ml). The following 
day, 5 ml of fresh pre-warmed culture broth aliquots were inoculated with 50 l of 
overnight culture and incubated for 2 hours. All incubation steps were carried out at 
37C in an orbital shaking incubator at 200 rpm. 
Un-induced 1 ml samples (un-induced control) were collected, centrifuged at 2,000g, 
resuspended in 150l PBS and 50l NuPAGE LDS Sample Buffer (Invitrogen, 
Carlsbad, CA, USA) then stored at -20C. Protein expression was then induced by 
adding isopropyl -D-l-thiogalactopyranoside (IPTG) at a final concentration of 2 
mM. The bacterial culture was incubated for another 2 hours. Subsequently, a primary 
1 ml induced sample (induced 1) was collected, pelleted, resuspended in 200 l PBS 
and dyed with 66 l NuPAGE LDS Sample Buffer (Invitrogen, Carlsbad, CA, USA) 
then stored at -20C. The remaining culture was incubated for a further 2 hours. A 




250 l PBS and dyed with 83 l NuPAGE LDS Sample Buffer (Invitrogen, 
Carlsbad, CA, USA). The residual bacterial culture was centrifuged at 2,000g for 5 
min and the resulting bacterial pellet was stored at -80C. 
In order to confirm protein expression, un-induced and induced samples 1 and 2 were 
analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) under denaturing and reducing conditions to allow optimal band visualisation. 
Briefly, samples were denatured by incubation at 99C for 10 mins and loaded into 
NuPAGE 4-12% Bis Tris 1 mm  15-well gels (Invitrogen, Carlsbad, CA, USA) and 
immersed in 200 ml NuPAGE MES SDS Running Buffer (Invitrogen, Carlsbad, CA, 
USA). A protein standard (SeeBlue Plus2 Pre-stained protein standard, Invitrogen, 
Carlsbad, CA, USA) was loaded for the determination of the molecular weight of 
protein bands and the gel was electrophoresed at 200 V for 40 min. The gel was washed 
three times for 5 min with dH2O on an orbital shaker, stained with Simply Blue Safe 
Stain, Coomassie G250 stain (Thermo Fisher Scientific, Waltham, MA, USA) for 1 
hour, washed with dH2O for another hour and visualised on ImageQuant (Ge Health 
Care Life Sciences, Little Chalfont, UK). 
Molecular weights of the truncated polyhistidine-tagged recombinant proteins were 
predicted from the amino acid sequences of each target region using the Compute 
pl/Mw tool in ExPASy (http://www.web.expasy.org/compute_pi/). 
 
2.2.6 Solubility assessment 
 
Once protein expression was confirmed, the pellet obtained from the IPTG induced 
bacterial culture was resuspended in Binding Buffer 1 (without urea) (5mM 
NaH2PO4, 15mM Na2HPO4, and 500mM NaCl) (Appendix I). The bacterial 
suspension was disrupted by sonication for 10 s at 200-300 W 25% amplitude, cooled 
on ice for 20 s and sonicated for another 10 s at 200-300 W 25% amplitude. After 
centrifugation at 13,148g, the supernatant, that should contain soluble proteins, was 
harvested and stored separately whereas the pellet, that should contain insoluble 
proteins, was resuspended in Binding Buffer 2 (urea) (8M urea, 200mM NaH2PO4, 
200mM Na2HPO4, 500mM NaCl) (Appendix I) then centrifuged. SDS-PAGE loading 




and insoluble fractions were analysed with SDS-PAGE in order to determine whether 




Large scale propagation of E. coli M15 [pREP4] [pQE-30 (NCLIV_040495-A)], 
[pQE-30 (NCLIV_040495-C)] and [pQE-30 (NCLIV_004430-B)] was set up by 
inoculating 500 ml of pre-warmed L-Broth containing ampicillin (100 g/ml) and 
Kanamycin (25 g/ml) with 10 ml of overnight bacterial culture from revived glycerol 
stocks. After 2 hours incubation at 37C in a shaking incubator (100 rpm), un-induced 
control samples were collected. Protein expression was then induced by adding IPTG, 
to a final concentration of 2 mM, to the bacterial cultures that were subsequently 
incubated for a further 5 hours. Induced samples were taken and the remaining culture 
was centrifuged at 5,000g for 10 minutes. The resulting pelleted bacteria were 
resuspended in 5 ml Binding Buffer 1 (without urea) (Appendix I), sonicated and 
treated as previously described to produce soluble and insoluble proteins fractions. 
SDS-PAGE analysis was carried out to ensure the expression of recombinant proteins 
was successful. Since the three expressed recombinant proteins were insoluble, the 
insoluble proteins fractions were diluted in Binding Buffer 2 (8M urea) (Appendix I) 
and used for protein purification. 
Hexahistidine-tagged tNcSRS44-A, tNcSRS44-C and tNcSRS12A-B proteins, 
encoded by target DNA fragments NCLIV_040495-A, NCLIV_040495-C, 
NCLIV_004430-B respectively, were purified by IMAC using HisPur™ Ni-NTA Spin 
Columns (Thermo Fisher Scientific, Waltham, MA, USA). 
The procedure, was carried out as specified by the manufacturer. Briefly, spin columns 
were previously equilibrated at room temperature for 30 min and washed with 6 ml 
Equilibration buffer (Appendix I) removed by centrifugation. All centrifugation steps 
were carried out at 700g for 2 min at room temperature. The protein extract was 
combined with an equal volume of Equilibration Buffer (200mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole in PBS [pH 7.4]) mixed thoroughly with the resin contained 
in the spin column, and incubated 30 min on an end-over-end mixer, at room 




columns were then centrifuged to remove supernatant and washed three times with 6 
ml Denaturing Wash Buffer (8M urea, 25mM imidazole in PBS [pH 7.4]) (Appendix 
I). After each centrifugation step the flow troughs were collected and stored separately. 
Elution was performed using Denaturing Elution Buffer (8M urea, 250mM imidazole 
in PBS [pH 7.4]) (Appendix I) in three sequential steps after each of which the eluted 
fraction was collected. The solutions resulting from the three washes and the three 
sequential elution steps were analysed with SDS-PAGE to ensure that no other 
proteins of bacterial origin had been eluted. 
In order to verify that the visualised protein bands were actually the polyHistidine-
tagged fusion proteins, a WB was carried out using monoclonal anti-polyHistidine 





In order to decrease the concentration of urea and remove the imidazole that may 
interfere with downstream processing of the recombinant protein, the flow through 
obtained from the three elution steps were combined and dialysed. 
Semi-permeable 10kDa dialysis tubing (Sigma-Aldrich, Munich, Germany) was 
boiled and cooled down in ultrapure dH2O twice. After clamping and triple-knotting 
one end, the dialysis tubing was filled with the protein elution, knotted at the other end 
and suspended in 1 l of 4M urea dialysis buffer (Appendix I). The dialysis buffer was 
renewed after 4 hours, changed to 2M urea dialysis buffer overnight, and finally 
changed to 1M urea dialysis buffer (Appendix I) for 4 hours. At each changeover the 
protein solution was visually checked for the presence of precipitate, indicating if the 
protein had become insoluble. After dialysis to 1M urea the protein solution was 
removed from the dialysis tubing and diluted 1:2, 1:5, 1:10 and 1:100 in 1M urea/PBS 










2.2.9 Immunogenicity assessment of recombinant proteins 
 
In order to assess whether the produced recombinant proteins were able to be 
recognised by specific N. caninum IgGs, WBs using a panel of reference sera from 
experimentally and naturally N. caninum infected cattle were carried out. 
 
2.2.9.1 N. caninum reference sera 
Acute infection (tachyzoite positive) 
Serum samples from Aberdeen Angus cross cattle experimentally infected with 5108 
N. caninum tachyzoites (NC-1 strain) administered subcutaneously during gestation 
(Benavides et al., 2012) were regarded as representative of acute infection. All serum 
samples used were collected 21 days post-infection and tested ELISA positive with a 
commercial test (IDEXX Neospora Ab Test, IDEXX Laboratories, Westbrook, ME, 
USA) according to the manufacturer’s cut-off values. A pool of 4 serum samples was 
tested by WB analysis. 
Persistent infection (bradyzoite positive) 
The serum of a naturally infected cow that repeatedly tested serologically negative, 
but from which N. caninum DNA was isolated from several tissues, was used as 
reference of persistent infection. Besides the absence of antibody titres detectable with 
commercial ELISAs, no cell-mediated responses to N. caninum tachyzoite antigens 
were observed in the lymphoproliferation assay (Benavides et al., 2012). Of relevance, 
antibodies against the recombinant bradyzoite-specific rNcSAG4, but not against 
rNcGRA7, were detected in this cow indicating that the animal was likely to be 
persistently infected (Aguado-Martinez et al., 2008). 
In addition, sera from 4 Holstein-Friesian male calves, sampled 12 months after a 
primary subcutaneous challenge with 1108 N. caninum tachyzoites (NC-1 strain), 
were also deemed to be representative of a persistent infection (Rocchi et al., 2011). 
The sera of these animals also responded positively when tested with the bradyzoite-
specific rNcSAG4 antigen. 
N. caninum negative 
Sera from negative control pregnant cattle used within a N. caninum experimental 
infection study, as well as sera from their foetuses collected and sampled after culling 




tested seronegative and no DNA of the parasite was detected in their tissues. A pool 
of 4 adult serum samples and one individual foetal serum were tested separately in two 
WBs. 
 
2.2.9.2 Western blot analysis 
Recombinant tNcSRS44-A, tNcSRS44-B and tNcSRS12A-B proteins (encoded by 
NCLIV_040495-A, NCLIV_040495-C and NCLIV_004430-B respectively) were 
boiled and electrophoresed by SDS-PAGE under denaturing and reducing conditions 
as previously described (paragraph 2.2.5.2), then transferred onto nitrocellulose 
membranes (Amersham, Ge Health Care Life Sciences, Little Chalfont, UK) by 
electrophoresis at 30V for 1 hour. Denaturing and reducing conditions were the 
optimal choice as the insolubility of tNcSRS44-A, tNcSRS44-B and tNcSRS12A-B 
would have hindered any attempt in purifying them under native conditions (Bornhorst 
and Falke 2000). 
After blocking with 4% w/v dried skimmed milk in PBS-T for 1 hour, nitrocellulose 
membranes were washed for 5 minutes in wash buffer (PBS 0.5% Tween® 80, 0.5 M 
NaCl) (Appendix I) three times and probed with reference sera diluted 1:200 in 2% 
w/v dried skimmed milk in PBS-T. Following 1 hour of incubation, the excess of 
serum was removed with three 5 min washes with wash buffer. Subsequently, horse-
radish peroxidase-conjugated rabbit anti-bovine IgG (αBovIgG-HRP) (Sigma-
Aldrich, Munich, Germany) was applied diluted 1:1,000 in PBS- T for 1 hour, 
membranes were rewashed as described previously and incubated for another 5 min 
with SuperSignal™ West Pico Chemiluminescent Substrate (Thermo Fisher 
Scientific, Waltham, MA, USA) and visualised on ImageQuant (Ge Health Care 
Life Sciences, Little Chalfont, UK). All incubation steps were performed at room 
temperature on an orbital shaker. 
 
2.2.10 Specificity of recombinant antigens 
 
Given the high predicted similarity between some of the recombinant N. caninum 
antigens and their homologous or orthologous T. gondii proteins, cross-reactivity was 
considered a likely occurrence. Recombinant N. caninum-derived proteins were tested 




from T. gondii seropositive cattle. Sera were collected from 5 Holstein Friesian calves 
orally infected with 1106 T. gondii (M4 strain) oocysts, 28 days post-infection. 
Seroconversion was confirmed through T. gondii ELISA (ID Screen® Toxoplasmosis 
indirect, IDVet, Montpellier, France) and modified agglutination test (MAT) (Dubey 
and Desmonts 1987). Reciprocal T. gondii antibody titres were 800 in one calf and 
1,600 in the other four calves when tested with MAT (Burrells et al., in preparation). 
The sera were kindly provided by Dr Alison Burrells (Moredun Research Institute). 
In order to exclude concurrent infection with N. caninum or the presence of anti-N. 
caninum antibodies of colostral origin, all calves were N. caninum ELISA tested (ID 
Screen® Neospora caninum indirect multispecies, IDVet, Montpellier, France) before 
using them in the present study and they were all negative. 
 
2.2.11 Quantification of recombinant proteins 
 
The concentration of recombinant antigens dissolved in 1 M urea was determined 
using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, 
USA). According to the manufacturer’s protocol, standard solutions of 1,000 μg/ml, 
750 μg/ml, 500 μg/ml, 250 μg/ml, 200 μg/ml, 100 μg/ml, 50 μg/ml, 25 μg/ml, 12.5 
μg/ml and 0 μg/ml bovine serum albumin (BSA) were prepared diluting the 2 mg/ml 
stock in 1M urea. These, as well as neat, 1:2, 1:5, 1:10 and 1:50 dilutions of the 
recombinant proteins were combined with the reagents provided and plated out in 
triplicate onto a 96-well flat bottomed microtitre plate. After 30 min incubation at 
37°C, the OD540 were measured on a plate reader (Dynex Technologies Headquarters, 
Chantilly, VA, USA). Recombinant proteins were diluted to a final concentration of 





Only recombinant tNcSRS44-A and tNcSRS12A-B that showed immunoreactivity 
when tested with N. caninum positive tachyzoite and bradyzoite sera, in the WB, were 
used for the development of indirect ELISAs. 
In order to establish the optimal working conditions, the 200 µg/ml stock solutions of 




1:200 (0.1 µg/100µl), 1:400 (50 ng/100µl), 1:800 (25 ng/100µl) and 1:1,600 (12.5 
ng/100µl) in coating buffer (0.1 M carbonate-bicarbonate buffer, [pH 9.6]). A 
checkerboard template was created to evaluate different concentrations of sera and 
secondary antibodies in relationship to different concentrations of coating antigen. 
One hundred microliters of coating antigen dilution per well were added to 96 well 
High Binding M129B ELISA polystyrene microtitre plates (Greiner Bio-One GmbH, 
Kremsmünster, Austria) and incubated at 4°C overnight. Similarly, a polyhistidine-
tagged NcSRS2 recombinant protein was used to coat part of each plate as a positive 
coating control. 
Coated plates were washed six times with PBS containing 0.05% Tween® 20 (PBS-
T) and blocked with 150 µl/well 4% w/v dried skimmed milk for 1h at 37°C. Plates 
were then washed twice with PBS-T and 100 µl cattle serum diluted 1:200 and 1:500 
in 2% w/v dried skimmed milk were added to duplicate wells. Initially three reference 
sera were tested: N. caninum tachyzoite positive, putatively bradyzoite positive and a 
N. caninum seronegative control (see reference sera Paragraph 2.2.9.1). After 
incubation for 1h at 37°C, plates were washed six times with PBS-T and incubated for 
another hour with 100 µl/well horse-radish peroxidase-conjugated rabbit anti-bovine IgG 
(αBovIgG-HRP) (Sigma-Aldrich, Munich, Germany) diluted 1:1,000 or 1:2,000 in 
PBS-T. Plates were washed six times with PBS-T and 100 µl/well SureBlue™ TMB 
(3,3’,5,5’-tetramethylbenzidine) Microwell Peroxidase Substrate (KPL, Gaithersburg, 
MD, USA) were added. Reactions were left to develop for 5 min at room temperature 
in the dark and stopped by adding 100 µl/well 0.1 M HCl. Absorbance values were 
read at 450 nm (OD450). 
 
2.2.13 ELISA using Nickel-chelate plates 
 
Immobilisation of 6His-tagged proteins onto microtitre plates can also be achieved 
using plates coated with nitrilotriacetic acid covalently modified to display divalent 
nickel ions (Ni2+), based on the same principle that enables purification (Paragraph 
2.2.4.2). 
Nunc Immobilizer™ Nickel-Chelate 96 well plates (Thermo Fisher Scientific, 
Waltham, MA, USA) were firstly washed four times with approximately 200 µl of 




µg/100 µl in coupling buffer (0.01 M KCl) were then dispensed into the wells and the 
plates incubated at 4°C overnight. After incubation, plates were rinsed four times with 
PBS-T and used for carrying out ELISAs as described in Paragraph 2.2.12. 
6His-tagged NcSRS2 recombinant protein, previously synthesised, was used to coat 
part of each plate as a positive coating control to check the validity of the protocol 
used. Overnight incubation with only coupling buffer provided a negative coating 
control. 
 
2.2.14 GST-fusion protein expression 
 
Expression of tNcSRS44-A and tNcSRS12A-B was attempted using the GST-fusion 
system. 
Glutathione-S-transferase (GST) from Schistosoma japonicum is a 26 kDa protein and 
is widely used as an affinity fusion partner for the purification of recombinant proteins. 
When positioned at the N-terminal end of recombinant proteins it aids the production 
of soluble products in E. coli. GST also protects the target protein from proteolytic 
degradation stabilising it into the soluble fraction. 
Gene fragments similar to those encoding tNcSRS44-A and tNcSRS12A-B 
(NCLIV_040495 and NCLIV_004430 respectively) were identified depending on 
their suitability for insertion into the pGEX vectors (i.e. absence of intra-sequence 
restriction sites identical to those used for the double digestion during the excision 
stage). Gene-specific primers were designed (Table 2.4) and PCR amplification from 
N. caninum genomic DNA was carried out as previously described (Paragraph 2.2.3). 
Initial cloning into pGEM-T Easy Vector System (Promega, Madison, WI, USA) 












Table 2.4 – Gene-specific primers of NCLIV_040495 and NCLIV_004430 designed for 
cloning into the pGEX-5x-1 vector, restriction sites added at the 5’ end of each primer, 
optimum annealing temperatures (Ta) and predicted amplicon sizes.  

































2.2.14.1 Cloning into pGEX 
 
GST-fusion protein expression constructs were generated by inserting the DNA 
fragments of interest into the multiple cloning site of the pGEX-5X-1 vector (Ge 
Health Care Life Sciences, Little Chalfont, UK). Double digestions using relevant 
restriction enzymes (Table 2.4) (New England BioLabs, Ipswich, MA, USA) were 
performed as previously described (Paragraph 2.2.4.2) and ligation of DNA inserts 
(amplicons shown in Table 2.4) into the pGEX-5X-1 vector carried as for 
manufacturer’s specifications. BL21 (DE3) competent E. coli were transformed with 
the insert/vector construct. Transformed bacteria were plated onto LB agar plates 
containing ampicillin (100 g/ml) and incubated at 37C, 5% CO2 overnight. Single 
colonies were then screened by colony PCR as described previously. PCR positive 
colonies were propagated by overnight culture in L-Broth/10mM 
MgCl2/ampicillin(100 g/ml)/0.2% glucose and glycerol stocks made for long-term 
storage. Plasmid DNA was isolated and sequenced using the pGEX forward and 
reverse primers (Eurofins Genomics, Ebersberg, Germany) as indicated by the 
manufacturer of the expression system. All gene targets listed in table 2.4 were 







2.2.14.2 Protein expression in E. coli strain BL21 (DE3) 
 
Five ml aliquots of L-Broth/MgCl2 10mM /ampicillin (100 g/ml)/0.2% glucose, pre-
warmed at 37C, were inoculated with 50 l of transformed BL21 (DE3) E. coli 
previously revived in overnight culture. Cultures of BL21 (DE3) E. coli transformed 
with the pGEX-5X-1 plasmid vector without any insert were also set up. Induction of 
protein expression in these bacteria leads to the production of the 26 kDa GST-tag that 
served as a protein expression control. 
Bacterial cultures were incubated at 37C in shaking incubator with vigorous shaking 
(200 rpm) until the optical density measured at 600 nm (OD600) reached 0.7 (about 2 
hours) before collecting a 1 ml un-induced sample (un-induced control). Protein 
expression was then induced by adding IPTG at a final concentration of 2 mM. Induced 
samples 1 and 2 were collected after 2 and 4 hours’ incubation respectively. Un-
induced control, induced samples 1 and 2 were treated and analysed with SDS-PAGE, 
to verify GST-fusion protein expression, as previously described (Paragraph 2.2.5.2). 
The residual bacterial culture was centrifuged at 2,000g for 5 min and the resulting 





















2.3.1 Expression of candidate genes using the pQE-30 vector 
 
Three of the newly designed gene fragments, tNcSRS44-A (Figure 2.5 lanes 2 and 3) 
tNcSRS44-C (Figure 2.5 lanes 5 and 6) and tNcSRS12A-B (Figure 2.5 lanes 8 and 9) 
were expressed in transformed E. coli strain M15 [pREP4]. The truncated recombinant 
proteins produced were denominated based on the homologous or orthologous proteins 
expressed in T. gondii as suggested by Howe and Sibley (Howe and Sibley 1999). 
Protein expression of the other candidate N. caninum gene regions, shown in Table 
2.3, was not achieved due to difficulties during one of the phases leading to 
recombinant protein production (Table 2.5). Most of the problems occurred due to 
incorrect sequences inserted into the pQE-30 vector, observed after sequencing. 
Unsuccessful steps were repeated; in the case of repeated failure, target gene regions 





















Table 2.5 – Progression of candidate gene regions towards recombinant protein production. 
✓- achieved step, ✗- failed step. Gene regions that were successfully expressed as 
recombinant proteins are shaded in yellow. 















NCLIV_004430-A ✓ ✓ ✓ ✓ ✓ ✗ 
NCLIV_004430-B 
(tNcSRS12A-B) 
✓ ✓ ✓ ✓ ✓ ✓ 
NCLIV_004430-C ✓ ✓ ✓ ✗ ✗ ✗ 
NCLIV_038900 ✓ ✓ ✓ ✗ ✗ ✗ 
NCLIV_053310 ✓ ✓ ✓ ✗ ✗ ✗ 
NCLIV_019580 ✓ ✓ ✓ ✓ ✓ ✗ 
NCLIV_023620 ✓ ✓ ✓ ✗ ✗ ✗ 
NCLIV_040495-A 
(tNcSRS44-A) 
✓ ✓ ✓ ✓ ✓ ✓ 
NCLIV_040495-B ✓ ✓ ✓ ✗ ✗ ✗ 
NCLIV_040495-C 
(tNcSRS44-C) 
✓ ✓ ✓ ✓ ✓ ✓ 
NCLIV_005760 ✓ ✓ ✓ ✓ ✓ ✗ 
 
 
Proteins tNcSRS44-A and tNcSRS44-C are regions of the locus CEL68278 
(www.ncbi.nlm.nih.gov/genbank/) currently defined TPA (Third-Party Annotation) 
DNA polymerase, related [Neospora caninum Liverpool]. Originally submitted as 
NCLIV_040495 and annotated as SAG-related sequence (SRS) domain containing 
protein (http://www.toxodb.org) (Reid et al., 2012), the sequence underwent 
resequencing and reannotation with reclassification of the predicted product 
(Ramaprasad et al., 2015) after it was selected and expressed as a candidate antigen 
within this work. tNcSRS44-A and tNcSRS44-C comprised 198 (positions 2 to 199) 
and 197 (positions 654 to 850) amino acids respectively within a 2,368 amino acids-
long sequence (accession n. CEL68278) that showed high similarity with TgSRS44 
(CST1) (accession n. KFG38379). Overall the proteins encoded by CEL68278 and 




displayed 74% (147/199) and 72% (141/197) amino acid identities respectively with 
the homologous regions in the T. gondii CST1 protein (Figure 2.4). 
The other expressed antigen, tNcSRS12A-B, is a 170 (positions 23 to 192) amino acid 
long peptide belonging to the NCLIV_004430 locus (accession n. XP003879997) 
sharing 47% (80/170) amino acid identity with its orthologue in the T. gondii genome 
TgSRS12A (Reid et al., 2012) (Figure 2.4). After reannotation, the predicted product 
of NCLIV_004430 remained unchanged: SRS-domain containing protein. 
The successful expression of tNcSRS44-A (Figure 2.5 lanes 2 and 3), tNcSRS44-C 
(Figure 2.5 lanes 5 and 6) and tNcSRS12-B (Figure 2.5 lanes 8 and 9) was confirmed 
by SDS-PAGE analysis. Protein bands, that were consistent with the predicted 
molecular weights for tNcSRS44-A, tNcSRS44-C and tNcSRS12-B (23, 25 and 
19kDa respectively), were observed 2 (Figure 2.5 lanes 2, 5 and 8) and 4 hours (Figure 
2.5 lanes 3, 6 and 9) after induction of E. coli M15 [pREP4] with IPTG. Such bands 
























tNcSRS44-A      KRIDVVSTEGSQRFECPVDSVLFPEQA-TGDSQSATVFAVGADDSCNIFDQPSRLGDLIP 
TgSRS44         KKIEVIHGSEGARFECPVESVLLPEQAMSGDIRAATVFAVAADGSCNIFDPPSLLGDVVP 
                *.*:*:  . . ******:***:**** :** .:******.**.****** ** ***::* 
 
tNcSRS44-A      GASLQEELSVTADSATKAYTLVIPGLPSKVVKLCYVCVHTDNPEDSQVVVITVGRAGDGE 
TgSRS44         GAYLQEELSVNADKAAKTYTLVIPGLPAKEVKLCYVCAHPDNPAGSQVTVITVRRSGDSE 
                ** *******.**.*:*:*********:* *******.*.*** .***.**** *:**.* 
 
tNcSRS44-A      RGIPASAPVCKPSFSLEAWALGVRQPEVVLDVTAPGQSVRFSCLSDATVFPHEAGARSAP 
TgSRS44         NGNPASSPVCRPSFSLEAWALGVRQPSVVLDVAAPGQSVRFSCLSTATELPSEAGARPAP 
                .* ***:***.***************.*****:************ ** :* *****.** 
 
tNcSRS44-A      TQVYPVDGRGWCDLSRGSS- 
TgSRS44         AQVYPVNGRGWCDLSKGPSS 
                :*****:********.*.* 
 




tNcSRS44-C      HTTLDNGEVTRKYTLTVEQLPGTPKRLCYLCVYNRDVLNSCGVMIDVASNRVGELLEQNE 
TgSRS44         ETAVDASEITTKYTFTVKQLPKTPKKLCYLCVYNRDVMNSCGVLIDVSSNSMTRLSKTSE 
                 *::* .*:* ***:**:*** ***.***********:*****:***:** :  * : .* 
 
tNcSRS44-C      DKIEPDQTVPSTVELQCPPDYSAHTAATGLRLPEMELLVDSANRTVRFICPDDSSVFPEV 
TgSRS44         EGIHTNPTVPTTLELQCPPDYSARTAATGLRLPEMELLVDSVNRTARFVCPDDSSVFPEI 
                : * .: ***:*:**********.*****************.***.**:**********: 
 
tNcSRS44-C      DEVADPPSGKVYRVAGDSCDTREETTLLRDEVPGAELRKRILVEGGVVQRFYTFTAERLP 
TgSRS44         DGEADPASGKVYRMTGDSCDTREETAFLQDEVPGAELQRRTVVDGGVVQRYYIFKASRLP 
                *  ***.******::**********::*.********..* :*:******:* *.*.*** 
 
tNcSRS44-C      AEDRRLCYLCVRQRNPA 
TgSRS44         EEDKKLCFLCVRQRNPA 
                 **..**:********* 
 




tNcSRS          AVCLDGVLLFSNGGAVAGDPVEGLLRRELSPDSSDAQGESGIAGVVATCTVASSGDAVTR 
TgNcSRS12A      AVCLSGVLLFSSGNTIAAESFEGLLRRNLSSGGNSNGAESVTPEIVATCPATSEGATAPV 
                ****.******.*.::*.:..******:**.....  .**  . :****..:*.* :.. 
 
tNcSRS          PATTLTLSSSTLVATLECMGQSMKALPADAATVCVA-EATASKELNSSNCSIGDTSMGNP 
TgNcSRS12A      PA-TLTLSKSSLTATVKCLDASHTAVPATATNVCVASDADVNGASDSESCIIGSSGGGKP 
                ** *****.*:*.**::*:. * .*:** *:.**** :* ..   :*..* **.:. *:* 
 
tNcSRS          VKLQELLGTNDPVQWKAISSSDGKNQGESRMLELSEASLPRTDKKFMVGCQ 
TgNcSRS12A      VTLQSLLEATHPISWTEKPASSDSQTGKERTLQLTETDLPRTDKTFFVGCQ 
                *.**.** :. *:.*.  .:*...: *:.* *:*:*:.******.*:**** 
 
Identities 80/170 (47%)  Gaps 1/170 (0%) 
 
Figure 2.4 – Amino acid sequence alignment of (A) tNcSRS44-A (NCLIV_040495-A) (B) 
tNcSRS44-C (NCLIV_040495-A) with their homologous regions in TgSRS44 
(TGME49_264660) and (C) tNcSRS12A-B (NCLIV_004430-B) with the orthologue 
TgSRS12A (TGME49_321490). (*) fully conserved residue, (:) conservation between groups 
of amino acids with strongly similar properties, (.) conservation between groups with weakly 









     
 
Figure 2.5 – SDS-PAGE showing protein expression of tNcSRS44-A (lanes 2 and 3), 
tNcSRS44-C (lanes 5 and 6), tNcSRS12A-B (lanes 8 and 9). M – molecular weight marker; 
lanes 1,4 and 7 – uninduced controls; lanes 2, 5 and 8 – IPTG induced (2 hours after induction); 
lanes 3, 6 and 9 – IPTG induced (4 hours after induction). (1) tNcSRS44-A (23 kDa), (2) 
tNcSRS44-C (25 kDa), (3) tNcSRS12A-B (19 kDa). 
 
 
2.3.2 Solubility assessment 
 
Proteins tNcSRS44-A, tNcSRS44-C and tNcSRS12A-B were insoluble in aqueous 
buffers that did not contain solubilising agents. SDS-PAGE analysis showed that all 
target proteins were detectable in the supernatant deriving from resuspension of 
sonicated bacterial pellets in Binding Buffer 1 containing urea (insoluble fraction), but 
not in the supernatant after resuspension in Binding Buffer 2 without urea (soluble 
fraction) (Figure 2.6). 
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Figure 2.6 – SDS-PAGE showing the solubility/insolubility profiles of tNcSRS44-A, 
tNcSRS44-C and tNcSRS12A-B. All the truncated recombinant proteins were found within 
the insoluble fractions. M – molecular weight marker; lanes 1, 4 and 7 – induced bacterial 
cultures; lanes 2, 5 and 8 – soluble fractions (supernatant of bacteria resuspended in Binding 
Buffer without urea); lanes 3, 6 and 9 – insoluble fractions (supernatant of sonicated bacteria 
resuspended in Binding Buffer 8M urea). (1) tNcSRS44-A (23 kDa), (2) tNcSRS44-C (25 
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2.3.3 Purification of expressed proteins 
 
Purity of tNcSRS44-A (Figure 2.7), tNcSRS44-C and tNcSRS12A-B (Figure 2.8) was 
verified by SDS-PAGE analysis following IMAC purification. The absence of 
additional visible bands, indicated that the target recombinant proteins were free from 
major protein contaminations of bacterial origin. 
 
                                         
 
Figure 2.7 – SDS-PAGE showing purified tNcSRS44-A. Lane 1 – un-induced control; lanes 
2, 3 and 4 – flow-through obtained from three sequential washes of the HisPur™ Ni-NTA 
Spin Columns; lanes 5, 6, 7 – flow-through obtained from three sequential elution steps; lane 
8 – control supernatant before urea treatment (soluble fraction). M – molecular weight marker. 
(1) tNcSRS44-A (23 kDa). 
                                               
 
Figure 2.8 – SDS-PAGE showing purified tNcSRS12A-B. Lane 1 – un-induced control; lanes 
2, 3 – flow-through obtained from two sequential washes of the HisPur™ Ni-NTA Spin 
Columns; lanes 4, 5 – flow-through obtained from two sequential elution steps; lane 6 – control 
supernatant before urea treatment (soluble fraction). M – molecular weight marker. (3) 
tNcSRS12A-B (19 kDa). 
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2.3.4 Immunoreactivity assessment of recombinant proteins 
 
Proteins tNcSRS44-A and tNcSRS12A-B were found to be immunoreactive showing 
clearly visible bands in WBs (Figures 2.9, 2.10 B and 2.11 B) when assayed using 
serum samples from cattle considered persistently infected with N. caninum that tested 
negative with tachyzoite antigens-based serological tests (bradyzoite antigens positive 
animals). Weaker immunoreactivity was observed in the tNcSRS44-C-based WB as 
indicated by faint bands (Figure 2.9, lanes 5 and 6). Due to the weaker 
immunoreactivity of tNcSRS44-C, further analyses were carried out using tNcSRS44-
A and tNcSRS12A-B only. 
Reduced immunoreactivity of N. caninum-specific antibodies produced during acute 
infection (tachyzoite antigens positive animals) was observed for both tNcSRS44-A 
and tNcSRS12A-B as indicated by the low intensity bands in Figures 2.10 B and 2.11 
B (lanes 2) with the latter showing a slightly higher band intensity. 
As shown in Figures 2.10 B and 2.11 B low levels of antigen detection were observed 
when a pool of four sera from adult, putatively uninfected, cattle (lanes 3) was assayed 
in the tNcSRS44-A and tNcSRS12A-B-based WB analysis, respectively. Very low 
binding with specific antibodies, with hardly any visible bands, was observed when 
the serum of the foetus from an uninfected dam was used as a negative control serum 
(lanes 4). 
Following dialysis of the recombinant proteins solubilised in urea, additional bands 
were observed in SDS-PAGE (Figures 2.10 A and 2.11 A) and consequently 
transferred to the WB (Figures 2.9, 2.10 B and 2.11 B) analysis. The molecular masses 
of these protein bands were consistent with those of dimers, trimers, tetramers and 
bigger multimers of tNcSRS44-A and tNcSRS12A-B that may have formed following 
the decrease of the urea concentration in the solubilising buffer following dialysis 
(Figures 2.9 and 2.10). In addition, the protein bands were confirmed to be 6His-
tagged proteins as they were recognised by monoclonal anti-polyHistidine antibodies 





                                         
Figure 2.9 – Western blot showing the immunoreactivity of tNcSRS44-A (lanes 1, 2 and 3), 
tNcSRS44-C (lanes 4, 5 and 6) and tNcSRS12A-B (lanes 7, 8 and 9) when assayed with the 
serum of a persistently infected cow that tested negative with ELISAs based on tachyzoite 
antigens (bradyzoite positive sera). Lanes 1, 4 and 7 – control supernatant after urea 
solubilisation (insoluble fraction) and IMAC removal of target protein; lanes 2, 5 and 8 - 
recombinant protein obtained from the first elution step; lanes 3,6 and 9 - second elution step. 
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Figure 2.10 – SDS-PAGE analysis showing dialysed tNcSRS44-A (A) and Western blot 
based on tNcSRS44-A (B). 1 – Bradyzoite positive: serum from a N. caninum persistently 
infected cow that tested seronegative with current commercial serological tests (IDEXX 
Neospora Ab Test, IDEXX Laboratories, Westbrook, ME, USA, and IDScreen® Neospora 
caninum indirect multi-species ELISA, IDVet, Montpellier, France); 2 – Tachyzoite positive: 
pool of 4 sera of acutely N. caninum infected cattle that tested seropositive with current 
commercial tests; 3 – Negative control 1: pool of 4 sera of putatively uninfected cattle that 
tested seronegative with current tests; 4 – Negative control 2: individual serum sample from 
the foetus of a seronegative cow; 5 – Anti-polyHistidine-peroxidase mouse monoclonal 
antibodies. M – molecular weight marker. (1) tNcSRS44-A (23 kDa). 
 
 
Figure 2.11 – SDS-PAGE analysis showing dialysed tNcSRS12A-B (A) and Western blot 
based on tNcSRS12A-B (B). 1 – Bradyzoite positive: serum from a N. caninum persistently 
infected cow that tested seronegative with current commercial serological tests (IDEXX 
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caninum indirect multi-species ELISA, IDVet, Montpellier, France); 2 – Tachyzoite positive: 
pool of 4 sera of N. caninum acutely infected cattle that tested seropositive with current 
commercial tests; 3 – Negative control 1: pool of 4 sera of putatively uninfected cattle that 
tested seronegative with current tests; 4 – Negative control 2: individual serum sample from 
the foetus of a seronegative cow; 5 – Anti-polyHistidine-peroxidase mouse monoclonal 
antibodies. M – molecular weight marker. (3) tNcSRS12A-B (19 kDa). 
 
 
2.3.5 Specificity of expressed antigens 
 
Five T. gondii seropositive bovine serum samples were pooled and used to test the 
tNcSRS44-A and tNcSRS12-B antigens applying the same conditions (antigen 
concentration of 200 µg/ml and sera dilution 1:200) used for testing the N. caninum 
reference sera. In addition, the soluble fraction of T. gondii (strain M4) tachyzoite 
lysate was used to confirm the presence of T. gondii-specific antibodies in the T. gondii 
reference sera (Figure 2.12 C). 
As shown in Figure 2.12 A and B, no detection of the recombinant N. caninum antigens 
by T. gondii-specific IgG antibodies (lanes 3) was observed. tNcSRS44-A and 
tNcSRS12A-B-based WBs were tested with the serum of a persistently infected cow (Figure 
2.12 A and B, lanes 1) and with the pool of four N. caninum antibody negative sera 





Figure 2.12 – Western blots showing the specificity of tNcSRS44-A (A) and tNcSRS12A-B 
(B). 1 – Positive control 1: serum from a N. caninum persistently infected cow that tested 
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Laboratories, Westbrook, ME, USA, and IDScreen® Neospora caninum indirect multi-species 
ELISA, IDVet, Montpellier, France); 2 – Negative control: pool of 4 sera of putatively 
uninfected cattle that tested seronegative with current tests; 3 – T. gondii positive: pool of 5 
sera from T. gondii experimentally infected and seropositive cattle. (1) tNcSRS44-A (23 kDa), 
(3) tNcSRS12A-B (19 kDa). (C) Positive control 2: T. gondii (strain M4) tachyzoite lysate-




2.3.6 Development of ELISAs based on the recombinant antigens 
tNcSRS44-A and tNcSRS12A-B 
 
2.3.6.1 Optimisation of ELISA variables 
Recombinant tNcSRS44-A and tNcSRS12A-B were used to set up serum antibody 
ELISAs. Checkerboard titrations were used to determine the best combinations of 
antigen concentrations, reference sera dilutions and secondary antibody (αBovIgG-
HRP) dilutions. OD450 values obtained using two representative coating antigen 
concentrations (0.4 and 0.2 g/100l) associated with two sera (1:50 and 1:100) and 
two conjugate (1:2,000 and 1:4,000) dilutions are shown in Figure 2.13 and 2.14. 
Subtracting the values obtained for the blank wells, the optical densities obtained for 
the reference sera from persistently (bradyzoite positive) and acutely (tachyzoite 
positive) infected N. caninum cattle were not indicative of specific antibody 
recognition when compared to those of the negative control. However, the overall 
validity of the protocol used was confirmed by the clearly positive results obtained 
testing a pool of sera from acutely infected animals with an in-house NcSRS2 ELISA 
that was simultaneously carried out on the same plate. Figures 2.13 and 2.14 show 
representative examples of several different repeated experiments. 
In order to evaluate the possible non-adherence of the coating antigens to the 
polystyrene plates as a cause of ineffectiveness of the assays, checkerboard titrations 
analyses using monoclonal anti-polyHistidine peroxidase conjugated antibodies 
(diluted 1:100, 1:200, 1:500, 1:1,000, 1:2,000) were carried out to detect the presence 
of the coating antigens. Strongly positive OD450 values were observed with all 
dilutions of the monoclonal antibodies tested demonstrating that the plates were 





2.3.6.2 ELISA using Nickel-Chelate plates 
The use of Nunc Immobilizer™ Nickel-Chelate 96 well plates was also investigated 
to assess whether a more organised binding to the plate (6His-tagged recombinant 
proteins should bind through the N-terminal end that displays the 6His-tag) could 
enable the detection of specific antibodies. Nonetheless, no improvement of the assay 
was observed as shown in Figure 2.15. In comparison to the 6His-tagged NcSRS2 
recombinant antigen, that detected specific antibodies in the serum of acutely infected 
cattle, no such recognition was observed when the novel tNcSRS44-A and 
tNcSRS12A-B were used to coat the plates following the same protocol. Figure 2.15 







    tNcSRS44-A NcSAG2 


























A 0.039 0.146 0.084 0.148 0.104 0.063 0.117 0.422 0.192 2.274 
B 0.049 0.147 0.090 0.150 0.109 0.060 0.119 0.411 0.184 2.200 
1:4,000 
C 0.038 0.112 0.072 0.119 0.090 0.060 0.096 0.334 0.136 1.739 
D 0.054 0.116 0.072 0.109 0.089 0.050 0.094 0.326 0.138 1.790 
1:100 
1:2,000 
E 0.062 0.076 0.044 0.165 0.051 0.028 0.117 0.187 0.089 1.750 
F 0.039 0.058 0.048 0.164 0.068 0.026 0.117 0.190 0.089 1.740 
1:4,000 
G 0.041 0.044 0.023 0.239 0.039 0.022 0.093 0.145 0.063 1.326 




Figure 2.13 – ELISA checkerboard analysis to determine the optimal combinations of coating antigen tNcSRS44-A (columns), serum dilution (1:50 and 
1:100) and secondary antibody (αbovIgG HRP) (1:2,000 and 1:4,000) (rows). In this example, the coating antigen was tested at the concentration of 
0.4µg/100µl and 0.2 µg/100µl. Results are expressed in OD450 values. 
Neg – pool of 4 sera from N. caninum putatively uninfected cattle; B+ – serum from a N. caninum infected cow that tested negative with tachyzoite 
antigen-based commercial serological tests (bradyzoite positive); T+ – pool of 4 sera from N. caninum acutely infected cattle (tachyzoite positive). The 
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A 0.041 0.184 0.112 0.101 0.125 0.092 0.074 0.419 0.225 2.304 
B 0.051 0.183 0.134 0.104 0.125 0.078 0.075 0.422 0.193 2.323 
1:4,000 
C 0.045 0.144 0.095 0.072 0.096 0.065 0.057 0.319 0.152 1.811 
D 0.045 0.158 0.097 0.078 0.109 0.065 0.059 0.245 0.134 1.795 
1:100 
1:2,000 
E 0.049 0.082 0.051 0.082 0.063 0.051 0.061 0.186 0.082 1.696 
F 0.046 0.083 0.05 0.07 0.067 0.037 0.058 0.167 0.131 1.719 
1:4,000 
G 0.036 0.051 0.041 0.057 0.045 0.03 0.048 0.149 0.068 1.397 




Figure 2.14 – ELISA checkerboard analysis to determine the optimal combinations of coating antigen tNcSRS12A-B (columns), serum dilution (1:50 
and 1:100) and secondary antibody (αbovIgG HRP) (1:2,000 and 1:4,000) (rows). In this example each coating antigens was tested at the concentration 
of 0.4µg/100µl and 0.2 µg/100µl. Results are expressed in OD450 values. 
Neg – pool of 4 sera from N. caninum putatively uninfected cattle; B+ – serum from a N. caninum infected cow that tested negative with tachyzoite 
antigen-based commercial serological tests (bradyzoite positive); T+ – pool of 4 sera from N. caninum acutely infected cattle (tachyzoite positive). The 






    tNcSRS44-A tNcSRS12A-B NcSAG2 


























A 0.075 0.149 0.105 0.199 0.117 0.107 0.113 0.179 0.135 1.651 
B 0.065 0.130 0.099 0.194 0.124 0.118 0.119 0.168 0.141 1.688 
1:4,000 
C 0.064 0.119 0.093 0.133 0.107 0.094 0.085 0.130 0.094 1.049 
D 0.061 0.113 0.088 0.141 0.090 0.101 0.075 0.136 0.092 1.150 
1:100 
1:2,000 
E 0.059 0.097 0.083 0.115 0.102 0.089 0.103 0.117 0.082 0.822 
F 0.060 0.093 0.085 0.106 0.121 0.091 0.099 0.112 0.083 0.860 
1:4,000 
G 0.060 0.088 0.073 0.109 0.086 0.082 0.071 0.095 0.083 0.516 




Figure 2.15 – ELISA checkerboard analysis using Nunc Immobilizer™ Nickel-Chelate plates to determine the optimal combinations of serum dilution 
(1:50 and 1:100) and secondary antibody (αbovIgG HRP) (1:2,000 and 1:4,000) (rows). In this example the novel recombinant antigens were tested at the 
concentration of 0.2 µg/100µl. 
Neg – pool of 4 sera from N. caninum putatively uninfected cattle; B+ – serum from a N. caninum infected sera and conjugate (αbovIgG HRP) dilutions 
were used. Results are expressed in OD450 values cow that tested negative with tachyzoite antigen-based commercial serological tests; T+ – pool of 4 sera 
from N. caninum acutely infected cattle. The same reference sera were tested with an in-house NcSRS2 ELISA (6xHistagged) that was run simultaneously 
to the novel antigens, on each plate.
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2.3.7 Expression of candidate genes using the pGEX expression 
system 
 
Since NcSRS44-A and NcSRS12A-B showed promising results within the 
immunoreactivity assessment but were not employable in the ELISA format, the 
production of GST-fusion proteins was considered as an alternative method to help the 
development of functional ELISAs. In order to achieve this, the pGEX expression 
system was used. 
No visible protein expression was observed after induction of BL21 (DE3) E.coli, 
transformed with the pGEX-5X-1 in which the N. caninum gene regions 
NCLIV_004430-D and E (Figure 2.16, lanes 5 and 6) and NCLIV_040495-D and E 
(Figure 2.16, lanes 7 and 8) were inserted. SDS-PAGE analysis showed that, despite 
successful expression of the 26 kDa control GST tag (Figure 2.16, lanes 1 to 4), no 
bands of the predicted molecular masses of the four target GST-fusion proteins (36.2 
(10.2+26), 38.9 (12.9+26), 53.9 (27.9+26) and 46.5 (20.5+26) kDa for tNcSRS12A-D 






Figure 2.16 – SDS-PAGE showing failed expression of tNcSRS12A-D (lane 5), tNcSRS12A-
E (lane 6), tNcSRS44-D (lane 7) and tNcSRS44-D (lane 8) as GST-fusion protein. Lane 1, 2, 
3 and 4 show expression of the GST tag control for each target protein respectively. M – 

































2.4.1 Potential usefulness of tNcSRS44-A and tNcSRS12A-B for the 
identification of cattle persistently infected with N. caninum 
 
One of the main challenges in the serological diagnosis of N. caninum in cattle is the 
detection of those animals that, despite harbouring the parasite, test serologically 
negative with current commercially available tests (Guido et al., 2016). Given the 
epidemiological importance of these individuals, i.e. the ability of maintaining the 
infection over a number of generations in a herd through endogenous vertical 
transmission (Thurmond and Hietala 1997), improved diagnostics may help to control 
the disease more effectively. 
Stage differentiation is a key event in the relationship between N. caninum parasites 
and the animal host (Hemphill et al., 2006). Besides the consequences for the 
pathogenesis and epidemiology of neosporosis, the onset of persistent infections 
sustained by the bradyzoite stage may influence the diagnosis of the disease as 
suggested for the closely related parasite T. gondii (Gross et al., 2004). 
Due to the quiescent nature of the bradyzoite stage, bradyzoite-specific immune 
responses are, in general, expected to be of a lower intensity when compared to those 
elicited by the tachyzoites that multiply actively spreading throughout the body of the 
host. Since bradyzoites are enclosed within tissue cysts, exposure of bradyzoite 
antigens to the effector cells of the host immune system may be limited and recurrent 
rupture of tissue cysts may be necessary to induce detectable immune responses in 
persistently infected animals (Gross et al., 2004). 
N. caninum bradyzoite-specific antigens may be successfully employed for the 
detection of antibodies produced during persistent infection (Aguado-Martinez et al., 
2008). However, none of these bradyzoite-specific antigens have been made 
commercially available to date and serological tools that would enable the reliable 
identification of persistently infected animals are currently lacking in the market. 
Accumulating evidence suggests that recombinant tachyzoite antigens derived from 
N. caninum show adequate specificity and sensitivity when used for the detection of 
specific antibodies produced against the parasite (Wapenaar et al., 2007b). In addition, 
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recombinant proteins are easily produced in large quantities with standardised methods 
(Howe et al., 2002). 
In the present study, bacterial (E. coli) systems for the production of recombinant 
proteins were used. Alternatively, yeast (Pinheiro et al., 2013), insect (Nishikawa et 
al., 2004) or mammalian cell systems might have been used. The metylotrophic yeast 
Pichia pastoris would have had the advantage to promote post-translational 
modification and the expression of soluble recombinant proteins (Cereghino and 
Cregg, 1999). P. pastoris has been used previously to produce N. caninum 
recombinant antigen NcSRS2 (Pinheiro et al., 2013). The same antigen was also 
effectively expressed using Spodoptera frugiperda (Sf9) cells co-transfected with 
recombinant baculovirus and Autographa californica nuclear polyhedrosis virus 
(AcNPV) (Nishikawa et al., 2001). In both studies, the recombinant surface antigens 
produced were successfully employed for the detection of N. caninum-specific 
antibodies in cattle. Furthermore, mammalian systems, such as Chinese hamster ovary 
(CHO) cells have proved to be effective for the expression of the T. gondii 
immunodominant antigen TgSAG1 (Kim et al., 1994). In this study, the recombinant 
antigen showed conformational characteristics which were very similar to the native 
protein (Kim et al., 1994). Nevertheless, most published studies in which recombinant 
N. caninum antigens were produced have used E. coli, since this expression system is 
reliable and cost-effective. 
For these reasons, the identification and testing of novel N. caninum antigens that are 
expressed during the bradyzoite/tissue cyst stage may be an advantageous strategy for 
improving the detection of N. caninum persistently infected animals. 
In the present work, a set of N. caninum DNA sequences putatively encoding antigens 
that are expressed by the bradyzoite stage of the parasite were selected. Sequence 
identification was based on inference from orthologous or homologous sequences in 
the T. gondii genome. The approach was dictated by the necessity of a simple and 
economical strategy that could capitalise on the existing genomic and transcriptomic 
information available for T. gondii and the genomic resources publicly available for 
N. caninum. Since the complete genome sequence is only available for the Liverpool 
strain of N. caninum, additional genome sequences would have helped to select target 
antigens for expression as recombinant proteins. The availability of multiple full 
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genome sequences of different strains of N. caninum would have enabled the selection 
of protein coding regions that are not polymorphic amongst strains, but are distinct 
from T. gondii sequences. 
An alternative method to aid gene selection would be to experimentally assess whether 
the expression profile of each candidate gene was bradyzoite specific. This could have 
been done through the analysis of complementary-DNA (cDNA) generated from 
bradyzoite messenger-RNA (mRNA) obtained from either in vivo or in vitro models 
of stage conversion (Vonlaufen et al., 2004). 
Amongst the selected sequences, tNcSRS44-A and tNcSRS12A-B were expressed as 
recombinant proteins and showed immunoreactivity as they were recognised by 
specific IgGs in sera from persistently and to a lesser extent acutely infected cattle. In 
particular, tNcSRS44-A was recognised almost exclusively by sera from persistently 
infected animals whereas a slightly more intense band in the tNcSRS12A-B-based WB 
may suggest that the assay may also detect specific antibodies in serum samples from 
acutely infected cattle. The immunoreactivity profiles observed suggest that, similar 
to their T. gondii homologue and orthologue counterparts (TgNcSRS44 and 
TgSRS12A) NcSRS44-A and NcSRS12A-B may be expressed by the bradyzoite stage 
of N. caninum. In addition, the observation of a certain degree of recognition from sera 
from acutely infected animals may also suggest that NcSRS12A-B is not exclusively 
expressed by the bradyzoite stage and may be displayed also during the tachyzoite 
stage. However, further investigations are required to confirm stage-expression of 
these antigens. For example, quantitative RT-PCR for the assessment of gene 
expression could be applied on experimental models of persistent infection as 
previously reported for other bradyzoite-specific genes such as NcBSR4 (Risco-
Castillo et al., 2007) and NcSAG4 (Aguado-Martinez et al., 2009) in mice models. 
Furthermore, immunolabelling assays using mono or polyclonal antibodies raised 
against tNcSRS44-A and tNcSRS12A-B could be carried out on N. caninum 
bradyzoites and tissue cysts (Kang et al., 2008b, Kobayashi et al., 2013) in order to 
assess the presence and localisation of the target proteins. These techniques, might also 
help to clarify the nature of tNcSRS44-A. Interestingly, the genic locus encoding 
tNcSRS44-A (accession n. CEL68278) was re-annotated after the fragment was 
cloned and expressed during this study. Formerly annotated as SRS-domain containing 
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protein, the sequence is now listed as predicted DNA-polymerase related protein. 
Surface localisation would suggest that tNcSRS44-A is more likely a surface antigen 
whereas a different (e.g. nuclear) localisation would provide indication of a possible 
relationship with DNA-polymerases. 
In addition to the immunoreactivity with sera from persistently and acutely infected 
cattle, detectable reactivity was observed when serum samples from cattle deemed N. 
caninum negative were tested. Although lower compared to the responses of reference 
sera from infected animals, this finding may suggest either non-specific binding of 
antibodies to the proteins or the presence of the serum of one or more N. caninum 
persistently infected cows within the pool of sera tested. Cross-reactions with antigens 
from related apicomplexans, the animals may have encountered, cannot be completely 
ruled out. 
In one study, insufficient purification of a recombinant dense granule (rNcGRA6) was 
reported to cause false-positive reactions (Jenkins et al., 2005). Following purification, 
the SDS-PAGE page analysis of tNcSRS44-A (Figure 2.7) and tNcSRS12A-B (Figure 
2.8) showed a good degree of purity of the recombinant proteins as indicated by the 
absence of additional protein bands. Therefore, the occurrence of false-positive 
reactions due to contamination was considered unlikely. 
Due to the striking similarities between N. caninum and T. gondii the possibility of 
serological cross-reactivity between the two parasites should be considered when 
developing diagnostic tools. Several cross-reactive antigens, located either on the 
surfaces of the parasites or within organelles, have been reported and characterised 
using monoclonal antibodies produced against N. caninum (Liao et al., 2005). In a 
proteomic study, using two-dimensional gel electrophoresis (2-DE) and 
immunoblotting with sera from rabbit immunised with N. caninum (strain KBA-2), a 
number of cross-reactive proteins such as heat shock protein 70 (HSP70), the protein 
disulphide isomerase (PDI), tubulin, actin α and β chains and enolase were identified 
(Lee et al., 2005). In addition, ELISAs based on crude N. caninum tachyzoite antigens 
show different degrees of cross-reactivity with T. gondii when used for the 
serodiagnosis of canine neosporosis (Silva et al., 2007). Interestingly, in one 
immunohistological study, antibodies against the bradyzoite-specific antigen of T. 
gondii, TgBAG5, cross-reacted with N. caninum bradyzoites (McAllister et al., 1996). 
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In the present study, tNcSRS44-A and tNcSRS12A-B were not recognised when tested 
with serum samples from T. gondii experimentally infected cattle that had 
seroconverted. Ideally, cross-reactivity should have been tested using sera from T. 
gondii infected cattle with evidence of persistent infection; however, these were 
unavailable. Serum samples from sheep seropositive for T. gondii could also have been 
used to assess the cross-reactivity of the two novel N. caninum antigens described. 
Possible cross-reactivity with apicomplexans of the genus Hammondia (in particular 
H. heydorni) should also be considered as these parasites are structurally and 
antigenically similar to N. caninum with which they are closely related (Gondim et al., 
2015, Monteiro et al., 2007). The information about serological cross-reactivity with 
N. caninum is scarce and bovine reference sera are difficult to obtain. In one study, a 
limited number of murine and ovine sera from H. heydorni experimentally infected 
animals did not show cross-reactivity with N. caninum surface antigens and total 
antigen extract when tested with IFAT and WB, respectively (Gondim et al., 2015). 
Overall, the preliminary data of the immunoreactivity and serological specificity, as 
assessed with regards to T. gondii, indicated that tNcSRS44-A and tNcSRS12A-B may 
be useful for the detection of specific antibody titres in N. caninum persistently 
infected cattle. Further validation is required to assess the real diagnostic usefulness 
of the two antigens using adequate panels of well-characterised reference sera that 
should include a number of samples from cattle that are good representatives of 
persistent infection. However, such panels are difficult to create due to the current 
limitations in detecting N. caninum persistent infections, especially those occurring in 
naturally infected animals. The panel of serum samples used for validation in the 
present study included relatively few serum samples from cows which were considered 
to be persistently infected with N. caninum. 
 
2.4.2 Towards a diagnostic ELISA for the identification of cattle 
persistently infected with N. caninum 
 
The ultimate aim of this study was the development of a serum antibody ELISA to 
detect antibodies against the selected N. caninum bradyzoite-expressed antigens. 
Having a simple and relatively rapid execution, as well as objective interpretation, the 
ELISA represents the diagnostic technique of choice for high-throughput analysis. 
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Despite showing promising diagnostic potential in the WB format, tNcSRS44-A and 
tNcSRS12A-B were not effective in detecting specific N. caninum antibodies in the 
ELISA formats tested. The main differences between the two serological techniques 
were the physicochemical conditions in which the novel recombinant antigens were 
used. WBs were carried out with the antigens being blotted under denaturing and 
reducing conditions whereas in the ELISA such degree of denaturation and reduction 
would have been difficult to achieve. 
Several studies reported the use of either reduced (i.e. the protein disulphide bonds are 
in the reduced state) or non-reduced (i.e. disulphide bonds are in the oxidised state) N. 
caninum immunodominant antigens in WBs (Atkinson et al., 2000, Barta and Dubey 
1992, Bjerkas et al., 1994). Compared to reduced, non-reduced antigens showed 
stronger reactions suggesting that conformational epitopes may be predominantly 
involved in N. caninum-specific antibody responses (Dubey and Schares 2006). Based 
on these observations, the predicted amino acid sequences encoded by each of the 
candidate genes investigated in this study were screened for the presence of 
conformational epitopes; regions containing at least one of these were selected. Since 
conformational epitopes are discontinuous sets of amino acids brought into physical 
proximity by protein folding, correct folding is essential for determining the 
conformation that enables antibody binding. In order to conserve such structures 
purification and immunological assessment of the recombinant antigens should be 
carried out under native (non-reducing and non-denaturing) conditions. 
Proteins tNcSRS44-A and tNcSRS12A-B were expressed as inclusion bodies in E. coli 
strain M15 p[REP4] as highlighted by their insolubility in aqueous solvents. Stored in 
the bacteria as inclusion bodies, recombinant proteins may fold assuming 
conformations that may differ significantly from the native protein (Baneyx and 
Mujacic 2004). In addition, purification of these proteins requires disruption of 
inclusion bodies and solubilisation using chaotropic agents, such as urea, that are 
denaturing. For this reason, denaturing and reducing conditions were an obligatory 
choice as the insoluble nature of tNcSRS44-A and tNcSRS12A-B would have 
hindered any attempt in purifying them under native conditions (Bornhorst and Falke 
2000). Nevertheless, assessing the immunoreactivity of the recombinant proteins 
under denaturing and reducing conditions can reveal the presence of linear epitopes as 
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the proteins are unfolded. This was the case of tNcSRS44-A and tNcSRS12A-B in 
which the immunoreactivity observed suggests the presence of linear epitopes within 
their amino acid sequences. Unfortunately, such linear epitopes may have been 
inaccessible to serum antibodies when the recombinant proteins were used for the 
development of indirect ELISAs. One hypothesis to explain this was the occurrence 
of protein re-folding or aggregation that may have prevented the binding of specific 
antibodies to the epitopes. Protein folding may have occurred as a result of the different 
chemical environment the recombinant proteins were exposed to in the ELISAs 
compared to the WBs. Aggregation with the formation of polymers (mostly dimers, 
trimers and tetramers) was observed after the concentration of the chaotropic agent 
(urea) was decreased, by dialysis, from 8 M to 1 M. This phenomenon had no effect 
on the immunoreactivity of the recombinant proteins when used in the WBs (Figures 
2.10 and 2.11); however, it may have interfered with the recombinant antigens when 
used to coat the ELISA plates. 
In order to produce antigens that were similar to tNcSRS12A-B and tNcSRS44-A but 
characterised by water solubility, the expression of DNA fragments belonging to the 
NCLIV_004430 (NcSRS12A) and NCLIV_040495 (NcSRS44) as GST-fusion 
proteins was attempted. Despite several attempts, this option did not prove effective 
and GST-fusion protein synthesis was not achieved. 
Assuming that structural rearrangements might have hidden the linear epitopes in 
tNcSRS44-A and tNcSRS12A-B, the possibility of developing ELISAs based on small 
(20 amino acids long) polypeptides was investigated. Synthetic polypeptides prepared 
from antigenic proteins may provide an alternative to the use of whole or bigger 
truncated proteins. In addition, they are stable, manufactured with highly standardised 
methods on a large scale and eliminate the risk of contamination with proteins of 
bacterial origin. 
This approach included epitope mapping for the precise localisation of the epitopes 
within tNcSRS12A-B and tNcSRS44-A. Briefly, the amino acid sequences of the two 
target truncated proteins were divided into 20 residues-long polypeptides. Overlapping 
polypeptides including the last 10 and the first 10 residues of two adjacent sequences 
were also identified. This was done in order to increase the chances of including 
epitopes that may be located across the junctions of the peptides. From the short amino 
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acid sequences identified, synthetic polypeptides were produced as biotinylated 
molecules (ThinkPeptides, ProImmune, Oxford, UK) and their ability to bind specific 
N. caninum IgGs was assessed with dot blot. 
In the dot blot analysis with reference cattle sera, 3 pairs of two contiguous peptides 
of tNcSRS44-A showed binding with N. caninum-specific antibodies in the serum of 
persistently infected cattle. 
The development of polypeptide ELISAs work is currently in progress and it is carried 





WBs based on the recombinant antigens tNcSRS12A-B and tNcSRS44-A may 
represent a supplementary diagnostic tool for bovine neosporosis. When associated 
with assays targeting tachyzoite-specific antibody responses, these tests could provide 
additional information particularly on those animals which tested antibody negative 
with tests based on tachyzoite antigens. Seropositivity with the tNcSRS12A-B and 
tNcSRS44-A WBs would suggest persistent infection whilst antibody negative results 
would enable to classify N. caninum seronegative cattle more confidently. 
This method could be applied in those field conditions in which in-depth serological 
investigations are required and economically justifiable. For example, it would be 
beneficial within the selection of breeding stock in high genetic merit herds. 
Further investigations are required for the development of functional ELISAs based 








Chapter 3: Evaluation of antibody ELISA tests 
and estimation of N. caninum seroprevalence in 





The serological diagnosis of N. caninum infection in live cattle plays a pivotal role 
within the overall management of the disease: from the investigation of abortion cases, 
in which the analysis of maternal antibody titres provides useful information on the 
involvement of the parasite in the foetal loss (McAllister 2016), through the 
assessment of the seroprevalence of the disease in specific cattle populations, to the 
implementation of control programmes that rely on the identification of infected 
animals and the selection of uninfected replacements (Reichel et al., 2014). 
Alongside the thorough investigation of abortion cases, the assessment of the serologic 
prevalence of bovine neosporosis provides useful insights on the distribution and 
impact of the disease, thus helping to shape effective control strategies both at the herd 
and the regional or national levels. 
In the United Kingdom, the first assessment of N. caninum seroprevalence in non-
aborting dairy cattle was provided by a case-control study conducted across England 
and Wales about 20 years ago (Davison et al., 1999c). The study compared the 
serological status of aborting and non-aborting animals showing that the proportion of 
seropositive animals in the group of aborting cows (18%; 95%CI: 15-21%) (n=633) 
was significantly higher than in the control group (6%; 95%CI: 4%-8%) (n=418). The 
latter figure was the earliest estimate of the seroprevalence of bovine neosporosis in 
the country (Davison et al., 1999c). During the same period, 17.1% of 4,295 cattle 
from 14 English dairy herds that had a history of N. caninum abortion were found to 
be seropositive (Davison et al., 1999a). In a more recent longitudinal study, 12.9% of 
15,736 cattle, which were tested at yearly intervals over a period of four years, were 
classified as N. caninum antibody positive at least once. Ninety-four percent of the 114 
dairy and suckler herds included in the study had at least one seropositive cow 
(Woodbine et al., 2008). 
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Another study investigating the association between N. caninum infection and the 
reproductive performance of 460 six-month-old dairy heifers reported a 7.2% 
seroprevalence. Seropositive heifers were more likely to suffer late embryonic or early 
foetal loss and abortion than seronegative heifers during their first (OR: 5.3, p<0.01) 
and second pregnancy (OR: 6.0 p<0.001) (Brickell et al., 2010). 
At the national level, bovine neosporosis is monitored by investigating bovine abortion 
cases (i.e. aborted foetuses with or without placenta usually with a corresponding 
serum sample from the aborting dam) that are submitted to the veterinary investigation 
centres as a mandatory requirement (APHA 2016). In 2014, N. caninum was diagnosed 
in about 25% of the bovine abortion cases that reached a diagnosis in England, 
Scotland and Wales (VIDA 2015). 
Serosurveillance for bovine neosporosis is not normally performed and updated 
information on the seroprevalence of N. caninum in British cattle is currently lacking. 
Understandably, estimates of the seroprevalence vary depending on the study 
population, the geographical area of interest and the characteristics of the selected 
herds. However, the type of serological tests carried out as well as the cut-off levels 
used also affect the proportion of seropositive animals observed (Wapenaar et al., 
2007c). 
Amongst the serological techniques that have been developed for the detection of N. 
caninum-specific antibodies in serum, plasma or milk (i.e. IFAT, ELISA, WB analysis, 
agglutination tests, and immunochromatographic tests), the enzyme-linked 
immunosorbent assay (ELISA) is the most frequently employed. Numerous variants 
and protocols have been reported (Dubey and Schares 2006). Although monoclonal 
and polyclonal antibodies have been used for the development of competitive 
inhibition ELISAs (CI-ELISAs) (Baszler et al., 1996, Shin et al., 2004), the vast 
majority of the tests that have been described to date, are based on the indirect format. 
Currently, most of the tests that are commercially available use sonicated or detergent-
soluble total tachyzoite lysates as antigen preparation (Alvarez-Garcia et al., 2013). 
However, assays based on native affinity-purified, ISCOMs-incorporated or 
recombinant tachyzoite antigens are also available (Alvarez-Garcia et al., 2013). 
N. caninum-specific antibody titres in cattle are known to fluctuate depending on the 
infection phase (i.e. acute, persistent and recrudescent infection) and the stage of 
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gestation (reviewed by Dubey and Schares 2006, Guido et al., 2016). In some cases, 
tachyzoite-specific antibody levels decline below the detection limits of commercially 
available tests that are based on tachyzoite antigens so that previously serologically 
positive animals may become seronegative. This may occur in both aborting and non-
aborting cows regardless of the stage of pregnancy (Nogareda et al., 2007) and may 
result in a proportion of infected animals testing falsely negative with current 
commercial tachyzoite antigen-based diagnostics. Consequently, the seroprevalence 
may be underestimated. 
Multiple testing with currently available tools may increase the chances of classifying 
individuals correctly (Ortega-Mora et al., 2006). For example, cattle which test falsely 
negative may become antibody positive when retested following recrudescence of 
infection that elicit an increase in tachyzoite-specific antibody levels. 
As previously discussed in Chapter 2, a few ELISAs were developed using antigens 
that are expressed by the bradyzoite stage of N. caninum in order to distinguish animals 
with persistent infection from those with acute or recrudescent infection (Aguado-
Martinez et al., 2008). However, none of these tools are commercially available to 
date. 
Used in parallel with currently available assays, that are effective in detecting antibody 
titres against the tachyzoite stage, assays that target animals with persistent 
neosporosis may help to identify those cows that may not be identified by current tests 
(Guido et al., 2016). This would also provide more accurate estimates of the 
seroprevalence of N. caninum in specific cattle populations. 
In the present study, a commercial indirect ELISA (IDScreen® Neospora caninum 
indirect multi-species, IDVet, Montpellier, France) based on sonicated lysate of N. 
caninum tachyzoites and 5 indirect ELISAs, based on recombinant antigens 
(rNcSRS2, rNcGRA7, rNcSAG4, rNcBSR4 and rNcSRS9), were used to assess the 
seroprevalence of bovine neosporosis in British dairy cattle. 
NcSRS2 is an immunodominant surface antigen which is shared by both the tachyzoite 
and bradyzoite stages of N. caninum (Hemphill and Gottstein 1996). Nonetheless, its 
involvement in tachyzoite host cell invasion and the downregulation observed during 
the tachyzoite-to-bradyzoite stage conversion suggest a prevalent role at the tachyzoite 
stage (Vonlaufen et al., 2004). In cattle, the detection of specific antibodies against 
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NcSRS2 has proven to be effective for the detection of infected animals (Ghalmi et 
al., 2009, Nishikawa et al., 2001, Pinheiro et al., 2013, Schares et al., 2000). 
The tachyzoite dense granule-associated antigen NcGRA7 is highly immunogenic and 
is also expressed by both tachyzoite and bradyzoite stages (Hemphill et al., 1998, 
Jenkins et al., 1997, Lally et al., 1996b). Several serological studies reported NcGRA7 
as a valuable marker of acute infection in aborting and non-aborting cows (Aguado-
Martinez et al., 2009, Alvarez Garcia et al., 2006, Huang et al., 2007). 
NcSAG4, NcBSR4 and NcSRS9 are N. caninum bradyzoite-specific antigens. 
NcSAG4 is expressed early in the bradyzoite conversion and was successfully 
employed for the detection of specific antibodies in cattle sera as well as foetal fluids 
(Fernandez-Garcia et al., 2006, Risco-Castillo et al., 2011). Used in parallel, antibody 
ELISAs based on recombinant NcSAG4 and NcGRA7 enabled the discrimination of 
cows with persistent, recrudescent or acute infection following a primary exposure to 
the parasite (Aguado-Martinez et al., 2008). The detection of anti-NcSAG4 IgGs was 
correlated with persistent infection whereas NcGRA7-specific IgGs were linked to 
acute infection. Detectable antibodies against both antigens were considered 
suggestive of recrudescence or re-infection (Aguado-Martinez et al., 2008). 
Differently from NcSAG4, the expression of NcBSR4 and NcSRS9 is upregulated at 
a later stage following bradyzoite conversion (Risco-Castillo et al., 2007, Risco-
Castillo et al., 2011). Since the expression of NcBSR4 and NcSRS9 was primarily 
observed in mature bradyzoites, it has been postulated that their exposure to the host 
immune system may be minimal and that rupture of tissue cysts would be required to 
elicit the production of specific antibodies during well-established persistent infections 
(Jimenez-Ruiz et al., 2012). WB analysis showed that NcBSR4 and NcSRS9 can be 
used for the serodiagnosis of bovine neosporosis; however, only a small proportion of 
N. caninum naturally persistently infected cattle were recognised using both NcBSR4 
and NcSRS9 antigens (Risco-Castillo et al., 2011). Although NcBSR4 and NcSRS9 
may be of some value for the identification of N. caninum persistently infected cattle, 
there is limited information to support their usefulness. 
Setting appropriate cut-off levels and evaluating the characteristics and performances 
of the diagnostic tools is essential for their rational use (Alvarez-Garcia et al., 2003, 
Jenkins et al., 2002). In addition, the comparison between tests helps the selection of 
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those tools that are best suited for specific applications. This is particularly important 
within the serological diagnosis of bovine neosporosis in which a number of tests, 
especially ELISAs, are available and can be applied within different scenarios and for 
different purposes (Ortega-Mora et al., 2006). For example, serological tests for the 
identification of infected cattle to be removed from the herd may require a higher 
sensitivity, thus lower cut-offs, than those used for the diagnosis of bovine abortions 
(Hall et al., 2005, Schares et al., 1999). Cut-off values favouring high sensitivity would 
also be required for purchase testing of individual animals to be introduced in herds 
that are free from the disease (Greiner and Gardner 2000, Roelandt et al., 2015) or to 
exclude infected dams from embryo-transfer (Baillargeon et al., 2001, Landmann et 
al., 2002). 
Within seroprevalence studies, accurate estimates require tests that are characterised 
by both high specificity and sensitivity. 
In general, none of the techniques currently available for the detection of N. caninum 
infection can be regarded as a gold standard (Roelandt et al., 2015). Historically, the 
immunofluorescence antibody test (IFAT) was considered the reference technique 
used in the evaluation of other serological tests. However, the interpretation of IFAT 
results is subjective and there is substantial inter-laboratory variation (Frossling et al., 
2003). In addition, as the serological test uses N. caninum tachyzoites, it targets 
exclusively antibodies produced against this stage of the parasite. 
In the absence of routine in vivo techniques for the direct detection of the parasite 
which enable the accurate estimates of the characteristic of serological tests, and in the 
absence of large panels of fully and reliably characterised samples, no gold standard 
(e.g. Bayesian) analysis is strongly advised (Greiner and Gardner 2000, Frössling et 
al., 2003, Dubey and Schares 2006). No gold standard methods are becoming 
increasingly employed for the assessment of serological tests used in seroprevalence 
studies when adequate panels of reference samples are lacking (Meredith et al., 2015, 
Opsteegh et al., 2010, Roelandt et al., 2015). In the present study, a bi-modal mixture 





In summary, the main aims of this study were to: 
1. Estimate the seroprevalence of N. caninum in British dairy cattle 
2. Evaluate the test characteristics of one commercial ELISA and two 
experimental ELISAs based on recombinant N. caninum rNcSRS2 and 
rNcGRA7 antigens when applied to the determination of the seroprevalence 
within epidemiological studies 
3. Evaluate the test characteristics of three experimental ELISAs based on the 
recombinant bradyzoite-specific antigens rNcSAG4, rNcBSR4 and rNcSRS9 
when applied to the determination of the seroprevalence within 
epidemiological studies 
4. Attempt to quantify the proportion of N. caninum infected animals that are not 


























3.2 Materials and methods 
 
3.2.1 Study population 
 
The study population consisted of adult female dairy cattle collected from herds across 
England, Scotland and Wales between November 2015 and February 2016. Cows were 
sampled as part of the metabolic profile blood testing that is periodically performed in 
a number of British dairy farms in order to assess the adequacy of the diet and prevent 
metabolic disorders at the herd level. These analyses were carried out by the Dairy 
Herd Health and Productivity Service (DHHPS), Royal (Dick) School of Veterinary 
Studies, the University of Edinburgh, which provided individual plasma samples and 
accompanying information. 
Depending on the sampling regime for standard metabolic profile testing, the DHHPS 
requires samples from 17 randomly selected female adult cows per herd, subdivided 
as follow: 7 cows in early lactation (between 10-20 days post-calving), 5 cows in mid-
lactation (80-120 days post-calving) and 5 dry cows (within 10 days from the expected 
calving date). However, the sample submitted did not always adhere to these 
recommendations. 
The sample size was calculate using the WinPepi (version 11.53) software package 
(Abramson 2004). With a fixed number of 17 animals per cluster, an expected 
seroprevalence of 15%, an accepted error of 5%, a confidence level of 95% and the 
design effect (i.e. the loss of accuracy for using a cluster sampling design instead of a 
simple random sampling) set at 5.0 (Segura-Correa et al., 2010), the necessary sample 
size was calculated at 969 cows from 57 herds. 
A total of 1,037 individual bovine plasma samples from 61 herds were collected and 
tested. 
Anonymised data for each sampled herd and individual animal were available through 
the DHHPS database. Selected herds were geographically located by the first three 
figures of their corresponding postal code. Individual information such as the 
productive/reproductive stage (early lactation, mid-lactation or dry period) with days 
in milk or predicted calving date as well as parity were provided. 
The study was authorised by the ethical committee of the Royal (Dick) School of 
Veterinary Studies, the University of Edinburgh (VERC 32/15, 4/05/2015). 
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3.2.2 Study plasma samples 
 
Individual whole blood samples collected into lithium heparin vacutainer tubes were 
centrifuged at 2,400g for 10 min at 4C soon after arrival at the DHHPS laboratory. 
From each individual sample, the plasma was carefully removed from the blood cell 
pellet by pipetting, aliquoted in 1 ml aliquots and stored at -20C until testing. 
 
3.2.3 Serological assays 
 
3.2.3.1 Commercial N. caninum antibody ELISA 
Presence of N. caninum-specific antibodies was initially determined using the 
commercial IDScreen® Neospora caninum indirect multi-species ELISA (IDVet, 
Montpellier, France). According to the manufacturer’s specification, the test can be 
used to analyse serum, plasma or milk samples. 
Testing was carried out as detailed by the manufacturer which supplied all reagents, 
buffer solutions and 96 microwell plates pre-coated with purified sonicated lysate of 
N. caninum tachyzoites. Briefly, 90 μl/well of Dilution Buffer was dispensed into the 
plate and 10 μl of test plasma, a positive and a negative control (N. caninum positive 
and negative freeze-dried bovine sera supplied by the manufacturer) were added in 
duplicate to the wells and incubated for 45 min at room temperature. After washing 
the plate three times with approximately 300 μl of Wash Solution, 100 μl of IgG-HRP 
conjugate was added to each well and the plate incubated for 30 min at room 
temperature. Wells were then washed three times with approximately 300 μl of Wash 
Solution, 100 μl of Substrate Solution was then added to each well and the plate 
incubated for 15 min at room temperature in the dark. The reaction was stopped by 
adding 100 μl of Stop Solution. The optical densities at 450 nm (OD450) were measured 
on a plate reader (Dynex Technologies, Chantilly, VA, USA). According to the 
manufacturer’s instruction, results were deemed valid if the mean OD450 of the positive 
control was >0.350 and the ratio of the mean OD450 of the positive and the negative 
control duplicates was >3. The ELISA results were expressed as sample to positive 
control (S/P) percentage calculated using the formula: S/P = (OD450 sample – OD450 
negative control) / (OD450Dpositive control - OD450 negative control) × 100, where 
OD450 is the mean value of the optical density of the duplicates. 
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3.2.3.2 Experimental N. caninum antibody ELISAs 
Plasma was also tested using five experimental indirect ELISAs based on recombinant 
NcSRS2, NcGRA7, NcSAG4, NcBSR4 and NcSRS9 N. caninum antigens. All 
recombinant antigens were 6His-tagged proteins produced using prokaryotic 
expression systems. 
 
3.2.3.2.1 Recombinant antigens 
Recombinant NcSRS2 (rNcSRS2) was previously produced in-house following a 
similar protocol as in Chapter 2 (Thomson, unpublished). Briefly, the NcSRS2 
sequence was amplified by PCR from genomic N. caninum DNA (NC-1 strain) using 
the primers NcSRS2-forward (ggtaccGGTGTCGGGTGCGTTCAAG) and NcSRS2-reverse 
(cccgggTCAGTACGCAAAGAT TGCCGTTGC). The amplicon obtained was then cloned 
into the pQE-31 vector system (Qiagen, Manchester, UK) and competent 
M15[pREP4] E. coli were transformed with the insert-vector construct. Following 
protein expression and verification the recombinant protein was purified as previously 
described (Chapter 2.2.7). 
Recombinant NcGRA7 (rNcGRA7) (Alvarez-Garcia et al., 2007), NcSAG4 
(rNcSAG4) (Fernandez-Garcia et al., 2006), NcBSR4 (rNcBSR4) (Risco-Castillo et 
al., 2007) and NcSRS9 (rNcSRS9) (Risco-Castillo et al., 2011) were kindly provided 
by Prof. Luís M. Ortega-Mora and Prof. Gema Alvarez-García (SALUVET, 
Complutense University of Madrid, Spain). Cloning, expression and purification of 
these antigens were carried out as described by Jimenez-Ruiz et al. (2012). 
 
3.2.3.3 Reference bovine serum and plasma samples used for 
preliminary optimisation of the ELISA protocols 
A small panel of reference sera from cattle deemed representative of acute (n=12) and 
persistent infection (n=4) as well as seronegative animals (n=15) was used for the 
preliminary intra-laboratory optimisation of the experimental ELISA protocols (Table 
3.1). 
Since rNcSRS2, rNcGRA7, rNcSAG4, rNcBSR4 and rNcSRS9 were to be applied to 
plasma specimens and plasma samples from experimentally infected cattle were 
unavailable, matched plasma and serum samples collected from naturally infected and 
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uninfected cows were compared. Matched plasma and serum samples were collected 
from aborting cows in which N. caninum was confirmed as causing agent (n=5), non-
aborting cows from N. caninum problem herds (n=5) and cows from herds without a 
history of N. caninum abortions (n=11) (Table 3.1). 
These samples were kindly provided by Dr Helen Carty (Scotland’s Rural College, 
Auchincruive Veterinary Centre) and Dr Alastair Macrae (DHHPS, Royal (Dick) 
School of Veterinary Studies, the University of Edinburgh) and collected between May 
and September 2015. 
For the preliminary optimisation, the sera from known acutely infected and putatively 
persistently infected and uninfected cattle described in Chapter 2.2.9.1 were used as 
positive and negative controls. Briefly, a pool of 4 sera from cattle experimentally 
infected with 5108 N. caninum tachyzoites (NC-1 strain) administered 
subcutaneously during gestation (Benavides et al., 2012) was used as a positive control 
(acute infection). These sera, collected 21 days post-infection, tested positive with two 
commercial ELISAs: IDEXX Neospora Ab Test (IDEXX Laboratories, Westbrook, 
ME, USA) and IDScreen® Neospora caninum indirect multi-species ELISA (IDVet, 
Montpellier, France) according to the manufacturers’ cut-off values. In addition, the 
serum from a naturally infected cow in which antibodies against the recombinant 
bradyzoite-specific rNcSAG4, but not against rNcGRA7, were detected, was used as 
a positive control for persistent infection (Aguado-Martinez et al., 2008). Finally, a 
pool of 4 sera from adult cattle used as negative control animals within an experimental 
N. caninum infection study (Benavides et al., 2012) was used a negative control. These 
animals always tested seronegative with the two ELISAs mentioned above and no 
DNA of the parasite was detected in their tissues. 
Individual results, expressed in S/P ratio, obtained for the reference serum and plasma 







Table 3.1 – Origin and characteristics of the reference serum and plasma samples from N. 
caninum seropositive and seronegative cattle used for the optimisation of the rNcSRS2, 
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Figure 3.1 – Preliminary optimisation of the ELISA protocols. Individual results, expressed 
as sample to positive percentage (S/P) ratio, obtained for the reference serum and plasma 
samples (described in Table 3.1) using the rNcSRS2, rNcGRA7, rNcSAG4, rNcBSR4 and 















3.2.3.4 ELISA protocols 
The rNcSRS2 iELISA was developed and optimised in-house whereas the rNcGRA7, 
rNcSAG4, rNcBSR4 and rNcSRS9 iELISAs were carried out as previously described 
(Aguado-Martinez et al., 2008, Jimenez-Ruiz et al., 2013) with minor modifications. 
Briefly, 96 well High Binding M129B polystyrene microtitre plates (Greiner Bio-One 
GmbH, Kremsmünster, Austria) were coated with 100 μl/well rNcSRS2 (0.1 
μg/100μl), rNcGRA7 (0.2 μg/100μl), rNcSAG4 (0.1 μg/100μl), rNcBSR4 (0.2 
μg/100μl) or rNcSRS9 (0.2 μg/100μl) diluted in coating buffer (0.1 M carbonate-
bicarbonate buffer, [pH 9.6]) and incubated at 4C overnight. After four washes with 
approximately 300 μl of PBS-T (PBS, 0.05% Tween® 20), plates were tapped dry and 
blocked with 150 μl/well of 4% w/v dried skimmed milk (rNcSRS2 iELISA), 4% w/v 
bovine serum albumin (BSA) (rNcGRA7, rNcBSR4 and rNcSRS9 iELISAs) or 2% 
horse serum (rNcSAG4 iELISA) diluted in PBS-T. The plates were incubated for 2h 
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at 37C then washed twice and tapped dry. Test plasma samples, negative and positive 
controls were applied diluted 1:100 in 2% w/v dried skimmed milk (rNcSRS2 iELISA) 
or in the corresponding blocking buffer (rNcGRA7, rNcSAG4, rNcBSR4 and 
rNcSRS9 iELISAs). After 1h incubation at 37C, plates were washed four times and 
incubated for another hour at 37C with 100 μl/well horse-radish peroxidase 
conjugated rabbit anti-bovine IgG (αBovIgG-HRP) (Sigma-Aldrich, Munich, 
Germany) diluted 1:2,000 (rNcSRS2 iELISA), 1:4,000 (rNcSAG4 and rNcGRA7 
iELISAs) or 1:6,000 (rNcBSR4 and rNcSRS9 iELISAs) in PBS-T. After 1h incubation 
at 37C, the conjugate was removed and the plates washed four times. One-hundred 
microliters/well of SureBlue™ TMB (3,3’,5,5’-tetramethylbenzidine) Microwell 
Peroxidase Substrate (KPL, Gaithersburg, MD, USA) was added, the reaction was left 
to develop for 5 min at room temperature in the dark and stopped by adding 100 µl/well 
of 0.1 M HCl. Absorbance values were read at 450 nm (OD450). ELISA protocols are 
summarised in Table 3.2. 
Controls and plasma samples were analysed in duplicate. Based on OD450 values, 
plates were retested if duplicates for one or both controls had a coefficient of variation 
(CV=standard deviation of replicates/mean of replicates) above 20%. Similarly, 
individual plasma samples were retested if CV of the duplicates was >20%. Based on 
intra-laboratory optimisation, the results were deemed valid if the mean OD450 of the 
positive controls was >0.8 and the ratio of the mean OD450 of the positive control 
duplicates and the negative control duplicates was >5. 
The ELISA results were expressed as sample to positive control percentages (S/P) 











Table 3.2 – Summary of the ELISA protocols used in this study. 
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3.2.3.5 Assessment of serological cross-reactivity 
In a previous study by Aguado-Martinez et al. (2008), the potential serological cross-
reactivity of rNcGRA7 and rNcSAG4 with closely related Apicomplexan parasites 
was assessed by analysing sera from cattle infected with S. cruzi, B. besnoiti and T. 
gondii. No cross-reactivity was detected. 
In the present study, the panel of T. gondii antibody positive sera from experimentally 
infected calves described in Chapter 2 (Paragraph 2.2.10) was used to check the 
specificity of the six tests employed. In addition, sera from six Holstein-Friesian, four 
weeks-old, calves which were experimentally infected with Cryptosporidium parvum 
were also tested. No cross-reactivity was observed. 
 
3.2.4 Data analysis 
 
3.2.4.1 Threshold, specificity and sensitivity determination 
In the absence of a gold standard method for the identification of truly N. caninum 
seropositive and seronegative animals and adequate numbers of appropriate reference 
plasma samples from confirmed N. caninum infected and uninfected cattle, the 
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threshold for classifying the ELISA results, was determined, for each test, using a 
statistical method as described in Opsteegh et al. (2010) and Meredith et al. (2015). 
Assuming that the study population consists of a mixture of seropositive and 
seronegative cattle, the frequency distribution of the observed ELISA results, in this 
case expressed as S/P percentages, should show two components that are both assumed 
to be normally distributed. These two normally distributed components of the study 
population should be characterised by different mean and standard deviation: a higher 
mean is assumed for the seropositive population and lower mean for the seronegative 
(Opsteegh et al., 2010). Estimates for mean and standard deviation of the distributions 
representing negative and positive results are obtained by fitting a bi-modal normal 
distribution model to the observed S/P values. Bayesian Markov chain Monte Carlo 
(MCMC) methods, implemented using the JAGS software (Denwood 2013) interfaced 
using the ‘runjags’ package (Plummer 2016) in R Studio (version 0.99.902) were used 
to fit the bi-modal normal distribution model. The analysis was performed with the 
help and under the supervision of Dr Darren Shaw (Royal (Dick) School of Veterinary 
Studies, the University of Edinburgh) who kindly provided the R script which was 
applied as previously described (Meredith et al., 2015). Nine chains with over-
dispersed starting values were used and trace plots visually assessed to ensure 
convergence, non-converging chains were excluded. Optimum threshold values, 
defined as the highest total sensitivity and specificity of each test, were calculated from 
the posterior distributions generated as output of this simulation. For each iteration of 
parameter values, two cumulative distribution functions were used to calculate the 
probability of observing an S/P value above and below the given threshold for the 
negative and positive component of the distribution respectively. 
Using the calculated threshold and distributions fitted to the observed data, median 
sensitivity and specificity were calculated for each test. 
ELISA results obtained with each one of the 6 ELISAs used were dichotomised based 
on the calculated thresholds (cut-offs) so that each animal was scored positive or 
negative with each test. 
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3.2.4.2 Test agreement 
Test agreement, expressed as Kappa statistic (κ), was calculated on pairs of tests using 
the “cohens.kappa” function interfaced using the ‘psych’ package in R Studio (version 
0.99.902). The kappa coefficients were interpreted according to the guidelines outlined 
by Landis and Koch, where the strength of the kappa coefficients was defined as slight 
(κ = 0.01-0.20), fair (κ = 0.21-0.40), moderate (κ = 0.41-0.60), substantial (κ = 0.61-
0.80) and almost perfect (κ = 0.81-1.00) (Landis and Koch 1977). Confidence intervals 
were reported alongside the Kappa-values. 
 
3.2.4.3 Comparison of seroprevalence by productive/reproductive 
group 
The binary response of outcome ELISA obtained with the IDVet iELISA (response 
variable) was modelled using generalised linear mixed-effect models with binomial 
errors fitted by maximum likelihood (Laplace approximation) to consider the variation 
in seroprevalence between the 3 different productive groups: early lactation, mid-
lactation and dry cows. 
The farm of origin was entered as a random effect to take into account farm-related 
epidemiological conditions, such as farm-specific infectious pressure, whereas the 
productive group (early, mid or dry) was added as fixed effect. 
Biological assumptions, based on the evidence that reactivation of the parasite is more 
likely to occur towards the last trimester of pregnancy (i.e. when the majority of N. 
caninum abortion cases are observed), suggest an increased likelihood of infected 
cattle to test serologically positive during the dry period. Therefore, testing dry cows 
for N. caninum-specific antibodies is generally advised in practice. 
In order to investigate whether there were statistically significant variations in the 
seroprevalence in cows tested during the dry period compared to early and mid-
lactation, the group dry was entered in the model as reference group (intercept). 
Regarding the lactation number, the cattle belonging to the study population for which 
the information was available were classified based on 6 levels (0, 1, 2, 3, 4, and >4). 
Lactation number was entered as a fixed effect in a univariate model and in association 
or in interaction with the productive/reproductive group in order to investigate its 
potential role as a confounder. The analysis was carried out using the “glmer” function 
available with the ‘lme4’ package in R Studio (version 0.99.902). Statistical 
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significance was determined at the level of p<0.05. The data were modelled with the 

































3.3.1 Descriptive statistics of cattle data 
 
A total of 1,037 plasma samples, collected from 61 British dairy farms, were tested for 
N. caninum-specific antibodies. The first three figures of the postal code were 
available for all farms. Only three postal codes were repeated twice; however, they 
identified different farms as indicated by the DHHPS customer identification numbers. 
Since the use of residual samples submitted for different diagnostic purposes was 
chosen for convenience, stratified sampling, to consider number and size of dairy 
farms in each region, was impractical. The South West and North West of England, 
regions with the highest number of dairy cattle, together with Scotland, were the areas 
where most of the sampled herds were located (Table 3.3). The geographical 
distribution of the herds tested is shown in Figure 3.2. 
At the time of sampling, 406 (39.1%) cows were in early lactation (days in milk: mean 
± SD 18.7 ± 7.2, median 15.00), 317 (30.5%) in mid-lactation (days in milk: mean ± 
SD 104.2 ± 36.1, median 97.00) and 314 (30.2%) during the dry period (days prior to 
expected calving date: mean ± SD 11.4 ± 9.6, median 7.00). 
In most herds, the sample included 7 cows in early lactation, 5 in mid-lactation and 5 
dry cows (41/61); however, in 9 herds the distribution early, mid or dry was 6-5-6 
respectively, in 6 herds 6-6-5 and 5-5-7, 7-6-4, 8-5-4, 9-3-5 and 0-12-5 in the 
remaining 5 herds respectively. 
The lactation number, that is indicative of parity and age, was reported for 952 out of 
the 1,037 (91.8%) cows and ranged between 0 (heifers due to calve for the first time) 
and 10 (mean ± SD 2.67 ± 1.71, median 2.00). All heifers belonged to the “dry cows” 









Figure 3.2 – Geographical distribution of the herds tested (n=61) based on the first three 
figures of the farm postcode (map generated using www.google.co.uk/maps). The postcodes 
(1) KA26, (2) LA12, (3) EX39 identify two distinct herds located within the same postcode 
area respectively. 
 
Table 3.3 – Number and proportion of cattle sampled per region and size of the dairy cattle 
population in each geographical area of Great Britain. 




Dairy cattle per 
region 
(AHDB Dairy, 2015) 
Proportion 
of cattle per 
region (%) 
Scotland 238 (14) 23.0 289,600 11.4 
North East, Yorkshire 
and Humber 
102 (6) 9.8 178,208 7.0 
North West 204 (12) 19.7 495,406 19.5 
East Midlands 51 (3) 4.9 140,698 5.5 
West Midlands 34 (2) 3.3 292,886 11.5 
Wales 34 (2) 3.3 246,331 9.7 
East of England 51 (3) 4.9 31,021 1.2 
South East 51 (3) 4.9 119,139 4.7 
South West 272 (16) 26.2 751,770 29.5 






3.3.2 Threshold determination and test characteristics 
 
The frequency distribution of the ELISA outcome (S/P percentages) obtained 
analysing the 1,037 plasma samples with the ELISA tests based on immunodominant 
antigens considered to be markers of acute infection (IDVet, rNcSRS2 and rNcGRA7) 
showed two distinct populations of negative and positive animals (Figure 3.3 – A-C). 
Such distinction was not observed in the ELISA outcome frequency distribution of the 
ELISA tests based on bradyzoite-specific antigens (rNcSAG4, rNcBSR4 and 
rNcSRS9) in which the higher S/P values were not clearly separated from the 
population characterised by lower S/P values and were skewed forming a long “tail” 
instead of a separate component (Figure 3.3 – D-F). This lack of two distinct 
components was particularly evident for the rNcBSR4 and rNcSRS9 iELISAs. 
The MCMC bi-modal normal mixture model converged upon two distinct distributions 
with median estimates representing the mean of the negative and positive population 
for each of the 6 antibody ELISAs used (Table 3.4). These distributions, that best 
described the two observed populations of negative and positive results, were fitted 
and drawn alongside the frequency distribution of the observed results (Figure 3.3). 
Optimum threshold values (defined as the highest total sensitivity and specificity of 
each test) were calculated from the fitted distributions based on the posterior 
distributional parameters and estimated at S/P value of 17.66, 34.11, 38.37, 52.62, 
25.17 and 29.40 for the IDVet, rNcSRS2, rNcGRA7, rNcSAG4, rNcBSR4 and 














Figure 3.3 – Frequency distribution of observed S/P ratios (%) in the IDVet (A), rNcSRS2 
(B), rNcGRA7 (C), rNcSAG4 (D), rNcBSR4 (E) and rNcSRS9 (F) iELISAs (n=1,037) with 
fitted distributions using median estimates of the mean and variance of the two distributions 
from the MCMC analysis (solid blue and red curves). The compound distribution derived from 
the two constituent normal distributions is added on top (purple curve). The vertical black 
solid line represents the best estimate threshold associated with the optimised maximum sum 

























From the estimated thresholds and the distributions fitted to the observed data, the 
model provided median sensitivity and specificity for each test analysed (Table 3.4). 
The IDVet iELISA showed the highest median sensitivity and specificity with 
estimated values of 99.6% (95% credible interval: 99.4-99.8) and 94.4% (89.1-98.4) 
respectively. 
The experimental iELISAs based on the recombinant N. caninum immunodominant 
antigens rNcSRS2 and rNcGRA7 showed higher estimated sensitivity of 87.7% (77.7-
96.1) and 93.7% (82.8-99.4) respectively compared to the recombinant bradyzoite-
specific antigen-based iELISAs rNcSAG4, rNcBSR4 and NcSRS9 that had median 
sensitivity of 82.4% (69.5-94.7), 71.4% (62.5-80.3) and 70.5% (61.6-80.0) 
respectively. 
In general, the estimated median specificity of the recombinant antigen-based iELISAs 
used was high and >90% in all tests: 97.2% (96.4-98.0), 97.4% (96.5-98.2), 96.2% 
(95.5-97.2) 93.3% (90.7-95.4), 92.7% (89.9-95.2) in rNcSRS2, rNcGRA7, rNcSAG4, 







Table 3.4 – Median estimates representing the mean of the negative and positive distributions, 






















7.57 77.06 17.66 94.4 (89.1-98.4) 99.6 (99.4-99.8) 
rNcSRS2 iELISA 21.02 58.61 34.11 87.7 (77.7-96.1) 97.2 (96.4-98.0) 
rNcGRA7 iELISA 22.25 63.26 38.37 93.7 (82.8-99.4) 97.4 (96.5-98.2) 
rNcSAG4 iELISA 34.43 81.51 52.62 82.4 (69.5-94.7) 96.2 (95.5-97.2) 
rNcBSR4 iELISA 15.13 35.03 25.17 71.4 (62.5-80.3) 93.3 (90.7-95.4) 
rNcSRS9 iELISA 18.58 39.30 29.40 70.5 (61.6-80.0) 92.7 (89.9-95.2) 
 
All test plasma samples were scored as antibody positive or negative with each test 
based on the estimated thresholds (Table 3.5). Similar proportions of antibody-positive 
cattle were obtained using the tests based on N. caninum recombinant antigens: 8.9% 
(95% CI: 7.3-10.8%), 9.2% (7.5-11.1) and 8.7% (7.1-10.5) for the IDVet, rNcSRS2 
and rNcGRA7 iELISA respectively. Within the evaluation of the bradyzoite-specific 
antibody responses, 4.7% (3.6-6.2), 8.4% (6.8-10.2) and 7.0% (5.6-8.8) of the animals 
tested were classified as antibody-positive using the rNcSAG4, rNcBSR4 and 
rNcSRS9 iELISAs respectively (Table 3.5). 
 
 
Table 3.5 – Number of plasma samples classified as antibody-positive and antibody-negative 
based on the estimated optimum thresholds for the 6 iELISAs used (n=1,037) and proportion 
of animals classified as antibody-positive (%). CI: confidence interval. 
Test Positive Negative  
Proportion (%) 
 (95% CI) 
IDScreen® Neospora caninum 
iELISA (IDVet) 
92 945 8.9 (7.3-10.8) 
rNcSRS2 iELISA 95 942 9.2 (7.5-11.1) 
rNcGRA7 iELISA 90 947 8.7 (7.1-10.5) 
rNcSAG4 iELISA 49 988 4.7 (3.6-6.2) 
rNcBSR4 iELISA 87 952 8.4 (6.8-10.2) 
rNcSRS9 iELISA 73 964 7.0 (5.6-8.8) 
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3.3.3 Test agreement 
 
Test pairs were graphically visualised in scatterplots in which the ELISA results 
(expressed in S/P percentages), obtained with two tests, were plotted against each 
other. Each dot in the scatter plot represents one individual animal and its position 
depends on the results obtained with the two tests considered. The preliminary visual 
analysis of the ELISA data dispersion suggested that, in general, a limited number of 
animals tested seropositive with both tests considered regardless of the test pair 
compared (Figure 3.4 and 3.5). 
 
Figure 3.4 – Scatter plots of test pairs based on N. caninum tachyzoites lysate and 
immunodominant recombinant antigens considered to be markers of acute infection. (A) 
IDVet and rNcSRS2 iELISAs, (B) IDVet and rNcGRA7 iELISAs, (C) rNcSRS2 and 
rNcGRA7 iELISAs. The threshold S/P value for each test is indicated by a red, orange or 
































Figure 3.5 – Scatter plots of tests pairs based on N. caninum bradyzoite-specific antigens. 
rNcSAG4 and rNcBSR4 iELISAs, (B) rNcSAG4 and rNcSRS9 iELISAs, (C) rNcBSR4 and 
rNcSRS9 iELISAs. The threshold S/P value for each test is indicated by a yellow, green or 
blue line for the rNcSAG4, the rNcBSR4 and the rNcSRS9 iELISAs respectively. 
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The agreement between each combination of test pair, expressed as Kappa statistic (κ) 
with confidence intervals, is shown in Table 3.6. Moderate agreement (κ = 0.41-0.60) 
was observed between tests using N. caninum immunodominant antigens (IDVet, 
rNcSRS2 and rNcGRA7 iELISAs) or between tests using bradyzoite-specific antigens 
(rNcSAG4, rNcBSR4 and rNcSRS9). In contrast, tests using immunodominant 
antigens considered to be markers of acute infection showed only slight agreement (κ 















Table 3.6 – Test agreement (κ) in different combinations of iELISA pairs with 95% 
confidence intervals. κ values indicative of moderate agreement between iELISAs targeting 
antibodies against N. caninum immunodominant antigens considered to be markers of acute 
infection are shaded in yellow whereas values indicating moderate agreement between pairs 
of iELISA based on bradyzoite antigens are shaded in green. In grey, κ values which are 
indicative of slight agreement between iELISAs based on antigens highly expressed by the 
tachyzoite stage and iELISAs which employ bradyzoite-specific antigens. 







































Collectively, the outcome of the six iELISAs used consisted of 249 (24.0%, 95%CI: 
21.5-26.7) animals with a positive result in at least one test and 788 (76.0%, 73.3-78.5) 
cattle which tested negative with all tests (Table 3.7). 
 
 
Table 3.7 – Tested dairy cattle (n=1,037) with positive test results by number of assays with 
which they were classified as positive. 
6 iELISAs outcome 
No. 
Cows 




(positivity with ≥ 1 test) 
249  
Positive with 6 tests 2 
Positive with 5 tests 6 
Positive with 4 tests 13 
Positive with 3 tests 59 
Positive with 2 tests 46 
Positive with 1 tests 123 
Negative 
(negativity with all tests) 
788   
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Only 2 plasma samples tested antibody-positive with all six assays whereas 123 
positive samples (50.6%, 44.4-56.7) were classified as such based on the positive 
outcome obtained with only one test of the six examined. 
As a result of the reduced agreement between tests based on antigens considered to be 
markers of acute infection which are highly expressed by the tachyzoite stage and test-
based bradyzoite-specific antigens, only 43 (35.0%, 27.1-43.7) of the 126 plasma 
samples which tested positive with more than one test had a positive result with at least 
one tachyzoite and one bradyzoite antigen-based iELISA at the same time (Table 3.8). 
 
Table 3.8 – Number of animals with merged test results for the panel of the iELISAs based 
on antigens highly expressed by tachyzoite stage (T) and the panel of bradyzoite antigens-
based iELISAs (B). T+/B+: cows which tested positive with at least one tachyzoite 
(T+)/bradyzoite (B+) antigens-based iELISA, T-/B-: cows which tested negative with all three 
tachyzoite (T-)/bradyzoite (B-) antigens-based iELISAs). Blue: positives with at least one 
tachyzoite and one bradyzoite iELISA. Yellow/green: positives with at least one tachyzoite 









43 88 131 
B- 
(No. Cows) 
118 788  
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Combinations of test results on the three iELISAs based on antigens highly expressed 
by the tachyzoite stage, that are considered as markers of acute infection, and the three 









Table 3.9 – Number of tested dairy cows (n=1,037) with specified combinations of test results 
on (A) one iELISA based on N. caninum tachyzoites lysate and two iELISAs based on 
recombinant N. caninum antigens considered to be markers of acute infection and (B) three 









Pos Pos Pos 41 
Pos Pos Neg 10 
Pos Neg Neg 32 
Pos Neg Pos 9 
Neg Pos Pos 14 
Neg Neg Pos 26 
Neg Pos Neg 30 
Neg Neg Neg 875 











Pos Pos Pos 27 
Pos Pos Neg 2 
Pos Neg Neg 17 
Pos Neg Pos 3 
Neg Pos Pos 22 
Neg Neg Pos 25 
Neg Pos Neg 34 
Neg Neg Neg 907 
















3.3.4 Threshold adjustment 
 
In order to compare the six iELISAs, for which optimal cut-offs were calculated using 
the bimodal normal distribution model, a set of antibody-positive reference samples 
was generated. The threshold of each iELISA was adjusted so that all plasma samples 
with S/P values within the fitted distribution of negative samples were arbitrarily 
considered as negatives. This also resulted in the classification of previous positive 
samples (i.e. characterised by S/P values within the interval in which the fitted 
distribution of the negative samples overlapped the fitted distribution of the positive 
ones) as negatives. Such classification ensured that no negative samples were 
classified as positives. In this way, the specificity of each iELISA was maximised at 
the expense of the sensitivity (Figure 3.6). However, this arbitrary method was 
exclusively instrumental to the identification of reference plasma samples which were 
likely to be truly N. caninum antibody positive. 
All plasma samples which tested antibody positive with at least one iELISA, based on 
the adjusted thresholds, were considered as truly positives. These samples were 173 
whereas the samples which tested negative with all six iELISAs (considered as truly 
negatives) were 864. This panel of positive and negative samples was used as a 
reference against which the Se of each iELISA was reassessed (Table 3.10). The 
reassessment was carried out using the iELISA outcome based on the cut-off S/P 













Figure 3.6 – Frequency distribution of observed S/P ratios (%) in the IDVet (A), rNcSRS2 
(B), rNcGRA7 (C), rNcSAG4 (D), rNcBSR4 (E) and rNcSRS9 (F) iELISAs (n= 1,037) with 
fitted distributions using median estimates of the mean and variance of the two distributions 
from the MCMC analysis (solid blue and red curves). The compound distribution derived from 
the two constituent normal distributions is added on top (purple curve). The vertical black 
solid line represents the best estimate threshold associated with the optimised maximum sum 
for specificity and sensitivity whereas the vertical green line represents the threshold adjusted 
















































Table 3.10 – Specificity (Sp) and sensitivity (Se) of the six iELISAs calculated using a panel 
of reference plasma samples generated by adjusting the threshold of each test so that all S/P 






















































1 Reference positive: plasma samples which were classified as positive with at least one test. 
2 Reference negative: plasma samples which tested negative with all 6 tests. 
* Based on the panel of reference samples generated. 
 
The overall diagnostic performances obtained using multiple N. caninum iELISAs in 
parallel were also evaluated. The combination of two assays based on tachyzoite 
antigens enabled to improve the Se with an exiguous loss in Sp; the commercial test 
(IDVet) associated to either the rNcSRS2 or the rNcGRA7 iELISAs showed a Sp of 
97.8% (95%CI: 96.6-98.7). The combination with rNcSRS2 provided a Se of 67.9% 
(60.1-74.5) whereas the in parallel use with rNcGRA7 gave a Se of 65.9% (58.3-72.3) 
(Table 3.11). 
A serological diagnostic tool using all three iELISAs targeting antibody responses 
against the tachyzoite stage of N. caninum (subsequently denominated test A) showed 
increased Se (81.5%; 74.9-86.9) and acceptable Sp (95.6%, 94.0-96.9). In contrast, a 
serological diagnostic protocol using all tests based on bradyzoite-specific antigens 
showed low Se (43.3%, 35.8-51.1) as well as lower Sp compared to the use of the 
tachyzoite antigens-based iELISAs. 
Within the tests based on either whole N. caninum tachyzoite lysate or recombinant 
immunodominant antigens considered to be markers of acute infection, the 
commercial IDVet iELISA associated with either the rNcSRS2 or the rNcGRA7 
provided higher Se and Sp compared to the use in parallel of the two experimental 
tests based on recombinant proteins. Furthermore, the combination of the commercial 
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assay with either rNcSRS2 or rNcGRA7 and one recombinant bradyzoite antigen-
based assay (rNcSAG4, rNcBSR4 and rNcSRS9) enabled to increase the Se. 
Nevertheless, this level of Se was similar to the Se obtained by using the IDVet, the 
rNcSRS2 and the rNcGRA7 iELISAs simultaneously. 
Finally, a diagnostic tool based on all proposed iELISAs employing antigens highly 
expressed by the tachyzoite stage  in association with a single bradyzoite antigen-based 
iELISA showed good Se and Sp (>90%). The Se and Sp of rNcSAG4 iELISA 
combined with the IDVet, rNcSRS2 and rNcGRA7 (test B) were 91.3% (86.1-95.1) 
and 96.6% (95.2-97.7) respectively. Notably, the rNcBSR4 iELISA had the greater 
























Table 3.11 – Diagnostic specificity (Sp) and sensitivity (Se) of selected combinations of 
iELISAs. Tested dairy cattle (n=1,037) with test results classified as positive, negative, falsely 
positive and negative based on the set of reference plasma samples generated by adjusting the 
































Test A: IDVet + 
rNcSRS2 + rNcGRA7 




















rNcSAG4 + rNcBSR4 + 
rNcSRS9 





IDVet + rNcSRS2 + 
rNcSAG4 





 IDVet + rNcGRA7 + 
rNcSAG4 





IDVet + rNcSRS2 + 
rNcBSR4 





IDVet + rNcGRA7 + 
rNcBSR4 





IDVet + rNcSRS2 + 
rNcSRS9 





IDVet + rNcGRA7 + 
rNcSRS9 





Test B: IDVet + 
rNcSRS2 + rNcGRA7 + 
rNcSAG4 





Test C: IDVet + 
rNcSRS2 + rNcGRA7 + 
rNcBSR4 





IDVet + rNcSRS2 + 
rNcGRA7 + rNcSRS9 





rNcSRS2 + rNcGRA7 + 
rNcSAG4 + rNcBSR4 





rNcSRS2 + rNcGRA7 + 
rNcSAG4 + rNcSRS9 





rNcSRS2 + rNcGRA7 + 
rNcBSR4 + rNcSRS9 










1 Reference positive: plasma samples which were classified as positive with at least one test based on the adjusted 
cut-off. 2Reference negative: plasma samples which tested negative with all 6 tests. 
* Based on the panel of reference samples generated. 
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3.3.5 Seroprevalence of N. caninum in British dairy cattle 
 
In order to enable easier comparison with previous estimates, the overall 
seroprevalence in dairy cattle is reported according to the results obtained with the 
commercial IDScreen® Neospora caninum indirect ELISA (IDVet). Similarly, to the 
tests employed in previous studies (Brickell et al., 2010, Woodbine et al., 2008), this 
test utilises native N. caninum tachyzoite extract as antigen preparation. 
Based on the cut-off of the IDVet test (S/P=17.66) obtained using the bi-modal normal 
mixture model previously described, the serological results were dichotomised into 
positives and negatives: 92 cows out of 1,037 were classified as seropositive, giving 
an apparent seroprevalence of 8.9% (95% CI: 7.3-10.8). 
In order to obtain the true prevalence (TP), the apparent prevalence (AP) was corrected 
according to the Rogan-Gladen estimator that takes into account sensitivity and 
specificity of the test used (TP=(AP+Sp-1)/(Se+Sp-1)) (Rogan and Gladen 1978) thus 
providing adjustment for misclassification by the diagnostic test. Considering that the 
Sp and Se calculated using the bi-modal normal mixture model were 99.6% and 94.4% 
respectively, the true overall prevalence would have been estimated at 9.0% (7.3-11.0). 
The apparent overall seroprevalence estimated using all 3 tests based on tachyzoite 
antigens in parallel (test A) or a combination of all iELISAs based on antigens which 
were considered to be markers of acute infection with the rNcSAG4 (test B) or the 
rNcBSR4 (test C) iELISA was estimated at 15.6% (13.5-18.0), 18.1% (15.9-20.6) and 













Table 3.12 – N. caninum seroprevalence in British dairy cattle (n=1,037) estimated using a 
commercial antibody ELISA (IDVet) and three serological tools combining all iELISAs based 
on antigens highly expressed by the tachyzoite stage (test A) or all iELISAs considered in test 
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(IDVet + rNcSRS2 + 






In comparison to a serological tool based on 3 different iELISAs based on antigens 
expressed by the tachyzoite stage (test A) or these 3 tests associated with either the 
rNcSAG4 (test B) or the rNcBSR4 (test C) bradyzoite antigen-based ELISAs, the 
seroprevalence detected with the commercial test (IDVet) was lower by 6.7%, 9.2% 
and 12.2% respectively. 
Considering the outcome of the IDVet iELISA, 41 herds out of 61 had at least one cow 
which was classified as seropositive (67.2%, 54.0-78.7). In these herds, the number of 
seropositive cows ranged from 1 to 12 (mean 2.2, median 2) corresponding to a mean 
within-cluster seroprevalence of 13.0% (10.1-16.0). Most clusters of 17 animals had 
only one (18/41, 43.9%, 29.9-59.0) or two (13/41; 31.6; 19.6-47.0) seropositive cows. 
In one cluster, 12 cows out of 17 were classified as antibody positive (Figure 3.7). 
Based on the outcome of test A, B and C, the between-herd seroprevalence was 93.4% 
(57/61, 84.3-97.4), 95.1% (58/61, 86.5-98.3) and 98.3 (60/61, 91.3-99.7). The 
frequency distribution of the number of animals classified as seropositive in each herd 





Figure 3.7 – Frequency distribution of the number of N. caninum seropositive cows in the 
sampled herds (n=61) as estimated with the commercial test (IDVet) and different 
combinations of the IDVet iELISA associated with experimental assays based on recombinant 
tachyzoite immunodominant and bradyzoite-specific antigens (Test A, B and C). 
 
The observed individual seroprevalence in relation to the region of origin of the 
samples is shown in Table 3.13. The highest seroprevalences based on the outcome of 
the commercial tests were observed in the North East, Yorkshire and the Humber 
(17.6%, 11.5-26.2) and North West England (11.8%, 7.7-17.0) compared to the other 
British macro-regions. Using test A and B the highest seroprevalences were found in 
cattle from the North East, Yorkshire and the Humber (test A: 27.4%, 19.7-36.8; test 
B: 30.4%, 22.3-39.9) and the Midlands (test A and B: 22.3%, 14.8-32.8). If the 
outcome of test C is considered, the North East of England, Yorkshire and the Humber 
and Wales had the highest seroprevalence: 29.4% (95%CI: 21.4-38.9 and 16.8-46.2). 



























Number of seropositive cows in each cluster
IDVet Test A (IDVet + rNcSRS2 + rNcGRA7)
Test B (IDVet + rNcSRS2 + rNcGRA7 + rNcSAG4) Test C (IDVet + rNcSRS2 + NcGRA7 + rNcBSR4)
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Table 3.13 – Observed individual seroprevalence of N. caninum in relation to the region of 
origin, in British dairy cattle (n=1,037) estimated with the commercial test (IDVet) and the 








 (95% CI) 
Test B2 
 (95% CI) 
Test C2 










North East England 











































































1 IDVet, rNcSRS2 and rNcGRA7 used in parallel. 
2 IDVet, rNcSRS2, rNcGRA7 and rNcSAG4 used in parallel. 















In general, the observed seroprevalence increased with the lactation number. However, 
a higher seroprevalence was observed amongst the heifers compared to animals during 
their first lactation, irrespective of the serological test or combination of tests 
considered (Table 3.14). 
 
Table 3.14 – Observed individual seroprevalence of N. caninum, in relation to parity, in 
British dairy cattle (n=952) sampled in 56 herds assessed with the commercial test (IDVet) or 








 (95% CI) 
Test B2 
 (95% CI) 
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1 IDVet, rNcSRS2 and rNcGRA7 used in parallel. 
2 IDVet, rNcSRS2, rNcGRA7 and rNcSAG4 used in parallel. 


















3.3.5.1 Seroprevalence in different production groups of dairy cattle 
Based on the outcome of the commercial iELISA (IDVet), the observed proportions 
of serologically positive cattle during the dry period, in early lactation and mid-
lactation were 7.0% (22/314, 95% CI: 4.7-10.4), 11.1% (45/406, 8.4-14.5) and 7.9% 
(25/317, 5.4-11.4) respectively (Figure 3.8). The seroprevalence observed in cattle in 
early lactation was higher compared to the seroprevalence in cows during the dry 
period; however, analysed within the GLMM, described previously, this difference 
was only just statistically significant (p=0.049) (OR=1.75, 95% CI: 1.000 – 3.066). In 
addition, there was no statistically significant difference in the seroprevalence between 
mid-lactation and the dry period (p=0.657) (OR=1.15, 0.617 – 2.147) (Table 3.21). 
Similar, although lower, seroprevalence variations between productive/reproductive 
groups were obtained using the combination of iELISAs based on whole tachyzoite 
lysate (IDVet) and recombinant antigens considered to be markers of acute infection 
(rNcSRS2 and rNcGRA7) (test A) and the test associated with the bradyzoite-specific 
rNcSAG4 (test B). Minimal variation in the seroprevalence of the 3 groups were 
observed when all iELISAs based on antigens highly expressed by the tachyzoite stage 
were used in combination with the bradyzoite-specific rNcBSR4 (test C). Using test 
C, the observed seroprevalence in dry, mid-lactating and early lactating cows were 
21.3% (67/314, 17.3-26.2), 20.9% (85/406, 17.3-25.2) and 21.1% (67/317, 17.0-26.0) 
respectively (Figure 3.8). 
The differences in seroprevalence observed among the productive/reproductive 
groups, using test A, B and C, were not statistically significant irrespective of the test 
combination considered (Table 3.21). 
Marginal variations in point estimates and p values in multivariate GLMMs, suggested 
that there was no evidence that the lactation number represented a confounder in the 
present study. Interaction between lactation number and productive/reproductive 
group was also excluded. Therefore, the results here presented refer to the GLMM 
fitted considering herd of origin as a random effect and productive group (Early 
lactation, Mid-lactation and Dry) as fixed effect (Table 3.15). 
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Test A: IDVet, rNcSRS2 and rNcGRA7 used in parallel. 
Test B: IDVet, rNcSRS2, rNcGRA7 and rNcSAG4 used in parallel. 




Figure 3.8 – Seroprevalence of N. caninum in cattle in early lactation (n=406), mid-lactation 
(n=317) and during the dry period (n=314) estimated with the commercial test (IDVet) and 









































Dry Early lactation Mid lactation
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Table 3.15 – Seroprevalence of N. caninum by IDVet iELISA or combinations of tests carried 
out in parallel denominated test A, B or C in cattle in early lactation (n=406), mid-lactation 
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Updated information on the seroprevalence of N. caninum in a cattle population is a 
prerequisite for shaping appropriate control programmes for bovine neosporosis. 
Furthermore, baseline seroprevalence data are needed to enable the reliable 
interpretation of serological results obtained from aborting dams within the 
investigation of abortion outbreaks (Davison et al., 1999c, McAllister 2016). 
One of the primary objectives of this study was to determine the seroprevalence of N. 
caninum in British dairy cattle. 
Five experimental antibody ELISAs based on recombinant antigens of N. caninum 
(rNcSRS2, rNcGRA7, rNcSAG4, rNcBSR4 and rNcSRS9) were used alongside a 
commercial test which was considered as a representative of the assays commonly 
used within serological surveys. Indeed, a previous study reported excellent agreement 
between the IDScreen® Neospora caninum indirect ELISA (IDVet) and most 
commercially available serological tests for bovine neosporosis which are based on 
the same principle and similar antigenic preparations (Alvarez-Garcia et al., 2013). 
A commercial iELISA based on native NcSRS2 surface antigen (Bio K 192, 
Monoscreen Ab ELISA, Bio-X Diagnostics, Rochefort, Belgium) (Ghalmi et al., 
2009) was available at the time of the study, the in-house rNcSRS2 iELISA was used 
for costs reasons. 
All six tests were used to test a sample of the British adult dairy cattle population for 
N. caninum-specific antibodies in plasma. 
Given the unavailability of a true gold standard test for bovine neosporosis (Ortega-
Mora et al., 2007) and a sufficient number of reference plasma samples, traditional 
methods to obtain a cut-off value with estimates of the characteristics of each test were 
inadequate (Jacobson 1998). For this reason, a bi-modal normal distribution model 
was used. The model fitted the data and a threshold value for each test was obtained. 
Estimation of the test characteristics from the model showed that Se and Sp of the tests 
based on antigens highly expressed by the tachyzoite stage and considered as markers 
of acute infection were superior compared to those of the tests based on bradyzoite-
specific antigens. Amongst the tests using antigens expressed by the tachyzoite stage, 
the commercial iELISA based on total extract of sonicated tachyzoites (IDVet) was 
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characterised by the highest estimated median Se (94.4%) and Sp (99.6%) followed 
by the experimental assay based on the recombinant NcGRA7 antigen (rNcGRA7) 
(Se: 93.7%, Sp:97.4%). Although characterised by adequate median Sp (97.2%), the 
rNcSRS2 iELISA showed lower median Se compared to the other two tests (87.7%). 
Within the group of tests based on bradyzoite antigens, the rNcSAG4 iELISA was 
characterised by the best median Sp (96.2%) and Se (82.4%) compared to the 
rNcBSR4 and the NcSRS9 iELISAs which showed lower median Se of 71.4% and 
70.5% respectively. 
Interestingly, the lower Se of the rNcSAG4 iELISA compared to the rNcGRA7 
iELISA is consistent with previous evaluations of these two tests (Aguado-Martinez 
et al., 2008). Aguado-Martinez et al., (2008) reported 96.0% and 89.0% Se for the 
rNcGRA7 and rNcSAG4 iELISA respectively; however, a direct comparison of test 
characteristics is not possible as the calculation of the optimal cut-offs, Se and Sp was 
carried out using methods based on a gold standard reference test and a panel of 
reference sera, implemented with TG-ROC analysis (Aguado-Martinez et al., 2008). 
Moderate, but not high, agreement was found amongst tests based on antigens highly 
expressed by the tachyzoites, either native (IDVet) or recombinant (rNcSRS2 and 
rNcGRA7) and amongst bradyzoite-specific antigen-based iELISAs (rNcSAG4, 
rNcBSR4 and rNcSRS9). 
High levels of agreement between diagnostic ELISAs may reflect the similarity of test 
principle, technical aspects (e.g. plasma and conjugate dilutions) and antigen 
preparation (Alvarez-Garcia et al., 2013). Tests based on different antigenic 
preparations may show lower levels of agreement because of the detection of 
antibodies directed against different epitopes of the parasite, expressed at different 
lifecycle stages of the parasite (Dubey et al., 1997, Jenkins et al., 2000). Therefore, 
the moderate agreement observed amongst tests targeting antibodies responses against 
antigens which are expressed by the same stage of N. caninum may be due to the 
different antigenic preparation and technical characteristics of each iELISA protocol. 
Notably, the only slight agreement observed when each iELISA employing antigens 
which are highly expressed by the tachyzoite stage was compared with each bradyzoite 
antigen-based iELISA may indicate that the two types of antigenic preparation are 
recognised by different antibody responses against N. caninum. These two aspects do 
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not necessarily overlap. Only a relatively small proportion (35.0%) of animals which 
tested positive with more than one test showed detectable antibodies against both 
tachyzoite and bradyzoite antigens (Tables 3.7-3.8). 
Most N. caninum antibody positive cows tested positive with only one test or showed 
detectable plasma antibodies exclusively against antigens predominantly expressed by 
the tachyzoite, but not bradyzoite-specific antigens, and vice versa. In practical terms, 
this may imply that the exclusive use of serological assays based on tachyzoite 
immunodominant antigens may result in false negative results. Such false negative 
results are not taken into account by the Se of the test used because cattle infected with 
N. caninum may have detectable antibody titres against antigens expressed by the 
bradyzoite stage but not against immunodominant antigens of the tachyzoite stage. 
The combined analysis of test results obtained with both tests based on antigens highly 
expressed by the tachyzoite stage, which are considered to be markers of acute 
infection, and bradyzoite-specific antigens, which have potential for identification of 
persistently infected animals, can provide information on the stage of infection (i.e. 
primary infection, recrudescence, reinfection, or persistent infection) as described in a 
previous study in which the rNcGRA7 and the rNcSAG4 iELISAs were used in 
parallel (Aguado-Martinez et al., 2008). 
In the present study, the background information available (e.g. history of N. caninum 
abortions at the herd and individual level) was not sufficient to support any evaluation 
of the stage of infection. Nonetheless, it might be possible to speculate that, out of the 
total number of animals with at least one positive iELISA result, cattle with at least 
one tachyzoite and one bradyzoite positive result (43/249; 17.3%, 95%CI: 13.1-
22.4%) were likely to be animals in which a recent acute infection became quiescent 
or cows in which reactivation or reinfection occurred. Cattle which tested positive with 
iELISAs using antigens highly expressed by N. caninum tachyzoites only (118/249; 
47.4%, 41.3-53.6%) experienced a primary exposure to the parasite and animals which 
tested positive with bradyzoite antigens-based tests only (88/249; 35.3%, 29.7-41.5%) 
harboured the quiescent stage of N. caninum within a persistent infection. 
Since the infection dynamics with regards to the level of exposure of bradyzoite 
antigens during the latent stage of N. caninum are currently unclear. The evaluation of 
tests targeting antibody responses elicited by the bradyzoite stage of the parasite is 
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difficult. Tissue cyst rupture or reactivation would be required for these antigens to be 
exposed to the host immune system. Further specific longitudinal studies are therefore 
required to assess how these mechanisms influence the presence of circulating stage-
specific antibodies in persistently infected cows. Although in one study the rNcSAG4 
iELISA was applied to the analysis of sera from persistently infected cows sampled 
longitudinally (Aguado-Martinez et al., 2008), additional work using an increased 
number of animals and a wider panel of iELISAs based on bradyzoite-specific antigens 
may help to clarify the presence and temporal dynamics of antibody titres against the 
quiescent stage of N. caninum. 
Combined results using more than one test showed that the Se of the serological 
diagnosis can be enhanced using multiple tests in parallel. However, there are practical 
and economic limitations to the number of tests that can be used routinely. 
Although the IDVet, rNcSRS2 and rNcGRA7 iELISAs used in combination and 
associated to one of the bradyzoite antigen-based assays were collectively 
characterised by Se and Sp > 90%, the simultaneous use of four tests would require 
careful cost-benefit analysis due to the increased costs. Alternatively, the development 
of one antibody ELISAs using a mixture of recombinant antigens to coat a single well 
may be explored as a strategy for the reduction of the costs involved. 
The use of three tests would provide a Se of 81.5% regardless of whether the 
commercial test is used alongside both rNcSRS2 and rNcGRA7 iELISAs or one of 
these two tests associated with the rNcSAG4 iELISA. These test combinations would 
provide comparable Sp (Table 3.11). 
Interestingly, the combination of all three tests based on antigens highly expressed by 
the tachyzoite stage with either the rNcBSR4 or the rNcSRS9 iELISA determined a 
slightly higher increase in Se compared to the use of the rNcSAG4 iELISA associated 
with these three tests. However, the univariate analysis and distribution of the results 
obtained with the rNcBSR4 and rNcSRS9 iELISAs highlighted generally poor 






3.4.1 Preliminary estimation of false negative results obtained with 
iELISAs based exclusively on N. caninum tachyzoite antigens 
 
A set of reference samples was generated by adjusting the cut-off of each iELISA to 
identify animals that were truly positive by scoring likely false positive results as 
negatives and by combining the test results obtained with all tests. This enabled the 
comparison of individual tests and combinations of tests against a panel of reference 
positive and negative samples based on all iELISAs evaluated. 
The use of all three assays based on antigens which are considered to be markers of 
acute infection (test A) enabled the identification of 81.5% (141/173; 95%CI: 75.0-
86.6) of the samples deemed as N. caninum antibody positive thus suggesting that 
approximately 18.5% false negative results could be attributed to the fact that assays 
based on bradyzoite-specific antigens were not included (Table 3.11). This would 
provide an approximate estimation of the number of animals that would not be 
correctly identified because, although they have bradyzoite-specific circulating 
antibodies, the levels of tachyzoite-specific antibodies are not detectable. Such 
estimate was supported by the increase in seroprevalence when one test based on 
bradyzoite antigens is used in parallel with all three tests based on tachyzoite antigens. 
The overall seroprevalence assessed with test B and C increased by 2.5% (from 15.6 
to 18.1%) and 5.5% (from 15.6 to 21.1%) respectively corresponding to an increment 
of 14.0% and 26.0% (Table 3.12). 
The reliable estimation of the proportion of animals which may truly show antibodies 
against the quiescent stage of N. caninum was hampered by the poor Se displayed by 
the rNcSAG4 iELISA and the inadequate Se and Sp of the rNcBSR4 and rNcSRS9 
iELISAs observed within the univariate analysis of these tests (Figure 3.3). This 
suggested that further optimisation and validation of these tests are required. 
Importantly, also tests based on immunodominant antigens predominantly expressed 
by the tachyzoite stage showed limited sensitivity when used singularly. If the outcome 
of the commercial test (IDVet) is considered alone, the proportion of animals classified 
as seronegative but in which levels of anti-N. caninum antibodies were detectable with 
at least one of the other tests would be as high as 46.8% (81/173, 39.5-54.2) (Table 
3.10). This indicated that a large proportion of infected animals may be misclassified 
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as seronegative if a single commercial assay based on antigens considered to be 
markers of acute infection (immunodominant tachyzoite antigens) was used. 
In the absence of assays which would provide improved performances, combining the 
results of different tests carried out in parallel should be considered as a strategy to 
improve the sensitivity of the serological diagnosis of bovine neosporosis. 
According to the analysis performed, 3 iELISAs based on immunodominant antigens 
expressed by the tachyzoite stage of N. caninum associated with 1 iELISA using a 
recombinant bradyzoite-specific antigen, either rNcSAG4 (test B) or rNcBSR4 (test 
C), would provide satisfactory Se and Sp levels (Table 3.11). Although not perfect, 
these serological tools may represent a valuable alternative to overcome the poor 
performances in terms of sensitivity observed when assays based exclusively on 
immunodominant tachyzoites antigens, used individually or in combination (test A), 
are employed for determining the N. caninum serological status in cattle. 
 
3.4.2 Seroprevalence of N. caninum in British dairy herds 
 
The proportion of N. caninum serologically positive animals is influenced by several 
factors and varies depending on the country, region and herd considered. In addition, 
the serological techniques and specific tests used as well as the cut-offs applied 
contribute significantly to the variations detected in different studies. The 
seroepidemiological data presented in this cross-sectional study are based on the 
outcome of a commercially available ELISA (IDVet) applied on a large sample of 
British adult dairy cattle. Likewise, most of the ELISAs used in previous 
seroprevalence studies, the commercial test employed used native N. caninum 
tachyzoite antigens for the detection of specific IgGs. Recalculation of the cut-off 
value of this test was carried out using the bimodal normal mixture model. Importantly, 
using this cut-off the test showed the highest estimated median Se and Sp compared 
to the other tests assessed. 
The overall N. caninum seroprevalence was estimated at 9.0%. This is similar to 
previous estimates of 6% (6%; 95% CI: 4-8) (Davison et al., 1999c) in normally 
calving dairy cattle in England and Wales and 12.9% in dairy and suckler bovines, 
longitudinally tested at yearly intervals for four years, in south-west England 
(Woodbine et al., 2008). In the latter study, 87.1% (86.1-87.6) of the cows always 
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tested negative, 8.1% (7.6-8.6) always tested positive whereas 4.8% (4.5%-5.2%) had 
different test results at different time points (Woodbine et al., 2008). A higher 
seroprevalence (17.1%) was reported in a cross-sectional serological survey conducted 
on a sample of English dairy cattle; however, only herds with history of N. caninum 
abortions were selected in this study (Davison et al., 1999a). 
If the cut-off suggested by the manufacturer of the IDVet iELISA (i.e. S/P=50, with 
samples in which 40<S/P<50 classified as doubtful) had been chosen, 60 cows out of 
1,037 would have been classified as seropositive thus giving a seroprevalence of 5.8% 
(4.5-7.4). Two animals would have had a doubtful test result. Sp and Se of the IDVet 
iELISA on the basis of the manufacturer’s cut-off were calculated by Alvarez-García 
et al. (2013) who used gold standard criterion defined pre-test information (i.e. 
reference positive and negative serum samples classified based on previous 
epidemiological, clinical and serological data). Sp and Se were 98.3% (96.3-100) and 
98.9% (97.6-100) respectively (Alvarez-Garcia et al., 2013). Based on this 
information, the true estimated prevalence, corrected as previously described using the 
Rogan-Gladen estimator would have been 5.9 %. 
Interestingly, using the rNcSRS2 and rNcGRA7 iELISAs similar seroprevalence 
estimates were obtained: 9.2% and 8.7% respectively which corrected based on the 
Rogan-Gladen estimator were 7.5% and 6.7% respectively. 
Collectively all tests based on antigens predominantly expressed by the tachyzoite 
stage (test A) classified as N. caninum-antibody positive 162 animals generating an 
apparent overall seroprevalence of 15.5% (13.5-18.0). Including the outcome of one 
assay based on bradyzoite antigens the estimated proportion of seropositive cows was 
18.1% (188/1,037; 15.9-20.6) with the rNcSAG4 (test B) and 21.1% (219/1,037; 18.7-
23.7) with the rNcBSR4 iELISA (test C). These combinations of assays were selected 
because they were characterised by good Se with minimal decrease in Sp (test B) or 
by the highest Se (test C) as calculated using the reference panel of samples generated 
(Table 3.11). 
The percentage of herds in which serological evidence of N. caninum was found was 
high (67.2%, 54.0-78.7% with IDVet) or very high (>90% with test A, B or C) thus 
confirming that the protozoan parasite is relatively common in dairy herds across Great 
Britain. In other European countries, the between-herd seroprevalence of N. caninum 
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at the national level is highly variable. A supranational large-scale serological study 
reported serological positivity for the parasite in 16%, 49%, 63% and 76% of dairy 
herds sampled in Sweden, Germany, Spain and the Netherlands respectively (Bartels 
et al., 2006a) using ELISAs that were based on whole tachyzoite extracts as antigen 
preparations. 
Bayesian MCMC methods represent an alternative strategy for the estimation of the 
seroprevalence. These techniques have been previously successfully applied to 
estimate the prevalence of animal and human infectious diseases using serological data 
(Opsteegh et al., 2010; Xia et al., 2013). In contrast to frequentist approaches, 
Bayesian MCMC simulations incorporate prior information about the parameters of 
each test, which are used to reach an overall best estimate of the prevalence (Basanez 
et al., 2004). In the present study, such methods were employed for the calculation of 
the optimal cut-off values and the analysis of the characteristics (Sp and Se) of the 
serological assays used in order to overcome the lack of a gold standard test for bovine 
neosporosis. 
 
3.4.2.1 Seroprevalence in different production groups of dairy cattle 
The serological screening of cattle in mid to late pregnancy has been traditionally 
advised as it is thought to give the best chances of revealing infected animals (Dannatt 
1997). In clinical practice, it is often recommended to serologically test cows during 
drying off, which is typically done 8 weeks before the predicted calving date, 
according to the general husbandry of dairy cattle (Figure 3.8). In addition, the current 
voluntary control scheme for bovine neosporosis proposed by the Cattle Health 
Certification Standards (CHeCS) (i.e. the self-regulatory body for cattle health 
schemes in the UK and Ireland) recommends testing pregnant animals between 12 and 
4 weeks pre-calving (CHeCS 2016). This sampling window is supported by the rise of 
N. caninum-specific antibody titres which was observed after the fifth month of 
gestation in naturally infected cows within a number of longitudinal studies 
(Andrianarivo et al., 2005, Cardoso et al., 2009, Dannatt 1997, Guy et al., 2001). In 
addition, the occurrence of most neosporosis-induced abortions during the 5th-6th 
month of gestation (Dubey 2003) led to the biological assumption that in non-aborting 
dams the reactivation of a quiescent infection would be likely to occur at this stage or 
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later. Reactivation would result in increased exposure of the parasite to the host 
immune system thus triggering an increase in detectable antibody levels. According to 
these observations, a higher seroprevalence amongst animals in late gestation would 
be expected. 
In the present study, the GLMM analysis of the serological data, which was performed 
to consider the farm of origin as a random effect, showed limited differences in the 
seroprevalence of three groups of animals sampled during three productive phases 
(early lactation, mid-lactation and dry period). These three productive stages reflect, 
with some approximation, three reproductive stages: non-gestation/uterine involution, 
early pregnancy and late gestation respectively (Figure 3.9). 
 
 
Figure 3.9 – Standard dairy cows’ productive cycle with blood sampling time intervals (blue 
lines): (A) early lactation (B) mid-lactation and (C) dry period. The green dashed line indicates 
the 12 to 4 weeks pre-calving sampling window historically recommended by the main UK 
provider of cattle health schemes for bovine neosporosis. 
 
In contrast to the hypothesis of a higher seroprevalence amongst cattle in late 
pregnancy, the observed proportion of N. caninum antibody-positive animals in the 
group of dry cows was (7.0%) similar and not significantly different to seroprevalence 
of cows in mid-lactation (7.9%) (p=0.657). Careful interpretation of the higher 
seroprevalence observed in early lactating cows (11.1%) is required as the difference 
from the seroprevalence during the dry period was only just statistically significant 
(p=0.049). Furthermore, on average, there were only approximately 30 days between 
the sampling time of early lactating (days in milk: mean ± SD 18.7 ± 7.2) and dry cows 
(days prior to the expected calving date: 11.4 ± 9.6). 
Additionally, equivalent GLMM analysis carried out based on the results obtained 
with different combination of assays used in parallel (Test A, B and C) showed that 
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there were no statistically significant differences between the seroprevalence observed 
in dry cows compared to the seroprevalence in early or mid-lactation. 
Overall, these findings indicate the lack of strong evidence to suggest that carrying out 
serological investigations for bovine neosporosis during a specific 
productive/reproductive stage of the three investigated would increase the chances of 
detecting infected animals. 
Due to the analysis of residual samples originally collected for a different purpose, the 
direct assessment of the actual validity of the recommended sampling window (12 to 
4 weeks pre-calving) was difficult since most of the dry cows were sampled less than 
4 weeks pre-calving (days prior to the expected calving date: mean=11.4, median=7.0, 
min=1, max=82). 
In dairy cattle, the concentration of total IgGs in peripheral blood steadily decreases 
from the 8th week (Herr et al., 2011) or the 5th-4th week (Detilleux et al., 1995, Franklin 
et al., 2005) ante-partum to parturition. Such pregnancy-associated phenomenon is 
considered physiological and most likely caused by the translocation of 
immunoglobulins to the mammary tissue for colostrum production (Herr et al., 2011). 
The decline of total IgGs towards term might have had an impact on the proportion of 
dry cows which showed N. caninum-specific plasma IgGs above the cut-off of the 
iELISA considered. Indeed, the vast majority of the animals in this group were close 
to calving hence to the stage in which the concentration of total IgGs is as its minimum. 
In summary, the cross-sectional data produced did not support the exclusive 
serological examination of cows during the dry period; however, further investigations 
are necessary. 
Longitudinal studies of a large number of cattle are required to investigate the 
dynamics of antibody titres during the different productive/reproductive stages and 
their impact on the serological diagnosis of bovine neosporosis under field conditions. 
This would help to identify the optimal time frame, if any, during which serological 







Tests based on tachyzoite antigens alone showed generally better performances than 
tests based on bradyzoite antigens. However, the use of tests based on bradyzoite 
antigens should be considered because of the evidence that a proportion of animals 
may display antibodies against antigens expressed by the quiescent stage of the 
parasite but not against the rapidly multiplying tachyzoite stage. These findings 
confirmed the concerns related to the potential lack of sensitivity of serological assays 
based exclusively on tachyzoite antigens. Such shortcoming may be overcome by 
carrying out multiple tests based on both N. caninum tachyzoite and bradyzoite 
antigens in parallel. This strategy would be particularly beneficial in those clinical 
scenarios in which high sensitivity is required, for example, to identify N. caninum 
infected cattle to cull or exclude from breeding replacement stock, or to screen 
prospective replacement cattle. 
The cross-sectional seroprevalence study showed that N. caninum is widespread 
amongst British dairy herds. In addition, the data collected did not support that testing 
animals in late pregnancy would increase the likelihood of detecting cattle infected 
















Chapter 4: Application of microsatellite markers 





Neospora caninum is a ubiquitous apicomplexan that has been detected in cattle in 
every country in which specific investigations were carried out. The parasite is 
expected to be widespread anywhere where definitive canid hosts and intermediate 
hosts are present (Goodswen et al., 2013). Since the first isolations of the parasite from 
infected dog pups (NC-1 isolate) (Dubey et al., 1988b) and aborted bovine foetuses 
(BPA-1 and BPA-2 isolates) (Conrad et al., 1993a) in the United States, many N. 
caninum isolates have been characterised from different host species and geographical 
areas (Al-Qassab et al., 2010b). 
A number of studies showed that several genetic and biological characteristics are not 
strictly conserved within the N. caninum species and substantial differences exist 
between isolates. Variations in virulence and in vitro growth rate are well documented 
(Atkinson et al., 1999, Pereira Garcia-Melo et al., 2010, Quinn et al., 2002b, Regidor-
Cerrillo et al., 2010, Schock et al., 2001). In cattle, Nc-Liverpool, which was originally 
isolated in the UK from the brain of a congenitally infected dog (Barber et al., 1995), 
is characterised by high virulence and was able to readily induce abortion in 
experimentally infected pregnant animals (Williams et al., 2000). Likewise, NC-1 
caused foetal death in intravenously challenged pregnant heifers; in contrast, no 
foetopathy was observed in experimental infections conducted with the Nc-Spain 1H 
isolate (Rojo-Montejo et al., 2009a). In a non-pregnant BALB/c mouse model of N. 
caninum infection, 8 Spanish isolates showed biological differences in terms of 
temporal dissemination of the parasite, parasite burden and histopathological lesions 
in the brains and lungs of infected mice (Pereira Garcia-Melo et al., 2010). A similar 
infection model showed that Nc-Liverpool infection results in severe clinical signs and 
histopathological lesions in the central nervous system whereas milder clinical and 
pathological findings are seen following infection with the Swedish isolate Nc-SweB1 
(Atkinson et al., 1999). Differences in pathogenicity of N. caninum isolates were also 
observed in pregnant BALB/c mouse models. In one study, three Spanish isolates (Nc-
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Spain 4H, Nc-Spain 5H, Nc-Spain 7) and Nc-Liverpool were associated with the onset 
of clinical signs in the dams and a higher neonatal mortality rate compared with 
another six Spanish isolates which showed lower morbidity (Regidor-Cerrillo et al., 
2010). In vitro, the same panel of N. caninum isolates displayed significant differences 
in the invasion rate (i.e. median number of intracellular parasites at a specific time) 
and proliferation kinetics (i.e. number of tachyzoites at a given time point measured 
by quantitative PCR). Interestingly, increased invasion rate and proliferation kinetics 
in vitro were correlated with high morbidity in mice (Regidor-Cerrillo et al., 2011). 
A degree of phenotypic and genotypic heterogeneity is expected for a parasite with 
few geographical barriers, a broad range of intermediate hosts and the capacity for 
sexual reproduction (Schock et al., 2001). 
The current knowledge of N. caninum sexual reproduction is scarce and mainly based 
on data extrapolated from the closely related apicomplexan T. gondii. Similar to T. 
gondii in the feline definitive host, N. caninum sexually reproduces in the intestinal 
cells of the canid host (Dubey et al., 2007). Although enteroepithelial schizont-like 
stages of N. caninum were noted in one dog pup (Kul et al., 2015), life cycle stages 
related to gametogony have not been demonstrated to date. Based on information 
obtained from T. gondii, sexual crosses between two different isolates simultaneously 
infecting the definitive host may occur (Grigg et al., 2001). This may lead to 
recombination and reassortment of genetic material between the parental genomes of 
the isolates involved in the coinfection, thus resulting in new isolates with distinct 
genotypic and phenotypic features (Grigg et al., 2001, Regidor-Cerrillo et al., 2013). 
Furthermore, it has been postulated that the genetic material of T. gondii may undergo 
meiotic recombination during the brief diploid stages within the predominantly 
haploid life cycle of the parasite (Grigg and Sundar 2009). The actual occurrence of 
these mechanisms in N. caninum is yet to be verified; however, they would represent 
possible sources of genetic variability. 
Discriminatory molecular methods are a key requirement for investigating the genetic 
heterogeneity of N. caninum and its implications in the epidemiology and pathogenesis 
of neosporosis (Beck et al., 2009). 
Preliminary studies used randomly amplified polymorphic DNA-PCR (RAPD-PCR) 
to assess the diversity amongst N. caninum isolates (Atkinson et al., 2000, Schock et 
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al., 2000) and to differentiate N. caninum from N. hughesi (Spencer et al., 2000). 
Based on short arbitrary primers that can bind different sites of the parasite genome, 
this technique provides limited detection of polymorphisms and is heavily reliant on 
the purity of the DNA template as well as on the amplification conditions (Al-Qassab 
et al., 2010b). 
The analysis of ribosomal DNA (18S subunit) has been used for phylogenetical studies 
of Neospora spp. and several related apicomplexans (Marsh et al., 1995). At this level, 
sequence conservation amongst N. caninum isolates was found (Barber et al., 1995, 
Marsh et al., 1995, Stenlund et al., 1997). This was attributed to the rare occurrence 
of nucleotide changes in the 18S sequences during N. caninum evolution from its 
closest ancestor (Al-Qassab et al., 2010b, Marsh et al., 1995). 
Although minor variations of the internal transcribed spacer sequence (ITS1) have 
been documented amongst Brazilian (Nc-Bahia), European (Nc-Liverpool and Nc-
SweB1) and North American (NC-1, Nc-Beef and Nc-Illinois) isolates, the 
polymorphism observed was considered insufficient for enabling differentiation at the 
isolate level (Gondim et al., 2004a). 
Other potentially polymorphic loci such as genes encoding the NcSAG1, NcSRS2 and 
NcSAG4 surface antigens (Fernandez-Garcia et al., 2006, Marsh et al., 1999), a-
tubulin (Siverajah et al., 2003), b-tubulin and HSP70 (McInnes et al., 2006a) were 
also investigated revealing sequence conservation or extremely limited variations 
amongst isolates (Beck et al., 2009). Finally, polymorphisms of the Nc5 repeat region 
of N. caninum genome were analysed (McInnes et al., 2006a); however, only small 
variations between isolates were detected (Gondim et al., 2004c, Wapenaar et al., 
2006). 
Currently, the multilocus analysis of micro- and minisatellites is considered the gold 
standard for the genotyping of N. caninum (Al-Qassab et al., 2010b, Donahoe et al., 
2015, Goodswen et al., 2013). Micro- and minisatellites are tandemly repeated 
sequences of nucleotides which are widely distributed throughout the genomes of 
eukaryotic organisms (Tautz and Renz 1984). Microsatellites are short (2-6 
nucleotides long) repetitive DNA motifs whereas minisatellites are characterised by 
longer repeated sequences (≥8 nucleotides) (Al-Qassab et al., 2009). Within these loci 
the recurring addition or deletion of repeat units (e.g. due to DNA replication errors 
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such as, for example, slipped-strand mispairing) result in sequence length 
polymorphisms (Gemayel et al., 2012); as a consequence, micro- and minisatellites 
are evolutionary relevant and represent useful DNA markers for the investigation of 
genetic diversity (Vieira et al., 2016). Typically, the determination of the number of 
tandem repeats at multiple loci within the genome is carried out by PCR amplification 
followed by amplicon sizing using capillary electrophoresis (CE) or sequencing 
(Basso et al., 2010). Microsatellite amplification by nested PCR showed higher 
sensitivity than conventional PCR (Basso et al., 2009, Pedraza-Diaz et al., 2009); 
therefore, it is generally preferred. 
Several polymorphic N. caninum micro- and minisatellite loci have been identified to 
date. Distinct genetic profiles amongst 9 laboratory-maintained N. caninum isolates 
were found analysing 13 microsatellite markers (MS1A, MS1B, MS2, MS3, MS4, 
MS5, MS6A, MS6B, MS7, MS8, MS10, MS12, MS21) (Regidor-Cerrillo et al., 2006). 
The same panel of markers was subsequently used to characterise 9 Spanish isolates 
obtained from asymptomatic infected calves. Unique genetic patterns were observed 
between most isolates; however, those originating from the same herd showed 
identical or similar genetic profiles (Regidor-Cerrillo et al., 2008). 
The application of these markers to clinical samples (i.e. brains of aborted bovine 
foetuses) provided useful epidemiological information. Sub-clustering of isolates 
according to their geographical origin was described in one study (Pedraza-Diaz et al., 
2009). Additionally, shared microsatellite patterns, observed in aborted foetuses from 
individual abortion outbreaks, supported the hypothesis that the epidemic pattern of 
bovine neosporosis results from horizontal transmission from a point source of 
infection (Basso et al., 2010). 
Further investigations enabled the identification of additional polymorphic tandem 
repeats regions highlighting that also minisatellite loci show a significant degree of 
polymorphism that can be used for the study of the intraspecific genetic variation (Al-
Qassab et al., 2009). In this context, multiplex PCR amplification of micro- and 
minisatellite markers was proposed as a convenient tool for the differentiation of 
isolates and strains (Al-Qassab et al., 2010a, Al-Qassab et al., 2009). 
Substantial genetic diversity amongst isolates has been observed showing that N. 
caninum exists as a diverse and genetically heterogeneous population (Al-Qassab et 
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al., 2009, Al-Qassab et al., 2010b, Basso et al., 2009, Beck et al., 2009, Regidor-
Cerrillo et al., 2013, Rojo-Montejo et al., 2009b). 
The genotyping of N. caninum by multilocus micro- and minisatellites analysis has 
multiple applications. These include the investigation of abortion outbreaks, the 
identification and discrimination of vaccine and challenge isolates within live vaccine 
research and the study of population genetics (Basso et al., 2010, Goodswen et al., 
2013, Regidor-Cerrillo et al., 2013). In particular, the application of molecular typing 
tools to bovine abortion outbreaks may provide valuable information on the source of 
infection and the predominant route of transmission, thus helping to shape control 
strategies for bovine neosporosis at the herd level. 
Suitable markers, characterised by adequate discriminatory power, are essential for the 
development of informative multilocus micro-/minisatellite tools. 
The current study aims to: 
1. Develop a panel of novel microsatellite loci to extend knowledge on 
polymorphic repetitive DNA sequences found in the N. caninum genome 
2. Investigate the applicability of the expanded microsatellite markers panel to 
study genetic diversity of N. caninum in both laboratory-maintained and 
clinical samples. 
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4.2 Materials and methods 
 
4.2.1 Laboratory-maintained N. caninum isolates 
 
A total of 14 laboratory-maintained N. caninum isolates, which originated from either 
bovine (n=10) or canine (n=4) hosts from different geographical areas, were analysed 
in this study (Table 4.1). All isolates were obtained from cryopreserved tachyzoites 
stocks held at the Moredun Research Institute. 
Tachyzoites of the Nc-LivB1, Nc-Spain2, Nc-JAP2 and Nc-JAP4 isolates were 
resuscitated from cryopreserved stocks and propagated in adherent and confluent 
monolayers of African Green Monkey Kidney (VERO) cells grown in 25 cm2 tissue 
culture flasks (Thermo Fisher Scientific, Waltham, MA, USA). Cells and parasites 
were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 
foetal bovine serum (4% v/v), penicillin G (50 U/ml) (Sigma-Aldrich, Munich, 
Germany) and streptomycin (50 μg/ml) (Sigma-Aldrich) at 37°C in a 5% CO2 
humidified incubator. Tachyzoites were harvested from the cell monolayer by 
disruption with a sterile cell scraper (Corning, NY, USA) and washed three times by 
centrifugation at 2,000g for 5 minutes and resuspension in sterile PBS (pH 7.4). The 
parasites were counted using a Neubauer haemocytometer (Sigma-Aldrich). Pellets 
containing approximately 5107 tachyzoites were prepared and stored at -80°C until 
DNA extraction. 
DNA samples of the other isolates were extracted directly from cryopreserved 2-5107 
parasites aliquots stored in freezing medium (50% v/v heat inactivated foetal bovine 
serum, 40% v/v IMDM and 10% v/v dimethyl sulfoxide (DMSO)). Prior to DNA 
extraction, the content of each cryogenic tube (Nalgene™, General Long-Term 
Storage Cryogenic Tubes, Thermo Fisher Scientific, Waltham, MA, USA) was thawed 
slowly on ice, resuspended in 10 ml cold PBS and centrifuged at 2,000g for 5 minutes 
in order to remove the freezing medium. The resulting parasite pellet was then stored 






Table 4.1 – Laboratory-maintained N. caninum isolates used in this study: host, geographic 





NC-1 Canine USA Dubey et al., 1988 
Congenitally infected dog pup 
(brain) 
BPA1 Bovine USA Conrad et al., 1993 Aborted foetus (brain) 
JAP-2 Bovine Japan Yamane et al., 1998 Congenitally infected calf (brain) 
JAP-4 Bovine Japan Yamane et al., 1998 Congenitally infected calf (brain) 
Nc-Beef Bovine USA McAllister et al., 1998 Naturally infected calf 
Nc-Drachten Bovine Netherlands - Naturally infected dog (oocysts) 
Nc-Freiburg02 Canine Germany - Naturally infected dog (oocysts) 
Nc-Freiburg03 Canine Germany - Naturally infected dog (oocysts) 
Nc-GER1 Canine Germany Peters et al., 2000 
Congenitally infected dog pup 
(brain and spinal cord) 
Nc-LivB1 Bovine UK Davison et al., 1999 Stillborn calf (brain) 
Nc-Poland Bovine Poland Cabaj et al., unpublished Aborted foetus (brain) 
Nc-Porto Bovine Portugal Canada et al., 2002 Aborted foetus (brain) 
Nc-Spain2 Bovine Spain Regidor-Cerillo et al., 2008 Naturally infected calf (brain) 
Nc-SweB1 Bovine Sweden Stenlund et al., 1997 Stillborn calf (brain)  
 
 
4.2.2 Clinical samples 
 
DNA samples extracted from brain, heart or placenta of 28 bovine aborted foetuses, in 
which N. caninum DNA was previously detected by ITS1 nested PCR (Katzer et al., 
unpublished), were included in the present study. All abortions originated from 13 
farms in the Dumfries and Galloway region in south-west Scotland and were collected 
between March 2008 and June 2011. 
 
4.2.3 Genomic DNA extraction 
 
4.2.3.1 Laboratory-maintained N. caninum isolates 
Parasite pellets from both cultured and cryopreserved N. caninum tachyzoites (~2-
5107 parasites) were resuspended in 100 l PBS, pre-treated with proteinase K (50 
mg/ml) (Sigma-Aldrich, Munich, Germany), mixed thoroughly and incubated at 56°C 
overnight. Genomic DNA was then extracted and purified using the DNeasy Blood 
& Tissue Kit (Qiagen, Venlo, The Netherlands) according to the manufacturer’s 
instructions. Following the same protocol, DNA samples were extracted from 
uninfected VERO cells and subsequently used as negative controls. 
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Concentration and purity of the DNA samples were determined by spectrophotometry 
using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, 
USA). DNA purity was assessed using the absorbance ratio at 260 nm and 280 nm. 
DNA samples were diluted to a final concentration of 100 ng/μl with DNase/RNase 
free water (Sigma-Aldrich, Munich, Germany) and stored at -20°C until used in PCR. 
 
4.2.3.2 Clinical samples 
Foetal tissues (brain or heart) or placental cotyledons were previously homogenised 
using 2 ml Precellys® tubes containing ceramic beads and a Precellys® homogeniser 
(both Bertin Instruments, Montigny-le-Bretonneux, France) in which 1 g of tissue and 
1 ml of Nuclei Lysis Solution (Promega, Southampton, UK) were added (Katzer and 
Bartley, unpublished). 
DNA extraction was performed from tissue homogenate as outlined in Bartley et al. 
(2013b) with minor modifications. Briefly, 400 μl of homogenate was added to 900 μl 
of Nuclei Lysis Solution and incubated overnight at 55°C. Once cooled, 300 μl of 
Protein Precipitation Solution (Promega) was added. The mixture was mixed 
thoroughly, incubated on ice for at least 5 min and centrifuged at 13,000g for 5 min. 
The resulting supernatant was then transferred to a 2 ml tube containing 900 μl of 
isopropanol. The tubes were mixed by inversion and incubated at -20°C overnight. 
Following centrifugation at 13,000g for 5 min, the supernatant was discarded and the 
DNA pellet washed with 600 μl of 70% ethanol. Centrifugation was repeated a second 
time and the residual ethanol was removed. The DNA pellet was then allowed to dry 
briefly before dissolving it in 100 l DNase/RNase free water (Sigma-Aldrich, 
Munich, Germany) at 4°C overnight. Concentration and purity of the DNA samples 
were assessed as described above. 
 
4.2.4 ITS1 nested PCR 
 
In order to confirm the presence of N. caninum DNA in the laboratory-maintained 
isolates and clinical samples as well as to exclude contamination of the negative 
control (DNA isolated from uninfected VERO cells), the N. caninum ITS1 nested PCR 
was carried as previously described (Bartley et al., 2013b, Buxton et al., 1998). PCRs 
were run in triplicate and the PCR products were electrophoresed on a 1.8% (w/v) 
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agarose/TAE gel (Appendix 1.1.3) incorporating Gel Red™ (Biotum, Hayward, CA, 
USA) and visualised under UV light. A 1kb DNA ladder (Promega, Madison, WI, 
USA) was used to identify the band (~ 297 bp) indicative of N. caninum ITS1 
amplification. 
 
4.2.5 Microsatellite markers 
Twelve microsatellite markers were selected amongst a broader panel of candidate loci 
that showed length polymorphisms in previous studies (Katzer and Bartley, 
unpublished). 
The identification of these loci was carried out by screening a large number of N. 
caninum expressed sequence tags (ESTs) for repetitive sequences, using the Tandem 
Repeats Finder software (Benson 1999). ESTs derived from tachyzoite cDNA libraries 
of the Nc-Liverpool isolate and were screened before the complete assembly and 
annotation of the parasite genome was made publicly available (Katzer, unpublished). 
In the present study, chromosomic localisation, repeat motif sequence and length of 
each microsatellite locus studied were cross-checked using the N. caninum Liverpool 
genome data that are currently available. Nomenclature of the microsatellite markers 
used and their chromosome location are shown Table 4.2. Furthermore, all the 
microsatellites used in the present study were compared with those previously 
described in other studies (Al-Qassab et al., 2009, Basso et al., 2009, Regidor-Cerrillo 













Table 4.2 – Attributes of the N. caninum microsatellite loci used in this study (source 
Neospora caninum Liverpool genome https://www.ncbi.nlm.nih.gov/genbank/ and 







(position within chromosome) 
MRI_002 VIIa (CTAT)11 
FR823388.1 
2541020-2541400 




MRI_014 VIIa (TCTA)11-(TA)10 
FR823388.1 
2267513-2267897 
MRI_016 VIII (AT)9-(TA)2-(AT)9 
FR823390.1 
6000078-6000405 
MRI_027 Ia (ATAC)14M 
FR823380.1 
335498-335865 
MRI_030 IV (TAC(A/G))40 
FR823384.1 
1827518-1827790 
MRI_036 VIII (AT)14 
FR823390.1 
214889-215138 
MRI_037 VI (TATG)11 
FR823387.1 
1319153-1319525 
MRI_040 II (AT)16 
FR823382.1 
1200461-1200685 
MRI_041 IX (A(T/C))94 
FR823385.1 
5208444-5208693 
MRI_042 Ib (TAGA)15-(TA)11 
FR823381.1 
1663036-1663277 




Based on the DNA sequences flanking the repeat region of each marker, internal and 
external primer pairs were designed to achieve nested PCR amplification (Table 4.3). 
Primers were designed using the Primer3 software (version 4.0.0) (Untergasser et al., 
2007) ensuring that the amplicon did not exceed 600 bp which is generally considered 
the upper limit for CE reproducibility in most capillary electrophoresis platforms 
(Nadon et al., 2013). The 5’ end of each internal forward primer was labelled with 6-
carboxyfluorescein (6-FAM). Both 6-FAM-labelled and unlabelled PCR primers were 
synthesised by Eurofins MWG Operon (Eurofins Genomics, Ebersberg, Germany). 
 
4.2.6 Nested PCR of repetitive DNA targets 
The reaction master mix, used during both the first and second rounds of nested PCR 
(nPCR), consisted of 2.5 l 10 NH4-based Reaction Buffer, 0.75 l 50mM MgCl2, 
0.25 l 10mM dNTP Mix and 2.5 units of BioTaq DNA Polymerase (all Bioline, 
London, UK), 0.2 μM of forward and reverse primers and DNase/RNase free water to 
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a final volume of 23 l per reaction. Approximately 0.2 g/reaction (2 l of the 0.1 
g/l stock) of template or control DNA or 2 l of DNase/RNase free water (blank 
control) were added to the master mix. 
A positive N. caninum (NC-1 strain) control was added. Negative controls included 
DNA isolated from uninfected VERO cells and T. gondii (RH strain) tachyzoites. 
PCRs were performed in a G-Storm thermocycler (G-Storm, Somerton, UK). Initial 
denaturation (95C for 5 min) was followed by 40 cycles of denaturation (95C for 1 
min), annealing (from 55 to 59C, depending on the set of primers, for 1 min) and 
elongation (72C for 1 min) with a final extension at 72C for 5 min. Optimum 
annealing temperatures were determined by gradient PCR reactions for each set of 
primers (Table 4.3). 
The nPCR products from the primary reaction were diluted 1:100 with DNase/RNase 
free water and used as a template (2 l/reaction) for the secondary round. 
PCR products were separated by electrophoresis on 1.8% (w/v) agarose/TAE gel 
(Appendix I) incorporating Gel Red™ (Biotum, Hayward, CA, USA), using a 1kb 
DNA ladder (Promega, Madison, WI, USA) as molecular marker. Gels were visualised 
under UV light and the intensity of each band was visually assessed and scored as 
weak, intermediate or strong. Based on band intensity scoring, the nPCR products were 
diluted 1:50 (weak), 1:100 (intermediate) or 1:200 (strong) in deionised 
DNAse/RNAse free water (Sigma-Aldrich, Munich, Germany) before submission for 






Table 4.3 – External and internal nPCR primers and annealing temperatures used to amplify the N. caninum microsatellite loci.  
Marker 
External PCR primers (5’-3’) 
 
Internal PCR primers (5’-3’) Ta  
Amplicon 
size 
 Forward Reverse  Forward Reverse (°C) (bp) 
MRI_002 AACGAACGCGTCAGAAGAAC GCAAGGAAAGCTCGAGACAC  *ATCCTACCCCGATCTCGACT CACGCAGCGTCTGTGTAGAT 58 381 
MRI_007 GGCGTCAATTCCAGAAAAAT CAGCCTCGCTTTCACCTACT  *AAACACGCTTCTTCACACCA TCAATGGCATAGATAGCTACGTT 58 291 
MRI_014 CCAGACGCCTCTGTATGTGA GACCCAAAACCGAACAGAAA  *ACATCCACACTCGTGCGTTA GACACAGCTTTGCCATCTTG 58 385 
MRI_016 TAGTACCTTGTGCCGCCAAT TTGCTCTTCTTCCCCTGCT  *GTCTCTGTTGACCCCTCAGC CACCTCGTCACTCCCATGTA 57 328 
MRI_027 GGCCCGTCCTCTAAATGAGT TTAAGGCCGACCCTTTACTG  *TGGCGTCTACACTGTGATCC CGTCTGCACGTATGTCCGTA 57 369 
MRI_030 TGCACACATGCATCTCGTAT AAGGCTGACGTTAGGGAACA  *ATATTCGTGCATCCATTTCG TCCGGGCAGATTACTGTTTT 55 273 
MRI_036 TGTATGCGCTTATCTGCACCT TGCAACGACAACACTACACG  *CTGTCGGACGCCTACACATA AAATACCCACACGCAGCATC 56 250 
MRI_037 CAATCGACATGTAGCCGTTC GAGCGACCAATCTCGTCTTC  *TCGTGTCTCCCCCATTCTAA AAAACGAGAGAAAGCCGTCA 56 373 
MRI_040 GAAAGCCCACCTGAGGATCT TCGACACATACGCCCATCTA  *ACTATTCGGGGGACGGTAAG CCGACGCTTGCTACCTATTC 57 225 
MRI_041 AGCCCACGCTTTTACCTACC CCAAAGTAACACGCTTCCAA  *GCACCTCCAAACACACACAA CACCTCGCATCACGTTCATA 58 250 
MRI_042 ACACGGAAGAGAGCCTAGCA TTCGTTCACGGACAAGACAC  *GCATTCACTTTTGTCCGTGT AACAGGAATGCCTCCAACTG 57 242 
MRI_045 CCAGTGCATTCACAGAGGTG GAAAGACAACGAGGGACGAA  *GGCACCTGCTTACTCACGTC AATGCTCGTCTTTCGCTCTC 57 291 
  
* Internal primers labelled with FAM at the 5’ end. Ta: annealing temperature
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4.2.7 Automated allele sizing and fragment analysis 
 
The size of the 6-FAM-labelled PCR products was determined by capillary 
electrophoresis (CE) using a 48-capillary ABI3730 DNA analyser (Applied 
Biosystems, Foster City, CA, USA) with the Genescan™ ROX500™ Size Standard 
(Applied Biosystems) at the University of Dundee (DNA Sequences and Services, 
Medical Science Institute, the University of Dundee). The electrophoretograms were 
then analysed using both the STRand (https://www.vgl.ucdavis.edu/ 
informatics/strand) and the Peak Scanner (Applied Biosystems) software. 
Allele numbers were assigned based on amplicon size as determined by CE and a 
multilocus fragment typing profile was generate for each DNA sample tested. Unique 
profiles were given a multilocus genotype (MLG) number. 
 
4.2.8 Sequencing of microsatellite markers 
 
Representative alleles in each locus were sequenced to ensure that the size variation 
observed between different alleles was due to differences in repeat unit copy numbers 
and that the regions flanking each repeat locus were conserved. In addition, sequencing 
enabled the characterisation of each allele based on the number of repeat units. 
Assessment of the microsatellite markers by sequencing was carried out as outlined by 
Nadon and colleagues (2013). 
PCR products were purified using a Wizard® SV gel and PCR Clean-up system 
(Promega, Madison, WI, USA) as detailed by the manufacturer. DNA sequencing, 
using both forward and reverse primers, was performed by Eurofins Genomics 
(Ebersberg, Germany). For each allele sequenced, a consensus sequence was obtained 
using the Lasergene Seqman Pro software (version 12) (DNASTAR, Madison, 
Wisconsin, USA). Consensus sequences of the different alleles of each microsatellite 
marker were then aligned for detecting length polymorphisms in the repeat regions. In 
case of failure or poor sequence quality, sequencing was repeated following cloning 




The purified PCR product was cloned using the pGEM-T Easy Vector System 
(Promega, Madison, WI, USA). Cloning and E. coli JM109 transformation were 
carried out as described in Chapter 2 (2.2.4.1). 
The plasmid DNA obtained from transformed bacteria was sequenced using the 
standard sequencing primers SP6-promoter and T7-promoter (Eurofins Genomics, 




The ability of each set of internal primers to exclusively amplify N. caninum DNA was 
initially assessed using primer BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-
blast/) to verify that primers did not align to other sequences of related species 
deposited in GenBank. 
Specificity was then experimentally evaluated by testing DNA samples from the 
related apicomplexan H. heydornii (isolate Giessen-1999), T. gondii (RH strain), S. 
cruzi, and B. besnoiti (Evora strain) in each locus-specific nPCR. The DNA samples 
originated from H. heydornii oocysts, S. cruzi bradyzoites isolated from bovine tissue 
cysts and T. gondii and B. beisnoiti tachyzoites cultured in vitro. 
DNA samples extracted from H. heydornii and B. besnoiti were kindly provided by Dr 
Gereon Schares (Friedrich Loeffler Institute, Greifswald, Germany). 
 
4.2.10 Data analysis 
 
4.2.10.1 Typeability of microsatellite markers 
Typeability, defined as the proportion of samples that were successfully assigned an 
allele number or a multilocus microsatellite genotype, was calculated for each 
microsatellite locus as the number of samples in which it was possible to assign an 
allele number divided by the total number of samples tested (Hotchkiss et al., 2015). 




4.2.10.2 Discriminatory power (Simpson’s Index of Diversity) 
The discriminatory power of a typing method is its ability to distinguish between 
unrelated samples. In this study, the Simpson’s Index of Diversity (SID), calculated 
using V-DICE (Variable Number Tandem Repeat and Confidence Extractor; 
http://www.hpa-bioinformatics.org.uk/cgi-bin/), was used to evaluate both the 
discriminatory ability of each individual microsatellite marker and the overall 
discriminatory power of the multilocus genotyping method. Based on the number of 
alleles and their relative frequencies, the SID provides an estimate of the probability 
that two epidemiologically-unrelated samples, randomly selected from the study 
population, will be attributed to different typing groups (Hunter and Gaston 1988). 
The SID ranges from 0 to 1, where 1 indicates that all samples analysed have different 
genotypes and 0 indicates that all samples have identical genotypes. 
 
4.2.10.3 Genetic and genotypic diversity 
Indexes of genetic diversity were calculated to describe the reference population of 
laboratory-maintained N. caninum isolates and the study population of DNA samples 
from bovine abortion cases collected from a specific geographic region of Scotland. 
Only the samples that were allocated an allele at all 12 loci and therefore a MLG were 
included in the analysis. 
Allelic richness and frequency were calculated using the FSTAT software (version 
2.9.3.2) (http://www2.unil.ch/popgen/softwares/fstat.htm) (Goudet 1995). 
The laboratory-maintained isolates with their worldwide origins were considered as 
the reference population and compared to the N. caninum population studied through 
the analysis of bovine abortion samples collected from a defined area of Scotland. Due 
to unequal sample size, allelic richness was corrected by standardisation to the smallest 
sample size in each dataset, corresponding to 8 individual samples. 
Nei’s unbiased genetic diversity (HNei) (Nei 1978) was measured to assess 
polymorphisms in each microsatellite locus using FSTAT. 
Genotypic diversity (G) was calculated as the number of unique MLGs observed (g) 
divided by the total number of individual DNA samples genotyped (n): G=g/n 
(Regidor-Cerrillo et al., 2013). The genotypic diversity was determined for the entire 
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sample of DNA samples, the reference population (laboratory-maintained isolates) and 
the study population (clinical samples from bovine abortions). 
 
4.2.10.4 Clustering analysis 
The multilocus microsatellite profiles obtained using the 12 markers were used to build 
a neighbour-joining dendrogram using ClustalW2 Phylogeny (https://www.ebi.ac.uk/ 
Tools/phylogeny/clustalw2_phylogeny/). The dendrogram was then visualised using 
the software FigTree v. 1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/). Only isolates 


























4.3.1 Characterisation of microsatellite markers and allele assignment 
 
BLAST searches on ToxoDB (http://www.toxodb.org) revealed that the 12 
microsatellite loci used in this study were located on 9 (Ia, Ib, II, IV, VI, VIIa, VIII, 
IX and XI) of the 14 chromosomes of the N. caninum genome. The microsatellite 
marker pairs MRI_002 and MRI_014, MRI_016 and M_036 and MRI_042 and 
MRI_045 were located within the same chromosome: VIIa, VIII and Ib respectively 
(Table 4.2). All microsatellite loci were in non-coding regions. MRI_007 was included 
within an intron sequence of the gene NCLIV_056440 while the other markers were 
situated in intergenic regions. 
Twelve nPCRs were developed using the internal and external primer pairs shown in 
(Table 4.3). Development and optimisation of the nPCRs and preliminary 
characterisation of the microsatellite markers were carried out using DNA samples 
from the 14 laboratory-maintained isolates. Amplification of the 12 microsatellite 
markers was successfully achieved in these samples. Besides showing the presence of 
a single band for each marker in each sample analysed, agarose gel electrophoresis of 
the nPCR products revealed noticeable length polymorphisms amongst amplicons 
within the same target locus. This provided a preliminary indication of the presence of 





Figure 4.1 – Agarose gel showing fragment size polymorphisms of the MRI_030 
microsatellite marker amongst N. caninum laboratory-maintained isolates. -: negative control 
(DNA isolated from uninfected Vero cells); 1: BPA-1, 2: Nc-Freiburg02, 3: Nc-Freiburgh03, 
4: Nc-GER1, 5: Nc-Porto; 6: Nc-Spain2; 7: Nc-Drachten; 8: JPA-2, 9: JPA-4, 10: Nc-SweB1, 
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Automated CE analysis of FAM-labelled nPCR products resulted in 
electropherograms that consisted of a single peak of fluorescence. For each locus, 
alleles were assigned based on this main peak corresponding to the size of the 
amplicon. 
Additional peaks differing from the primary peak by 2-4 bp were sporadically 
observed, these showed a considerably lower fluorescence and were attributed to 
strand slippage of the Taq polymerase on the microsatellite sequence (stutter peaks). 
In previous studies, secondary peaks with a height ≥ 30% of the primary peak were 
considered indicative of the presence of multiple genotypes within the same sample 
(Hotchkiss et al., 2015). Based on this arbitrary threshold, no evidence of mixed N. 
caninum genotypes was found in individual DNA samples. 
Direct sequence analysis was carried out on at least one representative of each allele 
identified. 
Allele size measured by automated fragment analysis was compared with the size 
obtained by direct sequence analysis for each allele identified. Discrepancies between 
fragment and sequence analysis were observed; however, these were consistent across 
the entire size range at each locus. Repeated nPCR and fragment analysis of 
representative alleles at each locus confirmed the consistency and repeatability of the 
sizing method (not shown). 
Sequencing of the nPCR products confirmed that the size variations observed at each 
locus derived from differences in the copy number of repeated units. In addition, the 
nature of the repeated motifs and the conservation of the regions flanking the repeat 
sequence were also verified. The variable repeats observed were either dinucleotide or 
tetranucleotide. Dinucleotide repeats were predominantly (AT)n (Table 4.4). 
Linear regression analysis showed that, within the panel of microsatellite markers 
examined in this study, the weak correlation (R2 = 0.281) between the length of the 
repeat and the number of alleles identified in each locus was not statistically significant 
(p = 0.075) (linear regression analysis was performed in Microsoft Excel, version 
15.28). 
The microsatellite markers MRI_002, MRI_027, MRI_030, MRI_036, MRI_037, 
MRI_040 and MRI_041 were characterised by polymorphism of individual repeat 
units whereas length variations in more than one tandemly repeated sequence were 
177 
found within the microsatellite markers MRI_007, MRI_014, MRI_016, MRI_042 and 
MRI_045. MRI_007 and MRI_045 had 3 variable dinucleotide or tetranucleotide 
repeat units within their sequences. MRI_014 and MRI_042 were both characterised 
by one tetranucleotide and one dinucleotide variable repeat: (TCTA)n and (TA)n, 
(TAGA)n and (TA)n respectively (Table 4.4). 
In MRI_016, 2 variable (AT)n repeats were separated by a single cytosine. In addition, 
a single nucleotide polymorphism (SNP) was detected in allele 7. 
In MRI_030, the variable repeat unit (TACA)n was intercalated with TACG motifs. 
Similarly, substitutions of the thiamine (T) with a cytosine (C) in the (AT)n repeats of 
MRI_041 were observed. 
After preliminary validation on laboratory-maintained N. caninum isolates the 
microsatellite analysis was applied to DNA samples extracted from clinical samples. 
Amplification of all microsatellite markers was not achieved in all clinical samples 
(see Typeability 4.3.2). 
Nomenclature, repeated motif and size determined by direct sequencing and CE for 
























Table 4.4 – Allele number allocations and sizes measured by sequence analysis and automated 






Amplicon size CE 
(range)  
MRI_002 (CTAT)11 1 381 382-383 
 (CTAT)12 2 385 386-387 
 (CTAT)13 3 389 390-391 
 (CTAT)14 4 393 394-395 
 (CTAT)15 5 397 398-399 
 (CTAT)16 6 401 402-403 
 (CTAT)17 7 405 406-407 
 (CTAT)18 8 409 410-411 
 (CTAT)19 9 413 414-415 
MRI_007 (TACA)14-TACG-(TACA)10-(AT)7 1 283 283.5-284.5 
 (TACA)15-TACG-(TACA)10-(AT)7 2 287 287.5-288.5 
 (TACA)14-TACG-(TACA)12-(AT)7 3 291 291.5-292.5 
 (TACA)15-TACG-(TACA)12-(AT)7 4 295 295.5-296.5 
 (TACA)16-TACG-(TACA)12-(AT)6 5 297 297.5-298.5 
 (TACA)18-TACG-(TACA)14-(AT)6 6 313 313.5-314.5 
 (TACA)19-TACG-(TACA)14-(AT)7 7 319 319.5-320.5 
 (TACA)21-TACG-(TACA)15-(AT)6 8 329 329.5-330.5 
MRI_014 (TCTA)6 -(TA)7 1 363 364-365 
 (TCTA)6 -(TA)9 2 367 368-369 
 (TCTA)x -(TA)y 3 NS 370-371 
 (TCTA)x -(TA)y 4 NS 374-375 
 (TCTA)9 -(TA)10 5 377 378-379 
 (TCTA)11 -(TA)9 6 383 384-385 
 (TCTA)11 -(TA)10 7 385 386-387 
 (TCTA)12 -(TA)13 8 395 390-391 
 (TCTA)x -(TA)y 9 NS 332-333 
MRI_016 (AT)8-C-(AT)10 1 326 326.5-327.5 
 (AT)11-C-(AT)9 2 330 330.5-331.5 
 (AT)12-C-(AT)9 3 332 332.5-333.5 
 (AT)12-C-(AT)10 4 334 334.5-335.5 
 (AT)12-C-(AT)11 5 336 336.5-337.5 
 (AT)15-C-(AT)10 6 340 340.5-341.5 
 (AT)16-C-(AT)11
SNP 7 342 342.5-343.5 
MRI_027 (ATAC)6 1 337 336.5-338 
 (ATAC)7 2 341 341-342.5 
 (ATAC)8 3 345 345-346.5 
 (ATAC)9 4 349 348.5-349.5 
 (ATAC)14 5 365 364.5-366.5 
MRI_030 (TAC(A/G))30 1 233 232.5-233.5 
 (TAC(A/G))31 2 237 236.5-237.5 
 (TAC(A/G))33 3 245 244.5-245.5 
 (TAC(A/G))34 4 249 248.5-249.5 
 (TAC(A/G))35 5 253 252.5-253.5 
 (TAC(A/G))36 6 257 256.5-257.5 
 (TAC(A/G))38 7 265 264.5-265.5 
 (TAC(A/G))39 8 269 268.5-269.5 
 (TAC(A/G))41 9 277 276.5-277.5 
MRI_036 (AT)10 1 242 242.5-243.5 
 (AT)13 2 248 248.5-249.5 
 (AT)14 3 250 250.5-251.5 
 (AT)15 4 252 252.5-253.5 
 (AT)17 5 256 256.5-257.5 
 (AT)19 6 260 260.5-261.5 







Amplicon size CE 
(range)  
MRI_036 (AT)22 8 266 266.5-267.5 
 (AT)32 9 286 286.5-287.5 
MRI_037 (TATG)10 1 369 368-370 
 (TATG)14 2 385 386-387 
 (TATG)15 3 389 390-391 
 (TATG)x 4 NS 395-396 
 (TATG)x 5 NS 400-401 
 (TATG)18 6 403 404-405 
 (TATG)x 7 NS 408-409 
 (TATG)x 8 NS 412-413 
 (TATG)21 9 415 416-417 
MRI_040 (AT)11 1 217 216.5-217.5 
 (AT)14 2 223 222.5-223.5 
 (AT)15 3 225 224.5-225.5 
 (AT)16 4 227 226.5-227.5 
 (AT)17 5 229 228.5-229.5 
 (AT)x 6 NS 234.5-235.5 
 (AT)x 7 NS 236.5-237.5 
 (AT)x 8 NS 238.5-239.5 
 (AT)23 9 241 240.5-241.5 
MRI_041 (A(T/C))85 1 232 233-234 
 (A(T/C))87 2 236 237-238 
 (A(T/C))88 3 238 239-240 
 (A(T/C))89 4 240 241-242 
 (A(T/C))90 5 242 243-244 
 (A(T/C))91 6 244 245-246 
 (A(T/C))92 7 246 247-248 
 (A(T/C))93 8 248 248.5-250 
 (A(T/C))94 9 250 251-252 
 (A(T/C))97 10 256 257-258 
 (A(T/C))98 11 258 258.5-260 
MRI_042 (TAGA)12-(TA)9 1 226 227-228 
 (TAGA)x-(TA)y 2 NS 233-234 
 (TAGA)x-(TA)y 3 NS 237-238 
 (TAGA)15-(TA)9 4 238 239-240 
 (TAGA)15-(TA)10 5 240 241-242 
 (TAGA)15-(TA)11 6 242 243-244 
 (TAGA)x-(TA)y 7 NS 245-246 
 (TAGA)x-(TA)y 8 NS 247-248 
 (TAGA)17-(TA)11 9 250 251-252 
 (TAGA)18-(TA)12 10 256 257-258 
MRI_045 (AT)8-(TAGA)7-(AT)9 1 257 258-259 
 (AT)x-(TAGA)y-(AT)z 2 NS 260-261 
 (AT)x-(TAGA)y-(AT)z 3 NS 262-263 
 (AT)9-(TAGA)8-(AT)9 4 263 264-265 
 (AT)x-(TAGA)y-(AT)z 5 NS 266-267 
 (AT)x-(TAGA)y-(AT)z 6 NS 268-269 
 (AT)9-(TAGA)9-(AT)10 7 269 270-271 
 (AT)x-(TAGA)y-(AT)z 8 NS 274-275 
 (AT)x-(TAGA)y-(AT)z 9 NS 276-277 
 (AT)9-(TAGA)15-(AT)9 10 291 287-292 
NS: sequence not analysed due to poor sequencing quality. 







All 14 laboratory-maintained N. caninum isolates were assigned an allele at all 12 
microsatellite loci. Fourteen unique multilocus profiles were obtained and allocated a 
MLG number (Table 4.5). Therefore, in these samples, the typeability of each 
individual marker as well as of the multilocus microsatellite typing tool was 1.0 (14/14, 
95%CI: 0.77-1.00). 
Within the clinical samples from bovine abortion cases, only 8 out of 28 N. caninum 
ITS1 nPCR positive samples were conclusively assigned a MLG (Table 4.6). 
The remaining 20 samples had at least one marker which could not be typed due to 
non-amplification during nested PCR or, less frequently, failure of automated 
fragment sizing that resulted in inconclusive electropherograms (Table 4.6). 
The typeability of the genotyping method was 0.28 (8/28, 95%CI: 0.15-0.47). At the 
marker level, the typeability ranged from 0.96 (95%CI: 0.82-0.99) (MRI_002, 
MRI_007, MRI_016 and MRI_027) to 0.43 (12/28, 95%CI: 0.26-0.60) (MRI_045) 
(Table 4.6). 
The typeability values of each microsatellite marker and the multilocus microsatellite 
typing tool when applied to laboratory-maintained isolates and clinical samples are 




Based on the primers-BLAST results, none of the primers used in nested PCR showed 
significant alignment to non-N. caninum apicomplexan species. 
Experimentally, the absence of amplification products from H. heydornii, T. gondii, S. 
cruzi, and B. besnoiti DNA samples indicated that the nPCRs developed for the 









Figure 4.2 – Agarose gel showing absence of amplification of the MRI_030 microsatellite 
marker from DNA samples of H. heydornii (2a-2b), T. gondii (3a-3b), S. cruzi (4a-4b) and B. 
besnoiti (5a-5b); 1a-1b: N. caninum BPA-1 positive control, 6a-6b: N. caninum Nc-Freiburg03 
positive control, -: negative control (DNA isolated from uninfected Vero cells). M(bp): 




Table 4.5 Multilocus microsatellite genotyping of the N. caninum laboratory-maintained isolates (n=14).  
Isolate MRI_002 MRI_007 MRI_014 MRI_016 MRI_027 MRI_030 MRI_036 MRI_037 MRI_040 MRI_041 MRI_042 MRI_045 MLG 
NC-1 1 2 6 2 5 9 3 1 4 9 5 10 1 
BPA1 4 8 6 1 2 5 5 2 7 10 6 3 2 
JAP-2 4 8 6 1 2 5 7 2 7 11 9 3 3 
JAP-4 4 8 6 1 2 8 5 2 7 10 5 3 4 
Nc-Beef 9 3 4 6 3 6 1 5 1 8 7 4 5 
Nc-Drachten 2 7 7 6 1 2 6 9 7 2 8 1 6 
Nc-Freiburg02 6 1 7 5 2 7 4 3 1 3 2 4 7 
Nc-Freiburg03 9 4 3 5 2 5 4 4 7 1 9 6 8 
Nc-GER 1 3 5 3 4 4 3 4 7 5 5 3 8 9 
Nc-LivB1 7 1 8 3 3 9 2 7 2 8 1 7 10 
Nc-Poland 2 6 9 6 1 2 7 9 9 11 10 1 11 
Nc-Porto 1 7 9 6 1 1 8 9 6 2 9 1 12 
Nc-Spain2 2 6 9 6 1 2 7 9 7 2 6 2 13 
Nc-SweB1 2 6 4 7 4 6 2 4 6 4 4 1 14 













MRI_002 MRI_007 MRI_014 MRI_016 MRI_027 MRI_030 MRI_036 MRI_037 MRI_040 MRI_041 MRI_042 MRI_045 MLG 
1 C421441 brain Mar-08 +++ 5 4 2 5 1 5 9 6 7 8 7 NA  
2 C425656 brain Sep-09 +++ 7 3 1 5 1 NA NA NA 3 6 4 6  
 C425673 brain Sep-09 ++- 7 4 4 5 1 NA 9 NA 3 7 4 6  
3 C421179 brain Apr-08 +++ 4 4 5 5 2 3 9 6 8 9 7 5 15 
4 C426552 brain Mar-10 +++ 6 5 NCE NA 1 4 9 6 7 8 5 NA  
5 C426622 brain Mar-10 +++ 5 3 1 5 1 3 9 6 7 4 5 6 16 
 C426628-1* brain Mar-10 +++ 5 3 1 5 1 3 9 6 7 4 5 6 16 
 C426628-2* brain Mar-10 ++- 5 3 1 5 1 3 9 6 7 4 5 6 16 
 C426655 brain Mar-10 +++ 5 3 NA 5 1 3 9 NA NA 4 5 NA  
 C426704 brain Mar-10 +-- 5 3 1 5 1 NA 9 6 NA 4 NA NA  
 C428452-1* heart Jun-11 +++ 5 5 2 5 1 5 9 2 7 4 5 6 17 
 C428452-2* placenta Jun-11 +++ 5 5 2 5 1 NA NCE 2 NA 4 5 NA  
 C428848 heart Jun-11 +++ 5 3 2 5 1 3 9 NA NA NA NA NCE  
 C431174-1* brain Jun-11 +++ 5 3 2 5 1 3 NA NA 7 4 5 NCE  
 C431174-2* brain Jun-11 +++ 5 3 2 5 1 3 NA NA NA NA NA NA  
 C431181 brain Jun-11 +++ 5 3 2 5 1 3 9 9 7 NA NA NA  
6 C422245 brain Aug-08 +++ 6 8 1 5 4 4 9 8 5 7 5 9 18 
7 C421369 brain Apr-08 +++ 7 4 1 4 1 3 9 6 7 8 3 6 19 
8 C423210 heart Dec-08 +++ 8 3 1 5 3 NA 9 9 6 7 8 NA  
 C423154 brain Dec-08 ++- 5 4 1 4 1 3 9 9 6 7 8 NA  
9 C422401-1* brain Aug-08 ++- 7 3 3 5 1 3 9 NA 7 6 7 NA  
 C422401-2* heart Aug-08 +-- NA NA 3 5 1 3 9 NA NA 6 7 NA  
10 C425723 brain Sep-09 +++ 6 3 1 5 1 3 9 7 NA 8 8 6  
 C423800 brain Mar-09 ++- 6 3 NA 5 NA NA 9 7 NA 8 NA NA  
11 C421682 brain Jun-08 +++ 7 5 1 5 1 4 9 9 9 7 7 7 20 
 C423152 brain Dec-08 +++ 7 5 1 5 1 3 NA NA 9 NA NA NA  
12 C426057 brain Dec-08 +++ 7 4 1 5 1 4 9 NA NA 8 7 6  
13 C420872 brain Mar-08 ++- 5 3 3 5 1 3 9 9 7 NA NA NCE  
* Foetuses aborted by different dams but submitted the same day. ITS1 nPCR results: +++ 3 positive replicates, ++- 2 positive replicates, +-- 1 positive replicate. 




Table 4.7 – Typeability and discriminatory power of the 12 microsatellite markers analysed. Typeability and Simpson’s Index of Diversity (SID) are reported for 
allele and multilocus genotype (MLG) assignment with 95% confidence interval (95% CI). 
  













































































































































































































































4.3.4 Discriminatory power (SID) 
 
The range of repeat units varied across the 12 microsatellite markers from 5 to 11 allele 
sizes identified per locus. This resulted in a generally high discriminatory power. 
Based on the results obtained from the laboratory-maintained N. caninum isolates 
together with the clinical samples, MRI_041 was the most discriminatory marker (SID 
0.85; 95%CI: 0.80-0.91) followed by MRI_042 (SID 0.84; 95%CI: 0.78-0.90) and 
MRI_014 with MRI_037 (both showing a SID of 0.81; 95%CI: 0.74-0.88). In contrast, 
MRI_027 (SID 0.50; 95%CI: 0.33-0.67), MRI_016 (SID 0.54; 95%CI: 0.37-0.70) and 
MRI_036 (SID 0.59; 95%CI: 0.41-0.77) were the least polymorphic markers of the 
panel (Table 4.7). 
Nevertheless, all markers showed relatively high discriminatory power (SID ≥ 0.75) 
when the reference population of laboratory-maintained isolates with worldwide 
origin was considered singularly. However, when the clinical samples were analysed 
independently, some microsatellite markers such as MRI_036 (SID 0.00; 95%CI: 
0.00-0.02), MRI_016 (SID 0.13; 95%CI: 0.00-0.30) and MRI_027 (SID 0.21; 95%CI: 
0.01-0.41) showed absent or very limited discriminatory power. 
The overall SID of the typing tool based on the 12 markers analysed was 0.94 (95%CI: 
0.91-0.97); however, the sample size was limited to the 14 laboratory-maintained 
isolates and only 8 clinical samples which were assigned a 12-marker MLG. The use 
of the 6 most informative markers (i.e. those with the highest discriminatory power) 
characterised by adequate typeability (>0.75) (MRI_002, MRI_007, MRI_014, 
MRI_037, MRI_041 and MRI_042) would have shown a very similar SID of 0.95 
(95%CI: 0.93-0.97). The simpler typing tool based on 6 selected markers showed an 
increase in typeability: from 0.52 (22/42; 95%CI: 0.38-0.67) to 0.64 (27/42; 95%CI: 








Table 4.8 Simpson’s Index of Diversity (SID) and typeability of the 12-markers genotyping 






(MLGs in clinical samples) 
SID 
(95%CI) 
Typeability (clinical samples) 
(95%CI) 
12 markers 22 (8) 20 (6) 
0.94 
(0.91-0.97) 




27 (13) 24 (10) 
0.95 
(0.93-0.97) 
27/42 0.64 (12/28 0.43) 
(0.49 – 0.77) 
* Number of samples for which a multilocus genotype (MLG) was assigned according to the different 
typing option. 
1 6 most discriminatory loci characterised by typeability > 0.75: MRI_002, MRI_007, MRI_014, 
MRI_037, MRI_041, MRI_042. 
 
The selection of this smaller panel of microsatellite markers was carried out based on 
both SID and typeability. In this study, the low typeability of some markers had a 
significant impact on the selection of the optimal markers and it is responsible for the 
exclusion of some discriminatory markers and the inclusion of markers which have 
lower SID. For example, MRI_045 that showed a relatively high overall SID (0.80; 
95%CI: 0.68-0.91) was discarded due to its low overall typeability (0.64; 95%CI: 0.49-
0.77). Conversely, MRI_007 that had a slightly lower SID (0.77; 95%CI: 0.69-0.86) 
was selected as it enabled the typing of most DNA samples (typeability = 0.98; 95%CI: 
0.88-0.99) besides having a SID of 0.77 (95%CI: 0.69-0.86) (Table 4.7). 
 
4.3.5 Genetic and genotypic diversity 
 
Frequency and distribution of the predominant alleles varied between the reference 
population of laboratory-maintained N. caninum isolates and the study population of 
Scottish clinical samples. In the Scottish clinical samples, new alleles of the 
microsatellite markers MRI_002 (alleles 5 and 8), MRI_014 (alleles 1, 2 and 5), 
MRI_030 (allele 4), MRI_036 (allele 9), MRI_037 (alleles 6 and 8), MRI_040 (alleles 
3 and 8), MRI_041 (alleles 6 and 7) and MRI_045 (alleles 5 and 9), that were not 
previously observed in the laboratory-maintained isolates, were found (Figure 4.3). 
Interestingly, at the locus MRI_036 all clinical samples in which amplification and 
fragment sizing were achieved were characterised by the allele 9 which was 
exclusively detected in this population. 
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All 12 microsatellite markers were highly polymorphic amongst the laboratory-
maintained isolates: the average number of alleles (A) per locus was 7.5 ± 1.31 and 
ranged from 5 (MRI_027) to 10 (MRI_042) (n=14). Within the clinical samples, the 
mean allele number per locus was reduced and corresponded to 4.1 ± 1.44 if the 
complete dataset of the clinical samples (n=28) was considered or to 3.25 ± 0.96 if 
only those samples (n=8) that were typed at all loci were examined. This resulted in 
an average allelic richness (Ar) of 6.79 ± 1.04 and 3.8 ± 1.35 (the Ar was calculated 
based on minimum sample size of 8 individuals) in the reference and study population 
respectively. Regardless whether the full or partial dataset was considered, the markers 
MRI_036 and MRI_016 showed absent or limited polymorphism with only 1 and 2 
alleles identified respectively within the clinical samples. 
The reference population was characterised by extensive genetic diversity showing an 
average Nei’s unbiased genetic diversity value (HNei) of 0.88 ± 0.04. Lower yet 
considerable genetic diversity was observed amongst the clinical samples (HNei = 0.55 
± 0.23) (Table 4.9). 
A, Ar and HNei per locus and population are summarised in Table 4.10. 
The same genetic indexes were also calculated based on the multilocus analysis of the 
6 microsatellite markers characterised by the highest discriminatory power and 
typeability > 0.75. The analysis using this multilocus microsatellite method was 
carried out considering the 13 samples that were assigned an allele at all 6 markers. 
Using this typing tool, the observed Ar was 7.82 ± 1.46 and 4.16 ± 0.23 whereas the 
HNei was 0.90 ± 0.03 and 0.70 ± 0.10 in the reference and study population respectively 
(Table 4.9). 
Full twelve-loci genotypes were obtained in 52.4% (22/42) of the samples analysed 
(100% or 14/14 of the samples of the reference population and 28.6% or 8/28 of the 
clinical samples). 
All MLGs in the reference population were different (G=14/14 or 1.00). Within the 
clinical samples, the genotypic diversity was 0.62 (G=6/8) as 3 samples showed 
identical MLGs. Interestingly, these three samples originated from the same herd (herd 
5) and were collected during a N. caninum abortion outbreak in March 2010. Within 
the complete dataset, 20 of the 22 samples typed at all loci showed a unique MLG thus 
resulting in a high observed genotypic diversity: 0.91. 
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When the multilocus analysis was carried out considering the 6 selected markers only, 
the genotypic diversity within the clinical samples increased from 0.62 to 0.77 
(G=10/13). Using this method, 4 new MLGs could be discriminated. One additional 
sample, for which definitive genotyping was not achieved with the 12-markers 
analysis, had a MLG identical to a previously observed one that was identified in the 
same herd (herd 5). 
Genetic and genotypic diversity indexes assessed with the 12- and 6-markers typing 
methods for the laboratory-maintained N. caninum isolates and the clinical samples 
are shown in Table 4.9. 
In the present study, linkage disequilibrium analysis to investigate the possible non-
random association of alleles at different microsatellite loci was not performed due to 
the limited samples size. However, no obvious relationship between alleles at different 
loci was observed. 
 
Table 4.9 – Genetic and genotypic diversity of N. caninum in the reference population and the 
study population when a 12- or 6-loci microsatellite analysis is applied.  






































13 4.16 ± 0.75 4.16 ± 0.75 0.70 ± 0.10 0.77 (10/13) 
 
1 MRI_002, MRI_007, MRI_ 014, MRI_037, MRI_041 and MRI_042. 
*1 Number of samples for which a multilocus genotype (MLG) was assigned using the different typing 
option. 
*2Average allelic richness per population corrected for unequal sample size by standardisation to the 











Table 4.10 Genetic diversity of N. caninum per locus in the reference population (laboratory-maintained isolates) and the study population (clinical 


































7 8 6 7 5 8 8 7 7 9 10 8 7.50 ± 1.31 







6.42 7.23 5.75 6.27 4.77 7.25 7.25 6.42 6.25 8.05 8.72 7.10 6.36 ± 0.97 







0.88 0.91 0.87 0.85 0.80 0.91 0.91 0.88 0.81 0.93 0.94 0.89 0.88 ± 0.04 
Clinical samples 0.75 0.75 0.46 0.25 0.46 0.61 0.00 0.64 0.64 0.75 0.61 0.64 0.55 ± 0.22 
HeNei: Nei’s unbiased genetic diversity. SD: standard deviation. 








Figure 4.3 – Allele frequency distribution of the 12 microsatellite markers in the laboratory-
maintained N. caninum isolates with worldwide origin (blue bars) and the clinical samples 
from bovine abortion cases collected in the Dumfries and Galloway region of Scotland (yellow 













































































































































































































































































































































4.3.6 Cluster analysis 
 
The relationship between laboratory-maintained isolates and clinical samples were 
investigated by constructing a neighbour-joining (NJ) dendrogram. This analysis was 
limited to those individual laboratory-maintained isolates (n=14) and clinical samples 
(n=8) for which an allele number was confidently allocated at all 12 microsatellite 
markers. Although the number of samples analysed was reduced, complete genotypic 
profiles were clustered using a distance-based phylogenetic algorithm. More refined 
genetic clustering should be applied to larger numbers of isolates to enable reliable 
inference on the population structure of the parasite. Nevertheless, this preliminary 
analysis provides evidence of sub-clustering of the samples obtained from abortion 
cases collected in the Dumfries and Galloway region of Scotland. Similarity between 
3 samples showing identical MLG and 1 sample collected from the same herd were 
also pinpointed (Figure 4.4). 
No obvious relationship amongst the other European, North American and Japanese 
isolates was observed depending on their geographical origin. However, the Japanese 
bovine isolates JAP-2 and JAP-4 formed a sub-cluster with the BPA-1 isolate from the 
United States (Figure 4.4). 
 
4.3.6.1 Polymorphism of microsatellite markers in Scottish clinical 
samples in relationship to herd of origin and abortion outbreak 
Within the Scottish samples, the analysis of complete and partial MLGs, obtained from 
samples collected from the same herd, provided preliminary information on the 
distribution of different genotypes at the herd level in relationship to specific abortion 
outbreaks. All foetuses analysed were aborted by different dams. 
In herd 5, the analysis of the 11 samples available showed that only the microsatellite 
markers MRI_014, MRI_030 and MRI_037 were polymorphic. The initial N. caninum 
abortion outbreak occurred in March 2010 was associated with the presence of a 
unique genotype (MLG 16). The full MLG was obtained for only 3 DNA samples. 
Partial multilocus profiles produced for another 3 samples were identical to MLG 16. 
Interestingly, a second abortion event that occurred on the same farm the following 
year in June was characterised by the presence of two different MLGs: the MLG 17 
and an additional one showing different alleles at level of the MRI_030 and MRI_037 
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loci (Table 4.6). Two clinical samples were analysed from each of the herds 2, 8, 9, 10 
and 11. At least 3 microsatellite markers were polymorphic in herd 2 (MRI_007, 
MRI_014 and MRI_041), 4 microsatellites in herd 8 (MRI_002, MRI_007, MRI_016, 
MRI_027) and 1 in herd 11 (MRI_027). In herds 2 and 8 both clinical samples 
originated from the same abortion outbreak: September 2009 (herd 2) and December 
2008 (herd 8) respectively. In contrast, the clinical samples from herd 11 were 
collected following two distant abortion events in June and December 2008 (Table 
4.6). 
The partial MLGs obtained for the two clinical samples originating from herd 9 
showed that none of the microsatellite markers, for which data were available, were 
polymorphic (Table 4.6). This may suggest that the two N. caninum DNA samples 
isolated following the same abortion outbreak may share an identical, or very similar, 
MLG. However, the unavailability of the full MLG data hindered definitive 
conclusions. Similarly, no polymorphisms were detected at any microsatellite markers, 
for which data were available, between the two clinical samples obtained from herd 
10. These two DNA samples originated from two separate abortion outbreaks which 




Figure 4.4 – Neighbour-joining (NJ) dendrogram showing the genetic relationships of 
laboratory-maintained and field N. caninum isolates based on multilocus analysis of the 12 
polymorphic microsatellite markers investigated. Only the isolates in which an allele number 























4.4.1 Novel microsatellite markers for the genotyping of N. caninum 
 
Discriminatory markers are a prerequisite for investigating the genetic diversity, 
taxonomy, epidemiology and pathogenicity of different N. caninum isolates (Regidor-
Cerrillo et al., 2006). 
Microsatellite markers have been successfully applied to the study of genetic diversity 
of several apicomplexan parasites of human and/or veterinary interest including T. 
gondii (Ajzenberg et al., 2010, Blackston et al., 2001), C. parvum (Feng et al., 2000, 
Hotchkiss et al., 2015, Widmer et al., 2004), Theileria parva (Katzer et al., 2011, Oura 
et al., 2003), Plasmodium falciparum (Anderson et al., 2000b) and Plasmodium vivax 
(Karunaweera et al., 2008) in addition to N. caninum (Al-Qassab et al., 2009, Regidor-
Cerrillo et al., 2006). 
Due to the high-resolution potential, the multilocus analysis of microsatellite markers 
has emerged as the gold standard technique for the differentiation of N. caninum at the 
strain or isolate level (Basso et al., 2010). In addition, genotyping methods based on 
microsatellite markers can be applied on DNA samples obtained directly from infected 
tissues (e.g. tissues samples from aborted foetuses or afterbirths) (Pedraza-Diaz et al., 
2009) or parasite oocysts in canine faeces (Basso et al., 2009) thus facilitating the 
genetic analyses of N. caninum for which the isolation of viable parasites is relatively 
difficult. 
Most studies published to date have investigated the genetic heterogeneity of N. 
caninum using the panel of polymorphic microsatellite markers proposed by Regidor-
Cerrillo and colleagues (2006). These microsatellite markers have been employed for 
the study of both laboratory-maintained N. caninum isolates, oocysts obtained from 
infected dogs and clinical samples from bovine and zebuine abortions (Basso et al., 
2009, Basso et al., 2010, Brom et al., 2014, Pedraza-Diaz et al., 2009). Furthermore, 
based on these microsatellite loci, one large-scale study on the population structure of 
the parasite was carried out (Regidor-Cerrillo et al., 2013). Additional polymorphic 
microsatellite and minisatellite markers were also reported and characterised by Al-
Qassab and co-workers (2009). 
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The aim of the present work was to characterise further N. caninum microsatellite loci 
that can be used for genotyping this ubiquitous parasite and that can be applied on 
tissue samples collected from bovine aborted foetuses. 
Twelve novel N. caninum microsatellite markers, that were not previously described, 
were investigated. Locus-specific nPCRs were developed and optimised using DNA 
samples isolated from in vitro cultured tachyzoites of different N. caninum isolates. 
Subsequently, the nPCRs were applied to the analysis of DNA samples extracted from 
infected foetal bovine tissues. 
All investigated loci show extensive polymorphism thus were promising markers for 
the study of the parasite’s genetic diversity. 
Besides confirming that the fragment length polymorphisms were ascribable to the 
variations in the number of the repeat elements, sequencing revealed that many of the 
loci analysed did not contain simple tandemly repeated units but showed multiple 
variable repeat elements (Table 4.4). Markers containing a single variable repeat 
element, such as MRI_002, MRI_027, MRI_030, MRI_036, MRI_037 and MRI_040, 
are preferable as allele assignment can be confidently achieved based only on fragment 
size. In contrast, the combination of multiple repeated elements within the same locus, 
observed in the MRI_007, MRI_014, MRI_016, MRI_042 and MRI_045, would 
hamper the accurate allele assignment if the analysis is carried out exclusively by 
fragment sizing (Nadon et al., 2013). Length variations occurring in more than one 
repeat within the same locus can result in alleles characterised by the same size despite 
showing different nucleotide sequences. For example, additions in a repeated element 
may compensate for deletions in another one without any gain or loss of nucleotides. 
In these cases, the exclusive use of automated fragment sizing would not detect 
sequence changes. As previously recommended for the well-characterised 
microsatellites MS2 and MS10 (Regidor-Cerrillo et al., 2006), which are also 
characterised by multiple repeated elements, complex markers should be analysed 
exclusively by sequencing (Basso et al., 2009). 
Despite having a single polymorphic repeat, the marker MRI_041 described in this 
study was characterised by an AT motif in which substitutions of the T with a C 
occurred; therefore, this marker should also rely on sequencing analysis for accurate 
allele assignment. 
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Fragment size analysis by CE is generally cheaper than sequencing; consequently, it 
may be relevant to consider this aspect when validating panels of microsatellite 
markers to be applied on numerous samples. Preferably, microsatellite markers with 
simple motifs should be selected. 
Most of the microsatellite markers used in this study had at least one polymorphic AT 
or TA repeat in their sequences. The abundance of AT tandem repeats in N. caninum 
was reported in a previous study (Regidor-Cerrillo et al., 2006) and is consistent with 
other phylogenetically related apicomplexan parasites such as T. gondii (Ajzenberg et 
al., 2002) and C. parvum (Feng et al., 2000). 
Although the nPCRs developed could amplify all 12 microsatellite markers from the 
DNA samples obtained from parasite isolates maintained in vitro, amplification was 
not achieved in all samples collected from bovine abortion cases in which the presence 
of N. caninum DNA was previously confirmed by ITS1 nPCR. 
The proportion of ITS1 nPCR-positive clinical samples amplified by each 
microsatellite-specific nPCR ranged from 96.4% (95%CI, 82.3-99.4) to 43.0% 
(95%CI, 26.5%-60.9%) (Table 4.7). Such differences in the sensitivity of each nPCR 
protocol, that affected the typeability of each marker, may have been influenced by the 
PCR conditions applied. However, the quality of the DNA specimens that originated 
from foetal tissues which may have undergone autolysis or mummification, with 
consequent DNA degradation, may have also hindered amplification observed for 
some target loci in several samples. In addition, since the clinical samples were 
collected several years before this study, long-term storage may have influenced the 
DNA quality. Effectively, the nPCR protocols enabled the amplification of all 
laboratory-maintained N. caninum DNA samples that were isolated from tachyzoites 
cultured in vitro not long before testing. 
Further studies using DNA samples recently extracted from non-autolytic aborted 
foetuses may help to clarify whether the quality of the DNA used might have had an 
effect on the low typeability observed for some microsatellite markers when applied 
to the clinical samples. Overall, the low typeability of some markers resulted in the 
successful assignment of a MLG in only 8 out of the 28 clinical samples examined 
(28.6%, 95%CI: 15.2%-47.0%). The nature of the sequences targeted by each 
microsatellite-specific nPCRs may have also had an impact on the sensitivity. Since 
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the ITS1 is a high-copy number element of the N. caninum genome (Homan et al., 
1997), DNA degradation may have had a less significant impact on the amplification 
of this target region when compared to the microsatellite loci. Reduced sensitivity of 
microsatellite nPCRs compared to the ITS1 nPCR was also observed in previous 
studies in which different markers were used (Pedraza-Diaz et al., 2009, Regidor-
Cerrillo et al., 2013). Regidor-Cerrillo et al. (2013) reported that about 50% of the 
ITS1 nPCR positive samples produced complete or partially complete multilocus 
microsatellite profiles. In the present study, complete MLGs based on the full panel of 
markers were obtained only for 28.6% of the clinical samples (8/28, 95%CI: 15.2%-
47.0%). 
The analysis of laboratory-maintained isolates evidenced the high discriminatory 
ability (SID≥0.75) of the twelve markers described (Table 4.7). Within the clinical 
samples collected from a specific area of Scotland, the novel alleles detected at 8 out 
12 microsatellite loci (MRI_002, MRI_014, MRI_030, MRI_036, MRI_037, 
MRI_040, MRI_041, MRI_045) provided additional evidence of the discriminatory 
power of the markers (Figure 4.3). Interestingly, at the level of the MRI_036 locus, all 
clinical samples shared a unique, not previously observed, allele. The lower SID values 
obtained when considering the clinical samples independently or the totality of the 
samples analysed should be interpreted carefully. Some markers, that otherwise 
showed good discriminatory ability, displayed low SID depending on the fact that they 
were monoallelic (e.g. MRI_036) or not very polymorphic (e.g. MRI_016 and 
MRI_027) in the Scottish samples (Table 4.7). Furthermore, the unequal sample size 
resulting from the variable typeability of the markers should be considered. 
The locus-specific nPCRs were unable to amplify DNA isolated from H. heydorni 
(isolate Giessen-1999), T. gondii (RH strain), S. cruzi, and B. besnoiti (Evora strain) 
suggesting the species-specificity of the molecular markers described in this study. A 
previous study by Regidor-Cerrillo and co-workers (2006) reported the amplification 
of 13 N. caninum microsatellite loci (MS1A, MS1B MS2, MS3, MS4, MS5, MS6A, 
MS6B, MS7, MS8, MS10, MS12, MS21) from the H. heydorni isolate Berlin-1996 
with 7 markers showing unique alleles; however, morphological and genetic analysis 
proved that this isolate and N. caninum were indistinguishable (Regidor-Cerrillo et al., 
2006). Testing the 12 novel microsatellite-specific nPCRs on additional DNA samples 
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from different H. heydorni isolates is required to confirm the non-amplification of 
DNA from this apicomplexan species as observed for the isolate Giessen-1999 used 
in this study. 
The in vitro stability represents another important feature that microsatellite markers 
should possess (Nadon et al., 2013, Regidor-Cerrillo et al., 2013). The reference, 
laboratory-maintained, N. caninum isolates are stored for prolonged periods of time 
and rapidly proliferating tachyzoites are periodically subjected to in vitro passages 
(Dubey et al., 2007). Further investigations aimed at genotyping numerous isolates, 
generated in different laboratories through serial passaging of the same strain, are 
required to evaluate the influence of multiple passages on the conservation of the 
repetitive motif for each microsatellite locus. 
This would help to exclude the occurrence of target loci modifications in vitro. 
Additionally, useful information on the stability of specific microsatellites may be 
obtained by genotyping attenuated and non-attenuated parasite strains kept in vitro for 
different lengths of time. 
At the inter-laboratory level, it would be advantageous to agree on the genotypic 
characteristics of the reference laboratory-maintained strains of N. caninum by using 
a shared genotyping framework. This would ensure that identical parasite strains are 
used when in vitro or in vivo experiments are conducted by different research groups 
thus enabling meaningful comparison and validation. 
 
4.4.2 Genetic diversity of N. caninum determined by multilocus 
microsatellite analysis 
 
The MLG analysis revealed extensive genetic and genotypic diversity amongst 14 
laboratory-maintained isolates of N. caninum. These isolates were obtained from both 
bovine and canine infected tissues as well as oocysts isolated from dog faeces collected 
in several different European countries, the United States of America and Japan (Table 
4.1). Due to the diverse origin of these isolates, a degree of genetic polymorphism was 
expected. 
The considerable genetic diversity of the parasite was also demonstrated by the 
differences in the frequencies of the predominant alleles between the reference 
(laboratory-maintained isolates) and the study population (clinical samples from a 
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specific area of Scotland) as well as by the detection of unique alleles in each 
population. 
Such high genetic diversity was also observed when a smaller panel of 6 arbitrarily 
selected microsatellite markers was applied (Table 4.9). 
These findings are consistent with previously reported microsatellite analyses of N. 
caninum (Regidor-Cerrillo et al., 2013, Regidor-Cerrillo et al., 2006). Likewise, 
considerable genetic diversity determined by multilocus microsatellite analysis was 
reported in the phylogenetically related apicomplexan T. gondii (Mercier et al., 2011, 
Verma et al., 2015). 
Unsurprisingly and as indicated by the genetic and genotypic diversity indexes 
calculated for the two populations (Table 4.9), lower genetic diversity was observed 
amongst the clinical samples which were obtained exclusively from bovine aborted 
foetuses or placentas that were collected in herds located in a relatively restricted area 
of Scotland. Nevertheless, the detection of identical MLGs exclusively within 
individual herds suggested that N. caninum is a highly genetically diverse parasite also 
at the regional level. Similar observations were made within previous microsatellite 
analyses of N. caninum DNA samples following abortion outbreaks (Basso et al., 
2010, Pedraza-Diaz et al., 2009, Regidor-Cerrillo et al., 2013). 
Clear sub-clustering of the clinical Scottish samples was observed (Figure 4.4); 
however, there was no obvious relationship amongst laboratory-maintained isolates 
depending on their geographical origin. 
A level of geographical sub-structuring between N. caninum populations was 
previously observed through the MLFT analysis of parasite isolates originating from 
Spain, Argentina, Germany and Scotland (Regidor-Cerrillo et al., 2013) (Figure 4.5). 
The closest relationships were between the Spanish and Argentinean populations, and 
between the German and Scottish populations (Regidor-Cerrillo et al., 2013). A degree 
of sub-clustering of the Scottish DNA isolates was also reported (Figure 4.5). In the 
present study, the NJ analysis showed indications of a closer relationship between the 
population from a restricted area of Scotland and two laboratory-maintained N. 
caninum isolates originally from Germany (NcGer1, NcFreiburg03) (Figure 4.4). 
However, in the study of Regidor-Cerrillo et al. (2013), the same NcGer1 isolate did 
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not exhibit an apparent relationship with the Scottish isolates, nor with other German 
isolates (Figure 4.5). 
The comparison between the two studies is difficult because the panels of 
microsatellite markers and the N. caninum isolates were both different. Importantly, 
the exclusive use of NJ analysis may fail to represent the complex population of N. 
caninum and accurately detect the relationships between geographical origin and 
genetic divergence (Pritchard et al., 2000). Multivariate analyses, such as principal 
component analysis (PCA), have been employed extensively to efficiently extract 
biological information from genetic markers (Cavalli-Sforza, 1966). PCA reduces data 
by geometrically projecting them onto lower dimensions, designated principal 
components (PCs), with the aim to find the best summary of the data using a limited 
number of PCs (Lever et al., 2017). Within the analysis of genetic markers, ordinations 
in reduced space are employed to find a few PCs that reflect as much of the genetic 
variability as possible (Jombart et al., 2009). In the present study PCA was not 










Figure 4.5 – Clustering of N. caninum country populations (from Regidor-Cerillo et al., 2013). 
Unrooted neighbour joining (NJ) tree inferred from allele shared genetic distances. Each tip 
represents a single multilocus genotype (MLG). Worldwide MLGs are identified by isolate 
name. Colour of circles in terminal branches indicates geographic origin (see legend). 
Percentage bootstrap values were generated from 1,000 replicates. Bootstrap values ≥70% are 
shown in black circles. Scale bar represents branch lengths. 
 
Amplification failure of some microsatellite markers in several clinical samples 
reduced an already limited sample size. Therefore, the multilocus analysis provided 
only preliminary information on the relationship of the MLGs detected and the origin 
(herd and abortion outbreak) of the clinical samples examined. Nevertheless, the 
preliminary data regarding the clinical samples from a restricted area of Scotland 
showed the potential usefulness of the proposed typing tool for the study of the genetic 
diversity of N. caninum at the herd or regional level. 
The genotyping tool may enable to confirm the transmission patterns within specific 
outbreaks of bovine neosporosis. Identical MLGs observed in multiple aborted 
foetuses collected within the same abortion outbreak would increase the confidence in 
attributing the abortion cases to the exposure of pregnant cows to a point-source of N. 
caninum oocysts. In contrast, a range of diverging N. caninum MLGs would suggest 
that the aborting dams presumably acquired the infection from several different 
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sources. Associated with the assessment of the abortion pattern (i.e. epidemic, 
endemic, sporadic) this information may help to confirm the predominant route of 
transmission hence shape appropriate control measures and prevention strategies. 
Furthermore, genotyping N. caninum DNA samples from tissues of other domestic and 
wildlife intermediate host species, in which clinical disease is not observed, may 
enable clarification of their role as potential reservoirs. For example, identities 
between the MLGs of N. caninum DNA samples from wildlife and cattle co-habiting 
the same environment, in which definitive canid hosts are present, may provide 
additional information on the contribution of certain species to the epidemiology of 
neosporosis in specific farms or geographical areas. 
Fragment size analysis by CE was chosen since it is less expensive than sequencing 
and therefore ideal for high-throughput analyses. Future studies may capitalise on the 
most recent high-throughput sequencing technologies (Reuter et al., 2015) to develop 
cost-effective N. caninum genotyping methods based on multilocus sequence typing 
(MLST). MLST tools have shown comparable typeability but greater discriminatory 
power, accuracy and reproducibility than MLFT when applied to the genotyping of the 
protozoan parasite C. parvum (Diaz et al., 2015). However, MLFT methods have the 
advantage of being able to readily detect mixed infections (i.e. different genotypes of 
the parasite in the same sample), which are identified by secondary peaks in the CE 
electrophoretograms (Hotchkiss et al., 2016). 
Whole genome sequencing might represent an alternative option for the study of the 
genetic diversity of N. caninum; however, its cost-efficiency might be limited. 
Finally, the availability of additional whole genome sequences of different N. caninum 
isolates would have helped the in silico identification of optimal microsatellite markers 
characterised by conserved primer binding sites. This strategy has been used 
successfully to optimise the MLFT analysis of C. parvum by using the available 








The novel microsatellite markers described and evaluated in the present study were 
highly polymorphic and showed their potential applicability to the study of the genetic 
diversity of N. caninum. Importantly, the microsatellite amplification and fragment 
analysis protocols developed were successfully applied to DNA samples obtained 
from bovine aborted foetuses and placentas in which the parasite was previously 
detected. 
The MLG offers a very useful discrimination typing tool although the analysis is 
highly dependent on the resolution of the markers used and sampling strategies 
applied. Further investigations, including the analysis of a larger number of laboratory-
maintained, clinical and non-clinical (e.g. domestic and wild asymptomatic 
intermediate hosts) samples, are required to enable the selection of optimal markers 
that may contribute, in association with previously described microsatellites (Regidor-
Cerrillo et al., 2006, Al-Qassab et al., 2010), to the generation of a standardised MLG 
framework that can be used at the inter-laboratory level as previously described for 
other apicomplexans of human and veterinary importance such as C. parvum 
(Chalmers et al., 2017, Hotchkiss et al., 2015).  
Refined MLG methods based on microsatellite markers would be beneficial to 
investigate the source of infection and infection dynamics at the herd or regional 
levels. In addition, they would aid the study of the association between the genetic 
heterogeneity of N. caninum and the diverse biological features in vitro and in vivo 
(i.e. virulence and pathogenicity) that are seen amongst different isolates. 
An international workshop to define and universally approve the number and choice 
of microsatellite markers to be used for genotyping N. caninum as well as determine 
the genotypic characteristic of the N. caninum laboratory-maintained isolates 







Chapter 5: Attitudes and perceptions of large 
animal veterinarians towards the diagnosis and 





The clinical advisory and consulting role of livestock veterinarians requires provision 
of advice to farmers and owners of the animals on the most appropriate herd health 
management practice for the local and national contexts (Caceres 2012). This implies 
a close collaboration with other stakeholders such as consultants of governmental 
animal health agencies, veterinary pathologists, clinical pathologists and specialists in 
the laboratory diagnosis of diseases as well as scientists involved in relevant research 
fields. 
Bovine neosporosis is a ubiquitous cause of abortion, stillbirth and, less frequently, 
neonatal mortality. Cattle veterinary practitioners are asked to advise on the 
management of the disease on a regular basis (Haddad et al., 2005). In this context, 
applying suitable diagnostic strategies and advising on the implementation of effective 
control measures are key areas in which appropriate veterinary input is most effective 
in helping to prevent and control the disease (Bronner et al., 2014). 
Abortion is the major problem associated with N. caninum infection and is seen most 
frequently between 4 and 7 months of gestation. Epidemic, endemic or sporadic 
abortion patterns are possible depending on the predominant transmission route 
(Goodswen et al., 2013). The aborted foetuses are typically autolysed without any 
characteristic gross lesions and the aborting dams generally do not show clinical signs. 
Retention of the foetal membranes and metritis may represent secondary 
complications that follow abortion (McAllister 2016). 
Frequently, N. caninum infections are subclinical; however, seropositive dams have 
an increased relative risk of abortion compared to seronegative. Meta-analysis of 
several different studies estimated that seropositive dams are approximately 3.5 times 
more likely to abort than seronegative (Reichel et al., 2013). 
Post-mortem, the presence of N. caninum is demonstrated by histopathological 
examination, immunohistochemistry, foetal serology, PCR and, rarely, isolation of the 
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parasite (Dubey and Schares 2006, Ortega-Mora et al., 2006). In live animals, serology 
is the diagnostic tool of choice and is predominantly carried out using ELISA 
techniques although IFAT, agglutination tests, immunoblots and 
immunochromatographic methods are also available (Ghalmi et al., 2014). 
Herd-based management to reduce the economic and welfare costs of N. caninum at 
the herd level depend on the country or region, typology of cattle herd (e.g. dairy or 
beef suckler herds), infection rate and the associated risk factors which may vary 
considerably from farm to farm (Dubey et al., 2017). At present, control options are 
restricted to management-based strategies relying on diagnosis of infection, informed 
breeding strategies and application of biosecurity measures due the lack of licensed 
vaccination and antiprotozoal treatments (Reichel et al., 2014). 
In the United Kingdom, several cattle herd health scheme providers offer a scheme for 
bovine neosporosis which is licensed by the Cattle Health Certification Standards UK 
since 2015 (CHeCS). The current scheme includes three programmes aimed at 
achieving accreditation as N. caninum-free herd, the eradication of the disease or the 
cost-effective control of bovine neosporosis at the herd level. All programmes are 
based on the identification of infected animals by serology and their removal from the 
herd (eradication programme) or exclusion from breeding replacement stock (disease 
control programme) (CHeCS 2016). In addition, biosecurity guidelines to prevent the 
reintroduction of the disease in uninfected herds as well as good practice 
recommendations for dealing with abortion cases are provided. Nevertheless, few 
farms across the country are currently enrolled in the scheme (CHeCS Neospora 
subgroup, personal communication). 
In general, there are numerous temporal, cultural and social elements which play a role 
in the management of infectious disease outbreaks (Kahan et al., 2010). This is also 
applicable to herd health issues, such as bovine neosporosis, in which the decisions 
taken by each veterinary practitioner are influenced by a multitude of individual (e.g. 
personal knowledge and experience) and social factors (e.g. attitude of farmers and 
colleagues to the problem). Nonetheless, the analysis of perceptions, attitudes, 
preferences and actions commonly taken to tackle N. caninum in cattle may help to 
better understand common veterinary practice in this specific context and identify 
current needs, knowledge gaps and potential areas of improvement. 
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In this chapter, a questionnaire-based survey for veterinary practitioners operating in 
the cattle sector was undertaken with the following objectives: 
1. Survey current perceptions of N. caninum and bovine neosporosis among 
practicing veterinarians 
2. Assess common practice and attitudes towards the diagnosis of N. caninum 
3. Evaluate actions and adopted strategies for the management of bovine 
neosporosis 
4. Identify needs and areas which may require improvement and knowledge 
























5.2 Materials and methods 
 
5.2.1 Questionnaire design 
 
The questionnaire consisted of three sections aimed at capturing different aspects 
related to the diagnosis and management advice relating to bovine neosporosis in 
current veterinary practice: (1) general assessment and perceptions, (2) diagnosis of 
bovine neosporosis and (3) control strategies. Basic demographic information was 
collected although the respondents were invited to complete the questionnaire 
anonymously. 
The survey consisted of 24 questions. Different types of question were included in the 
questionnaire. Most questions were based on a 4 or 5 point Likert-type scale; the 
respondents were either asked to state the level of agreement or disagreement with 
certain statements or to specify how frequently they were used to make determined 
recommendations, make specific decisions or adopt control measures. Open-ended 
questions were also included and used predominantly to explore common practice 
within the diagnosis of N. caninum and opinions regarding the disease and how to 
minimise its impact (Appendix III). 
The questionnaire was pilot tested with 6 cattle veterinary clinicians including 
representatives of consultancy institutions and a clinical academic. Two questions 
were removed and four revised or reworded. 
 
5.2.2 Target population and distribution 
 
The target population consisted of cattle veterinary practitioners in private practice or 
employed by diagnostic and research laboratories or public consulting veterinary 
institutions (i.e. veterinary investigation officers) with experience in cattle practice in 
the United Kingdom. The participants were selected by convenience sampling (Dohoo 
2003). 
The online questionnaire was created using the BOS online surveys tool produced and 
managed by the University of Bristol (https://www.onlinesurveys.ac.uk). 
An invitation letter including the link to the online questionnaire was distributed via 
email. Mailing lists of the members of the Moredun Foundation who were in veterinary 
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practice and users of the Dairy Herd Health and Productivity Service (Royal (Dick) 
School of Veterinary Studies, the University of Edinburgh) were used to disseminate 
the survey. 
In addition, paper copies were circulated among cattle veterinary practitioners who 
visited the Moredun Foundation marquee during the Royal Highland Show held in 
Edinburgh in June 2016 and at the UK Beef Expo event held at Melton Mowbray in 
2016. Paper questionnaires were completed at the event and returned immediately after 
completion. Distribution and publicity about the survey were also placed on the social 
networking sites of the Moredun Foundation (Twitter and LinkedIn). The data were 
gathered between January and June 2016. Due to the multimodal distribution of the 
questionnaire and the uncertainty on the number of veterinarians reached, the response 
rate could not be calculated. 
 
5.2.3 Data analysis 
 
Replies were logged onto a spreadsheet (Excel, Office 2016; Microsoft Corporation, 
USA). Data from unanswered questions or answered ambiguously were excluded from 
the analysis. Basic descriptive statistics were used to report the data collected. Each 
open-ended question was analysed by assessing the frequency with which each answer 
option recurred across all responses. Following a preliminary analysis, specific words 
or wording unambiguously related to a topic, option or area were identified and 
grouped. For example, when the participants were asked to state the diagnostic test or 
tests which were regarded as those providing the highest level of confidence for 
formulating a diagnosis of neosporosis in aborted foetuses, statements such as “lesions 
in foetal brain”, “pathology with lesions suggestive of protozoal abortion”, “foetal 
histology” or “microscopic lesions in foetal tissues” were grouped as 
“histopathology”. 
Sample proportions of participants selecting multiple choice answers or addressing 
open-ended questions with a determined topic, area or option were reported associated 
with 95% confidence intervals calculated using the Epitools confidence limits for 





A total of 53 respondents completed the questionnaire. Most respondents were 
veterinary surgeons in private practice (84.9%), about two-thirds of whom worked 
within the dairy cattle sector either exclusively (34.0%) or predominantly (32.1%). 
Less than one in ten responders were exclusively (1.9%) or mainly (7.5%) beef cattle 
practitioners (Table 5.1). Over half of the respondents (52.8%) were between 24 and 
35 years old, just over one third between 36 and 50 years of age (35.9%) and only 6 
(11.3%) were older than 50. Compared to other macro areas of Great Britain, Southern 
England was the region from which the highest number of completed surveys was 
received (Table 5.1). 
 
Table 5.1 – Primary professional activity, field within the cattle sector, age, years in practice 









Veterinary surgeon in private practice 45 84.9 
Diagnostics/research 5 9.4 
Veterinary investigation officer/consultant 3 5.7 
Field of activity within the cattle sector   
Dairy 13 24.5 
Beef 1 1.9 
Mixed 18 34.0 
Mixed mainly dairy 17 32.1 




24-35 28 52.8 
36-50 19 35.8 
51-65 5 9.4 
Over 65 1 1.9 
Years in veterinary practice 
 
 
Less than 5 years 12 22.6 
5-10 12 22.6 
11-20 21 39.6 
21-30 5 9.4 




Southern England 24 45.3 
Midlands 8 15.1 
Wales 2 3.8 
Northern England 11 20.8 
Scotland 8 15.1 
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5.3.1 Section 1: General assessment and perceptions 
 
Over 96% (51/53, 95%CI: 87.2-99.0) of the veterinary surgeons interviewed stated 
that N. caninum was one of the three most frequently diagnosed infectious causes of 
bovine abortion in their geographical area of professional activity. Of these, 66.7% 
(34/51, 53.0-78.0) indicated N. caninum as the most important infectious abortifacient 
diagnosed. Bovine viral diarrhoea virus (BVDV) was listed as the most frequently 
diagnosed pathogen by 22.6% (12/53, 13.4-35.5) of respondents followed by 
infectious bovine rhinotracheitis virus (IBRV, officially known as BoHV-1) and 
Bacillus licheniformis both were mentioned by 3.7% (2/53, 1.1-12.7) of the 
participants. Two respondents highlighted that the most common outcome within the 
aetiological diagnosis of bovine abortions was an inconclusive result (Figure 5.1). 
Overall, mycotic infections were cited within the first three main diagnosed causes of 
abortion relatively frequently (24.5%, 14.9-37.6); however, none of the respondents 
mentioned fungi as the most commonly diagnosed infectious cause of foetopathy. 
Likewise, salmonellosis was listed by 22.6% (12/53, 13.4-35.5) of the veterinarians 





Figure 5.1 – Infectious causes of bovine abortion diagnosed most frequently according to the 
experience of the respondents in their geographical area of professional activity (n=53). 
 
Among the causes of abortions cited, N. caninum infection was indicated as the most 
challenging to diagnose by 43.4% (23/53, 30.1-56.7) of the veterinarians followed by 
leptospirosis (13.2%, 6.5-24.8), which is primarily caused by Leptospira 
borgpetersenii serovar Hardjo and Leptospira interrogans serovar Hardjo in the 
United Kingdom, IBR (11.3%, 5.3-22.6) and BVD (9.4%, 4.1-20.2) (Figure 5.2). 
Seven respondents (13.2%, 6.5-24.8) stated that all abortifacient infections were 
equally difficult to diagnose whilst two (3.7%, 1.1-12.7) specified that the greatest 
challenge was represented by those cases in which a conclusive diagnosis is not 
achieved. These responses were provided by the same veterinarians who highlighted 
the frequent occurrence of inconclusive diagnoses. 
Most respondents indicated bovine neosporosis as the infection which poses the 
greatest challenges in terms of control (41/53, 64.5-86-5), whereas 13.2% (7/53, 6.5-
24.8) and 3.7% (2/53,1.1-12.7) considered respectively BVD and campylobacteriosis 
(Campylobacter foetus infection) as the most difficult infection to manage at the herd 
level; 5.6% (3/53, 1.9-15.3) said that all pathogens were uniformly difficult to manage 
(Figure 5.2). 
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Figure 5.2 – Infectious causes of bovine abortion perceived as the most challenging in terms 
of diagnosis and control (n=53). 
 
According to their personal experience, 62.3% (33/53, 48.8-74.1) and 3.7% (2/53, 1.0-
12.7) of the respondents rated the economic impact of bovine neosporosis as high or 
very high respectively. The remaining 34.0% (18/53, 22.7-47.4) considered N. 
caninum as a cattle pathogen with low economic consequences. Of these, 3 (5.7%, 1.9-
15.4) were beef cattle veterinary practitioners. 
When questioned about their general views on the laboratory diagnosis of N. caninum, 
irrespective of the method used, about half of the participants (47.2%, 34.4-60.3) 
disagreed or strongly disagreed that in some cases they had doubts about the 
interpretation of diagnostic results, 39.6% (21/53, 27.6-53.1) agreed and the remaining 
13.2% (7/53, 6.5-24.8) were unsure (Figure 5.3). 
The clear majority of respondents agreed (69.8%, 56.4-80.4) or strongly agreed 
(17.0%, 9.2-29.2) that positive results obtained with current diagnostics were 
trustworthy. In contrast, most cattle practitioners either disagreed (41.5%, 29.3-54.9) 
or strongly disagreed (17.0%, 9.2-29.2) that negative diagnostic results were 
trustworthy. Just over one-third (34.0%, 22.7-47.4) of the participants were unsure 




































Figure 5.3 – General perceptions on the laboratory diagnosis of bovine neosporosis (n=53). 
 
 
In general, the veterinarians interviewed felt confident about their understanding of 
the life cycle of N. caninum and bovine neosporosis; however, most of them (83.3%, 
70.7-90.8) disagreed or strongly disagreed that farmers understood the cycle of the 
parasite (Figure 5.4). General agreement with statements covering the importance of 
controlling bovine neosporosis to improve the profitability of dairy and beef farms was 
observed. Nevertheless, about half (50.9%, 37.9-63.9) of the veterinarians disagreed 
that their clients perceived bovine neosporosis as a major threat to their farming 
businesses (Figure 5.4). 
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Figure 5.4 – General perceptions of N. caninum and bovine neosporosis (n=53). 
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5.3.2 Section 2: Diagnosis of bovine neosporosis 
 
The association of N. caninum infection with one or more abortion cases, the 
occurrence of one abortion storm and the persistence of endemic abortions attributable 
to the protozoan were identified as the situations in which 88.7% (47/53, 95%CI: 77.4-
94.7), 71.7% (38/53, 58.4-82.0) and 67.9 (36/53, 54.5-78.9) of the respondents 
respectively would start to be concerned about the presence of N. caninum in a herd. 
These were the main warning signs alerting cattle practitioners to initiate specific 
further testing for N. caninum. The occurrence of abortion storms on neighbouring 
farms was a concern for only 15.1% of respondents (8/53, 7.8-27.0) (Figure 5.5). Other 
indicators that may suggest the possible involvement of N. caninum to the respondents 
were: general poor fertility performance, difficulty to get heifers pregnant, the 
presence of young dogs on the farm, history of low incidence of abortion not 
previously investigated and the presence of a bulk milk positive result for the presence 
of N. caninum specific antibodies. 
 
Figure 5.5 – Main triggers for the implementation of additional testing and N. caninum-
specific control measures (n=53). 
 
Understandably, 98.1% (52/53, 90.1-99.7) of the cattle veterinary practitioners 
interviewed said that their approach of choice in the case of suspected N. caninum 
abortion was the submission of the foetus to a veterinary investigation laboratory. 
Thirty-five percent of the respondents (19/53, 24.3-49.3) added that they would also 
submit a serum sample from the aborting dam for serological testing. Likewise, 
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advising farmers to submit aborted foetuses for histopathological examination and 
foetal serology as well as recommending the submission of serum samples from 
aborting dams were actions undertaken always by 60.3% (32/53, 49.9-72.2) and 66.0% 
(35/53, 53.6-77.3) of the respondents respectively. Such advice was frequently given 
by all other respondents except for one (Figure 5.7). 
Within the laboratory investigation of abortion cases, the diagnostic strategy which 
was generally perceived to enable the diagnosis of neosporosis with the highest level 
of confidence was, according to 69.8% (37/53, 55.4-80.4) of the respondents, a 
combination of two or more methods. Two respondents explained that they considered 
as equally reliable any positive result regardless of the test or technique used and 
another 2 participants were unsure. 
The histopathological examination of the aborted foetus associated with either the 
detection of N. caninum DNA in aborted material by PCR or the serological testing of 
the aborting dam were the most frequently mentioned combinations of diagnostic 
techniques both accounting for 20.4% (10/49, 11.5-33.6) of the answers received. 
Overall, histopathology was the diagnostic method most frequently mentioned; 67.3% 
(33/49, 53.4-78.8) of the respondents referred to this technique. Of these, 12.1% (4/33, 
4.8-27.3) specified that the use of immunohistochemistry to support histopathological 
findings increased their confidence in formulating a diagnosis of bovine neosporosis. 
PCR on foetal tissues was indicated by 42.9% (21/49, 30.0-56.7) of the respondents 
followed by maternal (38.8%, 26.4-52.7) and foetal serology (24.5%, 14.6-38.1). 
Maternal and foetal serology were always mentioned associated with at least one other 
diagnostic method (histopathology or PCR) and/or combined with each other. 
However, only 12.9% (4/31, 3.2-28.8) of the veterinarians who mentioned either 
maternal, foetal serology or both said that they felt confident to formulate a diagnosis 
of neosporosis based exclusively on the outcome of serological methods. 
Maternal serology was commonly applied and regarded as a useful tool to support the 
diagnosis of N. caninum infection in aborting dams. However, two-thirds of the 
respondents (66.0%, 53.6-77.3) agreed or strongly agreed that, in some cases, aborting 
dams can test serologically negative despite direct evidence of N. caninum being found 
in the aborted foetus (Figure 5.6). 
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In non-aborting animals, the assessment of the N. caninum infection status (i.e. 
infected or uninfected) was performed by all veterinarians (100%, 93.2-100.0) through 
the individual serological testing of a sample of cows. Approximately 55.0% (29/53, 
41.4-67.3) of the respondents said that they sampled animals in late pregnancy; of 
these, 31.0% (9/29, 17.3-49.3) mentioned the specific 12 to 4 weeks pre-calving 
sampling window which has been historically recommended and is still included in 
the standardised official herd health scheme for bovine neosporosis. The remaining 
participants tested pregnant cows irrespective of the gestational stage (18.9%, 10.6-
31.7) or both pregnant and non-pregnant cows (26.4%, 16.4-39.6). Serological 
examination of pre-colostral calves was mentioned in association with pre-calving 
maternal testing by a minority of veterinarians (3.7%, 1.0-12.7). In addition, three 
respondents (5.7%, 1.9-15.4) said that they also considered testing neonatal calves 
within the first 6 months of life. 
In dairy herds with a history of neosporosis, 30.2% (16/53, 19.5-43.5) of the 
respondents commonly tested bulk milk samples for N. caninum-specific antibodies to 
screen for the presence or absence of the parasite. These were all cattle practitioners 
whose clients were exclusively or predominantly dairy farmers and accounted for more 
than 50% of the respondents in this group (16/30, 36.1-68.0). Nevertheless, individual 
serology in pre-calving cows was considered as preferable to bulk milk testing by the 
clear majority of participants (86.8%, 75.1-93.4) who also acknowledged that a 
negative bulk milk result would not exclude the presence of the parasite in the herd 
(92.4%, 82.1-97.0) (Figure 5.6). 
All participants were specifically asked whether they thought serology-based 
diagnostics for N. caninum (ELISA format) gave reliable information on the exposure 
of the animals to the parasite: 54.7% (29/53, 41.4-67.3) provided an affirmative 
response, 24.5% (13/53, 14.9-37.5) were unsure and 20.7% (11/53, 12.0-33.5) did not 
think that the information obtained using the serological test was reliable. The reasons 
given to support views on the reliability of serological tests are shown in Table 5.2. 
Most participants who regarded serological testing as reliable added that there are 
important considerations to make when interpreting test results. These included the 
fluctuations of N. caninum-specific antibody titres as well as the occurrence of false 
negative results which might be attributable to the fact that antibody titres fluctuate 
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but also to the characteristic of the serological tests currently available. The remaining 
participants rarely had doubts about positive test results and perceived the specificity 
of the serological methods available as satisfactory or highlighted the fact that there 
are no other options for the diagnosis in vivo (Table 5.2). 
The respondents who thought that current serological diagnostics did not give reliable 
information mentioned the low sensitivity whereas two specified that, in their opinion, 
the antibody titre dynamics was at the origin of the unreliability of serological results. 
 
Table 5.2 – Views on the reliability of current serology-based diagnostics for bovine 
neosporosis (n=53). 
 
Do current N. caninum serology-based diagnostics 







“Important consideration must be made for correct 
interpretation of test results (i.e. antibody titres wax and 




 “High specificity: positive results are trustworthy.” 7 
13.2 
(19.5-43.5) 
YES “It is all we have got.” 4 
7.5 
(3.9-17.9) 
 “The results are consistent over time.” 1 
1.9 
(0.3-9.4) 
 “The results generally fit the clinical picture.” 1 
1.9 
(0.3-9.4) 
  29 
54.7 
(41.4-67.3) 
 “Low sensitivity / uncertainty about negative results.” 9 
17.0 
(6.5-24.8) 
NO “Fluctuations of antibody titres.” 2 
3.8 
(1.1-12.7) 
  11 
20.8 
(12.0-33.5) 








Figure 5.6 – Assessment of the presence or absence of N. caninum at the herd level (n=53)
0 20 40 60 80 100
In dairy herds, antibody ELISA on bulk milk is the most cost-effective way to assess
whether a herd is infected or not
In dairy herds, negative bulk milk testing results allow to conclude that the herd is
N. caninum free
ELISA testing sera from animals in the sampling window (12 to 4 weeks pre-
calving) is preferable to bulk milk testing in dairy herds
None of the available diagnostic tests can be considered as a gold standard for
bovine neosporosis
In some cases, dams that aborted test seronegative despite N. caninum evidence
being found in aborted foetuses
Proportion of respondents (%)






Figure 5.7 – Approaches taken during the investigation of N. caninum abortion outbreaks (n=53). 
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5.3.3 Section 3: Control strategies 
 
Approximately 40% (22/53, 95%CI: 29.3-54.9) of all respondents said that their 
veterinary practice had a common policy and agreed guidelines for the advice given to 
farmers in the implementation of control programmes for bovine neosporosis. Where 
present, practice policies and guidelines were predominantly based on the information 
provided by one of the herd health schemes providers operating in the United Kingdom 
(63.5%, 42.9-80.3) and were applied regardless of whether each specific farm had 
joined a health scheme or not. All providers mentioned were CHeCS accredited. 
Independently from the presence of defined practice policies, the control of the 
definitive canine host (i.e. farm and non-farm dogs) and the serological testing of the 
breeding stock were the key aspects emphasised by the veterinarians when advising 
farmers on the control of the disease. These aspects recurred in 54.7% (29/53, 41.4-
67.3) and 52.8% (28/53, 39.6-65.6) of the answers analysed. Vertical transmission of 
the parasite and the measures aimed at preventing it, the thorough investigation of 
abortion cases and general biosecurity and hygiene measures (i.e. removal and 
appropriate disposal of aborted foetuses and afterbirths) were additional key points 
frequently emphasised. 
High awareness and consideration of the importance of adequate biosecurity was 
observed. Collectively, over 90% of the veterinarians strongly agreed (45.3%, 32.7-
58.5) or agreed (49.2%, 36.2-62.1) that herd biosecurity plans should include specific 
measures for the control of bovine neosporosis. At the same time, the clear majority 
of the respondents (88.7%, 77.4-94.7) acknowledged that the introduction of N. 
caninum in a herd occurred frequently despite the implementation of good biosecurity 
measures and almost 70% of them agreed (49.1%, 36.1-62.1) or agreed strongly 
(20.7%, 12.0-33.5) that newly introduced cows posed a high risk of introducing the 
parasite in uninfected herds (Figure 5.9). However, less than one-third of the 
veterinarians (30.2%, 19.5-43.4) said that they always or frequently recommended 
serological testing of prospective purchased heifers and cows (Figure 5.10). 
The management of dogs’ access to cattle and feed storage areas was at the centre of 
the biosecurity and general hygiene measures for the prevention of neosporosis. 
Nevertheless, only 13.2% (7/54, 6.5-24.8) of the respondents also considered testing 
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farm dogs for N. caninum prior to implementing control programmes for cattle. Of 
these, five stated that they would carry out serological testing in dogs whereas two 
would request direct detection of parasite’s oocysts in faecal samples. 
Increased public engagement to make dog owners aware of the potential risk of N. 
caninum transmission to cattle posed by their animals was considered necessary by the 
clear majority of the respondents (94.3%, 84.6-98.1) (Figure 5.8). 
In terms of control strategies, about a quarter of the respondents (24.5%, 14.9-37.6) 
said that they would frequently consider a non-proactive “live with the disease” 
approach in herds in which the impact of neosporosis was perceived as low whereas 
75.5% (40/53, 62.4-85.1) would rarely (42.3%) or never (30.2%) consider such 
attitude to the problem (Figure 5.9). 
In a scenario characterised by a within-herd seroprevalence greater than 10% about 
one in ten veterinarians (88.6%, 77.4-94.7) would have frequently (41.5%) or always 
(47.1%) advised selective breeding of heifers which were born from seronegative 
dams. In herds with low seroprevalence (less than 5%) culling of seropositive cows 
would have been frequently or always advised by 64.1% (34/53, 50.6-75.7) of the 
respondents collectively. 
Less than one-fifth (18.9%, 10.6-31.4) of the cattle practitioners interviewed always 
or frequently advised embryo transfer from infected donors to seronegative recipients 
as a measure to control N. caninum transmission in high-genetic merit herds; the 





Figure 5.8 – Views on biosecurity and general hygienic measures (n=53)
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Figure 5.9 – Common practice and actions within the control of bovine neosporosis (n=53). 
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One third of the respondents (33.9%, 22.7-47.4) indicated the unavailability of a 
vaccine as one of the major limitations to the control of bovine neosporosis. This was 
followed by the farmers’ attitude to the problem and the limitations of current 
diagnostic tests which were mentioned in 28.0% (15/53, 18.0-41.5) and 26.4% (14/53, 
16.4-39.6) of the answers analysed respectively. 
The farmers’ attitude towards the problem (including low perception of the impact of 
neosporosis at the herd level, presence of other priorities or incomplete understanding 
of the disease) was the second most frequently mentioned limitation of control efforts. 
This can be summarised with the following statement made by one of the respondents: 
“Lack of awareness of prevalence and financial implications of Neospora. This may 
be due to more pressing need of modern farmers as many diseases are perceived to 
be, and indeed may be, more damaging to profitability than neosporosis (e.g. mastitis 
and lameness).” 
The limitations of current diagnostic tests all referred to the lack of sensitivity of the 
serological methods and difficult diagnosis in vivo to identify persistently infected 
animals. 
Other limitations highlighted were related to the intrinsic characteristics of N. caninum 
and its life-cycle (i.e. possibility of vertical transmission without overt clinical signs 
in either the dam or the offspring and establishment of persistent infections), cost of 
testing, difficult control of non-farm dogs’ access to cattle housing and grazing areas 
(footpaths, dog walking areas) and the complicated identification of the source of 
infection which appeared in 18.9% (10/53, 10.6-31.7%), 13.2% (7/53, 6.6-24.8), 
11.3% (6/53, 5.3-22.5) and 5.7% (3/53, 1.9-15.3) of the answers respectively. 
When asked their views about prospective tools to control abortions due to neosporosis 
over three-quarters (84.9%, 72.9-0.92) of the veterinarians interviewed declared that 
they would always or frequently consider the use of vaccination if available. In 
contrast, 37.7% (20/53, 25.9-51.2) of the respondents would always or frequently 
recommend the administration of antimicrobials if these were licensed for the 
prevention of N. caninum abortions (Figure 5.10). Almost all respondents (96.2%, 
87.2-99.0) strongly agreed or agreed that bovine neosporosis should be included in 
herd health schemes whereas the remaining two individuals were unsure (3.8%, 1.1-
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12.7%). However, less than a quarter (22.6%, 13.4-35.5%) reported that farmers did 
not perceive accreditation for bovine neosporosis as an added value to their businesses. 
 
 
Figure 5.10 – Prospective use of vaccination and antimicrobial therapy for the control of N. 
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Consistent with the official data available for England, Scotland and Wales (VIDA 
2015), N. caninum was regarded as the most frequently diagnosed infectious cause of 
abortion in cattle by the majority of veterinary practitioners interviewed. However, 
discrepancies between the perception of the respondents and the data available were 
observed for other abortifacients. For example, Bacillus licheniformis, the second most 
frequently diagnosed cause of bovine abortion in the United Kingdom (VIDA, 2015), 
was listed by the participants less frequently than BVD and IBR (Figure 5.1). 
According to the official data, these pathogens were ranked as the fifth and thirteenth 
abortifacient respectively (VIDA, 2015). The high overall impact of the two viral 
diseases in affected farms in terms of hypo- or infertility, in addition to abortion 
(Lanyon et al., 2014, Nandi et al., 2009), might have influenced the perceptions of the 
respondents. Importantly, the individual perception depends directly on the personal 
experience and the frequencies of certain bovine pathogens vary significantly 
depending on the region and specific area of the country. 
Although the rate of definitive diagnoses formulated in the case of abortion was not a 
subject covered in the survey, two respondents highlighted that, in most cases, an 
aetiological diagnosis is not reached. Effectively, in 2015, the identification of the 
causative agent occurred in only 15.5% of the cases of foetopathy submitted to the 
veterinary investigation centres (VIDA 2015) thus highlighting an important problem 
faced by the veterinary practitioners during the investigation of cattle abortions. 
N. caninum was considered the abortifacient of cattle most challenging to diagnose 
and control by most participants; however, a higher proportion (77.4%, 64.5-86-5) 
perceived the protozoan as particularly challenging to control rather than diagnose 
(43.4%, 30.1-56.7). Interestingly, leptospirosis which is normally considered difficult 
to control since it can be caused by several different serovars transmitted by various 
domestic and wild animals, was considered difficult to diagnose but not to control 
(Figure 5.2). Unlike neosporosis, leptospirosis can be controlled using vaccines 
against the bovine-adapted serovars as well as antimicrobials (Mughini-Gras et al., 
2014). The availability of these control tools may be the reason the disease was not 
listed amongst the abortifacient difficult to control. 
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Consensus on the importance of controlling N. caninum infection in both dairy and 
beef herds was observed indicating that the disease is regarded as an important health 
and welfare issue whose control would benefit individual farm businesses as well as 
the cattle industry as a whole (Figure 5.2). 
Farmers’ understanding of N. caninum life cycle was rated as insufficient by numerous 
respondents (83.3%) thus suggesting that enhanced knowledge transfer from 
veterinary practices as well as agricultural education institutions may be required. 
Alternatively, additional effort from the individual veterinarian may be necessary to 
inform those farmers who might not be up to date and guide them through the key 
aspects of the disease. A good understanding of the mechanisms and main routes of 
transmission would help farmers to implement control measures more proactively and 
effectively. 
In spite of the fact that the economic impact of bovine neosporosis was rated as high 
or very high by almost two-thirds of the veterinarians (66.0%), approximately half of 
the respondents (50.9%) disagreed that farmers perceived the disease as a major threat 
to their businesses. A comparison between dairy and beef veterinary practitioners 
would have enabled the investigation of potential differences in approaching the 
disease between the two groups; however, this was not possible due to the low number 
of beef cattle veterinarians who undertook the survey (Table 5.1). The higher number 
of respondents involved in the dairy sector who completed the survey may suggest a 
higher interest of dairy veterinarians to the topic. However, the distribution method 
(i.e. use of the mailing list of the Dairy Herd Health and Productivity Service in 
addition to other distribution channels) was the likely cause of the “dairy bias” 
observed. 
Interestingly, probing the general views about N. caninum and neosporosis provided 
an initial indication of the attitudes towards current N. caninum diagnostics. 
Regardless of the diagnostic method used, a different consideration on the reliability 
of positive and negative test results was observed. Over 75% (76.8%) of the 
participants said that they considered a positive result trustworthy whereas only 7.5% 
agreed that a negative result obtained with current diagnostics was trustworthy and 
34.0% of the sample was unsure (Figure 5.3). 
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Besides being a legal requirement in the UK, the submission of aborted foetuses for 
further investigations enables a general diagnostic workup to be done to include a 
range of major cattle abortifacients rather than focusing on a specific one. This is 
regarded as the optimal way to approach an abortion problem at the herd level 
(McAllister 2016). In addition, the submission of serum samples from aborting dams 
for serology can provide additional diagnostic information during abortion outbreaks. 
Both these practices were well established and almost all (98.1%) of the participants 
stated that they frequently or always recommended such measures suggesting high 
consistency of action in this area (Figure 5.7). 
The need for using different diagnostic techniques in parallel was a common notion 
amongst the veterinarians interviewed and 69.8% of them required a combination of 
two or more diagnostic methods for formulating a confident diagnosis of neosporosis. 
Effectively, several studies have illustrated this need by reporting limited agreement 
between histopathology, immunohistochemistry, PCR methods and foetal serology 
(Pereira-Bueno et al., 2003, Sanchez et al., 2009, Wouda et al., 1997). 
Histopathological examination and PCR detection of N. caninum DNA in tissues from 
aborted foetuses were the most frequently mentioned techniques for the investigation 
of abortion cases. 
In non-aborting cattle, individual serology was regarded as the method of choice for 
determining the infection status of the animals. Testing cows in late pregnancy was 
relatively common and more than half of the veterinarians (54.7%) were used to testing 
cows during this reproductive stage. As discussed in Chapter 3 (3.4.2.1) screening 
cattle in mid to late pregnancy has been traditionally advised as it is thought to increase 
the chances of detecting specific N. caninum antibodies (Dannatt 1997). 
The analysis of serum samples from pre-colostral calves paired to samples from their 
mothers is useful for the determination of the rate of vertical transmission and the 
predominant transmission route at the herd level (Dijkstra et al., 2001a, Dubey et al., 
2007). However, at the time of the survey, this practice was not common as it was 
mentioned by only 3.7% respondents. 
A limited proportion of respondents (5.7%) mentioned that they carried out serological 
testing in calves younger than 4 (1.9%) or 6 (3.8%) months. Unfortunately, the 
participants did not provide justification for this testing method which diverged from 
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the information available in literature. Since these responses were provided by a beef 
cattle veterinarian and two mixed beef and dairy cattle practitioners, it may be possible 
to speculate that the objective might have been to indirectly assess the serological 
status of the mother by detecting specific antibodies in post-colostral calves. If this 
was the case, the usefulness of this practice would be dubious. 
Current serological methods, specifically those based on the ELISA format, were 
considered to provide trustworthy information about the N. caninum infectious status 
by 57.4% of the respondents. In contrast, 20.8% did not think that N. caninum-
antibody ELISAs provided reliable information and 24.5% were unsure. Given the 
wide variety of diagnostic tests, both commercial and in-house, as well as the cut-offs 
used by different laboratories across the country, this outcome of the questionnaire 
should be interpreted as a general insight on the perceived reliability of serology-based 
diagnostics for N. caninum in cattle veterinary practice. 
Interestingly, irrespective of whether these assays were deemed as trustworthy or not, 
the awareness of the suboptimal sensitivity of the tests, which was either attributed to 
the tests themselves or the fluctuation of antibody titres emerged in most answers. 
Over 58% of the veterinary practitioners interviewed said that their practices did not 
have any agreed protocol for the control or management advice for N. caninum in 
infected herds. Although based on the same general principles, cost-effective strategies 
to control N. caninum are herd-specific and depend on the infection rate, associated 
risk factors, economic constraints and business objectives. Nevertheless, the use of 
protocols or guidelines agreed at the veterinary practice level may help to streamline 
the implementation of control and management measures, standardise the advice 
provided and, if reviewed regularly, include up to date scientific information according 
to the principle of evidence based veterinary medicine. 
The assessment of N. caninum infection in farm dogs was considered and potentially 
carried out by a relatively small proportion (13.2%) of the respondents. 
Dogs develop antibodies against N. caninum either post-natally, following the 
ingestion of food containing tissue cysts, or pre-natally, when foetuses are infected via 
the transplacental route (Dubey et al., 2017). Retrospective testing of dogs naturally 
infected post-natally showed that N. caninum-specific antibodies can persist for up to 
4 years; however, in animals with initial low titres (1:50), the antibody levels declined 
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below the detection limits of the tests used within a 1-2 year period (Barber and Trees, 
1998). Besides the IFAT, which is the most commonly used test in dogs, various 
iELISAs and NATs have been described. These include several commercial assays for 
the detection of N. caninum-specific antibodies in cattle, which have also been 
validated to test canine sera (reviewed in Dubey et al., 2017). 
Serological testing would provide evidence that farm dogs have been exposed to the 
parasite; however, it is unclear whether previously exposed canids would have a 
reduced risk of shedding oocysts following repeated infections. On the other hand, 
direct detection of parasite oocysts in faecal samples may help to identify the source 
of infection during abortion outbreaks; however, by the time of testing, farm dogs may 
no longer be shedding oocysts. Although one study reported prolonged shedding in 
naturally infected dogs (McGarry et al., 2003), there is evidence that experimentally 
infected canids only shed oocysts for about one week (Gondim et al., 2002, Rodrigues 
et al., 2004). Irrespective of the technique used and from a practical point of view the 
added value of testing farm dogs is questionable since there is no clear strategy about 
what to do with the information (McAllister 2016). 
Cattle veterinary practitioners acknowledged the importance of including bovine 
neosporosis in herd health schemes; however, they also reported that accreditation for 
N. caninum is generally not perceived as an added value by farmers. This was 
confirmed by the relatively low subscription rate for the voluntary N. caninum scheme 
reported by the major herd health scheme providers (CHeCS Neospora subgroup, 
personal communication). The collection of additional information by conducting 
further questionnaire-based or focus group studies may help to clarify the reasons for 
such low interest in the accreditation for bovine neosporosis. However, it is possible 
to speculate that this is likely due to the presence of more pressing health and 
production issues in modern cattle herds. These include general hypofertility, mastitis 
and lameness. 
According to the sample of veterinarians interviewed, the lack of a vaccine, the 
farmers’ attitude to the problem and the difficulties in interpreting serological test 
results were the major constraints to the effective control and management of the 
disease. 
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In agreement with the consensus in the research field, a vaccine was identified as the 
most desirable prospective control tool for bovine neosporosis. Although the lower 
interest displayed towards the use of a prospective antiprotozoal treatment may be 
attributed to the likely need for withdrawal periods, which may reduce the cost-
effectiveness of this option, the specific justifications for the preferential use of a 
vaccine instead of the administration of an antiprotozoal drug were not investigated. 
In questionnaire-based surveys, voluntary response bias occurs frequently, since the 
responders are self-enrolled. This potentially results in the selection of those 
responders who are more interested and may have a better knowledge of the specific 
topic covered. It would be difficult to determine whether the majority of veterinarians 
undertaking the present survey were those with a deeper knowledge of neosporosis 
than non-responders. It is most likely that all of the responders had direct experience 
of clinical neosporosis in cattle and were involved in the diagnosis and implementation 
of control measures. Nevertheless, the questionnaire-based survey presented here 
provides an interesting insight into the current practice and attitudes towards the 




Besides highlighting the need for more reliable serological diagnostics, the 
questionnaire-based survey evidenced the demand for enhanced guidance in the 
interpretation of test results, especially those obtained with serological assays. 
Continuing professional development (CPD) programmes for large animal 
veterinarians may be required to update on the characteristics and limitations of the 
diagnostic options, help the interpretation of the outcome of different tests and 
standardise the management advice given to farmers. A nationwide industry 
stakeholder group, similar to the COWS (Control of Worms Sustainability) and the 
SCOPS (Sustainable Control of Parasites in Sheep) initiatives which promote best 
practice in the control of ruminants’ parasites, may be created for providing 
veterinarians and farmers with up to date evidence-based information and learning 
opportunities related to the diagnosis and control of bovine neosporosis. 
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Finally, vaccination emerged as the preferred control strategy among the veterinarians 
interviewed suggesting the presence of a potentially wide market for an effective 











































Chapter 6: General discussion 
 
 
N. caninum is recognised as a major infectious agent of abortion in dairy and beef 
cattle responsible for important economic losses and causing animal welfare concerns 
worldwide (reviewed in Dubey et al., 2017, Reichel et al., 2013). 
Over the last three decades, significant research efforts have been invested to study N. 
caninum and bovine neosporosis with the ultimate objective of developing cost-
effective strategies to minimise the impact of the disease on cattle production. 
As described in Chapter 1, numerous biological features of the parasite as well as host-
parasite interaction mechanisms have been investigated and characterised. However, 
the host-parasite relationship during N. caninum infection and the pathogenesis of 
abortion are still not completely understood (Canton et al., 2013, Dubey et al., 2006a). 
Abortions not only occur in cows that have been recently exposed to the parasite but 
also in persistently infected animals following recrudescence of quiescent infections. 
Although complex interactions between N. caninum and the host’s immune system are 
recognised to play a major role, the exact mechanisms underlying the establishment of 
persistent infections, the long-term survival of the parasite while enclosed in tissue 
cysts and the reactivation of the bradyzoite stage have not been entirely clarified to 
date. 
Prophylactic and therapeutic options for neosporosis have been investigated (reviewed 
in Hemphill et al., 2016, Horcajo et al., 2016). Nevertheless, the measures available 
to prevent N. caninum abortions as well as horizontal and vertical transmission have 
been relatively unchanged for many years (Reichel et al., 2014). The lack of licensed 
vaccines and antiprotozoal treatments to prevent infection and/or abortion represents 
a primary constraint to the control of the disease. Even if available, drug treatment of 
N. caninum would carry the risk of residues in milk and meat and the likely need for 
long-term therapies would render this option uneconomical (Dubey and Schares 
2011). Vaccination is therefore regarded as the most desirable control measure. In the 
past few years, a vaccine based on killed N. caninum tachyzoites was licenced for use 
in cattle in certain countries but subsequently withdrawn from the market due to its 
limited efficacy in preventing vertical transmission (Weston et al., 2012). 
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Consequently, current control strategies are restricted to management practices 
(Reichel et al., 2014). 
In this context, the discrimination between infected and uninfected cattle through 
serology plays a key role. Since clearance of N. caninum from infected animals is 
thought to be highly unlikely, the detection of specific antibodies is not only indicative 
of exposure to the parasite but also of infection and increased risk of abortion (Weston 
et al., 2005). 
Numerous diagnostic tests for the detection of specific antibodies have been proposed 
and validated; however, limitations in the serodiagnosis of N. caninum have been 
reported (Dubey et al., 2007, Sinnott et al., 2017). 
In N. caninum-infected cattle, false-negative results are not only attributable to the 
characteristics of the serological assays used but can also arise due to the changing 
dynamics of the host-parasite interaction. Fluctuations of N. caninum-specific 
antibody titres during pregnancy are well-documented (Guy et al., 2001, Jenkins et al., 
2002, Waldner et al., 1998). Moreover, in persistently infected cattle, antibody 
responses elicited by the tachyzoite stage may decline following conversion to the 
quiescent bradyzoite stage which displays a different antigenic repertoire (Aguado-
Martinez et al., 2008, Campero et al., 2017, Guido et al., 2016). Since all commercially 
available serological tests for the detection of N. caninum-specific antibodies employ 
tachyzoite antigens and predominantly whole tachyzoite extract (Alvarez-Garcia et al., 
2013, Campero et al., 2017, von Blumroder et al., 2004) they may fail to identify those 
persistently infected animals that, despite being infected with N. caninum, do not show 
detectable antibody levels against the tachyzoite stage. 
The interesting observation of an infected cow whose antibody responses recognised 
bradyzoite-specific but not tachyzoite-specific antigens raised concerns about the 
sensitivity of tests based only on tachyzoite antigens (Benavides et al., 2012). Despite 
the post-mortem demonstration of the parasite in several tissues, this animal repeatedly 
tested seronegative with commercial and experimental tests based on tachyzoite 
antigens; however, seropositivity was detected using an experimental ELISA based on 
the bradyzoite-specific recombinant antigen NcSAG4. 
Antigens specifically expressed by the bradyzoite stage of N. caninum, such as 
NcSAG4 (Fernandez-Garcia et al., 2006), can be successfully employed for the 
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identification of persistently infected cattle (Aguado-Martinez et al., 2005). 
Additionally, the detection of bradyzoite-specific antibody responses in parallel with 
tachyzoite-specific antibody levels enables the discrimination of cattle which have 
experienced acute primary infection, reinfection, recrudescence of infection or are 
persistently infected (Aguado-Martinez et al., 2008). 
Nevertheless, none of the bradyzoite-specific antigens identified, characterised and 
used for the serodiagnosis of bovine neosporosis have been made commercially 
available to date and tools that would enable the detection of persistently infected 
cattle, which test seronegative with serological tests based on tachyzoite antigens, are 
currently lacking in the market. In addition, the potential benefits of combining both 
tachyzoite and bradyzoite-specific antigens to overcome a potential lack of sensitivity 
of tests based exclusively on tachyzoite antigens have not been fully investigated. 
 
Would a diagnostic test using tachyzoite and bradyzoite antigens enable 
the reliable identification of N. caninum infected cattle? 
One of the main aims of this thesis was to further evaluate the use of bradyzoite-
expressed antigens for the detection of cattle persistently infected with N. caninum. 
In Chapter 2, the identification and production of two novel bradyzoite-expressed 
recombinant antigens was described. Recombinant tNcSRS12A-B and tNcSRS44-A 
were employed for the detection of N. caninum-specific IgGs in cattle that, despite 
harbouring N. caninum, consistently tested antibody-negative with serological assays 
based on tachyzoite antigens. Preliminary data demonstrated that both antigens may 
be potentially useful for the identification of persistently infected animals. However, 
further validation using adequate panels of well-characterised reference sera, which 
should include samples from naturally infected cattle with persistent infections, are 
required. At present, such panels are difficult to generate. The characterisation of 
samples from persistently infected animals, which test antibody negative with assays 
based on tachyzoite antigens, may be limited because of the lack of tests based on 
antigens expressed by the bradyzoite stage. For the same reason, the selection of 
seronegative reference samples may require very strict criteria to rule out that they are 
obtained from animals which test negative with current tachyzoite-based assays 
despite being persistently infected with N. caninum. These criteria include the 
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selection of seronegative animals from maternal family lines in which no evidence of 
exposure to the parasite is observed (i.e. consistent seronegative results in several 
generations). Such animals should be selected from herds with no history of abortions 
and serological positive results for N. caninum. 
Furthermore, standardised models of persistent infection in ruminants are currently 
unavailable (Benavides et al., 2014). Although cattle that become infected with N. 
caninum are considered persistently infected for life, the development of experimental 
models, in which doses, route of administration, strain of N. caninum and long-term 
time points in which serological testing is carried out, may help to identify and 
characterise patterns in the antibody levels against different stage-specific antigens. 
Such models should include the periodic serological examination of experimentally 
infected pregnant dams during prolonged periods and subsequent pregnancies. This 
may enable a fuller picture to be obtained on the effects that the changes in the host-
parasite interaction may have on the detection of antibody levels against antigens 
expressed by different lifecycle stages of N. caninum. 
Overall, the inadequacy of serological tools based on bradyzoite-specific antigens and 
the lack of experimental models of persistent infection may be responsible for the 
limited knowledge regarding the humoral immune responses elicited by the bradyzoite 
stage of N. caninum during persistent infections. 
Acute infection with N. caninum results in the production of specific immunoglobulins 
against the tachyzoite stage of the parasite which is readily exposed to the host’s 
immune system since it rapidly proliferates and spreads throughout the body of 
infected animals (Williams et al., 2000). During persistent infections, recurrent rupture 
of tissue cysts with exposure of bradyzoites may be necessary to induce detectable 
antibody responses against antigens expressed by the bradyzoite stage, as suggested 
for the closely related apicomplexan T. gondii (Gross et al., 2004). There is limited 
information on the in vivo biology of N. caninum tissue cysts. Studies carried out in 
rodents infected with T. gondii showed that tissue cyst rupture occurs consistently over 
the lifetime of infected animals. In experimentally infected rats, this was not 
necessarily associated with reactivation from the bradyzoite to the tachyzoite stage 
(Dubey et al., 2016). In this way, bradyzoite antigens would be exposed to the effector 
cells of the host’s immune system, with subsequent production of specific antibodies, 
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without an increase of antibody titres against antigens displayed by the tachyzoite 
stage. 
Similarly to previous studies (Aguado-Martinez et al., 2008), in Chapter 2 and 3, 
antibody responses against bradyzoite antigens were successfully detected and 
considered as markers of persistent infection in cattle. Nonetheless, the number and 
localisation of tissue cysts, which are expected to be highly variable depending on the 
individual animal and virulence of the N. caninum isolate involved, as well as the 
frequency with which these cysts would rupture during persistent infections are 
currently unknown. Further studies are required to assess the level of exposure of N. 
caninum bradyzoite antigens to the bovine immune system. For this purpose, the 
development of ruminant models of persistent neosporosis may be explored. 
Antibody ELISAs based on tNcSRS12A-B and tNcSRS44-A would have enabled the 
further assessment of the diagnostic potential of these antigens; however, technical 
issues related to the physico-chemical conditions in which they were produced 
hindered the development of such tests. Subsequent attempts to obtain useable 
ELISAs, including the use of different expression and purification systems, did not 
prove successful. Nevertheless, WBs using tNcSRS12A-B and tNcSRS44-A may be 
beneficial to further characterise the serological status of cattle which test antibody 
negative with tests based on tachyzoite antigens. Antibodies detected with the 
tNcSRS12A-B and tNcSRS44-A WBs may suggest persistent infection whilst 
negative antibody results using these tests would enable the classification of N. 
caninum seronegative cattle more confidently. Notably, the application of these 
serological tools may be helpful when thorough serological analysis is required; for 
example, within the selection of breeding stock in high genetic merit herds in which 
the increased costs of the additional diagnostic methods would be justified. In vaccine 
studies, the use of improved tests using bradyzoite-specific antigens would increase 
the confidence in selecting truly naïve experimental animals and reduce the risk of 
enrolling persistently infected cattle which may test seronegative with current 
tachyzoite antigens-based tests. Previous exposure to the parasite would impact 
negatively vaccination experiments in which the evaluation of the immune responses 
in naïve cattle following a primary challenge is required. 
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In Chapter 3, one commercial and five experimental antibody ELISAs based on stage-
specific antigens (Aguado-Martinez et al., 2008, Risco-Castillo et al., 2007, Risco-
Castillo et al., 2011) were evaluated. All of the ELISA tests were adapted and 
reassessed to measure seroprevalence to N. caninum in a sample of British dairy cattle. 
The fitness for purpose should be the guiding principle for the application of a 
serological test to a specific situation (Dubey et al., 2017). The assessment and 
comparison of the diagnostic performances was limited by the absence of a true gold 
standard technique and a well-characterised panel of reference plasma samples as the 
N. caninum antibodies were measured in plasma instead of serum. These limitations 
were overcome by using a non-gold standard approach for the selection of the optimal 
cut-off to determine seropositive and seronegative animals. 
Assays using whole native and recombinant tachyzoite antigens showed better 
performances compared to tests based on recombinant bradyzoite-specific antigens. 
Apart from suggesting the need for further optimisation of the tests based on 
bradyzoite-specific antigens, this may reflect the variability in the intensity of the 
antibody responses against the antigens expressed by the bradyzoite stage which may 
be due to the variable level of exposure of these antigens to the host immune system. 
As previously discussed, this aspect of the host-parasite relationship of N. caninum is 
not well understood and supplementary studies investigating the antibody responses 
to bradyzoite-specific antigens are required. For example, the longitudinal serological 
assessment of persistently infected animals using assays based on several recombinant 
bradyzoite-specific antigens may help to clarify the frequency and intensity of the 
development of antibody responses to these antigens. The recombinant antigens 
tNcSRS12A-B and tNcSRS44-A described in this thesis may be included in the 
longitudinal serological analyses to complement the information obtained with other 
assays using bradyzoite-specific antigens of N. caninum which have been previously 
reported in literature. 
ELISAs using antigens expressed by different lifecycle stages of N. caninum showed 
only slight agreement. At the same time, moderate agreement was observed amongst 
assays based on tachyzoite immunodominant antigens, either native or recombinant, 
and amongst bradyzoite-specific antigen-based tests. This suggested that the two types 
of antigenic preparation are recognised by different antibody responses against N. 
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caninum. These two aspects do not necessarily overlap supporting the hypothesis that 
tests based exclusively on tachyzoite antigens may result in the misclassification of a 
proportion of infected animals as uninfected. The estimation of this proportion strictly 
depends on the test or combination of tests used. 
A single commercial test based on N. caninum whole tachyzoite extract misclassified 
as seronegative 46.8% (95%CI: 39.5-54.2) of the samples considered positive based 
on the outcome of all six ELISAs assessed. Similar proportions were obtained 
considering the outcome of individual ELISAs based on recombinant tachyzoite 
antigens (rNcSRS2 and rNcGRA7). When the results of all assays based on tachyzoite 
antigens were considered collectively, the proportion dropped to 18.5% (13.4-24.9). 
This figure may be considered a preliminary estimated of the proportion of cattle that 
despite being infected with N. caninum and showing detectable antibody responses to 
bradyzoite-specific antigens would test seronegative with tachyzoite antigens-based 
assays. 
However, careful interpretation is required since tests based on tachyzoite antigens, 
either native or recombinant, evaluated individually, also produced numerous false 
negative results. This was likely due to the moderate agreement observed between tests 
based on antigens expressed by the same stage of N. caninum which reflected the 
different antigenic preparations and technical characteristics of each ELISA. 
Consequently, the frequency and hence the epidemiological significance of 
persistently infected animals which would not be currently identified using assays 
based only on tachyzoite antigens is difficult to assess. 
When followed by the appropriate management of seropositive animals, the 
serodiagnosis using current commercial or in-house ELISAs, mostly based on native 
N. caninum tachyzoite antigens, can significantly reduce the impact of bovine 
neosporosis in those herds in which effective biosecurity and hygienic measures are 
implemented (McAllister 2016). However, the data produced in this thesis confirmed 
the concerns about the shortcomings of currently available serological diagnostic 
tools. The occurrence of false negative results should be considered when screening 
cattle for N. caninum antibodies and, where possible, a combination of tests executed 
in parallel or a single serological assay combining antigens expressed by different 
lifecycle stages of N. caninum should be advised. 
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The combination of 4 tests (3 tachyzoite antigen-based and 1 bradyzoite antigen-based 
ELISAs) provided satisfactory levels of sensitivity and specificity (>90%). In the 
absence of assays characterised by improved performances, the application of these 
tests in parallel should be considered as an effective strategy to increase the diagnostic 
sensitivity of the serological diagnosis of N. caninum in cattle. 
On-farm control programmes for bovine neosporosis would greatly benefit from the 
increased diagnostic sensitivity. Animals which may not test seropositive with current 
tachyzoite antigen-based assays, but are infected, may be identified and appropriately 
managed (i.e. culling or selective breeding) to reduce the prevalence of the disease at 
the herd level. 
 
Epidemiological information with practical implications 
Due to the different performances and characteristics of the tests and combination of 
tests evaluated, the seroprevalence of N. caninum in British dairy cattle varied 
considerably depending on the serological tool considered. The between-herd 
seroprevalence observed was high (>65%), when assessed using a single commercial 
test, or very high (>90%) considering the outcome of different combinations of tests, 
confirming that N. caninum is widespread in British dairy herds. 
Interestingly, the cross-sectional seroprevalence study enabled the evaluation of 
serologically testing cattle for N. caninum in different productive/reproductive stages. 
No statistically significant differences between the seroprevalence observed in animals 
during the dry period (i.e. during late pregnancy) and cows in mid- and early lactation 
were observed suggesting the lack of evidence for restricting testing during late 
pregnancy. 
In the UK, current health schemes recommend carrying out serological screening for 
N. caninum in cows between 12 and 4 weeks pre-calving (CHeCS 2016). This 
sampling window would be justified by the rise of N. caninum-specific antibody titres 
after the fifth month of gestation (Andrianarivo et al., 2005, Cardoso et al., 2009, 
Dannatt 1997, Guy et al., 2001) which would increase the probability of detecting 
infected animals. Based on this assumption a significantly higher seroprevalence in 
dry cows (late gestation) compared to cows in early lactation (non-pregnant) or mid-
gestation (early pregnancy) was hypothesised. However, this was not observed 
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irrespective of the single test or combination of tests used for estimating the 
seroprevalence. Since most of the dry cows tested were sampled during the last two 
weeks prior to the expected calving date, the physiological drop in the concentration 
of the total IgGs in peripheral blood observed in bovines close to calving (Detilleux et 
al., 1995, Franklin et al., 2005) may have resulted in a lower seroprevalence observed 
in this group. 
In summary, the validity of restricting the serological testing of cows during late 
pregnancy was not confirmed suggesting that different sampling regimes, which 
include non-pregnant cows or animals in early gestation, may not affect the reliability 
in identifying infected animals when serological screening campaigns are carried out 
within control programmes. However, further cross-sectional studies including a 
larger number of cows sampled at earlier stages in the dry period (i.e. during late 
pregnancy but not close to parturition) may be useful to confirm this finding. 
Supplementary longitudinal studies to assess whether cows in late pregnancy have a 
significantly higher probability of testing seropositive compared to cows at different 
reproductive stages would also be useful. 
 
Application of a MLFT tool for understanding the epidemiology of 
neosporosis 
In Chapter 4, a MLFT tool was optimised and successfully applied to the study of the 
genetic diversity of N. caninum. In general, the 12 microsatellite markers proposed 
were species-specific and showed good discriminatory power and typeability. The 
microsatellite markers proposed may contribute to the creation of an internationally 
recognised MLFT tool which would capitalise on the different panels of micro- and 
minisatellite loci previously described in literature (Al-Qassab et al., 2010a, Regidor-
Cerrillo et al., 2006); this may require an international workshop to select and define 
optimal markers. 
In the research field, the possible applications of this tool encompass studies of the 
population genetics of N. caninum and the discrimination of vaccine and challenge 
isolates within the development of live vaccines (Basso et al., 2010, Goodswen et al., 
2013, Regidor-Cerrillo et al., 2013). 
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In clinical practice, the MLFT can be used for the discrimination of different isolates 
involved in abortion outbreaks. In this context, the study of the genetic diversity can 
be very useful for providing additional information on the source of infection and the 
predominant route of transmission at the herd level (Basso et al., 2010). Additionally, 
the detection of identical N. caninum genotypes in cattle and wildlife living in the same 
environment, in which definitive canine hosts are present, may enable the 
identification of potential reservoirs of the parasite. 
 
Support for veterinarians in the interpretation of serological diagnostics 
Finally, the questionnaire-based survey for large animal veterinarians described in 
Chapter 5 provided an interesting insight into current veterinary practice related to the 
diagnosis and management of bovine neosporosis in the United Kingdom. 
Concerns about the difficult interpretation of the results obtained with currently 
available serological tests and the occurrence of false negative results appeared from 
the survey. Besides highlighting the need for improved diagnostics, these findings 
supported the demand for continuing professional training opportunities for both 
veterinarians, regarding the interpretation of test results and evidence-based measures 
for managing N. caninum infections effectively, and farmers, in order to clarify the 
infection mechanisms and transmission routes of the parasite. 
An effective vaccine was indicated as the control tool which would have the highest 
beneficial impact on the management of bovine neosporosis in future. Besides 
indicating the existence of a potential wide market for a commercial product, the 
consensus on the requirement for a prophylactic option strongly supported the view 
that vaccine development should be a primary focus in N. caninum research (Marugan-
Hernandez 2017, Nishikawa 2017). New avenues for the identification of potential 
vaccine candidates, including in silico methods which capitalise on the great wealth of 
genomic, transcriptomic and proteomic information available, should therefore be 





6.1 Concluding remarks 
 
Management-based control programmes are currently the only option to reduce the 
impact of N. caninum in cattle herds worldwide (Reichel et al., 2014). While there is 
consensus that vaccination would enable the effective and economically sustainable 
control of bovine neosporosis, an effective vaccine may not be available for several 
years to come (Reichel et al., 2013). 
The optimisation and refinement of current control programmes would have an 
immediate positive impact on the control of the disease at the herd, regional and 
national levels. 
Integrated high health schemes are the way forward to control bovine neosporosis. 
These should combine recommendations on evidence-based biosecurity and hygienic 
measures to prevent the introduction and transmission of N. caninum as well as 
guidance on the characteristics of the diagnostic tests to be used and their application 
in different situations (i.e. confirmation of neosporosis in aborting dams, diagnosis of 
the disease in non-aborting animals and assessment of the within-herd prevalence). 
Serology-based diagnostics play a key role in informing on the infection status of 
individual animals. The data presented in this thesis highlighted the shortcomings of 
current tests based on tachyzoite antigens, the need for the development of improved 
serological tests and suggested that using a wider range of N. caninum antigens, 
expressed by different lifecycle stage of the parasite, may be a valid strategy to 
increase diagnostic sensitivity. 
In the absence of a single serological method able to detect also those animals which 
would not be currently identified with assays based on tachyzoite antigens, the 
combination of multiple tests based on antigens expressed by both the tachyzoite and 
bradyzoite stages of N. caninum can be used to increase the sensitivity. Serological 
tools combining three ELISAs based on tachyzoite antigens and one assay based on a 
recombinant bradyzoite-specific antigen showed good sensitivity and specificity 
suggesting that a combination of tests, carried out in parallel, should be considered to 
improve the serological diagnosis of bovine neosporosis. 
In uninfected herds, serological tests characterised by high diagnostic sensitivity are 
essential for testing prospective purchased breeding cattle to prevent the introduction 
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of N. caninum. Likewise, in N. caninum problem herds, the management of 
neosporosis would benefit enormously from improved diagnostics as these will not 
only enable the reliable identification of infected animals but also allow the accurate 
estimation of the within-herd seroprevalence. Indeed, knowing the seroprevalence of 
N. caninum in a herd is fundamental to carry out the cost-benefit analysis which is a 
prerequisite for preferring a specific control option rather than a different one (e.g. 
culling instead of selective breeding in herds with low prevalence). 
Furthermore, the investigation of N. caninum abortion outbreaks using molecular 
typing tools to study the genetic diversity of the parasite may help in shaping effective 
control strategies by providing useful epidemiological information related to the 
source of infection and the predominant transmission route. 
Collectively, the reliable identification of N. caninum-infected cattle and the 
availability of supplementary in-depth epidemiological information would enable 
large animal veterinarians to provide farmers with the optimal advice on the best 
course of action to tackle neosporosis. 
Effective management of the disease obtained using improved diagnostics will be of 
great benefit to the cattle sector as it will result in enhanced livestock health and 
welfare and increased productive efficiency in both dairy and beef farms worldwide. 
Alongside vaccine research, which should be a priority, the development of innovative 
diagnostics characterised by high accuracy, reduced cost and short execution time 
should be supported (Ghalmi et al., 2014). For example, rapid pen-side 
immunochromatographic tests, employing N. caninum stage-specific antigens, may be 
investigated as an option to reduce execution times and costs of the serological 
diagnosis. 
In future, in silico tools currently applied to the selection of suitable vaccine candidates 
may be employed for the identification of target proteins and peptides that may be used 
for designing novel epitope-based serological diagnostics (Bui et al., 2007, Goodswen 
et al., 2014a, Goodswen et al., 2014b). 
Finally, the questionnaire-based survey highlighted that specialist cattle veterinary 
practitioners and farmers would benefit from knowledge exchange opportunities to 
discuss the most up to date information available on the diagnosis and control of 
bovine neosporosis.  
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General laboratory practice and solutions 
 
PCR and cloning reagents 
Tris-acetate-EDTA (TAE) buffer 
The following reagents were combined to prepare a concentrated 50  TAE solution: 
242 g Tris base 
57.1 ml glacial acetic acid 
100 ml 0.5 M EDTA (pH 8.0) 
dH2O to 1 litre. 
DNA loading buffer 
A 6  concentrated gel loading buffer was made by combining the following: 
15 % v/v Fycoll® (type 400) in dH2O 
0.25 % bromophenol blue 
0.25 % xylene cyanol FF 
The loading buffer was stored at 4°C. 
1.8% agarose gel 
3.6 g agarose were combined with 1  TAE buffer to a final volume of 200 ml and 
heated on full power in a microwave until complete dissolution of the agarose. The 
mix was cooled to approximately 45°C before adding 12 l 10,000  Gel Red™ 
(Biotum, Hayward, CA, USA). The gel was then poured into an electrophoresis tank 
with pre-positioned combs to give the number and size of wells required. After 
solidification, the combs were removed and the gel was submerged with 1  TAE. 
DNA samples combined with DNA loading buffer and a 1 kb DNA ladder (Promega, 
Madison, WI, USA) were then loaded into the relevant wells. The tank was attached 
to a power supply. 100 V were applied for approximately 45 mins and the gel 
visualised using UV. 
LB-Broth (Luria-Bertani Medium) 
10 g Bacto®-tryptone 
5 g Bacto®-yeast extract 
10 g NaCl 
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The volume was made up to 1 litre with distilled water and the pH adjusted to 7.5 with 
NaOH. This was then autoclaved to sterilise. 
For LB agar plates, 15 g agarose were added prior to autoclaving. 
Solutions for recombinant protein purification 
Phosphate-buffered saline (PBS) 
0.8 g NaCl 
0.2 g KCl (potassium chloride) 
1.8 g Na2HPO42H2O (sodium phosphate dibasic dihydrate) 
0.3 g KH2PO4 (monopotassium phosphate) 
sterile dH2O to 1 litre. 
Autoclave at 121°C for 15 min. 
200 mM sodium phosphate buffer monobasic (NaH2PO4) 
4.8 g NaH2PO4 
sterile dH2O to 200 ml. 
200 mM sodium phosphate buffer dibasic (Na2HPO4) 
14.25 g Na2HPO4 
sterile dH2O to 100 ml. 
2 M imidazole 
13.62 g imidazole 
sterile dH2O to 500 ml. 
Binding buffer 1 
5.7 g 200mM NaH2PO4 
24.3 g 200mM Na2HPO4 
8.7 g NaCl 
sterile dH2O to 300 ml. 
Binding buffer 2 (8M urea) 
5.7 g 200mM NaH2PO4 
24.3 g 200mM Na2HPO4 
8.7 g NaCl 
144.14 g urea 
sterile dH2O to 300 ml 
Sterile dH2O was warmed up to ease urea dissolution. 
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Denaturing equilibration buffer 
50 ml 10  PBS 
2.5. ml 2M imidazole 
242.5 g urea 
sterile dH2O to 500 ml. 
Denaturing wash buffer 
50 ml 10  PBS 
6.25 ml 2M imidazole 
242.5 g urea 
sterile dH2O to 500 ml. 
Denaturing elution buffer 
50 ml 10  PBS 
62.5 ml 2M imidazole 
242.5 g urea 
sterile dH2O to 500 ml. 
Dialysis buffer 1 (1M urea) 
60.06 g urea 
1  PBS to 1 litre. 
Dialysis buffer 2 (2M urea) 
120.12 g urea 
1  PBS to 1 litre. 
Dialysis buffer 3 (4M urea) 
240.24 g urea 
1  PBS to 1 litre. 
Solutions for Western Blot 
Transfer buffer 
50 ml NuPAGE® transfer buffer 20  
1 ml NuPAGE® antioxidant 
200 ml methanol 
dH2O to 1 litre. 
Blocking buffer (4% dried skimmed milk) 
58.44 g NaCl 
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10 ml Tween® 80 
20 g dried skimmed milk (Marvel) 
1  PBS to 500 ml 
Filter, aliquot in 15 ml aliquots and store at -20°C. 
Wash buffer 
58.44 g NaCl 
10 ml Tween® 80 






































Questionnaire for cattle veterinary practitioners 
(final version) 
 
Diagnosis and control of Neospora caninum infection in cattle: a questionnaire 
for cattle veterinary practitioners 
Approaching the diagnosis of bovine neosporosis and deciding the best course of action to 
control the disease and prevent future infections can be problematic sometimes. The present 
survey will take approximately 20 minutes to complete and will allow us to analyse how 
veterinary practitioners perceive bovine neosporosis and what are their attitudes towards the 
diagnosis and control of the disease. 
 
Section 1 – General assessment and perceptions 
 
1) Which infectious causes of bovine abortion are the most frequently diagnosed in your 
area? (please, rank in descending order of frequency the top 3 (from 1 = 1st most frequently 




Which one would you rate as the most challenging in terms of diagnosis? 
…………………. 
Which one would you rate as the most challenging in terms of control? 
…………………. 
2) According to your personal experience, how would you rate the economic impact of 
bovine neosporosis in cattle herds? 
Very low  
Low               
    High   
    Very high  
3) The following statements will cover your perceptions of N. caninum and bovine 
neosporosis. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
I feel confident about my understanding of bovine neosporosis 
and N. caninum life cycle 
     
N. caninum infection in cattle can be very difficult to control      
Control of bovine neosporosis is important for the profitability 
of dairy farms 
     
Control of bovine neosporosis is important for the profitability 
of beef suckler herds 
     
Farmers perceive N. caninum as a major threat to their farming 
businesses 
     
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Farmers understand N. caninum life cycle      
Control of N. caninum is important to the cattle farming 
industry as a whole 
     
Sometimes I have doubts about how to interpret N. caninum 
diagnostic tests 
     
Positive results produced with current diagnostics are 
trustworthy  
     
Negative results produced with current diagnostics are 
trustworthy 
     
 
Section 2 – Diagnosis of bovine neosporosis 
 
4) When do you start to be concerned about N. caninum in a herd (i.e. consider doing 
further testing specific for the parasite)? (select all that apply) 
Abortion storm on farm       
Abortion storms in neighbouring farms     
One or more confirmed N. caninum abortion case/s   
Ongoing endemic N. caninum abortions     
Other, please specify    …………………. 
 
5) a. How do you deal with N. caninum abortion suspects? 
………………….………………….………………….………………….…………… 
b. What test options give you most confidence to make a diagnosis of neosporosis? 
………………….………………….………………….………………….…………… 
 
6) a. How do you assess the N. caninum infection status (present of absent) in live 
animals in a herd? 
………………….………………….………………….………………….…………… 
b. Which animals do you sample and what samples do you collect? 
………………….………………….………………….………………….…………… 
c. What diagnostic tests do you use? 
………………….………………….………………….………………….…………… 
 
7) The following statements will cover the assessment of N. caninum infection at the herd 
level (present or absent). 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
Antibody ELISA on bulk milk is the most cost-effective way 
to assess whether a herd is infected or not 
     
Negative bulk milk testing results mean that the herd is N. 
caninum free 
     
In some cases, dams that aborted test seronegative despite N. 
caninum evidence being found in aborted foetuses 
     
ELISA testing sera from animals in the sampling window (12 
to 4 weeks pre-calving) is preferable to bulk milk testing 
     
In some cases, dams that aborted test seronegative despite N. 
caninum evidence being found in aborted foetuses 
     
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None of the available diagnostic tests can be considered as a 
gold standard for bovine neosporosis 
     
 
8) The following statements cover the assessment of N. caninum infection at the herd level 
(present or absent). 
Please, state how frequently you undertake the following procedures. 
Always (A), Frequently (F), Rarely (R), Never (N) 
 
 A F R N 
I bleed animals within the sampling window (12 to 4 weeks pre-
calving) to test for specific N. caninum antibodies 
    
In herds with N. caninum problems, I recommend carrying out serum 
antibody ELISA test on all dry cows 
    
I consider cows to be Neospora negative if they test negative twice 
for N. caninum antibodies, when tested in the sampling window over 
two pregnancies 
    
I recommend submission of aborted foetuses and placentas to a 
veterinary laboratory for foetal serology and histopathological 
examinations 
    
I recommend serology testing for N. caninum in aborting dams     
When a N. caninum abortion is confirmed, I sample all the animals in 
the same cohort as the dam that aborted 
    
 
9) The next statements will cover the diagnosis of N. caninum abortion cases. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
PCR positive results require foetal and/or dam serology to 
confirm N. caninum as the cause of the abortion 
     
Blood testing dams that have recently aborted with serum 
antibody ELISA is essential to confirm N. caninum as the 
cause of abortion when evidence is found in aborted foetuses 
     
In some cases, dams that aborted test seronegative despite N. 
caninum evidence being found in aborted foetuses 
     
 
10) Do current Neospora serology based diagnostics (ELISAs) give reliable information? 
  Yes   
  No   
Unsure   
a. Why or why not? 
………………….………………….………………….………………….…………… 









Section 3 – Control strategies 
 
11) Has your practice got a common/agreed protocol for the diagnosis and advices on the 
control of bovine neosporosis? 
 Yes   
 No    
12)  If yes, is it based on what is indicated by a herd health scheme provider? 
 Yes   
 No    
If yes, which is the herd health scheme provider?  ………………… 
13) Do you consider testing farm dogs prior starting control programmes for bovine 
neosporosis? 
 Yes   
 No    
If yes, would you: 
 Do serology for N. caninum specific antibody titres  
 Test faeces for N. caninum oocysts     
 
14) The following statements will examine biosecurity measures for bovine neosporosis. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
Good biosecurity practice is essential for the control of 
bovine neosporosis 
     
Biosecurity measures should be aimed at minimizing 
horizontal transmission (ingestion of N. caninum oocysts 
shed by dogs) 
     
The prompt removal and proper disposal of afterbirths is seen 
as a priority in most dairy herds during calving 
     
The prompt removal and proper disposal of afterbirths is seen 
as a priority in most beef sucklers herds during calving 
     
Vermin control still represents an issue in most farms      
Despite a good biosecurity plan, N. caninum can be easily 
introduced in uninfected herds 
     
Herd biosecurity plans should include measures that are 
specific for the control of bovine neosporosis 
     
Regardless of their serological status, dogs should be kept out 
of calving areas, feed facilities and pastures 
     
Increased public engagement is needed in order to make dog 
owners aware of the potential risk their dogs could represent 
to cattle  
     
Buying in replacement animals is one of the most likely ways 
to introduce N. caninum to an uninfected herd  
     
 
15) Do you recommend testing prospective purchased heifers and cows for N. caninum 
prior introducing them into the herd? 
Always   
 Frequently   
 Rarely   
Never   
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16) The following statements will cover control strategies for bovine neosporosis. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
Bovine neosporosis should be included in herd health 
schemes 
     
As for other infection diseases, farmers perceive 
accreditation for N. caninum as an added value to their 
businesses 
     
17) The following statements will cover control strategies for bovine neosporosis. 
Please, state how frequently you undertake the following procedures. 
Always (A), Frequently (F), Rarely (R), Never (N) 
 
 A F R N 
In farms with seroprevalence >10%, I recommend selective breeding 
of heifers from dams that test N. caninum antibody negative 
    
In farms with seroprevalence <5%, I recommend culling of 
seropositive animals 
    
I would advise the use of Embryo Transfer to seronegative recipients 
from high genetic merit cow donors because they are N. caninum 
seropositive 
    
I consider the "Live with the disease - Do nothing" option as a 
possible approach in those herds in which the impact (abortion 
cases) is low 
    
If available, I would recommend a vaccine to prevent N. caninum 
infections and/or abortions 
    
If licensed, I would recommend antimicrobials to prevent N. 
caninum abortions in problem herds 
    
 
18) Which are the key points you emphasize when informing and advising farmers about the 
control of bovine neosporosis? 
………………….………………….………………….………………….…………… 





20) What is your primary activity? 
Veterinary surgeon in private practice        
Veterinary investigation officer/consultant (e.g. employee of APHA, SRUC/SAC)  
Diagnostics/Research          
 
21) How old are you? 
24-35    
36-50    
51-65    




22) How many years have you been working as a farm animal veterinary practitioner? 
5 years or less                    
5-10                                    
10-20                     
20- 30             
40 or more             
 
23) Please, state your field of activity within the cattle sector 
Dairy     
Beef   
Mixed   
Mixed mainly dairy     
Mixed mainly beef  
 




























Questionnaire for cattle veterinary practitioners 
(trial version) 
Questions removed or reworded are marked in red. 
 
Diagnosis and control of Neospora caninum infection in cattle: a questionnaire 
for cattle veterinary practitioners  
 
Section 1 – General assessment and perceptions 
 
1) Which infectious causes of bovine abortion are the most frequently diagnosed in your 
area? (please, rank in descending order of frequency the top 3 (from 1 = 1st most frequently 




Which one would you rate as the most challenging in terms of diagnosis? 
…………………. 
Which one would you rate as the most challenging in terms of control? 
…………………. 
2) According to your personal experience, how would you rate the economic impact of 
bovine neosporosis in cattle herds? 
Very low  
Low               
    High   
    Very high  
3) The following statements will cover your perceptions of N. caninum and bovine 
neosporosis. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
I feel confident about my understanding of bovine neosporosis 
and N. caninum life cycle 
     
N. caninum infection in cattle can be very difficult to control      
Control of bovine neosporosis is important for the profitability 
of dairy farms 
     
Control of bovine neosporosis is important for the profitability 
of beef sucklers herds 
     
Farmers perceive N. caninum as a major threat to their farming 
businesses 
     
Farmers understand N. caninum life cycle      
Control of N. caninum is important to the cattle farming 
industry as a whole 
     
Sometimes I have doubts about how to interpret N. caninum 
diagnostic tests 
     
Positive results produced with current diagnostics are 
trustworthy  
     
Negative results produced with current diagnostics are 
trustworthy 
     
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Section 2 – Diagnosis of bovine neosporosis 
 
4) When do you start to be concerned about N. caninum in a herd (i.e. consider doing 
further testing specific for the parasite)? (select all that apply) 
Abortion storm on farm       
Abortion storms in neighbouring farms     
Ongoing endemic N. caninum abortions     
Other, please specify    …………………. 
* question altered in the final version 
 
5) a. How do you deal with N. caninum abortion suspects? 
………………….………………….………………….………………….…………… 
b. What test options give you most confidence to make a diagnosis of neosporosis? 
………………….………………….………………….………………….…………… 
 
6) a. How do you assess the N. caninum infection status in live animals in a herd? 
* question altered in the final version 
………………….………………….………………….………………….…………… 
b. Which animals do you sample and what samples do you collect? 
………………….………………….………………….………………….…………… 
c. What diagnostic tests do you use? 
………………….………………….………………….………………….…………… 
 
7) [Question removed] 
a. How do you assess the prevalence in infected herds? 
………………….………………….………………….………………….…………… 
b. Which animals do you sample and what samples do you collect? 
………………….………………….………………….………………….…………… 
c. What diagnostic tests do you use? 
………………….………………….………………….………………….…………… 
 
8) The following statements will cover the assessment of N. caninum infection at the herd 
level (present or absent). 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
Antibody ELISA on bulk milk is the most cost-effective way 
to assess whether a herd is infected or not 
     
Negative bulk milk testing results mean that the herd is N. 
caninum free 
     
In some cases, dams that aborted test seronegative despite N. 
caninum evidence being found in aborted foetuses 
     
ELISA testing sera from animals in the sampling window (12 
to 4 weeks pre-calving) is preferable to bulk milk testing 
     
In some cases, dams that aborted test seronegative despite N. 
caninum evidence being found in aborted foetuses 
     
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None of the available diagnostic tests can be considered as a 
gold standard for bovine neosporosis 
     
 
9) The following statements cover the assessment of N. caninum infection at the herd level 
(present or absent). 
Please, state how frequently you undertake the following procedures. 
Always (A), Frequently (F), Rarely (R), Never (N) 
 
 A F R N 
I bleed animals within the sampling window (12 to 4 weeks pre-
calving) to test for specific N. caninum antibodies 
    
In herds with N. caninum problems, I recommend carrying out serum 
antibody ELISA test on all dry cows 
    
I consider cows to be Neospora negative if they test negative twice 
for N. caninum antibodies, when tested in the sampling window over 
two pregnancies 
    
I recommend submission of aborted foetuses and placentas to a 
veterinary laboratory for foetal serology and histopathological 
examinations 
    
I recommend serology testing for N. caninum in aborting dams     
When a N. caninum abortion is confirmed, I sample all the animals in 
the same cohort as the dam that aborted 
    
 
10) The next statements will cover the diagnosis of N. caninum abortion cases. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
PCR positive results require foetal and/or dam serology to 
confirm N. caninum as the cause of the abortion 
     
Blood testing dams that have recently aborted with serum 
antibody ELISA is essential to confirm N. caninum as the 
cause of abortion when evidence is found in aborted foetuses 
     
In some cases, dams that aborted test seronegative despite N. 
caninum evidence being found in aborted foetuses 
     
 
11) Do current Neospora serology based diagnostics (ELISAs) give reliable information? 
  Yes   
  No   
Unsure   
c. Why or why not? 
………………….………………….………………….………………….…………… 




Section 3 – Control strategies 
 
12) Has your practice got a common/agreed protocol for the diagnosis and advices on the 
control of bovine neosporosis? 
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 Yes   
 No    
13)  If yes, is it based on what is indicated by a herd health scheme provider? 
 Yes   
 No    
If yes, which is the herd health scheme provider?  ………………… 
14) Do you consider testing farm dogs prior starting control programmes for bovine 
neosporosis? 
 Yes   
 No    
If yes, would you: 
 Do serology for N. caninum specific antibody titres  
 Test faeces for N. caninum oocysts     
 
15) The following statements will examine biosecurity measures for bovine neosporosis. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
 
 SA A U D SD 
Good biosecurity practice is essential for the control of 
bovine neosporosis 
     
Biosecurity measures should be aimed at minimizing 
horizontal transmission (ingestion of N. caninum oocysts 
shed by dogs) 
     
The prompt removal and proper disposal of afterbirths is seen 
as a priority in most dairy herds during calving 
     
The prompt removal and proper disposal of afterbirths is seen 
as a priority in most beef sucklers herds during calving 
     
Vermin control still represents an issue in most farms      
Despite a good biosecurity plan, N. caninum can be easily 
introduced in uninfected herds 
     
Herd biosecurity plans should include measures that are 
specific for the control of bovine neosporosis 
     
Regardless of their serological status, dogs should be kept out 
of calving areas, feed facilities and pastures 
     
Increased public engagement is needed in order to make dog 
owners aware of the potential risk their dogs could represent 
to cattle  
     
Buying in replacement animals is one of the most likely ways 
to introduce N. caninum to an uninfected herd  
     
 
16) Do you recommend testing prospective purchased heifers and cows for N. caninum 
prior introducing them into the herd? 
Always   
 Frequently   
 Rarely   
Never   
17) The following statements will cover control strategies for bovine neosporosis. 
Please, state if you strongly agree (SA), agree (A), are unsure (U), disagree (D) or 
strongly disagree (SD) with the following statements. 
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 SA A U D SD 
Bovine neosporosis should be included in herd health 
schemes 
     
As for other infection diseases, farmers perceive 
accreditation for N. caninum as an added value to their 
businesses 
     
18) The following statements will cover control strategies for bovine neosporosis. 
Please, state how frequently you undertake the following procedures. 
Always (A), Frequently (F), Rarely (R), Never (N) 
 
 A F R N 
In farms with HIGH seroprevalence, I recommend selective 
breeding of heifers from dams that test N. caninum antibody 
negative *reworded in the final version 
    
In farms with LOW seroprevalence, I recommend culling of 
seropositive animals *reworded the in final version 
    
I would advise the use of Embryo Transfer to seronegative recipients 
from high genetic merit cow donors because they are N. caninum 
seropositive 
    
I consider the "Live with the disease - Do nothing" option as a 
possible approach in those herds in which the impact (abortion 
cases) is low 
    
If available, I would recommend a vaccine to prevent N. caninum 
infections and/or abortions 
    
If licensed, I would recommend antimicrobials to prevent N. 
caninum abortions in problem herds 
    
 
19) Which are the key points you emphasize when informing and advising farmers about the 
control of bovine neosporosis? 
………………….………………….………………….………………….…………… 
20) When do you advise selective breeding instead of culling? [Question removed] 
………………….………………….………………….………………….…………… 





22) What is your primary activity? 
Veterinary surgeon in private practice        
Veterinary investigation officer/consultant (e.g. employee of APHA, SRUC/SAC)  
Diagnostics/Research          
 
23) How old are you? 
24-35    
36-50    
51-65    
Over 65    
 
 
24) How many years have you been working as a farm animal veterinary practitioner? 
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5 years or less                    
5-10                                    
10-20                     
20- 30             
40 or more             
 
25) Please, state your field of activity within the cattle sector 
Dairy     
Beef   
Mixed   
Mixed mainly dairy     
Mixed mainly beef  
 
26)  Where is your practice located?  Postcode: …………………. 
 
